<SEC-DOCUMENT>0001493152-25-014244.txt : 20250919
<SEC-HEADER>0001493152-25-014244.hdr.sgml : 20250919
<ACCEPTANCE-DATETIME>20250919160536
ACCESSION NUMBER:		0001493152-25-014244
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		24
CONFORMED PERIOD OF REPORT:	20250919
FILED AS OF DATE:		20250919
DATE AS OF CHANGE:		20250919

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			SONIM TECHNOLOGIES INC
		CENTRAL INDEX KEY:			0001178697
		STANDARD INDUSTRIAL CLASSIFICATION:	TELEPHONE & TELEGRAPH APPARATUS [3661]
		ORGANIZATION NAME:           	04 Manufacturing
		EIN:				943336783
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38907
		FILM NUMBER:		251326855

	BUSINESS ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		650-378-8100

	MAIL ADDRESS:	
		STREET 1:		4445 EASTGATE MALL
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>formdef14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:SONM="http://sonimtech.com/20241231">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02C_ECD%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_034_SONM_sonimtech.com_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20240101_20241231 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_057_edei%2D%2DEntityCentralIndexKey_0001178697 -->
<!-- Field: Set; Name: xdx; ID: xdx_077_XDX_Z%2D%2D\2025 OPERATIONS\EDGAR\09 SEPTEMBER\SONIM TECHNOLOGIES INC__DELEGATED\09%2D18%2D2025\Form DEF 14A\Draft\Production\formpre14a.xdx -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_065_Ratio_4_xbrli%2D%2Dpure -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000004" name="dei:EntityCentralIndexKey">0001178697</ix:nonNumeric>
  <ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011" name="dei:DocumentType">DEF 14A</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="sonm-20241231.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="From2024-01-01to2024-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2022-01-01</xbrli:startDate>
        <xbrli:endDate>2022-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2023-01-01</xbrli:startDate>
        <xbrli:endDate>2023-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001178697</xbrli:identifier>
        <xbrli:segment>
          <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
          <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
        </xbrli:segment>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2024-01-01</xbrli:startDate>
        <xbrli:endDate>2024-12-31</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
    <xbrli:unit id="Ratio">
      <xbrli:measure>xbrli:pure</xbrli:measure>
    </xbrli:unit>
  <ix:relationship fromRefs="Fact000015" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000016" toRefs="Footnote000033 Footnote000034 Footnote000035"/>
  <ix:relationship fromRefs="Fact000017" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000018" toRefs="Footnote000033 Footnote000034 Footnote000035"/>
  <ix:relationship fromRefs="Fact000019" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000020" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000021" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000022" toRefs="Footnote000033 Footnote000034 Footnote000035"/>
  <ix:relationship fromRefs="Fact000023" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000024" toRefs="Footnote000033 Footnote000034 Footnote000035"/>
  <ix:relationship fromRefs="Fact000025" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000026" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000027" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000028" toRefs="Footnote000033 Footnote000034 Footnote000035"/>
  <ix:relationship fromRefs="Fact000029" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000030" toRefs="Footnote000033 Footnote000034 Footnote000035"/>
  <ix:relationship fromRefs="Fact000031" toRefs="Footnote000033"/>
  <ix:relationship fromRefs="Fact000032" toRefs="Footnote000033"/>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90B_edei--DocumentType_dxL_c20240101__20241231_zAvLQz6G8QFl" title="::XDX::DEF%2014A"><span style="-sec-ix-hidden: xdx2ixbrl0011">SCHEDULE
14A</span></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Proxy
Statement Pursuant to Section 14(a) of the</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
Exchange Act of 1934</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by the Registrant &#9746;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
by a party other than the Registrant &#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
the appropriate box:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &#167;240.14a-12</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt"><b><span id="xdx_90B_edei--EntityRegistrantName_c20240101__20241231_zcwo5BQe0N4"><ix:nonNumeric contextRef="From2024-01-01to2024-12-31" id="Fact000012" name="dei:EntityRegistrantName">Sonim
Technologies, Inc.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
of Registrant as Specified In Its Charter)</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
of Filing Fee (Check all boxes that apply):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9746;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9744;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"></p>

<!-- Field: Rule-Page --><div style="margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font-size: 1pt">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 50%"><img src="formdef14a_001.jpg" alt=""/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&#160;</p>
                                                                                             <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">&#160;</p>
                                                                                             <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right">Sonim
                                            Technologies, Inc.</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
    Eastgate Mall, Suite 200</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
    Diego, CA 92121</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Notice
of 2025 Special Meeting</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>and
Proxy Statement</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date
    and Time:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Thursday,
    October 16,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> 2025<br/>
    9:00 a.m., Pacific Time</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Location:</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Participate
    virtually at www.proxydocs.com/SONM</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 50%"><img src="formdef14a_001.jpg" alt=""/></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
    Technologies, Inc.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
    Eastgate Mall, Suite 200</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
    Diego, CA 92121</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><b>NOTICE OF 2025
SPECIAL MEETING OF STOCKHOLDERS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<table cellspacing="0" cellpadding="0" style="margin-left: auto; width: 3in; border-collapse: collapse; margin-right: auto">
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date and Time:</b></span></td>
    <td style="width: 60%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Thursday, October 16, 2025</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">9:00 a.m., Pacific Time</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Virtual Meeting:</b></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Participate online at</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">www.proxydocs.com/SONM</p></td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td>
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td style="font: 11pt Calibri, Helvetica, Sans-Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Record Date:</b></span></td>
    <td>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">Close of business on</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">September 15, 2025</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
our Stockholders:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc. (&#8220;Sonim,&#8221; the &#8220;Company,&#8221; or &#8220;we&#8221;) will hold its 2025 Special Meeting of Stockholders
(the &#8220;Special Meeting&#8221;) on Thursday, October 16, 2025, at 9:00 a.m., Pacific Time. To provide the opportunity for
participation by a broader group of stockholders and provide a consistent and convenient experience to all stockholders regardless of
location, the Special Meeting will be held in a virtual-only meeting format. Stockholders will not be able to physically attend the Special
Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a registered stockholder or beneficial owner of our common stock at the close of business on September 15, 2025, the record
date of our Special Meeting, you may attend the virtual meeting, submit questions and vote your shares electronically during the meeting
via live audio webcast by visiting www.proxydocs.com/SONM and using the 12-digit control number included on your proxy card or the instructions
that accompanied your proxy materials.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At
the Special Meeting, holders of our outstanding shares of common stock will be asked to consider and vote upon the following proposals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to our certificate of incorporation to effect a reverse split stock of our outstanding common stock at a ratio
    of not less than 1-for-2 and not greater than 1-for-30, with the exact ratio to be set within that range at the discretion of our
    board of directors and with such action to be effected at such time and date, if at all, as determined by the board of directors
    prior to the one-year anniversary of the date on which the reverse stock split is approved by our stockholders at the Special Meeting
    without further approval or authorization of our stockholders (the &#8220;Reverse Stock Split Proposal&#8221;);</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to our certificate of incorporation to increase the number of authorized shares of our common stock from 100,000,000
    shares to 1,000,000,000 shares (the &#8220;Authorized Shares Proposal&#8221;); </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
    approve an amendment to the Sonim Technologies, Inc. 2019 Equity Incentive Plan, as amended, to increase the aggregate number of
    shares of common stock authorized for issuance by 1,000,000 shares (the &#8220;Equity Incentive Plan Increase Proposal&#8221;); and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">4.</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0">To
                                            approve one or more adjournments of the Special Meeting, if necessary or appropriate, from
                                            time to time, to a later date or dates, even if a quorum is present, to solicit additional
                                            proxies if there are not sufficient votes at the time of the Special Meeting to approve the
                                            Reverse Stock Split Proposal, the Authorized Shares Proposal, or the Equity Incentive Plan
                                            Increase Proposal (the &#8220;Adjournment Proposal&#8221;).</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">You
may vote on these matters virtually or by proxy. Each outstanding share of our common stock is entitled to one vote. Whether or not you
plan to virtually attend the Special Meeting, we ask that you vote by one of the following methods to ensure that your shares
will be represented at the meeting in accordance with your wishes (see &#8220;<i><a href="#SL_010">How do I vote?</a></i>&#8221; on page
<a href="#SL_010">3</a> in the accompanying proxy statement):</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    online or by telephone, by following the instructions included with the proxy card; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Vote
    by mail, by completing and returning the enclosed proxy card in the enclosed addressed stamped envelope.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement and the form of proxy were first sent or given to stockholders on or about September 19, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">If you have any questions or require any assistance
with voting your shares, please contact Sodali &amp; Co, our proxy solicitor assisting us in connection with the Special Meeting:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 24pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 24pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="logo_01.jpg" alt=""/></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">430 Park Avenue, 14th Floor</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">New York, New York 10022</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Stockholders Call Toll-Free in North America: (800)
662-5200</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">Outside of North America Call Collect: (203) 658-94000</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0">E-mail: <span style="text-decoration: underline">SONM@investor.sodali.com</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    Order of the Board of Directors,</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"/></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><img src="formdef14a_002.jpg" alt=""/></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Secretary</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -1pt; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt -1pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, California</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">September <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">19,</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TABLE
OF CONTENTS</b>&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"/>
    <td style="border-bottom: Black 1pt solid; font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Page</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: normal 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: normal 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_001">Proxy
    Statement</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="#vv_003">Important Information Regarding Delivery of Proxy Materials</a></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_002">Cautionary
    Note Regarding Forward-Looking Statements</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_003">Website
    Information</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_004">General
    Information about 2025 Special Meeting</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_005"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When are this proxy statement and the accompanying materials scheduled to be sent to stockholders?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_006"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Why
    did I receive these proxy materials?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_007"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Who is soliciting my vote?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_008"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When
    is the record date for the Special Meeting?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_009"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How many votes do I have?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How do I vote?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How does the Board recommend that I vote on the proposals?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_012"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Are
    there any matters to be voted on at the Special Meeting that are not included in this proxy statement?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_013"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">May I change or revoke my proxy?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_014">What
    does it mean if I receive more than one set of materials?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_015"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How is a quorum reached?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_016"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">What is the effect if I fail to give voting instructions to my broker, bank, or other nominee?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_017">What are my voting options with respect to each proposal and how many votes are required to approve each proposal?</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_018"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">What are the costs of soliciting these proxies?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_019"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How are votes counted?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_020"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How
    do I attend the Special Meeting?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_021"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Will there be a question and answer session?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_022"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">What if I need technical assistance?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#SL_023"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">How can I know the voting results?</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify">

    <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    <a href="#vv_004">Proposal 1 &#8212; Reverse Stock Split</a>
    </span>
    </td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_046">Proposal
    2 &#8212; Increase of Authorized Shares of Common Stock</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">16</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#SL_048">Proposal 3 &#8212; Increase of the Shares Available under the Sonim Technologies, Inc. 2019 Equity Incentive Plan</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">19</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><a href="#vv_005">Proposal 4 &#8212; Adjournment Proposal</a></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center">29</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#mj_002">Executive and Director Compensation</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#aab_007">Security
    Ownership of Certain Beneficial Owners and Management</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">38</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#aab_009">Other
    Matters</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#aab_010"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Householding of proxy materials</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><a href="#aab_011"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
    proposals for the 2026 annual meeting of stockholders</span></a></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#aab_013">Annex A &#8212; Certificate of Amendment to Certificate of Incorporation: Reverse Stock Split</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A-1</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: rgb(204,238,255)">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#aab_014">Annex B &#8212; Certificate of Amendment to Certificate of Incorporation: Authorized Share Increase</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>B-1</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; background-color: White">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><a href="#aab_015">Annex C &#8212; Amended Sonim Technologies, Inc. 2019 Equity Incentive Plan</a></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>C-1</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 4 -->
    <div style="border-bottom: Black 1pt solid; margin-top: 0pt; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: justify"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: bottom; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="formdef14a_001.jpg" alt="" style="height: 66px; width: 195px"/></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
    Technologies, Inc.</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
Eastgate Mall, Suite 200</span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, California 92121</span></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_001"></span>PROXY
STATEMENT<br/>
FOR THE 2025 SPECIAL MEETING OF STOCKHOLDERS<br/>
To be held on Thursday, October 16, 2025</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">This proxy statement contains
information about the 2025 Special Meeting of Stockholders (the &#8220;Special Meeting&#8221;) of Sonim Technologies, Inc. (&#8220;Sonim,&#8221;
the &#8220;Company,&#8221; or &#8220;we&#8221;), which will be held on Thursday, October 16, 2025, at 9:00 a.m., Pacific Time.
The Special Meeting will be held virtually via live audio webcast. You will be able to virtually attend the Special Meeting as well as
vote and submit your questions during the live audio webcast of the meeting by visiting www.proxydocs.com/SONM and entering the control
number included on your proxy card or in the instructions that accompanied your proxy materials.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
properly submitted proxies will be voted in accordance with the instructions contained in those proxies. If no instructions are specified,
the proxies will be voted in accordance with the recommendation of our board of directors ( the &#8220;board&#8221; or &#8220;our
board,&#8221; whether capitalized or not) with respect to each of the matters set forth in the accompanying
notice of meeting. You may revoke your proxy at any time before it is exercised at the meeting by one of the methods described under
the title &#8220;<i><a href="#SL_013">May I change or revoke my proxy?</a></i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">This proxy statement and the form
of proxy were first sent or given to stockholders on or about September 19, 2025.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
mailing address of our principal executive offices is Sonim Technologies, Inc., 4445 Eastgate Mall, Suite 200, San Diego, California
92121.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span id="vv_003"></span><b>IMPORTANT INFORMATION REGARDING DELIVERY OF
PROXY MATERIALS</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Under the Securities and Exchange Commission (the &#8220;SEC&#8221;) rules, a company
may select either of the following options for making proxy materials available to its stockholders:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">the full set delivery option; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">the option often referred to as the &#8220;notice and access&#8221;
    option or the &#8220;notice-only&#8221; option. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">A company may use a single
method for all of its stockholders or use full set delivery for some while adopting the notice-only option for others.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Full set delivery option</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Under the full set delivery
option, a company delivers all proxy materials to its stockholders by mail. In addition to delivery of proxy materials to stockholders,
a company must post all proxy materials on a publicly accessible website and provide information to stockholders about how to access
the website. <b>In connection with the Special Meeting, we have elected to use the full set delivery option.</b> Accordingly, you will
receive all proxy materials by mail.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Notice-only option</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Under the notice-only option,
which we have elected <b>NOT</b> to use for the Special Meeting, a company must post all proxy materials on a publicly-accessible website.
Instead of delivering proxy materials to its stockholders, a company may deliver a notice of Internet availability of proxy materials,
which includes, among other things:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: left"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">information regarding the date and time of the meeting of stockholders, as well as the items to be considered at the meeting;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">information regarding the website where the proxy materials are
    posted; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-size: 10pt">various means by which a stockholder can request paper or e-mail
    copies of the proxy materials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">If a stockholder requests
paper copies of the proxy materials, these materials must be sent to the stockholder within three business days and by first class mail.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Use the notice and access option in the future</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Although we have elected to use
the full set delivery option in connection with the Special Meeting, we may choose to use the notice-only option in the future. By reducing
the amount of materials that a company needs to print and mail, the notice and access option provides an opportunity for cost savings
as well as conservation of paper products. We will evaluate the future possible cost savings as well as the possible impact on stockholder
participation as we consider future use of the notice-only option.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;<b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 5; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_002"></span>CAUTIONARY
NOTE REGARDING FORWARD-LOOKING STATEMENTS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
proxy statement includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such
forward-looking statements involve known and unknown risks, uncertainties, and other important factors that may cause the actual results,
performance, or achievements of the Company and its subsidiaries to be materially different from any future results, performance, or
achievements expressed or implied by such forward-looking statements. The words or phrases &#8220;anticipate,&#8221; &#8220;believe,&#8221;
&#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;plan,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221;
&#8220;will,&#8221; &#8220;would,&#8221; &#8220;could,&#8221; &#8220;should,&#8221; &#8220;potential,&#8221; &#8220;seek,&#8221; &#8220;evaluate,&#8221;
&#8220;pursue,&#8221; &#8220;continue,&#8221; &#8220;design,&#8221; &#8220;impact,&#8221; &#8220;affect,&#8221; &#8220;forecast,&#8221;
&#8220;target,&#8221; &#8220;outlook,&#8221; &#8220;initiative,&#8221; &#8220;objective,&#8221; &#8220;priorities,&#8221; &#8220;goal,&#8221;
or the negative of such terms and similar expressions are intended to identify forward-looking statements, although not all forward-looking
statements contain these identifying words. These forward-looking statements include, but are not limited to statements concerning our
goals, commitments, strategies and mission, our plans and expectations regarding:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: top">
    <td style="width: 0.5in">&#160;</td>
    <td style="width: 0.5in"><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">potential benefits and risks of the reverse stock split and its effect on our common
    stock;</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">potential effects of the increase of authorized shares of common stock; </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">the impact of the increase in the shares authorized for issuance under our equity incentive
    plan on our ability to retain qualified employees; and </span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td><span style="font-size: 10pt">&#9679;</span></td>
    <td><span style="font-size: 10pt">our ability to regain compliance with the Nasdaq Listing Rules.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements, and you should not
place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions,
and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties
that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation,
risks related to the reverse stock split discussed in the section of this proxy statement titled &#8220;<i><a href="#vv_002">Certain risks associated with the Reverse Stock Split</a></i>&#8221; and other risks and uncertainties described in the section titled &#8220;Risk
Factors&#8221; in our most recent Annual Report on Form 10-K, Quarterly Report on Form 10-Q, and other documents we have
filed with the SEC thereafter. Other unknown or unpredictable factors also could have material adverse effects on our future results,
performance, or achievements. In light of these risks, uncertainties, assumptions, and factors, the forward-looking events discussed
herein may not occur. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date
stated, or if no date is stated, as of the date hereof. Except as required by applicable law, the Company does not undertake any obligation
to publicly update or revise any forward-looking statements because of new information, future events, or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_003"></span>WEBSITE
INFORMATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
<b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Websites
throughout this proxy statement are provided for reference only. Websites referred to herein are not incorporated by reference into this
proxy statement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 6; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_004"></span>GENERAL
INFORMATION ABOUT 2025 SPECIAL MEETING</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
<b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_005"></span>When
are this proxy statement and the accompanying materials scheduled to be sent to stockholders?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">On or about September 19, 2025, we will begin
mailing our proxy materials, including the Notice of the 2025 Special Meeting of Stockholders, this proxy statement, and the accompanying
proxy card or, for shares held in street name (<i>i.e.</i>, held for your account by a broker, bank, or other nominee), a voting instruction
form. Additionally, our proxy materials will be made available to our stockholders on the Internet at https://ir.sonimtech.com/ on or
about the same date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&#160;<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_006"></span>Why did I receive these proxy materials?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">We have delivered printed proxy materials to
you because our board is soliciting your proxy to vote at the Special Meeting, including any continuation, postponement, or adjournment.
You are invited to attend the Special Meeting online to vote on the proposals described in this proxy statement. However, you do not
need to attend the Special Meeting to vote your shares. Instead, you may simply complete, sign, and return the proxy card, or follow
the instructions below to submit your proxy over the telephone or via the Internet.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in">These proxy materials include a proxy card for
the Special Meeting. The proxy cards are being solicited on behalf of the board. The proxy materials include detailed information about
the matters that will be discussed and voted on at the Special Meeting and provide updated information about the Company that you should
consider in order to make an informed decision when voting your shares.</p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_007"></span>Who
is soliciting my vote?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
board is soliciting your vote for the Special Meeting.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_008"></span>When
is the record date for the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
record date for the determination of stockholders entitled to receive notice of and to vote at the Special Meeting has been set as the
close of business on September 15, 2025.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_009"></span>How
many votes do I have?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Each share of common stock outstanding
on the record date entitles the holder thereof to one vote, without cumulation, on each matter to be voted upon at the meeting. As of
the record date for the Special Meeting, there were 17,781,919 shares of common stock, issued, outstanding, and entitled
to vote.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_010"></span>How
do I vote?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you are a stockholder of record as of the record date, there are several ways for you to vote, or authorize a proxy to vote, your shares.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Whether or not you plan to attend
the Special Meeting, we urge you to vote by proxy. If you vote by proxy, the individuals named on the proxy card, or your &#8220;proxies,&#8221;
will vote in the manner you indicate. If you submit a proxy but do not indicate any voting instructions, your votes will be voted in
accordance with our board&#8217;s recommendations. Voting by proxy will not affect your right to attend the Special Meeting.
The procedures for voting depend on whether your shares are registered in your name or are held by a bank, broker, or other nominee who
is the recordholder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 7; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are registered directly in your name through our stock transfer agent, or if you have stock certificates registered in your
name, you may vote:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
    Internet or by telephone.</b> Follow the instructions included in the proxy card to vote by Internet or telephone. Telephone and
    Internet voting facilities for stockholders of record will be available 24 hours a day and will close at 08:59 p.m. Pacific
    Time on October 15, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
    mail.</b> As described in the notice of Internet availability, you may request printed proxy materials, in which case you may complete,
    sign, and return the proxy card in the postage pre-paid envelope accompanying the proxy materials so that it is received prior to
    the Special Meeting.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>At
    the meeting.</b> If you attend the Special Meeting, you can vote using the 12-digit control number in your notice of Internet
    availability of the proxy materials, on your proxy card or in the instructions that accompanied your proxy materials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in &#8220;street name&#8221; (meaning the shares are held in the name of a bank, broker, or other nominee who is
the record holder), you must provide the bank, broker, or other nominee with instructions on how to vote your shares and can do so as
follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9679;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
    Internet or by telephone.</b> Follow the instructions you receive from the bank, broker, or other nominee to vote by Internet or
    telephone.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9679;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>By
    mail.</b> You will receive instructions from the bank, broker, or other nominee explaining how to vote your shares.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9679;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>At
    the meeting.</b> If you attend the Special Meeting, you can vote using the 12-digit control number in your notice of Internet
    availability of the proxy materials, on your proxy card or in the instructions that accompanied your proxy materials.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">To
ensure that your vote is counted, please remember to submit your vote by the date and time indicated on your proxy card, voting instruction
form, or e-mail notification, as applicable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_011"></span>How
does the Board recommend that I vote on the proposals?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There
are four proposals scheduled for a vote:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 60%"><span style="font-size: 10pt"><b>Voting Matter</b></span></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Board Vote</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><b>Recommendation</b></p></td>
    <td style="padding-bottom: 1pt; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; width: 18%">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Page Reference</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>For More</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Information</b></p></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Proposal 1 &#8212; The Reverse Stock Split
    Proposal</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">FOR</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><a href="#vv_004">8</a></span></td></tr>
  <tr style="background-color: white">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Proposal 2 &#8212; The Authorized Shares Proposal</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">FOR</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><a href="#SL_046">16</a></td></tr>
  <tr style="background-color: #CCEEFF">
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Proposal 3 &#8212; The Equity Incentive Plan
    Increase Proposal</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt">FOR</span></td>
    <td style="vertical-align: top">&#160;</td>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><a href="#SL_048">19</a></span></td></tr>
  <tr>
    <td style="vertical-align: top; text-align: justify"><span style="font-size: 10pt">Proposal 4 &#8212; The Adjournment Proposal</span></td>
    <td style="vertical-align: top; text-align: justify">&#160;</td>
    <td style="text-align: center; vertical-align: top"><span style="font-size: 10pt">FOR</span></td>
    <td style="vertical-align: bottom; text-align: center"/>
    <td style="vertical-align: bottom; text-align: center"><span style="font-size: 10pt"><a href="#vv_005">29</a></span><span style="font-size: 8pt">&#160;</span></td></tr>
  </table>


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 8; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_012"></span>Are
there any matters to be voted on at the Special Meeting that are not included in this proxy statement?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">No. Pursuant to our amended
and restated bylaws, any business transacted at any Special Meeting of stockholders is limited to the matters stated in the notice of
the meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_013"></span>May
I change or revoke my proxy?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Yes. You may change or revoke
your previously submitted proxy at any time before the Special Meeting or, if you attend the Special Meeting virtually, at the Special
Meeting before the polls close.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you hold your shares as a record holder, you may change or revoke your proxy in any one of the following ways:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    re-voting at a subsequent time by Internet or by telephone as instructed above;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    signing a new proxy card with a date later than your previously delivered proxy and submitting it as instructed above;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    delivering a signed revocation letter to the following address: P.O. BOX 8016, Cary, NC 27512-9903 c/o Mediant Communications; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By
    attending the Special Meeting and voting virtually. Attending the Special Meeting virtually will not in and of itself revoke a previously
    submitted proxy. You must specifically request at the Special Meeting that it be revoked by voting at the Special Meeting.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Your
latest-dated proxy card, Internet, or telephone vote is the one that is counted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in the name of a bank, broker, or other nominee, you may change your voting instructions by following the instructions
of your bank, broker, or other nominee.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_014"></span>What
does it mean if I receive more than one set of materials?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
you receive more than one set of materials, it means you hold your shares in more than one name or account. In order to vote all of your
shares, you should sign and return all of the proxy cards you receive or follow the instructions for any alternative voting procedures
on the proxy cards or notices you receive.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Please
vote in the manner described under &#8220;<i><a href="#SL_010">How do I vote?</a></i>&#8221; for each account to ensure that all of your
shares are voted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_015"></span>How
is a quorum reached?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Our amended and restated bylaws
provide that the presence, in person, by remote communication, or by proxy of the holders of one-third of the voting power of the outstanding
shares of our common stock entitled to vote will constitute a quorum for the transaction of business at the Special Meeting. Thus,
votes of stockholders of record who are present at the Special Meeting virtually or by proxy, broker non-votes, and abstentions
will be counted for purposes of determining whether a quorum exists.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">As noted above, as of the record
date for the Special Meeting, there were 17,781,919 shares of common stock, issued, outstanding, and entitled to vote,
which means that 5,927,307 shares of common stock must be present in person or represented by proxy at the Special Meeting
to establish a quorum.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Under the General Corporation
Law of the State of Delaware, shares that are voted &#8220;abstain&#8221; or &#8220;withheld&#8221; and &#8220;broker non-votes&#8221;
are counted as present for purposes of determining whether a quorum is present at the Special Meeting. If a quorum is not present,
the meeting may be adjourned until a quorum is obtained.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 9; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_016"></span>What
is the effect if I fail to give voting instructions to my broker, bank, or other nominee?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
your shares are held in &#8220;street name&#8221; by a broker, bank, or other nominee, your broker, bank, or other nominee is required
to vote your shares according to your instructions.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A
&#8220;broker non-vote&#8221; occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because
the nominee does not have discretionary voting power with respect to that item, and has not received instructions from the beneficial
owner.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a proposal is routine and, therefore, a discretionary item, your broker, bank, or other nominee will be able to vote on such proposal
even if it does not receive instructions from you. If a proposal is a non-routine proposal and, therefore, a &#8220;non-discretionary&#8221;
item, in the event you do not instruct your broker how to vote with respect to such proposal, your broker, bank, or other nominee may
not vote for this proposal, and those votes will be counted as &#8220;broker non-votes.&#8221; If you do not give instructions to your
broker, bank, or other nominee, the broker, bank, or other nominee will still be able to vote your shares with respect to certain &#8220;discretionary&#8221;
items on &#8220;routine&#8221; proposals, but will not be allowed to vote your shares with respect to &#8220;non-discretionary&#8221;
items.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table set forth below illustrates whether each proposal is routine or non-routine.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center; width: 64%"><span style="font-size: 10pt"><b>Voting Matter</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center; width: 2%">&#160;</td>
    <td style="border-bottom: black 1pt solid; padding-left: 0pt; text-align: center; width: 34%"><span style="font-size: 10pt"><b>Routine
    or non-Routine </b></span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Proposal 1 &#8212; The Reverse Stock Split Proposal</span></td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 0pt"><span style="font-size: 10pt">Routine</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Proposal 2 &#8212; The Authorized Shares Proposal</span></td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 0pt"><span style="font-size: 10pt">Routine</span></td></tr>
  <tr style="vertical-align: top; background-color: rgb(204,238,255)">
    <td><span style="font-size: 10pt">Proposal 3 &#8212; The Equity Incentive Plan Increase Proposal</span></td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 0pt"><span style="font-size: 10pt">Non-routine</span></td></tr>
  <tr style="vertical-align: top; background-color: White">
    <td><span style="font-size: 10pt">Proposal 4 &#8212; The Adjournment Proposal</span></td>
    <td>&#160;</td>
    <td style="text-align: center; padding-left: 0pt"><span style="font-size: 10pt">Routine</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_017"></span>What
are my voting options with respect to each proposal and how many votes are required to approve each proposal?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
table set forth below illustrates the voting options, vote required, and effect of abstentions and broker non-votes for each proposal,
assuming a quorum is present at the Special Meeting:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Voting Matter</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Voting Options</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Vote Required</b></span></td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Broker Discretionary Voting Allowed</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Effect of Broker<br/>
    Non-Votes</b></span></td>
    <td>&#160;</td>
    <td style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Effect of Abstentions</b></span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Proposal 1 &#8212; The Reverse Stock Split Proposal</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">For, against, or abstain</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Affirmative vote of the holders of a majority of the votes cast affirmatively or negatively
    (votes cast FOR the proposal must exceed votes cast AGAINST the proposal to approve it)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Yes</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">N/A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td></tr>
  <tr style="vertical-align: top; background-color: white">
    <td><span style="font-size: 10pt">Proposal 2 &#8212; The Authorized Shares Proposal</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">For, against, or abstain</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Affirmative vote of the holders of a majority of the votes cast affirmatively or negatively
    (votes cast FOR the proposal must exceed votes cast AGAINST the proposal)</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Yes</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">N/A</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td></tr>
  <tr style="vertical-align: top; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Proposal 3 &#8212; The Equity Incentive Plan Increase Proposal</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">For, against, or abstain</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">Affirmative vote of the holders of a majority of the voting power of the shares present in person
    or by proxy at the Special Meeting and entitled to vote on the matter</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">No effect</span></td>
    <td>&#160;</td>
    <td style="text-align: center"><span style="font-size: 10pt">Against</span></td></tr>
  <tr style="vertical-align: top">
    <td style="width: 14%"><span style="font-size: 10pt">Proposal 4 &#8212; The Adjournment Proposal</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 14%"><span style="font-size: 10pt">For, against, or abstain</span></td>
    <td style="width: 2%"/>
    <td style="width: 35%"><span style="font-size: 10pt">Affirmative vote of the holders of a majority of the voting power of the
    shares present in person or by proxy at the Special Meeting and entitled to vote on the matter</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 9%"><span style="font-size: 10pt">Yes</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 9%"><span style="font-size: 10pt">N/A</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="text-align: center; width: 9%"><span style="font-size: 10pt">Against</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 10; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_018"></span>What
are the costs of soliciting these proxies?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
will pay all of the costs of soliciting these proxies. Our directors, officers, and employees may solicit proxies in person or by e-mail
or other electronic means, or by telephone. We will pay these directors, officers, and employees no additional compensation for these
services. We will ask banks, brokers, and other nominees to forward these proxy materials to their principals and to obtain authority
to execute proxies. We will then reimburse them for their reasonable, out-of-pocket expenses. The expense associated with the solicitation
of proxies will include reimbursement for postage and clerical expenses to brokerage houses and other custodians, nominees, or fiduciaries
for forwarding proxy materials and other documents to beneficial owners of stock held in their names. We have engaged the services
of Sodali &amp; Co&#160;with respect to proxy soliciting matters at an
expected cost of approximately $20,000, not including incidental expenses.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_019"></span>How
are votes counted?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Votes
will be counted by the inspector of election appointed for the Special Meeting by the board. We expect that</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
votes will be counted by our Secretary, as the inspector of election appointed for the Special Meeting, who will separately
tabulate the votes with respect to all proposals.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_020"></span>How
do I attend the Special Meeting?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">We will host the Special Meeting
live online via audio webcast. Any stockholder as of the record date will be able to attend and participate in the Special Meeting
online by accessing www.proxydocs.com/SONM. To join the Special Meeting, you will need to enter your 12-digit control number included
on your proxy card or in the instructions that accompanied your proxy materials. Beneficial owners who do not have a control number may
gain access to the meeting by logging into their broker, brokerage firm, bank, or other nominee&#8217;s website and selecting the shareholder
communications mailbox to link through to the meeting. Instructions should also be provided on the voting instruction card provided by
your broker, bank, or other nominee. Even if you plan to attend the Special Meeting online, we recommend that you also vote by
proxy as described herein so that your vote will be counted if you decide not to attend the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">The live audio webcast of the
Special Meeting will begin promptly at 9:00 a.m., Pacific Time. Online access to the audio webcast will open approximately 15
minutes prior to the start of the Special Meeting to allow time for you to log in and test the computer audio system. We encourage
our stockholders to access the meeting prior to the start time.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_021"></span>Will
there be a question-and-answer session?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
<b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">As part of the Special Meeting,
we will hold a live question and answer session, during which we intend to answer pertinent questions submitted prior to and during the
meeting via the Q&amp;A, as time permits and based on the nature of the questions. Questions and answers may be grouped by topic, and
substantially similar questions may be grouped and answered once. We may also elect to address all the questions following the Special
Meeting in order to provide more detailed and accurate information to our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_022"></span>What
if I need technical assistance?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Beginning 15 minutes prior to
the start of and during the Special Meeting, we will have a support team ready to assist stockholders with any technical difficulties
they may have accessing or hearing the virtual meeting. If you encounter any difficulties accessing the virtual meeting during the check-in
or meeting time, you should call the support team listed on the virtual meeting website at www.proxydocs.com/SONM.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_023"></span>How
can I know the voting results?</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">We plan to announce preliminary
voting results at the Special Meeting and will publish final results in a Current Report on Form 8-K to be filed with the SEC
within four business days following the Special Meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 11; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span id="vv_004"></span><b>PROPOSAL 1 &#8212; REVERSE STOCK
SPLIT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>General</b></p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 10pt">Our
board approved and declared advisable, subject to stockholder approval, a certificate of amendment to our amended and restated certificate
of incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;), which would effect a reverse stock split of our outstanding
common stock by combining outstanding shares of common stock into a lesser number of outstanding shares of common stock at a ratio of
not less than 1-for-2 and not more than 1-for-30 (the &#8220;Reverse Stock Split&#8221;) at any time prior to the one-year anniversary
of the date on which the Reverse Stock Split is approved by our stockholders at the Special Meeting, with the exact ratio to be set within
this range by our board at its sole discretion. The form of the proposed certificate of amendment to our Certificate of Incorporation
to effect the Reverse Stock Split is attached as <span style="color: blue"><a href="#aab_013"><b>Annex A</b></a></span> to this Proxy
Statement (the &#8220;Reverse Split Amendment&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Upon the effectiveness of the Reverse
Split Amendment, the outstanding shares of our common stock will be reclassified and combined into a lesser number of shares such that
one share of our common stock will be issued for a specified number of shares in accordance with the ratio for the Reverse Stock Split
selected by our board. The number of shares of common stock underlying outstanding equity awards and available for future awards under
our equity incentive plans, as well as the number of shares issuable upon exercise of outstanding warrants, would also be proportionately
reduced in the same manner as a result of the Reverse Stock Split. The Reverse Split Amendment that will be filed to effect the Reverse
Stock Split will include the Reverse Stock Split ratio fixed by our board, within the range approved by our stockholders.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 10pt">If the
Reverse Stock Split Proposal is approved by our stockholders, our board would have the sole discretion to effect the amendment and the
Reverse Stock Split at any time prior to the one-year anniversary of the date on which the Reverse Stock Split is approved by our stockholders
at the Special Meeting, and to fix the specific ratio for the Reverse Stock Split, provided that the ratio would be not less than 1-for-2
and not more than 1-for-30. We believe that enabling our board to fix the specific ratio of the Reverse Stock Split within the stated
range will provide us with the flexibility to implement the split in a manner designed to maximize the anticipated benefits to us and
our stockholders, as described below. The determination of the ratio of the Reverse Stock Split will be based on a number of factors,
described further below under the heading &#8220;<span style="color: blue"><i><a href="#vv_001">Determination of the Reverse Stock Split ratio</a></i></span></span><span style="font-size: 8pt">.</span><span style="font-size: 10pt; color: blue"></span><span style="font-size: 10pt">&#8221;
</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">If the Reverse Stock Split Proposal
is approved by our stockholders and our board determines to effect the Reverse Stock Split, the Reverse Stock Split will become effective
upon the time specified in the Reverse Split Amendment, as filed with the Secretary of State of the State of Delaware. The exact timing
of the filing of the Reverse Split Amendment and the Reverse Stock Split will be determined by our board based on its evaluation as to
when such action will be the most advantageous to us and our stockholders. Our board reserves the right, notwithstanding stockholder
approval and without further action by our stockholders, to abandon the Reverse Split Amendment and the Reverse Stock Split if, at any
time prior to the effectiveness of the filing of the Reverse Split Amendment with the Secretary of State of the State of Delaware, our
board, in its sole discretion, determines that it is no longer in our best interest and the best interests of our stockholders to proceed.
If our board does not effect any Reverse Stock Split on or prior to the one-year anniversary of the Special Meeting, stockholder approval
would again be required prior to implementing any reverse stock split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Reasons for the Reverse Stock Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><i>Regaining Compliance with the Minimum Bid Price Rule</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Our primary objective in asking for
the authority to effect the Reverse Stock Split is to raise the per share trading price of our common stock. Our common stock is publicly
traded and listed on Nasdaq Capital Market under the symbol &#8220;SONM.&#8221; To maintain listing, Nasdaq requires, among other things,
that our common stock maintain a minimum closing bid price of $1.00 per share (the &#8220;Minimum Bid Price Rule&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">On August 13, 2025, we received a letter
from Nasdaq notifying us that, because the bid price for our common stock has fallen below $1.00 per share for 30 consecutive business
days, we no longer comply with the Minimum Bid Price Rule for continued listing. In accordance with Nasdaq Listing Rule 5810(c)(3)(A),
we were provided a period of 180 calendar days, or through February 9, 2026, to regain compliance with the Minimum Bid Price Rule. To
regain compliance, the closing bid price of our common stock must be at least $1.00 per share for a minimum of ten (10) consecutive business
days as required under Nasdaq Listing Rule 5810(c)(3)(A) (unless the Nasdaq staff exercises its discretion to extend this 10-day period
pursuant to Nasdaq Listing Rule 5810(c)(3)(H)). We have not regained compliance with the Minimum Bid Price Rule as of the date of this
proxy statement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">While we intend to monitor the closing
price of our common stock and consider available options depending on the trading price of our common stock, no assurance can be made
that we will in fact be able to comply with the Minimum Bid Price Rule. Reducing the number of outstanding shares of our common stock
should, absent other factors, result in an increase in the per share market price of our common stock, although we cannot provide any
assurance that our minimum bid price would, following the Reverse Stock Split, remain over any applicable minimum bid price requirements.
Accordingly, our board believes that it is in the best interest of the Company and its stockholders that the board has the ability to
effect, in its discretion, the Reverse Stock Split to improve the price level of our common stock so that we are able to maintain continued
compliance with the Minimum Bid Price Rule and minimize the risk of future delisting from Nasdaq.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><i>Additional Reasons to Effect the Reverse Stock Split</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">In addition to the primary purpose
for effecting the Reverse Stock Split, an increase in the per-share trading price of our common stock is expected to:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">increase
                                            the acceptability of our common stock to long-term investors who may not find our shares
                                            attractive at their current prices due to the trading volatility often associated with stocks
                                            below certain prices;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                            our common stock eligible for investment by brokerage houses and institutional investors
                                            that have internal policies and practices that either prohibit them from investing in low-priced
                                            stocks or tend to discourage individual brokers from recommending low-priced stocks to their
                                            customers or by restricting or limiting the ability to purchase such stocks on margin; </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
                                            our common stock more attractive for investors who may be dissuaded from purchasing stocks
                                            below certain prices because the brokerage commissions, as a percentage of the total transaction
                                            value, tend to be higher for such low-priced stocks; and </span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">expand
                                            our options in connection with the strategic alternatives process and continuation of our
                                            business following the disposition of our legacy business pursuant to an asset purchase agreement
                                            entered into on July 17, 2025.</span></td></tr></table>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 10pt">In evaluating
whether to effect the Reverse Stock Split, our board has taken, and will take, into consideration negative factors associated with reverse
stock splits. These factors are delineated under the heading &#8220;<span style="color: blue"><i><a href="#vv_002">Certain risks associated with the Reverse Stock Split</a></i></span></span><span style="font-size: 8pt">&#160;</span><span style="font-size: 10pt">.&#8221; In approving and recommending
the Reverse Stock Split Proposal, our board determined that these potentially negative factors were significantly outweighed by the potential
benefits.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Although we expect that the Reverse
Stock Split will increase the market price of our common stock as a result of having fewer outstanding shares, the Reverse Stock Split
may not result in a permanent increase in the market price of our common stock, which will continue to be dependent on many factors,
including general economic, market, and industry conditions and other factors detailed from time to time in the reports we file with
the SEC. In addition, there can be no assurance that our common stock will not be delisted due to a failure to meet other continued listing
requirements of Nasdaq even if the market price per post-split share of our common stock remains in excess of $1.00.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="vv_001"></span><b>Determination of the Reverse Stock Split ratio</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">If our stockholders approve the Reverse
Stock Split Proposal, our board will be authorized to proceed with the Reverse Stock Split. The exact ratio of the Reverse Stock Split,
within the 1-for-2 to 1-for-30 range, would be determined by our board in its sole and absolute discretion and publicly announced by
us prior to the effective time of the Reverse Stock Split. In determining whether to proceed with the Reverse Stock Split and setting
the appropriate ratio for the Reverse Stock Split, our board will consider, among other things, factors such as:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; width: 0.5in; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; width: 0.5in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            historical trading prices and trading volume of our common stock;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            number of shares of our common stock outstanding;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            then-prevailing and expected trading prices and trading volume of our common stock and the
                                            anticipated impact of the Reverse Stock Split on the trading market for our common stock;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">our
                                            ability to maintain our listing on the Nasdaq Capital Market;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
                                            anticipated impact of a particular ratio on our ability to reduce administrative and transactional
                                            costs;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">business
                                            developments affecting us; and</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">prevailing
                                            general market and economic conditions. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span id="vv_002"></span><b>Certain risks associated with the Reverse Stock Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Before voting on this proposal, you
should consider the following risks associated with the implementation of the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; width: 0.5in; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; width: 0.5in; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            we expect that the Reverse Stock Split will result in an increase in the market price of
                                            our common stock, we cannot assure you that the Reverse Stock Split, if implemented, will
                                            increase the market price of our common stock in proportion to the reduction in the number
                                            of shares of common stock outstanding or result in a permanent increase in the market price.
                                            The effect the Reverse Stock Split may have upon the market price of our common stock cannot
                                            be predicted with any certainty, and the history of similar reverse stock splits for companies
                                            in similar circumstances to ours is varied. The market price of our common stock is dependent
                                            on many factors, including our business and financial performance, general market conditions,
                                            prospects for future success, and other factors detailed from time to time in the reports
                                            we file with the SEC. Accordingly, the total market capitalization of our common stock after
                                            the proposed Reverse Stock Split may be lower than the total market capitalization before
                                            the proposed Reverse Stock Split and, in the future, the market price of our common stock
                                            following the Reverse Stock Split may not exceed or remain higher than the market price prior
                                            to the proposed Reverse Stock Split. </span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
                                            the Reverse Stock Split is consummated, but the trading price of our common stock declines,
                                            the percentage decline as an absolute number and as a percentage of our overall market capitalization
                                            may be greater than would occur in the absence of the Reverse Stock Split.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Although
                                            our board believes that the decrease in the number of shares of our common stock outstanding
                                            as a consequence of the Reverse Stock Split and the anticipated increase in the market price
                                            of our common stock could encourage interest in our common stock and possibly promote greater
                                            liquidity for our stockholders, such liquidity could also be adversely affected by the reduced
                                            number of shares outstanding after the Reverse Stock Split.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Furthermore,
                                            the implementation of the Reverse Stock Split would not change the total number of shares
                                            of our common stock authorized for issuance. As a result, the number of shares of our common
                                            stock available for issuance following the implementation of the Reverse Stock Split would
                                            increase to the extent the Reverse Stock Split reduces the number of outstanding shares of
                                            our common stock. Such available shares may be used for future corporate purposes, including
                                            future acquisitions, investment opportunities, the establishment of collaboration or other
                                            strategic agreements, capital raising transactions involving equity or convertible debt securities,
                                            future at-the-market offerings of common stock, or issuance under current or future employee
                                            equity plans, and the issuance of equity securities in connection with such transactions
                                            may result in potentially significant dilution of our current stockholders&#8217; ownership
                                            interests in the Company.</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            addition, although the purpose of the Reverse Stock Split is not to establish any barriers
                                            to a change of control or acquisition of the Company, investors might consider the increased
                                            proportion of unissued authorized shares to issued shares to have an anti-takeover effect
                                            under certain circumstances because the proportion allows for dilutive issuances. We are
                                            not aware of any attempt or plan to obtain control of us. </span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
                                            Reverse Stock Split may result in some stockholders owning &#8220;odd lots&#8221; of fewer
                                            than one hundred (100) shares of our common stock on a post-split basis. These odd lots may
                                            be more difficult to sell, or require greater transaction costs per share to sell, than shares
                                            in &#8220;round lots&#8221; of even multiples of one hundred (100) shares.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Principal Effects of the Reverse Stock Split</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Capital stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">After the effective date of the Reverse
Stock Split, each stockholder will own a reduced number of shares of our common stock. However, the Reverse Stock Split will affect all
of our stockholders uniformly and will not affect any stockholder&#8217;s percentage ownership interests in the Company, except to the
extent that the Reverse Stock Split results in any of our stockholders owning a fractional share (as described below). Voting rights
and other rights and preferences of the holders of our common stock will not be affected by a Reverse Stock Split (except for adjustments
that may result from the treatment of fractional shares). For example, a holder of 1% of the voting power of the outstanding shares of
our common stock immediately prior to a Reverse Stock Split would continue to hold 1% (assuming there is no impact as a result of the
adjustments that may result from the treatment of fractional shares) of the voting power of the outstanding shares of our common stock
immediately after such Reverse Stock Split. The number of stockholders of record will not be affected by a Reverse Stock Split. The Reverse
Stock Split would not change the terms of our common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">After the effective time of the Reverse
Stock Split, our common stock will have a new Committee on Uniform Securities Identification Procedures (&#8220;CUSIP&#8221;) number,
which is a number used to identify our equity securities, and stock certificates with the older CUSIP number (if any) will need to be
exchanged for stock certificates with the new CUSIP number.</p>

<p style="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 10pt">Unless
the Authorized Shares Proposal is approved by our stockholders and implemented by our board, as more particularly described in &#8220;<span style="color: blue"><i><a href="#SL_046">Proposal 2 &#8212; Increase of Authorized Shares of Common Stock</a></i></span>,&#8221; the number of authorized shares of our common stock will remain
at 100,000,000. </span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The number of authorized shares of
our preferred stock will remain at 5,000,000. The Reverse Stock Split also will not change the number of shares of Series A Junior Participating
Preferred Stock authorized and designated under our Certificate of Incorporation in connection with the adoption of the Company&#8217;s
poison pill in the form of a stockholder rights plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The Reverse Stock Split is not intended
as, and would not have the effect of, a &#8220;going private transaction&#8221; covered by Rule 13e-3 under the Exchange Act. Following
the Reverse Stock Split, we would continue to be subject to the periodic reporting requirements of the Exchange Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Outstanding warrants</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">If the Reverse Stock Split is approved
and effected, under the terms of the warrants, the exercise price per share of such warrants will be increased by multiplying the current
exercise price by a fraction of which the numerator shall be the number of shares of our common stock outstanding immediately before
the Reverse Stock Split and of which the denominator shall be the number of shares of our common stock outstanding immediately after
the Reverse Stock Split, and the number of shares issuable upon exercise of the warrants shall be proportionately adjusted such that
the aggregate exercise price of the warrants shall remain unchanged.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Plans and outstanding awards</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">We maintain our EIP and ESPP (together,
the &#8220;Plans&#8221;), which are designed primarily to provide stock-based incentives to our employees and other individual service
providers. Our board generally has the discretion to determine the appropriate adjustments to the Plans and outstanding awards and purchase
rights under the Plans in the event of a reverse stock split. Accordingly, if the Reverse Stock Split is implemented, the number of shares
of common stock subject to outstanding options, restricted stock unit awards, and other equity awards issued under the Plans, and the
number of shares reserved for future issuance and all other share limits under the Plans will be reduced by the same ratio as the reduction
in the outstanding shares, in each case rounded down to the nearest whole share. Furthermore, the exercise price of any outstanding options
would be proportionately increased based on the Reverse Stock Split ratio selected by our board, and any fractional cents that may result
therefrom shall be rounded up.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"></p>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Poison Pill</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">On April 21, 2025,
following the approval by our board, the Company entered a limited duration stockholder rights agreement, dated as of April 21, 2025
(the &#8220;Rights Agreement&#8221;), by and between the Company and Equiniti Trust Company, LLC (the &#8220;Rights Agent&#8221;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">In connection
with the Rights Agreement, the Company declared a dividend of one right (&#8220;Right&#8221;) to purchase one-thousandth of one share
of the Company&#8217;s newly designated Series A Junior Participating Preferred Stock, par value $0.001 per share (each, a &#8220;Preferred
Share&#8221; and collectively, the &#8220;Preferred Shares&#8221;), for each outstanding share of the Company&#8217;s common stock to
the stockholders of record as of the close of business on May 2, 2025. The Rights Agent currently serves as the Company&#8217;s transfer
agent with respect to its common stock and also has been appointed transfer agent with respect to the Preferred Shares, if any, that
may be issued pursuant to the exercise of rights under the Rights Agreement. The Rights will expire on April 21, 2026, unless the rights
are earlier redeemed or exchanged by the Company.&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">If the Reverse
Stock Split is implemented, then</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; width: 0.5in; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; width: 0.5in; padding-bottom: 0pt"><span style="font-size: 10pt">(i)</span></td><td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt"><span style="font-size: 10pt">the
                                            number of one one-thousandth of a Preferred Share purchasable after the Reverse Stock Split
                                            upon proper exercise of each Right shall be determined by multiplying the number of one one-thousandth
                                            of a Preferred Share so purchasable immediately prior to the Reverse Stock Split by a fraction,
                                            the numerator of which is the number of shares of our common stock outstanding immediately
                                            before the Reverse Stock Split and the denominator of which is the number of shares of our
                                            common stock outstanding immediately after the Reverse Stock Split; </span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt">&#160;</td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-size: 10pt">(ii)</span></td><td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt"><span style="font-size: 10pt">each
                                            share of our common stock outstanding immediately after the Reverse Stock Split shall have
                                            issued with respect to it that number of Rights that each share of common stock outstanding
                                            immediately prior to the Reverse Stock Split had issued with respect to it, and </span></td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt">&#160;</td><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt">&#160;</td><td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt">&#160;</td></tr>
<tr style="vertical-align: top">
<td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"/><td style="text-align: left; padding-top: 0pt; padding-bottom: 0pt"><span style="font-size: 10pt">(iii)</span></td><td style="padding-top: 0pt; text-align: left; padding-bottom: 0pt"><span style="font-size: 10pt">the
                                            purchase price (as determined in accordance with the Rights Agreement) (the &#8220;Purchase
                                            Price&#8221;) immediately prior to the effective date of the Reverse Stock Split shall be
                                            adjusted so that the Purchase Price after the Reverse Stock Split shall be determined by
                                            multiplying the Purchase Price in effect immediately prior to the Reverse Stock Split by
                                            a fraction, the numerator of which is the number of shares of our common stock outstanding
                                            immediately prior to the Reverse Stock Split and the denominator of which is the number of
                                            shares of our common stock outstanding immediately after the Reverse Stock Split. </span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><b><i>Illustration of the effect
of the Reverse Stock Split in a tabular form</i></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The following table
illustrates the effects of the Reverse Stock Split at various ratios, without giving effect to any adjustments for fractional shares
of common stock, on our outstanding shares of common stock as of September 15, 2025, the record date of the Special Meeting. We
have also demonstrated the effect on authorized shares of common stock, should the Authorized Shares Proposal be approved:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Before</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>Reverse</b></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">After Reverse Stock Split</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-size: 12pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Stock Split</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1-for-2</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1-for-15</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">1-for-30</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: left">Shares of common stock issued and outstanding</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">17,781,919</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">8,890,959</td><td style="width: 1%; text-align: left"/><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">1,185,461</td><td style="width: 1%; text-align: left">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: left">&#160;</td><td style="width: 11%; text-align: right">592,730</td><td style="width: 1%; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Total number of shares of common stock authorized to be issued (if
    the Authorized Shares Proposal is <b>NOT</b> approved)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">100,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Total number of shares of common stock authorized to be issued (if
    the Authorized Shares Proposal <b>is approved</b>)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1,000,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total number of shares of preferred stock authorized to be issued</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000,000</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">5,000,000</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left"><span style="font-size: 10pt">Shares reserved for future grants of awards under the EIP (if the Equity
    Incentive Plan Increase Proposal <b>is not approved</b>)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">43,927</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">21,963</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">2,928</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">1,464</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left"><span style="font-size: 10pt">Shares reserved for future grants of awards under the EIP (if the Equity
    Incentive Plan Increase Proposal <b>is approved</b>)</span></td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">1,043,927</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">521,963</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">69,595</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">34,797</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Shares reserved for issuance upon exercise of outstanding warrants to purchase common stock</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">1,133,625</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">566,812</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">75,575</span></td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right"><span style="font-size: 10pt">37,787</span></td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">Total number of one one-thousandth of a Preferred Share purchasable upon exercise of each Right (Poison
    Pill)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">2</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">15</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">30</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: left">Rights per share of common stock (Poison Pill)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">1</td><td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">The Purchase Price for each one-thousandth of a Preferred Share (Poison Pill)</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">$4</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">$8</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">$60</td><td style="text-align: left">&#160;</td><td>&#160;</td>
    <td style="text-align: left">&#160;</td><td style="text-align: right">$120</td><td style="text-align: left">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Procedures for effecting a Reverse
Stock Split </b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Reverse Split
Amendment</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">If stockholders approve
the Reverse Stock Split Proposal, and if our board determines to effect the Reverse Stock Split (with the ratio to be determined in the
sole discretion of our board within the parameters described), we will file the Reverse Split Amendment with the Secretary of State of
the State of Delaware, reflecting such Reverse Stock Split ratio determined by the board. The Reverse Stock Split will become effective
at the time and on the date of filing of, or at such later time as is specified in the Reverse Split Amendment, which we refer to as
the &#8220;effective time&#8221; and the &#8220;effective date,&#8221; respectively. The effective time of the Reverse Split Amendment
and the Reverse Stock Split shall be determined in the sole discretion of our board and in accordance with applicable law. The text of
the Reverse Split Amendment is subject to modifications to include such changes as may be required by the office of the Secretary of
State of the State of Delaware and as the board deems necessary and advisable to effect the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"></p>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Registered
holders of common stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Certain of our registered
stockholders hold some or all of their shares electronically in book-entry form with our transfer agent. These stockholders do not hold
physical certificates evidencing their ownership of our common stock. However, they are provided with a statement reflecting the number
of shares of our common stock registered in their accounts. If a stockholder holds shares of common stock in book-entry form with our
transfer agent, no action needs to be taken to receive post-Reverse Stock Split shares. As soon as practicable after the effective time
of the Reverse Stock Split, the Company&#8217;s transfer agent will send to your registered address a statement of ownership indicating
the number of post-Reverse Stock Split shares of common stock you hold, together with any ancillary documents, to the extent applicable.
If applicable, a check representing a cash payment in lieu of fractional shares will also be mailed to your registered address as soon
as practicable after the effective time of the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white"><i>Beneficial
owners of common stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Upon the Reverse
Stock Split, we intend to treat stockholders holding our common stock in &#8220;street name,&#8221; through a bank, broker, or other
nominee, in the same manner as registered stockholders whose shares are registered in their names. Brokers, banks, or other nominees
will be instructed to process a reverse stock split for their beneficial holders holding our common stock in &#8220;street name.&#8221;
However, these banks, brokers, or other nominees may have different procedures than registered stockholders for processing a reverse
stock split and making payment for fractional shares. If you hold your shares with a bank, broker, or other nominee, and if you have
any questions in this regard, we encourage you to contact your nominee.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Treatment of fractional shares</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">No fractional shares
of common stock will be issued in connection with the Reverse Stock Split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">No scrip or fractional
shares would be issued if, as a result of the Reverse Stock Split, a stockholder would otherwise become entitled to a fractional share
because the number of shares of common stock they hold before the Reverse Stock Split is not evenly divisible by the split ratio ultimately
determined by the board. Instead, each stockholder will be entitled to receive a cash payment in lieu of such fractional share equal
to the fraction of which such stockholder would otherwise be entitled multiplied by the closing price per share of common stock on the
date of the effective time as reported by Nasdaq (as adjusted to give effect to the Reverse Stock Split). No transaction costs would
be assessed to stockholders for the cash payment. Stockholders would not be entitled to receive interest for their fractional shares
for the period of time between the effective time and the date payment is received.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">After the Reverse
Stock Split, then-current stockholders would have no further interest in the Company with respect to their fractional shares. A person
entitled to a fractional share would not have any voting, dividend or other rights in respect of their fractional share except to receive
the cash payment as described above. Such cash payments would reduce the number of post-Reverse Stock Split stockholders to the extent
that there are stockholders holding fewer than that number of pre-Reverse Stock Split shares within the ratio of the Reverse Stock Split
that is determined as described above. Reducing the number of post-Reverse Stock Split stockholders, however, is not the purpose of this
proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Stockholders should
be aware that, under the escheat laws of the various jurisdictions where stockholders reside, where we are domiciled and where the funds
for fractional shares would be deposited, sums due to stockholders in payment for fractional shares that are not timely claimed after
the effective time may be required to be paid to the designated agent for each such jurisdiction. Thereafter, stockholders otherwise
entitled to receive such funds may have to seek to obtain them directly from the state to which they were paid.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>No appraisal rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">No action is proposed
herein for which the laws of the State of Delaware, our Certificate of Incorporation, or our amended and restated bylaws provide a right
to our stockholders to dissent and obtain an appraisal of, or payment for, such stockholders&#8217; common stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Accounting matters</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The Reverse Stock
Split would not affect the par value of our common stock per share, which would remain $0.001 par value per share, while the number of
outstanding shares of common stock would decrease, in accordance with the Reverse Stock Split ratio. As a result, as of the effective
time of the Reverse Stock Split, the stated capital attributable to common stock on our balance sheet would decrease, and the additional
paid-in capital account on our balance sheet would increase by an offsetting amount. In addition, cash paid to the shareholders for the
fractional shares to which they would have been entitled from the Reverse Stock Split will be recorded as a reduction to the additional
paid-in capital account. Following the Reverse Stock Split, the reported per-share net income or loss would be higher because there would
be fewer shares of common stock outstanding and we would adjust historical per-share amounts set forth in our future financial statements.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Reservation of right to abandon the
amendment to our Certificate of Incorporation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">As previously stated,
the board reserves the right, notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed
with the Reverse Stock Split if, at any time prior to effectiveness of the Reverse Split Amendment, the board, in its sole discretion,
determines that it is no longer in the best interests of the Company and its stockholders to proceed with the Reverse Stock Split. By
voting in favor of the Reverse Stock Split, you are expressly also authorizing the board to delay or abandon the Reverse Stock Split.
If our board does not effect any Reverse Stock Split on or prior to the one-year anniversary of the Special Meeting, stockholder approval
would again be required prior to implementing any reverse stock split.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Material U.S. Federal income tax consequences
of the Reverse Stock Split to U.S. Holders</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="letter-spacing: -0.1pt">The
following discussion describes some anticipated material U.S. Federal income tax consequences to &#8220;U.S. holders&#8221; (as
defined below) of our common stock relating to the Reverse Stock Split. This discussion is based upon the Internal Revenue Code of
1986, as amended (the &#8220;Code&#8221;), applicable treasury regulations thereunder (&#8220;Treasury Regulations&#8221;), judicial
authorities, published positions of the Internal Revenue Service (&#8220;IRS&#8221;), and other applicable authorities, all as
currently in effect and all of which are subject to change or differing interpretations (possibly with retroactive effect). There
can be no assurance that the IRS or a court will not take a contrary position to that discussed below regarding the income tax
consequences of the proposed Reverse Stock Split. The following discussion is for information purposes only and is not intended as
tax or legal advice. Each stockholder should seek advice based on the stockholder&#8217;s particular circumstances from an
independent tax advisor.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="letter-spacing: -0.1pt"><b>Each
stockholder should consult his, her or its own tax advisors concerning the particular U.S. Federal tax consequences of the proposed Reverse
Stock Split, as well as the consequences arising under the laws of any other taxing jurisdiction, including any state, local or foreign
tax consequence as it relates to the ownership, purchase, or disposition of common stock</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="letter-spacing: -0.1pt">For
purposes of this discussion, the term &#8220;U.S. holder&#8221; means a beneficial owner of our common stock that for U.S. Federal income
tax purposes, is or is treated as:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            individual citizen or resident of the U.S.;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            corporation (or other entity treated as a corporation for U.S. Federal income tax purposes)
                                            organized under the laws of the United States, any state thereof, or the District of Columbia;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">an
                                            estate with income subject to U.S. Federal income tax regardless of its source; or</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            trust that (a) is subject to the primary supervision of a court within the United States
                                            and all of its substantial decisions are subject to the control of one or more &#8220;United
                                            States persons&#8221; (within the meaning of Section 7701(a)(30) of the Code), or (b) has
                                            a valid election in effect under applicable Treasury Regulations to be treated as a
                                            U.S. person.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="letter-spacing: -0.2pt">This
discussion is limited to U.S. holders who hold our common stock as a &#8220;capital asset&#8221; within the meaning of Section 1221
of the Code (generally, property held for investment). This discussion does not address all of the tax consequences that may be
relevant to a particular stockholder or to stockholders that are subject to special treatment under U.S. Federal income tax laws
including, but not limited to, banks, financial institutions, tax-exempt organizations, insurance companies, regulated investment
companies, real estate investment trusts, entities such as partnerships or S corporations that are treated as
&#8220;flow-through&#8221; entities, persons that
are broker-dealers, traders in securities who elect the mark-to-market method of accounting for their securities, persons holding
their shares of our common stock as part of a &#8220;straddle,&#8221; &#8220;hedging transaction,&#8221; &#8220;conversion transaction,&#8221; or
other integrated transaction, U.S. expatriates, persons subject to the alternative minimum tax, persons whose shares constitute
&#8220;qualified small business stock&#8221; for purposes of Code Section 1202, persons who acquired our common stock in connection
with employment or the performance of services, or persons who hold their Company common stock through individual retirement or
other tax-deferred accounts. This discussion also does not address the tax consequences to us, or to the stockholders that own 5% or
more of our common stock, are our affiliates, or are not U.S. holders. In addition, this discussion does not address other U.S.
Federal taxes (such as gift or estate taxes or alternative minimum taxes), the tax consequences of the Reverse Stock Split under
state, local, or foreign tax laws or certain tax reporting requirements that may be applicable with respect to the Reverse Stock
Split. No assurance can be given that the IRS would not assert, or that a court would not sustain, a position contrary to any of the
tax consequences set forth below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20"></p>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; color: #231F20">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="letter-spacing: -0.2pt">If
a partnership (or other entity or arrangement treated as a partnership for U.S. Federal income tax purposes) is a Company stockholder,
the tax treatment of a partner will generally depend upon the status of the person and the activities of the partnership or other entity
or arrangement treated as a partnership for U.S. Federal income tax purposes.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><i>Tax Consequences
of the Reverse Stock Split to U.S. Holders</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The Reverse
Stock Split is intended to constitute a &#8220;recapitalization&#8221; for U.S. Federal income tax purposes. As such, except as described
below with respect to cash received in lieu of a fractional share, a U.S. holder should not recognize gain or loss as a result of
the Reverse Stock Split. A U.S. holder&#8217;s aggregate tax basis in the shares of the common stock received pursuant to the
Reverse Stock Split should equal the U.S. holder&#8217;s aggregate tax basis in the shares of the common stock surrendered
(excluding any portion of such basis that is allocated to any fractional share of our common stock), and such U.S. holder&#8217;s
holding period in the shares of the common stock received should include the holding period of the shares of the common stock
surrendered. Treasury Regulations provide detailed rules for allocating the tax basis and holding period
of shares of common stock surrendered pursuant to the Reverse Stock Split to shares of common stock received pursuant to the Reverse
Stock Split. U.S. holders holding shares of common stock that were acquired on different dates and at different prices should
consult their tax advisors regarding the allocation of the tax basis and holding period of such shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Assuming the Reverse
Stock Split constitutes a &#8220;recapitalization,&#8221; the receipt of cash in lieu of fractional shares of common stock pursuant
to the Reverse Stock Split should be a taxable transaction&#160;for U.S. Federal income tax purposes. A U.S. holder who receives cash in
exchange for a fractional share will generally recognize capital gain or loss for U.S. Federal income tax purposes equal to the difference,
if any, between the amount of cash received in lieu of the fractional share and the portion of the U.S. holder&#8217;s adjusted tax basis
allocated to the fractional share exchanged. Capital gains or losses would be treated as short-term with respect to fractional shares with a holding period of
one year or less and as long-term with respect to fractional shares with a holding period of more than one year. The deductibility of
net capital losses by individuals and corporations is subject to limitations. Stockholders should consult their own tax advisors regarding
the tax consequences to them of a payment for fractional shares.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><i>Information Reporting and Backup Withholding</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Cash payments received
by a U.S. holder of our common stock pursuant to the Reverse Stock Split are generally subject to information reporting and may be subject to backup
withholding at the applicable rate (currently 24%) if the holder fails to provide a valid
taxpayer identification number and comply with certain certification procedures or otherwise establish an exemption from backup withholding.
Backup withholding is not an additional U.S. Federal income tax. Rather, the U.S. Federal income tax liability of the person subject
to backup withholding will be reduced by the amount of the tax withheld. If backup withholding results in an overpayment of taxes, a
refund may be obtained provided that the required information is timely furnished to the IRS.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Vote required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">Approval
of the Reverse Stock Split Proposal requires the affirmative vote of holders of a majority of the votes cast affirmatively or negatively
(excluding abstentions) on the proposal at the Special Meeting. Abstentions will have no effect on the proposal. No broker non-votes
are expected in connection with the proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>Board recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">The board unanimously
recommends <span style="background-color: white">a vote</span> FOR the Reverse Stock Split Proposal.</p>




<p style="font: 10pt Times New Roman, Times, Serif; margin-right: 0pt; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"></p>


<!-- Field: Page; Sequence: 19; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_046"></span>PROPOSAL
2 </b></span><b>&#8212; INCREASE OF AUTHORIZED SHARES OF COMMON STOCK</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-size: 10pt">The
Board has unanimously approved, declared advisable, and recommended that our stockholders approve, an amendment to our Certificate of
Incorporation, as amended, in substantially the form attached hereto as <b><a href="#aab_014">Annex B</a></b></span><span style="font-size: 8pt">&#160;</span>
<span style="font-size: 10pt">(the &#8220;Authorized Shares Amendment&#8221;), to increase the number of authorized shares of our common
stock from 100,000,000 to 1,000,000,000. The text of the Authorized Shares Amendment is subject to modifications to include such changes
as may be required by the office of the Secretary of State of the State of Delaware and as the Board deems necessary and advisable to
effect the Authorized Shares Proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Following stockholder approval
of the Authorized Shares Proposal, the increase in authorized shares of our common stock would become effective upon the filing of the
Authorized Shares Amendment with the Secretary of State of the State of Delaware, or such later effective time as is specified in such
Authorized Shares Amendment as permitted under Delaware law. The exact timing of the amendment will be determined by our Board based
on its evaluation as to when such action will be the most advantageous to us and our stockholders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Capitalization</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Common Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: left; text-indent: -0.1in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">As of September 15, 2025,
the record date, the Company was authorized to issue up to 100,000,000 shares of common stock, par value $0.001 per share, 17,781,919
of which were issued and outstanding, 702,736 reserved for issuance under our equity compensation plans, and 1,133,625 reserved for
issuance in connection with our outstanding warrants. Accordingly, as of September 15, 2025, the record date, there were 80,381,720
shares of our common stock available for all other corporate purposes, such as additional capital-raising activities or potential acquisitions,
prior to the addition of the shares for which we are seeking approval pursuant to this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>Preferred Stock</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: left; text-indent: -0.1in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">In addition to our authorized
shares of common stock, we are authorized to issue up to 5,000,000 shares of preferred stock, par value of $0.001 per share, of which
none are issued and outstanding and of which 500,000 shares are designated Series A Junior Participating Preferred Stock. The Authorized
Shares Proposal will not change the total number of authorized shares of our preferred stock.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The following table illustrates
the effect of the Authorized Shares Amendment on the capitalization of the Company. This table does not show the effect of the Reverse
Stock Split (if approved by the stockholders and implemented by our Board).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td style="text-align: center">&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>As of the <br/>
    record date</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Upon Effectiveness<br/>
    of Authorized<br/>
    Shares Amendment</b></span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 60%; text-align: justify"><span style="font-size: 10pt">Authorized shares of common stock</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 16%; text-align: right"><span style="font-size: 10pt">100,000,000</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td>
    <td style="width: 16%; text-align: right"><span style="font-size: 10pt">1,000,000,000</span></td>
    <td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-size: 10pt">Authorized shares of preferred stock</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5,000,000</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5,000,000</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">Outstanding shares of common stock</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">17,781,919</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">17,781,919</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-size: 10pt">Shares of common stock reserved for issuance under equity compensation
    plans</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">702,736</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">702,736</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="text-align: justify"><span style="font-size: 10pt">Shares of common stock subject to outstanding warrants</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,133,625</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,133,625</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="text-align: justify"><span style="font-size: 10pt">Shares of common stock available for issuance</span></td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">80,381,720</span></td>
    <td style="text-align: justify">&#160;</td>
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">980,381,720</span></td>
    <td style="text-align: justify">&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b></b></p>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Rationale for the Authorized Shares Amendment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Over the past several years,
we have used shares of our common stock, among other things, to engage in financings, incentivize and compensate employees and other
service providers, to engage in a transaction that involved a change of control and transformed our business, and for other general corporate
purposes. Our board believes that it is in the best interests of our company to increase the number of authorized shares of common stock
in order to give us greater flexibility in considering and planning for potential business needs, including recently announced strategic
initiatives in connection with the continuation of our business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The increase in the number of
authorized but unissued shares of common stock would enable us, without the expense and delay of seeking stockholder approval, to issue
shares from time to time as may be required for proper business purposes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">We anticipate that we may issue
additional shares of common stock in the future in connection with one or more of the following:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">financing
    transactions, such as public or private offerings of common stock or convertible securities;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">strategic
    investments and transactions;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">grants
    under our equity incentive plans; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other
    corporate purposes that have not yet been identified.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: left; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">As previously announced, the
board is contemplating a continuation of the Company&#8217;s business following the consummation of the asset purchase agreement entered
into by the Company on July 17, 2025. We believe that the approval of the Authorized Shares Amendment will increase the Company&#8217;s
chances to pursue strategic initiatives that the board deems to be in the interest of the Company and its stockholders, in addition to
the sale of its legacy business. However, we cannot guarantee that any of the strategic initiatives will be consummated following the
approval of the Authorized Shares Amendment. We, nevertheless, believe that the availability of additional authorized shares of our common
stock will afford us the needed flexibility in acting upon financing transactions to strengthen our financial position or engaging in
strategic activities without using cash. Unless required by applicable law or stock exchange rules, no further vote of the holders of
common stock will be required with respect to any such transaction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Potential effects of the Authorized Shares Amendment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>General</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: left; text-indent: -0.1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The additional shares of common
stock for which authorization is sought would be identical in powers, privileges, and rights to the shares of common stock that are now
authorized. Holders of common stock do not have preemptive rights to subscribe to additional securities that we may issue.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Dilutive effect</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: left; text-indent: -0.1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The issuance of additional shares
of common stock may, among other things, have a dilutive effect on earnings per share and on stockholders&#8217; equity and voting rights.
Furthermore, future sales of substantial amounts of our common stock, or the perception that these sales might occur, could adversely
affect the prevailing market price of our common stock or limit our ability to raise additional capital. Stockholders should recognize
that, as a result of this proposal, they will own a smaller percentage of shares relative to the total authorized shares of the Company
than they presently own.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><i>Anti-takeover effect</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.6in; text-align: left; text-indent: -0.1in"><i>&#160;</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The Authorized Shares Amendment
could, under certain circumstances, have an anti-takeover effect. Our Board might be able to delay or impede a takeover or transfer of
control of our Company by causing such additional authorized but unissued shares to be issued to holders who might side with our Board
in opposing a takeover bid that the Board determines is not in the best interests of our Company and our stockholders. The Authorized
Shares Proposal could therefore have the effect of discouraging unsolicited takeover attempts. By potentially discouraging the initiation
of any such unsolicited takeover attempts, the Authorized Shares Proposal could limit the opportunity for our stockholders to dispose
of their shares at a higher price generally available in takeover attempts or that may be available under a merger proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Our board has not proposed an
increase in the number of authorized shares with the intention of discouraging tender offers or takeover attempts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Reservation of right to abandon the Authorized
Shares Amendment</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Our board reserves the right,
notwithstanding stockholder approval and without further action by the stockholders, to elect not to proceed with the Authorized Shares
Amendment if, at any time prior to effectiveness of the Authorized Shares Amendment, the board, in its sole discretion, determines that
it is no longer in the best interests of the Company and its stockholders to proceed with the Authorized Shares Amendment. By voting
in favor of the Authorized Shares Proposal, you are expressly also authorizing the board to delay or abandon the Authorized Shares Amendment.
If our Board does not effect any Authorized Shares Amendment on or prior to the one-year anniversary of the Special Meeting, stockholder
approval would again be required prior to implementing any increase in the shares of our common stock authorized for issuance.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>No Appraisal Rights</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Our stockholders are not entitled
to appraisal rights under Delaware law or the Certificate of Incorporation with respect to the Authorized Shares Amendment, and we will
not independently provide our stockholders with any such right.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Vote required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Approval of the Authorized Shares
Proposal requires the affirmative vote of holders of a majority of the votes cast affirmatively or negatively (excluding abstentions)
on the proposal at the Special Meeting. Abstentions will have no effect on the proposal. No broker non-votes are expected in connection
with the proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left"><b>Board recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The board unanimously recommends
a vote FOR the approval of the Authorized Shares Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left">&#160;</p>


<!-- Field: Page; Sequence: 22; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="SL_048"></span>PROPOSAL
3 &#8212; INCREASE OF THE SHARES AVAILABLE UNDER<br/>
THE SONIM TECHNOLOGIES, INC. 2019 EQUITY INCENTIVE PLAN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>General</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">On September 18, 2025,
our Board approved an amendment to the Sonim Technologies, Inc. 2019 Equity Incentive Plan, as amended (the &#8220;EIP&#8221; or &#8220;2019
Plan&#8221;), subject to stockholder approval, and accordingly, the Board directed that such amendment be submitted to the stockholders
for approval at the Special Meeting. The amendment would increase the number of authorized shares of our common stock available for issuance
under the 2019 Plan as of the record date by 1,000,000 shares: from 1,874,054 shares to 2,874,054 shares. No other changes are being
made to the 2019 Plan. The proposed 2019 Plan, as amended and restated assuming this proposal is approved by our stockholders, is included
as <b><a href="#aab_015">Annex C</a></b> hereto.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Stockholder
approval of the amendment to the 2019 Plan is being sought in order to (i) meet Nasdaq listing requirements and (ii) allow for incentive
stock options to meet the requirements of the Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). For additional information
regarding our current officer and director compensation, see the section titled &#8220;<i><a href="#mj_002">Executive and Director Compensation</a>.</i>&#8221;
We also encourage you to review the section titled &#8220;<i><a href="#ni_001">Equity compensation plan information</a></i>&#8221; for
more information with regard to all our equity compensation plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
our stockholders approve this proposal, the amendment to the 2019 Plan will become effective as of the date of the Special Meeting.
We intend to file a Registration Statement on Form S-8 to register additional shares available for issuance under the 2019 Plan as a
result of the amendment. If our stockholders fail to approve this proposal, the 2019 Plan will remain as is without any changes thereto.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
of September 15, 2025, the record date, the number of shares of our common stock available for grant under the 2019 Plan
was 43,927. As of the record date, the Company has outstanding stock options to purchase approximately 658,809 shares of common
stock and no shares of common stock subject to outstanding restricted stock units, all of which were granted under the 2019 Plan and
various other prior plans.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reasons
to vote approve the proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b><i>Equity awards are an important part of
our compensation philosophy</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Our board believes that
it is very important that our eligible employees, consultants, and directors (collectively, &#8220;Participants&#8221;) receive part
of their compensation in the form of equity awards to foster their investment in us, reinforce the link between their financial interests
and those of our other stockholders, and maintain a competitive compensation program. Equity compensation fosters a Participant ownership
culture, motivates Participants to create stockholder value and, because the awards are typically subject to vesting and other conditions,
promotes a focus on long-term value creation. The equity incentive programs we have in place have worked to build stockholder value by
attracting and retaining extraordinarily talented employees, consultants, and directors. The board believes we should continue
to offer competitive equity compensation packages in order to attract and motivate the talent necessary for our continued growth and
success.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b><i>We expect to expand our team and anticipate
the eventual growth of our business</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
purposes of the 2019 Plan are to attract, retain, and motivate officers and key employees (including prospective employees), directors,
consultants, and others who may perform services for the Company to compensate them for their contributions to the long-term growth and
profits of the Company and to encourage them to acquire a proprietary interest in the success of the Company. Therefore, the remaining
pool should always be sufficient if needed for new hires or other special circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b><i>The 2019 Plan combines compensation and
governance best practices designed to protect our stockholders&#8217; interests</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
recognize that equity compensation awards dilute stockholder equity and must be used judiciously. Our equity compensation practices are
designed to be in line with industry norms, and we believe our historical share usage has been responsible and mindful of stockholder
interests. Certain provisions in the 2019 Plan are designed to protect our stockholders&#8217; interests and to reflect corporate governance
best practices including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 23; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Flexibility
in designing equity compensation schemes.</i> The 2019 Plan allows us to provide a broad array of equity incentives, including traditional
stock option grants, stock appreciation rights, restricted stock awards, restricted stock unit (&#8220;RSU&#8221;) awards, performance
stock awards, and performance cash awards. By providing this flexibility we can quickly and effectively react to trends in compensation
practices and continue to offer competitive compensation arrangements to attract and retain the talent necessary for the success of our
business.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
discounted stock options or stock appreciation rights.</i> All stock options and stock appreciation rights granted under the 2019 Plan
must have an exercise price or strike price equal to or greater than the fair market value of our common stock on the date the stock
option or stock appreciation right is granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Limits
on non-employee director compensation.</i> The maximum number of shares of common stock subject to awards granted under the 2019 Plan
or otherwise during any one calendar year to any non-employee director, taken together with any cash fees paid by us to the non-employee
director during that year for service on our Board, will not exceed $600,000 in total value (calculating the value of the awards based
on the grant date fair value for financial reporting purposes), or, with respect to the calendar year in which a non-employee director
is first appointed or elected to our Board, $1,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Awards
are subject to forfeiture/clawback.</i> Awards granted under our 2019 Plan are subject to recoupment in accordance with any clawback
policy that we are required to adopt pursuant to the listing standards of any national securities exchange or association on which our
securities are listed or as is otherwise required by the Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable
law. In addition, we may impose other clawback, recovery, or recoupment provisions in a stock award agreement, including a reacquisition
right in respect of previously acquired shares or other cash or property upon the occurrence of cause. For more information about our
clawback policy see the section of this proxy statement titled &#8220;<i>Directors, Executive Officers, and Corporate Governance&#8212;Clawback policy (recoupment of erroneously awarded incentive-based compensation)</i>.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
single trigger accelerated vesting upon change in control.</i> The 2019 Plan does not provide for any automatic mandatory vesting of
awards upon a change in control.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>No
liberal change in control definition.</i> The change in control definition in the 2019 Plan is not a &#8220;liberal&#8221; definition.
A change in control transaction must actually occur in order for the change in control provisions in the 2019 Plan to be triggered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Termination
of stock options and stock appreciation rights on a participant&#8217;s termination for cause.</i> If a participant&#8217;s service is
terminated for cause, as defined under the 2019 Plan (which includes the participant&#8217;s commission of any felony or any crime involving
fraud, dishonesty, or moral turpitude and the participant&#8217;s unauthorized use or disclosure of our confidential information or trade
secrets), the participant is prohibited from exercising his or her stock options and stock appreciation rights.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><b><i>We manage our equity award usage carefully</i></b></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The following table provides
certain additional information regarding our equity incentive plans as of the record date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>As of</b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>September 15, 2025</b></p></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td style="width: 80%"><span style="font-size: 10pt">Total number of shares of common stock subject to outstanding stock options</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="text-align: right; width: 16%"><span style="font-size: 10pt">658,809</span></td>
    <td style="width: 1%"><span style="font-size: 10pt"></span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Weighted-average exercise price of outstanding stock options</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-size: 10pt">6.4483</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Weighted-average remaining term of outstanding stock options</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1.29 years</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Total number of shares of common stock subject to outstanding full value awards</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">&#8212;</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Total number of shares of common stock available for grant under the 2019 Plan</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">43,927</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Total number of shares of common stock available for grant under other equity incentive plans<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">25,824</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Total number of shares of common stock outstanding</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">17,781,919</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Per-share closing price of common stock as reported on Nasdaq Capital Market</span></td>
    <td>&#160;</td>
    <td><span style="font-size: 10pt">$</span></td>
    <td style="text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">0.7536</span></td>
    <td>&#160;</td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(1)</span></td>
    <td><span style="font-size: 10pt">Represents shares issuable pursuant to our 2019 ESPP.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The following table provides
detailed information regarding the activity related to our equity incentive plans for fiscal years 2022, 2023, and 2024, which has been
retroactively adjusted to reflect the 1-for-10 reverse stock split that became effective on July 17, 2024.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fiscal Year<br/>
    2024</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fiscal Year<br/>
    2023</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td><td style="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Fiscal Year<br/>
    2022</td><td style="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 49%; font-size: 10pt; text-align: left">Total number of shares of common stock subject to stock options granted</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 13%; font-size: 10pt; text-align: right">259,000</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 13%; font-size: 10pt; text-align: right">180,300</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 2%; font-size: 10pt">&#160;</td>
    <td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td><td style="width: 13%; font-size: 10pt; text-align: right">482,945</td><td style="width: 1%; font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left">Total number of shares of common stock subject to full value awards granted</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">64,178</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">44,522</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">84,107</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-size: 10pt; text-align: left">Weighted-average number of shares of common stock outstanding</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,718,141</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">4,278,694</td><td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">3,007,669</td><td style="font-size: 10pt; text-align: left">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-size: 10pt; text-align: left"><span style="font-size: 10pt">Burn Rate <sup>(1)</sup></span></td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">7</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">5</td><td style="font-size: 10pt; text-align: left">%</td><td style="font-size: 10pt">&#160;</td>
    <td style="font-size: 10pt; text-align: left">&#160;</td><td style="font-size: 10pt; text-align: right">19</td><td style="font-size: 10pt; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%">
  <tr style="vertical-align: top">
    <td style="text-align: justify; width: 0.25in"><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Burn rate is the summation of the total number of stock options
    granted and full value awards granted divided by the weighted-average shares outstanding.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Description
of the 2019 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
material features of the 2019 Plan (as proposed to be amended and modified and assuming that the increase of the shares authorized under
the 2019 Plan is approved) are outlined below. This summary is qualified in its entirety by reference to the complete text of the 2019
Plan. Stockholders are encouraged to read the actual text of the 2019 Plan, which is included in this proxy statement as <b><a href="#aab_015">Annex C</a></b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Awards.
</i>The 2019 Plan provides for the grant of incentive stock options (&#8220;ISOs&#8221;), nonstatutory stock options (&#8220;NSOs&#8221;),
stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based stock awards, and other stock awards,
or collectively, stock awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Eligibility</i>.
Employees, non-employee directors, and consultants are eligible to participate in the 2019 Plan. All of our 95 employees, four non-employee
directors, and 20 consultants are currently eligible to participate in the 2019 Plan and may receive all types of stock awards, other
than ISOs, under the 2019 Plan. ISOs may be granted under the 2019 Plan only to our employees in the United States.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Authorized
Shares.</i> If this proposal is approved, the total number of our common stock reserved for issuance under the 2019 Plan will not exceed
2,874,054, which number is the sum of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">18,851</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares that were approved in connection with the 2019 Plan&#8217;s initial adoption;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares subject to outstanding stock options or other stock awards that were granted under our 2012 Equity Incentive Plan,
    as amended, as of the initial adoption of the 2019 Plan, to the extent such awards are forfeited, terminated, expire, or are otherwise
    not issued;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">30,000</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares that were approved at our 2020 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iv)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares that were approved at our 2022 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(v)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">200,000</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares that were approved at our 2023 annual meeting of stockholders;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vi)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">300,000 shares that were approved at our 2024 annual meeting
    of stockholders;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(vii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    entirety of the shares added pursuant to the evergreen provision of the 2019 Plan; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(viii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,000,000</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
    shares to be added pursuant to this proposal.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 25; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally,
the number of shares of our common stock reserved for issuance under the 2019 Plan automatically increases on January 1 of each calendar
year for ten (10) years ending on and including January 1, 2029, in an amount equal to 5% of the total number of shares of our capital
stock outstanding on December 31 of the prior calendar year, unless our Board or compensation committee determines prior to the date
of increase that there will be a lesser increase or no increase.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Shares
subject to stock awards granted under our 2019 Plan that expire or terminate without being exercised in full, or that are paid out in
cash rather than in shares, do not reduce the number of shares available for issuance under our 2019 Plan. Additionally, shares become
available for future grants under our 2019 Plan if they were issued under stock awards under our 2019 Plan and we repurchase them or
they are forfeited. This includes shares used to pay the exercise price of a stock award or to satisfy the tax withholding obligations
related to a stock award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Plan
Administration.</i> Our Board and our Compensation Committee administer our 2019 Plan. Our Board may also delegate to one or more of
our officers the authority to (i) designate employees (other than officers) to receive specified stock awards, and (ii) determine the
number of shares subject to such stock awards. Under our 2019 Plan, our Board has the authority to determine and amend the terms of awards,
including:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">recipients;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    exercise, purchase, or strike price of stock awards, if any;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    number of shares subject to each stock award;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    fair market value of a share of our common stock in the event no public market exists for our common stock;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    vesting schedule applicable to the awards, together with any vesting acceleration; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    form of consideration, if any, payable upon exercise or settlement of the award.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
our 2019 Plan, our Board also generally has the authority to effect, with the consent of any adversely affected participant:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    reduction of the exercise, purchase, or strike price of any outstanding award;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    cancellation of any outstanding stock award and the grant in substitution therefor of other awards, cash, or other consideration;
    or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">any
    other action that is treated as a repricing under generally accepted accounting principles.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Non-Employee
Director Limitation.</i> The maximum number of shares of common stock subject to awards granted under the 2019 Plan or otherwise during
any one calendar year to any non-employee director, taken together with any cash fees paid by us to the non-employee director during
that year for service on our Board, will not exceed $600,000 in total value (calculating the value of the awards based on the grant date
fair value for financial reporting purposes), or, with respect to the calendar year in which a non-employee director is first appointed
or elected to our Board, $1,000,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 26; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>&#160;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Options.</i> ISOs and NSOs are granted pursuant to stock option agreements adopted by the plan administrator. The plan administrator
determines the exercise price for stock options, within the terms and conditions of our 2019 Plan, provided that the exercise price of
a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Options granted
under our 2019 Plan vest at the rate specified in the stock option agreement as determined by the plan administrator. The plan administrator
determines the term of stock options granted under the 2019 Plan, up to a maximum of ten years. Unless the terms of an optionholder&#8217;s
stock option agreement provide otherwise, if an optionholder&#8217;s service relationship with us, or any of our affiliates, ceases for
any reason other than disability, death, or cause, the optionholder may generally exercise any vested options for a period of three months
following the cessation of service. The option term may be extended in the event that the exercise of the option following such a termination
of service is prohibited by applicable securities laws or our insider trading policy. If an optionholder&#8217;s service relationship
with us or any of our affiliates ceases due to disability or death, or an optionholder dies within a certain period following cessation
of service, the optionholder or a beneficiary may generally exercise any vested options for a period of 12 months in the event of disability
and 18 months in the event of death. Except as otherwise provided in the applicable stock option agreement or other written agreement
between us or any of our affiliates and the participant, options terminate immediately upon the termination of the individual&#8217;s
employment for cause. In no event may an option be exercised beyond the expiration of its term. Acceptable consideration for the purchase
of common stock issued upon the exercise of a stock option will be determined by the plan administrator and may include (1) cash, check,
bank draft, or money order, (2) a broker-assisted cashless exercise, (3) the tender of shares of our common stock previously owned by
the optionholder, (4) a net exercise of the option if it is an NSO, and (5) other legal consideration approved by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Tax
Limitations on ISOs</i>. The aggregate fair market value, determined at the time of grant, of our common stock with respect to ISOs that
are exercisable for the first time by an optionholder during any calendar year under all of our stock plans may not exceed $100,000.
Options or portions thereof that exceed such limit will generally be treated as NSOs. No ISO may be granted to any person who, at the
time of the grant, owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our affiliates
unless (i) the option exercise price is at least 110% of the fair market value of the stock subject to the option on the date of grant
and (ii) the term of the ISO does not exceed five years from the date of grant. The maximum number of shares of our common stock that
may be issued upon the exercise of ISOs under our 2019 Plan is equal to three times the aggregate number of shares reserved under the
2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Unit Awards.</i> Restricted stock unit awards are granted pursuant to restricted stock unit award agreements adopted by the plan
administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration that may be acceptable
to our Board and permissible under applicable law. A restricted stock unit award may be settled by cash, delivery of stock, a combination
of cash and stock as deemed appropriate by the plan administrator, or in any other form of consideration set forth in the restricted
stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares covered by a restricted stock unit
award. Except as otherwise provided in the applicable award agreement, restricted stock units that have not vested will be forfeited
once the participant&#8217;s continuous service ends for any reason.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Restricted
Stock Awards.</i> Restricted stock awards are granted pursuant to restricted stock award agreements adopted by the plan administrator.
A restricted stock award may be awarded in consideration for cash, check, bank draft, or money order, past services to us, or any other
form of legal consideration (including future services) that may be acceptable to our Board and permissible under applicable law. The
plan administrator determines the terms and conditions of restricted stock awards, including vesting and forfeiture terms. If a participant&#8217;s
service relationship with us ceases for any reason, we may receive any or all of the shares of common stock held by the participant that
have not vested as of the date the participant terminates service with us through a forfeiture condition or a repurchase right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Performance
Awards.</i> The 2019 Plan permits the grant of performance awards. A performance award is a stock or cash award that is payable (including
that may be granted, may vest, or may be exercised) contingent upon the achievement of pre-determined performance goals during a performance
period. A performance award may require the completion of a specified period of continuous service. The length of any performance period,
the performance goals to be achieved during the performance period, and the measure of whether and to what degree such performance goals
have been attained will generally be determined by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 27; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
goals under the 2019 Plan are based on any one or more of the following performance criteria: (1) earnings (including earnings per share
and net earnings); (2) earnings before interest, taxes and depreciation; (3) earnings before interest, taxes, depreciation and amortization;
(4) total stockholder return; (5) return on equity or average stockholder&#8217;s equity; (6) return on assets, investment, or capital
employed; (7) stock price; (8) margin (including gross margin); (9) income (before or after taxes); (10) operating income; (11) operating
income after taxes; (12) pre-tax profit; (13) operating cash flow; (14) sales or revenue targets; (15) increases in revenue or product
revenue; (16) expenses and cost reduction goals; (17) improvement in or attainment of working capital levels; (18) economic value added
(or an equivalent metric); (19) market share; (20) cash flow; (21) cash flow per share; (22) share price performance; (23) debt reduction;
(24) implementation or completion of projects or processes; (25) subscriber satisfaction; (26) stockholders&#8217; equity; (27) capital
expenditures; (28) debt levels; (29) operating profit or net operating profit; (30) workforce diversity; (31) growth of net income or
operating income; (32) billings; (33) the number of subscribers, including but not limited to unique subscribers; (34) employee retention;
and (35) other measures of performance selected by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance
goals may be based on a company-wide basis, with respect to one or more business units, divisions, affiliates, or business segments,
and in either absolute terms or relative to the performance of one or more comparable companies or the performance of one or more relevant
indices. Unless specified otherwise by the plan administrator at the time the performance goals are established, the plan administrator
will appropriately make adjustments in the method of calculating the attainment of performance goals for a performance period as follows:
(1) to exclude restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes
to generally accepted accounting principles; (4) to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221;
as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures;
(7) to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance
period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of our common stock by reason of
any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination or exchange
of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends; (9) to exclude
the effects of stock based compensation and the award of bonuses under our bonus plans; (10) to exclude costs incurred in connection
with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; and (11)
to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally accepted accounting
principles.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Stock
Appreciation Rights.</i> Stock appreciation rights are granted pursuant to stock appreciation grant agreements adopted by the plan administrator.
The plan administrator determines the purchase price or strike price for a stock appreciation right, which generally cannot be less than
100% of the fair market value of our common stock on the date of grant. A stock appreciation right granted under our 2019 Plan vests
at the rate specified in the stock appreciation right agreement as determined by the plan administrator.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Other
Stock Awards.</i> Our plan administrator may grant other awards based in whole or in part by reference to our common stock. Our plan
administrator will set the number of shares under the stock award and all other terms and conditions of such awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Changes
to Capital Structure.</i> In the event that there is a specified type of change in our capital structure, such as a stock split or recapitalization,
appropriate adjustments will be made to (i) the class and the maximum number of shares reserved for issuance under our 2019 Plan, (ii)
the class and the maximum number of shares that may be issued upon the exercise of ISOs, and (iii) the class and the number of shares
and exercise price, strike price, or purchase price, if applicable, of all outstanding stock awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Corporate
Transactions.</i> Our 2019 Plan provides that in the event of certain specified significant corporate transactions including: (i) a sale
of all or substantially all of our assets, (ii) the sale or disposition of more than 50% of our outstanding securities, (iii) the consummation
of a merger or consolidation where we do not survive the transaction and (iv) the consummation of a merger or consolidation where we
do survive the transaction but the shares of our common stock outstanding prior to such transaction are converted or exchanged into other
property by virtue of the transaction, each outstanding award will be treated as the plan administrator determines unless otherwise provided
in an award agreement or other written agreement between us and the award holder. The plan administrator may take one of the following
actions with respect to such awards:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrange
    for the assumption, continuation, or substitution of a stock award by a successor corporation;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 28; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrange
    for the assignment of any reacquisition or repurchase rights held by us to a successor corporation;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accelerate
    the vesting, in whole or in part, of the stock award and provide for its termination prior to the transaction;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">arrange
    for the lapse, in whole or in part, of any reacquisition or repurchase rights held by us;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">cancel
    or arrange for the cancellation of the stock award, to the extent not vested or not exercised prior to the effective time of the
    transaction, in exchange for such cash consideration, if any, as the plan administrator may deem appropriate; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">make
    a payment, in the form determined by the plan administrator, equal to the excess, if any, of the value of the property the participant
    would have received on exercise of the awards before the transaction over any exercise price payable by the participant in connection
    with the exercise, multiplied by the number of shares subject to the stock award. Any escrow, holdback, earnout, or similar provisions
    in the definitive agreement for the transaction may apply to such payment to the holder of a stock award to the same extent and in
    the same manner as such provisions apply to holders of our common stock.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
plan administrator is not obligated to treat all stock awards or portions of stock awards, even those that are of the same type, in the
same manner in the event of a corporate transaction.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event of a change in control, awards granted under our 2019 Plan will not receive automatic acceleration of vesting and/or exercisability,
although this treatment may be provided for in an award agreement or in any other written agreement between us and the participant. Under
our 2019 Plan, a change in control generally will be deemed to occur in the event: (i) the acquisition by any person or company of more
than 50% of the combined voting power of our then outstanding stock; (ii) a merger, consolidation, or similar transaction in which our
stockholders immediately before the transaction do not own, directly or indirectly, more than 50% of the combined outstanding voting
power of the surviving entity or the parent of the surviving entity; (iii) a sale, lease, exclusive license or other disposition of all
or substantially all of our assets other than to an entity more than 50% of the combined voting power of which is owned by our stockholders;
or (iv) an unapproved change in the majority of our Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Transferability.
</i>A participant generally may not transfer stock awards under our 2019 Plan other than by will, the laws of descent and distribution,
or as otherwise provided under our 2019 Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Term,
Termination, and Amendment.</i> Unless sooner terminated by our Board, the 2019 Plan will terminate on the tenth anniversary of the date
our Board originally adopted our 2019 Plan, or &#8206;&#8206;March&#8206; &#8206;26&#8206;, &#8206;2029. No award will be granted after termination
of the 2019 Plan (or if it is suspended by our Board), but awards outstanding upon termination of the 2019 Plan will remain outstanding
in accordance with their applicable terms and conditions and the terms and conditions of the 2019 Plan. Our Board has the authority to
amend, suspend, or terminate our 2019 Plan, provided that such action does not materially impair the existing rights of any participant
without such participant&#8217;s written consent. Certain material amendments also require the approval of our stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>U.S.
federal income tax consequences</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following is a summary of the principal United States federal income tax consequences to Participants and us with respect to participation
in the 2019 Plan. This summary is not intended to be exhaustive and does not discuss the income tax laws of any local, state, or foreign
jurisdiction in which a participant may reside. The information is based upon current federal income tax rules and therefore is subject
to change when those rules change. Because the tax consequences to any participant may depend on his or her particular situation, each
participant should consult the participant&#8217;s tax adviser regarding the federal, state, local, and other tax consequences of the
grant or exercise of an award or the disposition of stock acquired under the 2019 Plan. The 2019 Plan is not qualified under the provisions
of Section 401(a) of the Code, and is not subject to any of the provisions of the Employee Retirement Income Security Act of 1974. Our
ability to realize the benefit of any tax deductions described below depends on our generation of taxable income as well as the requirement
of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of our tax reporting obligations.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 29; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>&#160;</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Nonstatutory
Stock Options</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
there is no taxation upon the grant of an NSO if the stock option is granted with an exercise price equal to the fair market value of
the underlying stock on the grant date. Upon exercise, a participant will recognize ordinary income equal to the excess, if any, of the
fair market value of the underlying stock on the date of exercise of the stock option over the exercise price. If the participant is
employed by us or one of our affiliates, that income will be subject to withholding taxes. The participant&#8217;s tax basis in those
shares will be equal to their fair market value on the date of exercise of the stock option, and the participant&#8217;s capital gain
holding period for those shares will begin on that date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Incentive
Stock Options</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
2019 Plan provides for the grant of stock options that are intended to qualify as &#8220;incentive stock options,&#8221; as defined in
Section 422 of the Code. Under the Code, a participant generally is not subject to ordinary income tax upon the grant or exercise of
an ISO. If the participant holds a share received upon exercise of an ISO for more than two years from the date the stock option was
granted and more than one year from the date the stock option was exercised, which is referred to as the required holding period, the
difference, if any, between the amount realized on a sale or other taxable disposition of that share and the participant&#8217;s tax
basis in that share will be long-term capital gain or loss.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If,
however, a participant disposes of a share acquired upon exercise of an ISO before the end of the required holding period, which is referred
to as a disqualifying disposition, the participant generally will recognize ordinary income in the year of the disqualifying disposition
equal to the excess, if any, of the fair market value of the share on the date of exercise of the stock option over the exercise price.
However, if the sales proceeds are less than the fair market value of the share on the date of exercise of the stock option, the amount
of ordinary income recognized by the participant will not exceed the gain, if any, realized on the sale. If the amount realized on a
disqualifying disposition exceeds the fair market value of the share on the date of exercise of the stock option, that excess will be
short-term or long-term capital gain, depending on whether the holding period for the share exceeds one year.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
purposes of the alternative minimum tax, the amount by which the fair market value of a share of stock acquired upon exercise of an ISO
exceeds the exercise price of the stock option generally will be an adjustment included in the participant&#8217;s alternative minimum
taxable income for the year in which the stock option is exercised. If, however, there is a disqualifying disposition of the share in
the year in which the stock option is exercised, there will be no adjustment for alternative minimum tax purposes with respect to that
share. In computing alternative minimum taxable income, the tax basis of a share acquired upon exercise of an ISO is increased by the
amount of the adjustment taken into account with respect to that share for alternative minimum tax purposes in the year the stock option
is exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
are not allowed an income tax deduction with respect to the grant or exercise of an ISO or the disposition of a share acquired upon exercise
of an ISO after the required holding period. If there is a disqualifying disposition of a share, however, we will generally be entitled
to a tax deduction equal to the taxable ordinary income realized by the participant, subject to the requirement of reasonableness and
the provisions of Section 162(m) of the Code, and provided that either the employee includes that amount in income or we timely satisfy
our reporting requirements with respect to that amount.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in"></p>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify">&#160;</p>

<p style="font: 12pt Cambria, Times, Serif; color: #243F60; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Awards</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the recipient of a restricted stock award will recognize ordinary income at the time the stock is received equal to the excess, if any,
of the fair market value of the stock received over any amount paid by the recipient in exchange for the stock. If, however, the stock
is not vested when it is received (for example, if the employee is required to work for a period of time in order to have the right to
sell the stock), the recipient generally will not recognize income until the stock becomes vested, at which time the recipient will recognize
ordinary income equal to the excess, if any, of the fair market value of the stock on the date it becomes vested over any amount paid
by the recipient in exchange for the stock. A recipient may, however, file an election with the Internal Revenue Service, within 30 days
following his or her receipt of the stock award, to recognize ordinary income, as of the date the recipient receives the award, equal
to the excess, if any, of the fair market value of the stock on the date the award is granted over any amount paid by the recipient for
the stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock
award will be the amount paid for such shares plus any ordinary income recognized either when the stock is received or when the stock
becomes vested.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Restricted
Stock Unit Awards</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
the recipient of a restricted stock unit award structured to conform to the requirements of Section 409A of the Code or an exception
to Section 409A of the Code will recognize ordinary income at the time the stock is delivered equal to the excess, if any, of the fair
market value of the stock received over any amount paid by the recipient in exchange for the stock. To conform to the requirements of
Section 409A of the Code, the stock subject to a restricted stock unit award may generally only be delivered upon one of the following
events: a fixed calendar date (or dates), separation from service, death, disability or a change in control. If delivery occurs on another
date, unless the restricted stock unit award otherwise complies with or qualifies for an exception to the requirements of Section 409A
of the Code, in addition to the tax treatment described above, the recipient will owe an additional 20% federal tax and interest on any
taxes owed.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
recipient&#8217;s basis for the determination of gain or loss upon the subsequent disposition of shares acquired from a restricted stock
unit award will be the amount paid for such shares plus any ordinary income recognized when the stock is delivered.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the restricted stock
unit award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Stock
Appreciation Rights</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Generally,
if a stock appreciation right is granted with an exercise price equal to the fair market value of the underlying stock on the grant date,
the recipient will recognize ordinary income equal to the fair market value of the stock or cash received upon such exercise. Subject
to the requirement of reasonableness, the provisions of Section 162(m) of the Code, and the satisfaction of a tax reporting obligation,
we will generally be entitled to a tax deduction equal to the taxable ordinary income realized by the recipient of the stock appreciation
right.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Limitation
on the Employer&#8217;s Compensation Deduction</i></b></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Section
162(m) of the Code limits the deduction certain employers may take for otherwise deductible compensation payable to certain executive
officers of the employer to the extent the compensation paid to such an officer for the year exceeds $1 million.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>The
discussion above is intended only as a summary and does not purport to be a complete discussion of all potential tax effects relevant
to recipients of awards under the 2019 Plan. Among other items this discussion does not address are tax consequences under the laws of
any state, locality, or foreign jurisdiction, or any tax treaties or conventions between the United States and foreign jurisdictions.
This discussion is based upon current law and interpretational authorities which are subject to change at any time.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>


<!-- Field: Page; Sequence: 31; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>New
plan benefits under 2019 Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Grants of awards under the 2019
Plan to our executive officers, employees, and other eligible Participants are subject to the discretion of our board or its
Compensation Committee, as applicable. As of the date of this proxy statement, no awards have been granted under the 2019 Plan
subject to the stockholder approval of the amendment to the 2019 Plan sought in this proposal. Therefore, it is not possible to
determine the future benefits that will be received by the participants under the 2019 Plan other than with respect to the value of
RSUs that will be received by our non-employee directors. Additionally, following our 2025 annual meeting of stockholders, there
were insufficient shares of our common stock to issue awards with a value of $60,000 each to our non-employee directors, and cash
awards with the vesting schedules were issued to resemble the mechanics of restricted stock units.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0.5in">Accordingly, the table below
provides information solely with respect to our non-employee directors in connection with awards granted following the 2026 annual meeting, as well as the non-executive chairman of the board following the 2025
annual meeting.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Dollar value ($)<sup>(1)</sup></b></span></td><td style="padding-bottom: 0.06in; font-weight: bold"><sup>&#160;</sup></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Number of Shares</td><td style="padding-bottom: 0.06in; font-weight: bold"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter Hao Liu, <i>Chief Executive Officer</i></span></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay Crolius, <i>Chief Financial Officer</i></span></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles Becher, <i>Chief Commercial Officer and General Manager of North America</i></span></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">All executive officers as a group (three persons)</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Non-employee directors as a group (four persons)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 16%; text-align: right">340,000</td><td style="padding-bottom: 0.06in; width: 1%; text-align: justify"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 16%; text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; width: 1%; text-align: justify"><sup>(3)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">All employees as a group, other than executive officers</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 0.06in; text-align: justify"><sup>&#160;</sup></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Represents
                                            grant date fair value of award.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
                                            accordance with our non-employee director compensation policy, each non-employee director
                                            who will continue to serve as a non-employee director immediately following the annual meeting
                                            will automatically be granted an award of RSUs on the date of our annual meeting, with the
                                            number of RSUs determined by dividing (i) $60,000 by (ii) the closing trading price of our
                                            common stock on the grant date. Additionally, the non-executive chairman of the Board will
                                            also be entitled to receive additional RSUs determined by dividing (i) $50,000 by (ii) the
                                            closing trading price of our common stock on the grant date, which is the anniversary of
                                            the attainment of the status of the non-executive chairman of our board and is currently expected to be November 12, 2025, and 2026, respectively.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
                                            described in the footnote (2) above, for non-employee directors, the number of shares reflects
                                            the number of restricted stock units granted following the annual meeting or the date of
                                            the RSU grant to the chairman of the board. Accordingly, the number of shares is not
                                            included in the table.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Consequences
of failing to approve the proposal</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
the amendment to increase the number of shares authorized under our 2019 Plan is not approved by stockholders, the 2019 Plan will continue
in full force and effect in accordance with its terms. Once the share reserve under the 2019 Plan is exhausted, we may elect to provide
compensation through other means, such as cash-settled awards or other cash compensation, to assure that Sonim and its affiliates can
attract and retain qualified personnel.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Vote
required</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approval of the Equity Incentive
Plan Increase Proposal requires the affirmative vote of the holders of a majority of the voting power of the shares of our common stock
present in person or represented by proxy at the Special Meeting and entitled to vote on the matter. Abstentions will have the effect
of a vote against the proposal. Broker non-votes will have no effect on this proposal.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The board unanimously recommends
a vote FOR the approval of the Equity Incentive Plan Increase Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 32; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span id="vv_005"></span><b>PROPOSAL 4 &#8212; ADJOURNMENT PROPOSAL</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>General</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">
<span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">

If at the Special Meeting the number of shares voting in favor of the approval of the Reverse Stock Split Proposal, the Authorized Shares Proposal, or the Equity
Incentive Plan Increase Proposal is insufficient to approve such proposals, we intend to move to adjourn the Special Meeting in order
to enable the board to solicit additional proxies in respect of the approval of such proposals. In that event, we may ask the stockholders
to vote only upon the Adjournment Proposal during such portion of the Special Meeting.

</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are asking that you approve
the Adjournment Proposal, which will authorize the adjournment of the Special Meeting, if necessary or appropriate, from time to time,
to a later date or dates, even if a quorum is present, to solicit additional proxies. If the stockholders approve the Adjournment Proposal,
we could adjourn the Special Meeting and use the additional time to solicit additional proxies in favor of the Reverse Stock Split Proposal,
the Authorized Shares Proposal, or the Equity Incentive Plan Increase Proposal, including the solicitation of proxies from stockholders
that have previously voted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Vote required</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">Approval of the Adjournment
Proposal requires the affirmative vote of the holders of a majority of the voting power of the shares of our common stock present in
person or represented by proxy at the Special Meeting and entitled to vote on the matter. Abstentions will have the effect of a vote
against the proposal. Broker non-votes will have no effect on this proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Board recommendation</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in">The Board unanimously recommends
a vote FOR the approval of the Adjournment Proposal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"></p>



<!-- Field: Split-Segment; Name: split_001 -->
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="mj_002"></span>EXECUTIVE
AND DIRECTOR COMPENSATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="mj_003"></span>Executive
compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
NEOs for the year ended December 31, 2024, consisted of three individuals:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.75in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Peter
    Liu, our current Chief Executive Officer, who served as our principal executive officer during the year ended December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Clay
    Crolius, our current Chief Financial Officer, who was serving as our executive officer at the end of the fiscal year ended December
    31, 2024; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Charles
    Becher, our Chief Commercial Officer, who was serving as our executive officer at the end of the fiscal year ended December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.25in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_066"></span>Summary
compensation table</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding compensation earned during the years ended December 31, 2024 and December 31, 2023 by
our NEOs.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name and Principal Position</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Year</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Salary</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Bonus</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Awards</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)<sup>(1)</sup></b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>All
                                            Other</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Total <br/> ($)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">Peter Hao Liu</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: center">&#160;</td><td style="width: 6%; text-align: center">2024</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">450,000</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">175,630</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">&#8212;</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">47,288</td><td style="width: 1%; text-align: justify"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">672,918</td><td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: justify">Chief Executive Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">450,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">180,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">47,226</td><td style="text-align: justify"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">677,226</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Clay Crolius</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">320,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">93,669</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">89,352</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">503,021</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="font-style: italic; text-align: justify">Chief Financial Officer</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">323,750</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">96,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">157,520</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">577,270</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Charles Becher</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2024</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">400,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">345,144</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">745,144</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-style: italic; text-align: justify">Chief Commercial Officer and General Manager of North America</td><td>&#160;</td>
    <td style="text-align: center">&#160;</td><td style="text-align: center">2023</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">400,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">275,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">675,000</td><td style="text-align: justify">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    column reflects the full grant date fair value for stock awards or options, respectively, granted during the fiscal year as measured
    pursuant to ASC Topic 718 as stock-based compensation in our consolidated financial statements. The grant date fair value of stock
    awards was based on the closing price per share of our common stock on the applicable grant date. These amounts do not necessarily
    correspond to the actual value that may be recognized from the stock options and stock awards by the NEOs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amount
    reported primarily consists of a housing and car allowance for Mr. Liu.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 33; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_065"></span>Outstanding
equity awards at December 31, 2024</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following tables provide information about outstanding equity awards held by each of our named executive officers as of December 31,
2024. Awards for the named executive officers were granted under our 2019 Equity Incentive Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt; text-align: center">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="12" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option
    Awards<sup>(1)</sup></b></span></td><td style="border-bottom: Black 1pt solid; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Name</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Grant Date</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Underlying</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercised</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unexercisable</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Price</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Expiration</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Date</b></span></p></td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 15%; text-align: justify">Peter Hao Liu</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: right">6/30/2015</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 13%; text-align: right">67</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 13%; text-align: right">&#8212;</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 13%; text-align: right">150.00</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 15%; text-align: right">06/30/2025</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">12/2/2019</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">500</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">248.00</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: right">12/01/2029</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">11/18/2022</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">150,903</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">150,540</td><td style="text-align: justify"><sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">4.188</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: right">10/26/2032</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Clay Crolius</td><td>&#160;</td>
    <td style="text-align: right">1/27/2023</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">4.940</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: right">1/27/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">11/24/2023</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">20,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">7.000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: right">11/24/2033</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td>&#160;</td><td>&#160;</td>
    <td style="text-align: right">4/8/2024</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">17,000</td><td style="text-align: justify"><sup>(3)</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">6.154</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: right">4/8/2034</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Charles Becher</td><td>&#160;</td>
    <td style="text-align: right">11/18/2022</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">10,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">17,500</td><td style="text-align: justify"><sup>(4)</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">4.188</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: right">10/26/2032</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    vesting is subject to the recipient&#8217;s continued service through the applicable vesting date and is subject to accelerated vesting
    in certain circumstances. For additional discussion, please see &#8220;<i><a href="#a_063">Agreements with our Named Executive Officers</a></i>&#8221;
    and &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential payments upon termination or change in control</a></span></i>.&#8221;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stock options vest in 10 equal quarterly installments beginning on January 14, 2024, and ending on April 14, 2026.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stock options vest in three (3) equal yearly installments beginning April 8, 2025.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    stock options vest in 11 equal quarterly installments commencing on February 29, 2024, and ending on August 29, 2026</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td colspan="10" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    Awards<sup>(1)</sup></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Name</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Grant
    Date</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Shares or</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Units
    of Stock that</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Have
    Not Vested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(#)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Market
                                            Value of Shares or Units of</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock
    That Have Not Vested</b></span></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 24%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8212;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 4.3pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
    vesting is subject to the recipient&#8217;s continued service through the applicable vesting date and is subject to accelerated vesting
    in certain circumstances. For additional discussion, please see &#8220;<i><span style="text-decoration: underline"><a href="#a_063">Agreements with our Named Executive
    Officers</a></span></i>&#8221; and &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential payments upon termination or change in control</a></span></i><span style="text-decoration: underline">.</span>&#8221;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 34; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_063"></span>Agreements
with our Named Executive Officers</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Set
forth below are descriptions of our employment agreements with our named executive officers. For a discussion of the severance pay and
other benefits to be provided in connection with a potential termination of employment and/or a change in control under the arrangements
with our named executive officers, see &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential payments upon termination or change in control</a></span></i><span style="text-decoration: underline">.</span>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Liu</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2023, the Company entered an amended and restated employment agreement with Mr. Liu (the &#8220;Liu Employment Agreement&#8221;),
which superseded his previous employment arrangements. Under the Liu Employment Agreement, Mr. Liu receives an annual base salary of
$450,000. Additionally, Mr. Liu is eligible to participate in our EIP in connection with Mr. Liu&#8217;s equity awards. Mr. Liu received
stock option grants (subject to applicable vesting periods), to purchase in the aggregate a total of 401,443 shares of the Company&#8217;s
common stock (the &#8220;Options&#8221;) granted pursuant to the EIP. Each Option vests over four (4) years, with one-fourth (1/4th)
of the shares underlying such Option vesting on the one-year anniversary of the date of Mr. Liu&#8217;s appointment as CEO, and one-twelfth
(1/12th) of the shares underlying such Option vesting in quarterly installments thereafter. The Options will have a maximum term of ten
(10) years from each grant date and will terminate earlier upon the termination of employment prior to the ten-year period. The Liu Employment
Agreement has no specified term, is on an at-will basis, and contains, <i>inter alia</i>, customary confidentiality, non-disparagement,
and cooperation provisions. On April 2, 2025, the Company and Mr. Liu amended the Liu Employment Agreement, changing the terms of Mr.
Liu&#8217;s severance in the event of a change in control, as described below under the title &#8220;<i><span style="text-decoration: underline"><a href="#a_064">Potential
Payments upon Termination or Change in Control</a></span>.&#8221;</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Crolius</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
December 8, 2023, the Company entered an amended and restated letter agreement with Mr. Crolius (the &#8220;Crolius Letter Agreement&#8221;),
which superseded his previous employment arrangements. The Crolius Letter Agreement delineates the terms of Mr. Crolius&#8217;s employment:
he is entitled to a base salary of $320,000 per year (the &#8220;Crolius Base Salary&#8221;), a discretionary bonus, and other benefits
generally applicable to all employees of the Company. The Crolius Letter Agreement provides for the at-will employment of Mr. Crolius,
references the Company&#8217;s policies, and contains other customary conditions. The Crolius Base Salary was conditioned to be retroactively
effective as of November 1, 2023, and Mr. Crolius was entitled to receive a lump sum payment of the difference between the Crolius Base
Salary and the base salary pursuant to his previous employment arrangements. On April 15, 2025, the Company and Mr. Crolius amended the
Crolius Letter Agreement, changing the terms of Mr. Crolius&#8217;s severance in the event of a change in control, as described below
under the title &#8220;<a href="#a_064">Potential Payments upon Termination or Change in Control.</a>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Mr.
Becher</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On
August 23, 2022, the Company and Mr. Becher entered into a letter agreement (the &#8220;Becher Letter Agreement&#8221;), delineating
the terms of Mr. Becher&#8217;s employment: he is entitled to a guaranteed cash compensation of $400,000 per year consisting of a base
salary and a guaranteed minimum cash incentive compensation program, a discretionary bonus, and to other benefits generally applicable
to all employees of the Company. The Becher Letter Agreement provides for the at-will employment of Mr. Becher, references the Company&#8217;s
policies, and contains other customary conditions. The Becher Letter Agreement provides for variable compensation and a cash bonus plan
and also entitles Mr. Becher to receive options to purchase shares of our common stock (the &#8220;Becher Options&#8221;) as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">40,000
    options to purchase shares of our common stock vesting with respect to 25% of such options on the one-year anniversary of August
    29, 2022, and the remainder vesting in equal quarterly installments thereafter, each installment equal to 1/16 of the 40,000 options;
    and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">10,000
    options to purchase shares of our common stock per year over a four-year period, in the event that revenue targets are achieved,
    as determined by the board of directors.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-align: left; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Becher Options are subject to the terms and conditions of the EIP.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 35; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="a_064"></span>Potential
payments upon termination or change in control</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our NEOs is covered by arrangements that specify certain payments to be made in the event that the executive&#8217;s employment is
terminated in certain circumstances. These severance benefits are intended to reflect market practices and are designed to attract, retain,
and appropriately incentivize and further motivate them to contribute to our short- and long-term success for the benefit of our stockholders,
particularly during uncertain times. The severance benefits of all NEOs are subject to customary conditions and applicable tax and other
deductions and withholdings.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Liu
Employment Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we terminate Mr. Liu&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; (as defined therein) at any time
up to the twelve-month anniversary of the closing of a change in control, we must pay Mr. Liu a lump-sum cash severance payable within
30 days of his termination. Such severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    sum equivalent to one hundred fifty percent (150%) of his yearly base salary in effect as of his termination date, and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
    guaranteed pro-rated bonus. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Crolius
Letter Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we terminate Mr. Crolius&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; (as defined therein) at any
time up to the twelve-month anniversary of the closing of a change in control, we must pay Mr. Crolius a lump-sum cash severance payable
within 30 days of his termination. Such severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            sum equivalent to six (6) months of his base salary in effect as of his termination date;
                                            and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a
                                            guaranteed pro-rated bonus.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Becher
Letter Agreement</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
we terminate Mr. Becher&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; (as defined therein) outside
the context of a change in control, we must pay Mr. Becher a severance. Such severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six
    (6) months of salary continuation; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six
    (6) months of COBRA reimbursement. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">However,
if we terminate Mr. Becher&#8217;s employment without cause or if he resigns for &#8220;good reason&#8221; at any time up to the thirteen-month
anniversary of the closing of a change in control, the severance will consist of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 31.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">twelve
    (12) months of salary continuation; </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">six
    (6) months of COBRA reimbursement; and </span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">accelerated
    vesting of all unvested equity awards under the EIP that would have otherwise vested within four years of the termination date. </span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pension
benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
named executive officers did not participate in, or otherwise receive any benefits under, any pension or defined benefit retirement plan
sponsored by us during 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Nonqualified
deferred Compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
named executive officers did not participate in, or earn any benefits under, a nonqualified deferred compensation plan sponsored by us
during 2024.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 36; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Employee
benefit plans</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
believe that our ability to grant equity-based awards is a valuable and necessary compensation tool that aligns the long-term financial
interests of our executive officers with the financial interests of our stockholders. In addition, we believe that our ability to grant
options and other equity-based awards helps us to attract, retain and motivate executive officers and encourages them to devote their
best efforts to our business and financial success. Vesting of equity awards (other than awards granted in lieu of cash salary or bonus)
is generally tied to continuous service with us and serves as an additional retention measure. Our executive officers generally are awarded
an initial new hire grant upon commencement of employment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our named executive officers currently employed by us holds equity awards under our 2019 Equity Incentive Plan that were granted subject
to the general terms thereof and the applicable forms of award agreement thereunder. The specific vesting terms of each named executive
officer&#8217;s equity awards are described under &#8220;<i><span style="text-decoration: underline"><a href="#a_065">Outstanding equity awards at December 31, 2024</a>.</span></i>&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Prior
to our initial public offering, we granted all equity awards pursuant to our 2012 Equity Incentive Plan. We currently grant all equity
awards pursuant to our 2019 Equity Incentive Plan. All options are granted with a per share exercise price equal to no less than the
fair market value of a share of our common stock on the date of the grant. All options have a maximum term of up to 10 years from the
date of grant, subject to earlier expiration following the cessation of an executive officer&#8217;s continuous service with us.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Options
generally remain exercisable for three months following an executive officer&#8217;s termination, except in the event of a termination
for cause or due to disability or death. Restricted stock unit awards (&#8220;RSUs&#8221;) generally vest annually over 4 years (other
than awards granted in lieu of cash salary or bonus, which may be vested at grant), subject to the continued service with us through
each vesting date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Health
and welfare benefits</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
pay premiums for medical insurance, dental insurance, and vision insurance for all full-time employees, including our named executive
officers. These benefits are available to all full-time employees, subject to applicable laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>401(k)
Plan</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a defined contribution retirement plan that provides eligible U.S. employees with an opportunity to save for retirement on a
tax advantaged basis. Eligible employees may defer eligible compensation on a pre-tax, or after-tax, basis, up to the statutorily prescribed
annual limits on contributions under the U.S. Internal Revenue Code of 1986, as amended (the &#8220;Code&#8221;). Contributions are allocated
to each participant&#8217;s individual account and are then invested in selected investment alternatives according to the participants&#8217;
directions. Employees are immediately and fully vested in their contributions. The 401(k) plan is intended to be qualified under Section
401(a) of the Code with the 401(k) plan&#8217;s related trust intended to be tax exempt under Section 501(a) of the Code. As a tax-qualified
retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are
not taxable to the employees until withdrawn or distributed from the 401(k) plan. We currently provide a matching contribution under
the 401(k) plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Director
compensation</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth information regarding compensation earned during the year ended December 31, 2024, by our non-employee directors
who served as directors during such year. Mr. Liu, our Chief Executive Officer, serves on our board of directors but does not receive
compensation for his service as a director and the compensation paid to Mr. Liu for his service as an employee during the year ended
December 31, 2024, is set forth in the &#8220;<i><a href="#a_066">Summary compensation table</a></i>&#8221; above.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Name</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fees
                                            earned or</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Paid
                                            in Cash</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Stock</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>awards<sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Option</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>awards<sup>(1)</sup></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Total</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>($)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Current Directors</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#160;</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Michael Mulica<sup>(3)</sup></span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 11%; text-align: right">100,000</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 11%; text-align: right">160,000</td><td style="width: 1%; text-align: justify"><sup>&#8239;(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 11%; text-align: right">&#8212;</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 11%; text-align: right">260,000</td><td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jeffrey Wang<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">35,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: justify">&#8239;<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">95,000</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jack Steenstra<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">55,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: justify">&#8239;<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">115,000</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">James Cassano<sup>(3)</sup></span></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">55,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">60,000</td><td style="text-align: justify">&#8239;<sup>(2)</sup></td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">115,000</td><td style="text-align: justify">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    column reflects the full grant date fair value for stock awards granted during the year ended December 31, 2024 as measured pursuant
    to ASC Topic 718 as stock-based compensation in our consolidated financial statements. The grant date fair value of stock awards
    was based on the closing price per share of our common stock on the applicable grant date. These amounts do not necessarily correspond
    to the actual value that may be recognized from the stock awards by the non-employee directors.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Following
    the 2024 annual meeting of the Company&#8217;s stockholders, each non-employee director was awarded 7,895 RSUs on June 20, 2024 having
    a grant date fair value of $60,000.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
    of December 31, 2024, each non-employee director held the following number of unvested RSUs:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Mulica &#8212; 22,019; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Mr.
    Wang, Mr. Steenstra, and Mr. Cassano &#8212; 11,022.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 37; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Non-employee
director compensation policy</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
maintain a non-employee director compensation policy pursuant to which our non-employee directors are eligible to receive compensation
for service on our board of directors and committees of our board of directors. Our board of directors or Compensation Committee may
amend the non-employee director compensation policy from time to time. Effective as of January 1, 2024, our board of directors amended
and restated the Non-Employee Director Compensation Policy.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Equity
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
new non-employee director who joins our Board of Directors is granted an initial award of RSUs under the EIP, having a grant date fair
market value of $60,000. If a non-employee director is appointed or elected to our board of directors other than in connection with an
annual meeting of stockholders, then such non-employee director shall be awarded the full initial grant upon such non-employee director&#8217;s
appointment or election, and the annual grant to be awarded to such non-employee director at the first annual meeting of stockholders
following such appointment or election shall be pro-rated for the number of months served prior to such annual meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
of our non-employee directors continuing to serve on the board of directors also receives an annual equity award of RSUs under the EIP.
On June 20, 2024, Messrs. Mulica, Cassano, Steenstra, and Wang each received an RSU grant of 7,895 RSUs, having a grant date fair value
of $60,000, vesting in one installment on the earlier of the first anniversary of the grant date or immediately prior to the 2025 annual
meeting of stockholders.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
non-executive chairperson of our board of directors receives an additional annual equity award of RSUs having a grant date fair market
value of $50,000 under the EIP. On January 9, 2024, Mr. Mulica received an RSU grant related to his November 12, 2023 appointment to
non-executive chairperson of the board of directors of 6,668, retroactively adjusted for the Reverse Stock Split, vesting in one installment
on the anniversary of his appointment, having a grant date fair value of $50,000. On November 12, 2024, Mr. Mulica received an RSU grant
of 14,124 vesting in one installment on the first anniversary of the grant date, having a grant date fair value of $50,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
RSU award granted under the policy will fully vest upon a change of control or the non-employee director&#8217;s death or disability.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash
Compensation</i></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
non-employee director receives an annual cash retainer of $35,000 for serving on our board of directors. The non-executive chairperson
of our board of directors receives an additional annual cash retainer of $50,000.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
chairperson and members of the three principal standing committees of our board of directors are entitled to the following annual cash
retainers:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Board Committee</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; font-weight: bold">Chairperson Fee</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right; font-weight: bold">Member Fee</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 60%; text-align: justify">Audit Committee</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 16%; text-align: right">15,000</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 16%; text-align: right">7,500</td><td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Compensation Committee</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">10,000</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">5,000</td><td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Nominating and Corporate Governance Committee</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">7,500</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">3,750</td><td style="text-align: justify">&#160;</td></tr>
  </table>

<p style="font: 12pt/115% Arial, Helvetica, Sans-Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">All
annual cash compensation amounts will be payable in equal quarterly installments in arrears, pro-rated based on the days served in the
applicable fiscal quarter.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
also reimburse all reasonable out-of-pocket expenses incurred by non-employee directors for their attendance at meetings of our board
of directors or any committee thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 38; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->


<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="ni_001"></span>Equity
compensation plan information</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table provides certain information with respect to all of Sonim&#8217;s equity compensation plans in effect as of December
31, 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">Plan Category</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>to
                                            be Issued upon</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants
                                            and Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted-Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exercise
                                            Price of</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Outstanding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Options,</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Warrants
                                            and</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Rights</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Number
                                            of Securities</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining
                                            Available for Future</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Issuance
                                            Under Equity</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
                                            Plans (Excluding</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Securities
                                            Reflected in Column (a))</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)</b></span></p></td><td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">Equity compensation plans approved by security holders</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 12%; text-align: right">823,456</td><td style="width: 1%; text-align: justify"><sup>(1)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">6.4834</td><td style="width: 1%; text-align: justify"><sup>(2)</sup></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">&#160;</td><td style="width: 12%; text-align: right">424,871</td><td style="width: 1%; text-align: justify"><sup>(3)</sup></td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Equity compensation plans not approved by security holders</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">&#160;</td><td style="border-bottom: Black 1pt solid; text-align: right">&#8212;</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td>Total</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">823,456</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">6.4834</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">&#160;</td><td style="text-align: right">424,871</td><td style="text-align: justify">&#160;</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    aggregate number consists of the following:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-indent: -1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(i)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,301
    shares subject to options to purchase common stock issued pursuant to our 2012 Equity Incentive Plan as of December 31, 2024;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(ii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">754,193
    shares subject to options to purchase common stock issued pursuant to our 2019 Equity Incentive Plan as of December 31, 2024; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(iii)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">67,962
    shares issuable upon vesting of outstanding RSUs issued pursuant to our 2019 Equity Incentive Plan as of December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
    weighted average exercise price does not reflect shares that will be issued upon the vesting of outstanding RSUs.</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Includes
    404,047 shares authorized for future issuance under our 2019 Equity Incentive Plan and 20,824 shares authorized for future issuance
    under our 2019 Employee Stock Purchase Plan as of December 31, 2024.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2019 Employee Stock Purchase Plan, the number of shares of common stock reserved for issuance automatically increases on January
1 of each calendar year for 10 years, starting January 1, 2020, and ending on, and including, January 1, 2029, in an amount equal to
the lesser of 1% of the total number of shares of capital stock outstanding on December 31st of the prior calendar year, and (ii) 5,000
shares, unless the Board of Directors or Compensation Committee determines prior to such date that there will be a lesser increase, or
no increase. Effective January 1, 2025, 5,000 additional shares were added to the 2019 Employee Stock Purchase Plan, provided that such
shares have not been registered by means of filing a Registration Statement on Form S-8.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
the 2019 Equity Incentive Plan, the number of shares subject to outstanding stock options or other stock awards that were granted under
the 2012 Option Plan that are forfeited, terminated, expire, or are otherwise not issued are available for issuance. Additionally, the
number of shares of common stock reserved for issuance under the 2019 Equity Incentive Plan automatically increases on January 1 of each
calendar year for 10 years, starting January 1, 2020 and ending on and including January 1, 2029, in an amount equal to 5% of the total
number of shares of capital stock outstanding on December 31 of the prior calendar year, unless the board of directors or Compensation
Committee determines prior to the date of increase that there will be a lesser increase, or no increase. Effective January 1, 2025, 249,193
additional shares were added to the 2019 Equity Incentive Plan. Subject to certain express limits of the 2019 Equity Incentive Plan,
shares available for award purposes under the 2019 Equity Incentive Plan generally may be used for any type of award authorized under
that plan, including options, stock appreciation rights, restricted stock, RSUs, performance-based stock or cash awards or other similar
rights to purchase or acquire shares of our common stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 39; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Pay
versus performance</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As
required by Section 953(a) of the Dodd-Frank Wall Street Reform and Consumer Protection Act and Item 402(v) of Regulation S-K, we are
providing information about the relationship between executive compensation actually paid to our PEO and the non-PEO NEOs (as calculated
in accordance with Item 402(v) of Regulation S-K) and certain financial performance of the Company for each of the last three completed
fiscal years.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Pay
versus performance table</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000014" name="ecd:PvpTableTextBlock"><table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_z47h2QC5BAEg" summary="xdx: Disclosure - Pay vs Performance Disclosure" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Year<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48F_eecd--PeoTotalCompAmt_zPWYpX7BY1y4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary
    Compensation Table Total for PEO</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--PeoActuallyPaidCompAmt_z6QTbuWckXr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    Actually Paid to PEO <span><sup id="xdx_F5E_zlxExA700jh9">(2)(3)</sup></span></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zmX6tJNMchSa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average
    Summary Compensation Table Total for non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_482_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zK8qojNlOHC5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
    Compensation Actually Paid to non-PEO NEOs<span><sup id="xdx_F5D_zcAGgP7m0JGh">(2)(3)</sup></span></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zFsTtwURtV06" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value
    of Initial Fixed $100 Investment Based on Total Shareholder Return</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--NetIncomeLoss_pn4n6_zujGOLenNDSb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net
    Income $(M)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_419_20240101__20241231_z17raC7cefBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">2024 <span id="xdx_F4F_zKye9O5bypN8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000015" format="ixt:numdotdecimal" decimals="0" unitRef="USD">672,918</ix:nonFraction></td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000016" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,334</ix:nonFraction></td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000017" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,083</ix:nonFraction></td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000018" format="ixt:numdotdecimal" decimals="0" unitRef="USD">513,490</ix:nonFraction></td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2024-01-01to2024-12-31" id="Fact000019" format="ixt:numdotdecimal" decimals="2" unitRef="USD">34.23</ix:nonFraction></td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2024-01-01to2024-12-31" id="Fact000020" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">33.65</ix:nonFraction></td><td style="width: 1%; text-align: justify">)</td></tr>
  <tr id="xdx_411_20230101__20231231_zgepqSx6J0dd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023 <span id="xdx_F48_z39ZYnRz6Yy9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000021" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,266</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000022" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,136,138</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31" id="Fact000023" format="ixt:numdotdecimal" decimals="0" unitRef="USD">626,135</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31" id="Fact000024" format="ixt:numdotdecimal" decimals="0" unitRef="USD">688,442</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2023-01-012023-12-31" id="Fact000025" format="ixt:numdotdecimal" decimals="2" unitRef="USD">79.72</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2023-01-012023-12-31" id="Fact000026" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">0.09</ix:nonFraction></td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_419_20220101__20221231_z3t53rsJkoB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2022 <span id="xdx_F40_zr6nbVDxiDD5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000027" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,986,962</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000028" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,975,045</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31" id="Fact000029" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420,553</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31" id="Fact000030" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,019</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:TotalShareholderRtnAmt" contextRef="From2022-01-012022-12-31" id="Fact000031" format="ixt:numdotdecimal" decimals="2" unitRef="USD">46.08</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="us-gaap:NetIncomeLoss" contextRef="From2022-01-012022-12-31" id="Fact000032" format="ixt:numdotdecimal" decimals="-4" scale="6" sign="-" unitRef="USD">14.09</ix:nonFraction></td><td style="text-align: justify">)</td></tr>
  </table></ix:nonNumeric>

<p style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p><table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; width: 48px"><span id="xdx_F0A_zPQXMzgQtuGl" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_zMSvEzrWvW3e" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000033" xml:lang="en-US">The
    PEO in all reporting years is Hao (Peter) Liu. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</ix:footnote></span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; width: 48px"><span id="xdx_F0C_zhguKNClr2Sj" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1C_zwcOjN7hiTM" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000034" xml:lang="en-US">Amounts
    reflect Summary Compensation Table (&#8220;SCT&#8221;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</ix:footnote></span></td></tr>
</table>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; display: none; text-align: left; width: 48px"><span id="xdx_F05_zCM3WG1VRqub" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span id="xdx_F1B_z55mUfmXByJb" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><ix:footnote id="Footnote000035" xml:lang="en-US">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</ix:footnote></span></td></tr>
</table>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000037" name="ecd:NamedExecutiveOfficersFnTextBlock"><p id="xdx_894_eecd--NamedExecutiveOfficersFnTextBlock_dU_zJDYIFlhrccc" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    PEO in all reporting years is <span id="xdx_904_eecd--PeoName_c20220101__20221231_zWQXT0fWJXb1"><ix:nonNumeric contextRef="From2022-01-012022-12-31" id="Fact000038" name="ecd:PeoName">Hao (Peter) Liu</ix:nonNumeric></span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
    The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles Becher. The non-PEO NEOs in the 2022 reporting
    year are Clay Crolius, Charles Becher and Robert Tirva.</span></td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AD_zSGEfxo4XKpi" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amounts
    reflect Summary Compensation Table (&#8220;SCT&#8221;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</span></td></tr>
</table>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000040" name="ecd:AdjToPeoCompFnTextBlock"><p id="xdx_89F_eecd--AdjToPeoCompFnTextBlock_dU_zhtKAfqlD0A8" style="margin: 0">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zRmyg8yiJwW1" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zM8TeJ3zPbl8" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20241231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zeIEOg4C9Gbc" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PEO: Liu, Hao (Peter)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_403_eecd--PeoTotalCompAmt_z8wTlCOLAoNl" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember" id="Fact000042" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,986,962</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember" id="Fact000043" format="ixt:numdotdecimal" decimals="0" unitRef="USD">677,266</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:PeoTotalCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember" id="Fact000044" format="ixt:numdotdecimal" decimals="0" unitRef="USD">672,918</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_ziC9i9iwwajb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal
    Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000046" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">1,501,393</ix:nonFraction></td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000047" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000048" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zEx3ioprQtFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards
    Granted in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000050" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,445,577</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000051" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000052" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zRGNaL9ew0Ih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000054" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">2,346</ix:nonFraction></td><td style="text-align: justify">)</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000055" format="ixt:numdotdecimal" decimals="0" unitRef="USD">681,465</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000056" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">610,049</ix:nonFraction></td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zNrcz4FKd753" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000058" format="ixt:numdotdecimal" decimals="0" unitRef="USD">47,046</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000059" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000060" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zYpBRL2k8dIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000062" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">801</ix:nonFraction></td><td style="text-align: justify">)</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000063" format="ixt:numdotdecimal" decimals="0" unitRef="USD">777,407</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000064" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">197,203</ix:nonFraction></td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zziuWZWGhd5i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock
    Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000066" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000067" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000068" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_407_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_z1r5DOJCEK6g" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000070" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000071" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000072" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_401_eecd--PeoActuallyPaidCompAmt_z6sgagb5w35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember" id="Fact000074" format="ixt:numdotdecimal" decimals="0" unitRef="USD">1,975,045</ix:nonFraction></td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember" id="Fact000075" format="ixt:numdotdecimal" decimals="0" unitRef="USD">2,136,138</ix:nonFraction></td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">(<ix:nonFraction name="ecd:PeoActuallyPaidCompAmt" contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember" id="Fact000076" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">134,334</ix:nonFraction></td><td style="font-weight: bold; text-align: justify">)</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AA_z1PCABkBUfy7" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000078" name="ecd:AdjToNonPeoNeoCompFnTextBlock"><p id="xdx_89A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zLHcZwDFeuE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOgDLtqyoti" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zluQS9WxHLq2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zmt9hzDfbUWi" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eecd--NonPeoNeoAvgTotalCompAmt_zwsyvuSEQ4W3" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember" id="Fact000080" format="ixt:numdotdecimal" decimals="0" unitRef="USD">420,553</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember" id="Fact000081" format="ixt:numdotdecimal" decimals="0" unitRef="USD">626,135</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$<ix:nonFraction name="ecd:NonPeoNeoAvgTotalCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember" id="Fact000082" format="ixt:numdotdecimal" decimals="0" unitRef="USD">624,083</ix:nonFraction></td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zFzemYrirRga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal
    Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000084" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">87,981</ix:nonFraction></td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000085" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">78,760</ix:nonFraction></td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000086" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">44,676</ix:nonFraction></td><td style="width: 1%; text-align: justify">)</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zwNHF0PogJC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards
    Granted in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000088" format="ixt:numdotdecimal" decimals="0" unitRef="USD">48,383</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000089" format="ixt:numdotdecimal" decimals="0" unitRef="USD">91,269</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" id="Fact000090" format="ixt:numdotdecimal" decimals="0" unitRef="USD">19,886</ix:nonFraction></td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zWh8lRkfNPV3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000092" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000093" format="ixt:numdotdecimal" decimals="0" unitRef="USD">37,406</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" id="Fact000094" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">35,262</ix:nonFraction></td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zO92Vm5FeK7j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000096" format="ixt:numdotdecimal" decimals="0" unitRef="USD">38,115</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000097" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" id="Fact000098" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zD8Di9Vq7wCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000100" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">10,049</ix:nonFraction></td><td style="text-align: justify">)</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000101" format="ixt:numdotdecimal" decimals="0" unitRef="USD">12,392</ix:nonFraction></td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(<ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" id="Fact000102" format="ixt:numdotdecimal" decimals="0" sign="-" unitRef="USD">50,540</ix:nonFraction></td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zxjsv5Jo25E3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock
    Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000104" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000105" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000106" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zjNkJj75UDyf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000108" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000109" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right"><ix:nonFraction name="ecd:AdjToCompAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" id="Fact000110" format="ixt:numdotdecimal" decimals="0" unitRef="USD">0</ix:nonFraction></td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_40C_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zSQ8dUpTohCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember" id="Fact000112" format="ixt:numdotdecimal" decimals="0" unitRef="USD">409,019</ix:nonFraction></td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember" id="Fact000113" format="ixt:numdotdecimal" decimals="0" unitRef="USD">688,442</ix:nonFraction></td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right"><ix:nonFraction name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember" id="Fact000114" format="ixt:numdotdecimal" decimals="0" unitRef="USD">513,490</ix:nonFraction></td><td style="font-weight: bold; text-align: justify">&#160;</td></tr>
</table>

</ix:nonNumeric><p id="xdx_8AE_zWpmt7CnJDWd" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000116" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock"><p id="xdx_892_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKBM8YzztKd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and TSR</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s cumulative indexed Total Shareholder
Return (&#8220;TSR&#8221;) (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="formdef14a_004.jpg" alt="" style="width: 28px; height: 30px"/></span></p>

</ix:nonNumeric><p id="xdx_8A7_zNJbKpVQFbF3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<ix:nonNumeric contextRef="From2024-01-01to2024-12-31" escape="true" id="Fact000118" name="ecd:CompActuallyPaidVsNetIncomeTextBlock"><p id="xdx_891_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zrGuaEIDN0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and net income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s net income (loss) for the fiscal
years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="formdef14a_005.jpg" alt=""/></span></p>

</ix:nonNumeric><p id="xdx_8A1_ziH3R9BiXPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0in"></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_007"></span>SECURITY
OWNERSHIP OF CERTAIN</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BENEFICIAL
OWNERS AND MANAGEMENT</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Security
Ownership of Certain Beneficial Owners and Management</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
following table sets forth certain information with respect to the beneficial ownership of our common stock as of September 15,
2025, the record date for the Special Meeting, by:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our named executive officers;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            of our directors;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">all
                                            of our current directors and executive officers as a group; and</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif">&#160;</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each
                                            person known by us to be the beneficial owner of more than 5% of the outstanding shares of
                                            our common stock.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 1in; text-align: left; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have determined beneficial ownership in accordance with the rules of the SEC, and thus it represents sole or shared voting or investment
power with respect to our securities. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table
have sole voting and sole investment power with respect to all shares that they beneficially owned, subject to community property laws
where applicable. The information does not necessarily indicate beneficial ownership for any other purpose, including for purposes of
Sections 13(d) and 13(g) of the Securities Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We
have based our calculation of the percentage of beneficial ownership on 17,781,919 shares of our common stock outstanding as of September
15, 2025. In accordance with SEC rules, we have deemed shares of our common stock subject to stock options, warrants, or other
rights that are currently exercisable or exercisable within sixty (60) days of September 15, 2025, and shares of our common stock
underlying RSUs that are currently releasable or releasable within sixty (60) days of September 15, 2025 to be outstanding and
to be beneficially owned by the person holding the common stock options or RSUs for the purpose of computing the percentage ownership
of that person. We did not deem these shares outstanding, however, for the purpose of computing the percentage ownership of any other
person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Unless
otherwise indicated, the address of each beneficial owner listed in the table below is c/o Sonim Technologies, Inc., 4445 Eastgate Mall,
Suite 200, San Diego, CA 92121. The information provided in the table is based on our records, information filed with the SEC, and information
provided to us, except where otherwise noted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="vertical-align: bottom">
    <td>&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="6" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Shares Beneficially
    Owned</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="border-bottom: black 1pt solid"><span style="font-size: 10pt"><b>Beneficial Owner Name</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Number</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: black 1pt solid; text-align: center"><span style="font-size: 10pt"><b>Percentage</b></span></td>
    <td style="padding-bottom: 1pt">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt"><b>Directors and Named Executive Officers</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td style="width: 60%"><span style="font-size: 10pt">James Cassano</span></td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><span style="font-size: 10pt">49,126</span></td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 2%">&#160;</td>
    <td style="width: 1%">&#160;</td>
    <td style="width: 16%; text-align: right"><span style="font-size: 10pt">*</span></td>
    <td style="width: 1%">&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Peter Liu<sup>(1)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">514,528</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">2.85</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Mike Mulica</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">73,292</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Jack Steenstra</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">49,139</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">George Thangadurai</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">723</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Clay Crolius<sup>(2)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">66,625</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Charles Becher<sup>(3)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">80,168</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">*</span></td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">All current executive officers and directors as a group (7 persons)<sup>(4)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">833,601</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">4.61</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt"><b>Five Percent Holders</b></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right">&#160;</td>
    <td>&#160;</td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">AJP Holding Company, LLC<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,968,647</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11.07</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">Orbic North America, LLC<sup>(5)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,968,647</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">11.07</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">Laurence W. Lytton<sup>(6)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">987,465</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.55</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: white">
    <td><span style="font-size: 10pt">CVI Investments, Inc.<sup>(7)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,000,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.62</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom; background-color: #CCEEFF">
    <td><span style="font-size: 10pt">L1 Capital Global Opportunities Master Fund, Ltd.<sup>(8)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">1,000,000</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.62</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  <tr style="vertical-align: bottom">
    <td><span style="font-size: 10pt">1 Main Capital Management, LLC<sup>(9)</sup></span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">908,410</span></td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td>&#160;</td>
    <td style="text-align: right"><span style="font-size: 10pt">5.07</span></td>
    <td><span style="font-size: 10pt">%</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-size: 10pt">*</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Represents beneficial ownership of less than one percent (1%) of
    the outstanding shares of our common stock.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(1)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Includes options to purchase 245,140 shares of common stock exercisable
    within 60 days of September 15, 2025.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(2)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Includes options to purchase 35,667 shares of common stock exercisable
    within 60 days of September 15, 2025.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: -0.5in"></p>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: -0.5in">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0">
  <tr style="vertical-align: top">
    <td style="width: 0.5in"><span style="font-size: 10pt">(3)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Includes options to purchase 17,500 shares of common stock exercisable
    within 60 days of September 15, 2025.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(4)</span></td>
    <td style="text-align: justify"><span style="font-size: 10pt">Includes options to purchase 298,307 shares of common stock exercisable
    within 60 days of September 15, 2025.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(5)</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Based solely on (A) a Schedule 13D/A filed with the SEC on June 26, 2025
    (the &#8220;Orbic Group Report&#8221;), by the group consisting of (i) Jeffrey Wang, (ii) AJP Holding Company, LLC (&#8220;AJP&#8221;);
    (iii) Orbic North America, LLC (&#8220;Orbic); (iv) Ashima Narula, the sole member and manager of Orbic; and (v) Parveen Narula,
    the Chief Executive Officer of Orbic (collectively (i) through (v), the &#8220;Orbic Group&#8221;), and (B) Section 16 filings of
    Mr. Wang. Section 13(d) and Rule 13d-5 under the Exchange Act provide that, when two or more beneficial owners of a class of equity
    security registered under Section 12 agree to act together as a group for the purpose of voting equity securities of an issuer, the
    &#8220;group&#8221; will be deemed to have acquired beneficial ownership of all shares held by all members of the group. Consists
    of (i) 21,302 shares of common stock held directly by Mr. Wang (which were not disclosed in the Orbic Group Report), (ii)
    1,946,345 shares of common stock held by AJP (to which the members of the Orbic Group share voting and dispositive power),
    and (iii) 1,000 shares of common stock held by Orbic (to which the members of the Orbic Group share voting and dispositive power).
    The 1,946,345 shares held by AJP are subject to a proxy agreement by and between AJP and Orbic that limits AJP&#8217;s dispositive
    power and grants the voting power to Orbic. Mr. Wang is the sole manager of AJP. The principal office address or business of each
    member of the Orbic Group is as follows: (i) for AJP and Jeffrey Wang &#8212; P.O. Box 2729, Sunnyvale, CA 94087 and (ii) for Orbic,
    Ashima Narula, and Parveen Narula &#8212; 555 Wireless Blvd., Hauppauge, NY 11788.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(6)</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Based solely on the Schedule 13G/A filed with the SEC by Mr. Lytton
    on July 9, 2025. Mr. Lytton has (i) the sole voting and dispositive power with regard to 187,465 shares of common stock and (ii)
    shared voting and dispositive power with regard to 800,000 shares of common stock held by Lytton-Kambara Foundation (the &#8220;Foundation&#8221;),
    of which Mr. Lytton is the President. The amount does not include warrants to purchase 400,000 shares of common stock exercisable
    within 60 days of August 1, 2025, because the warrants are subject to a beneficial ownership limitation of 4.99%, which limitation
    restricts the holder from exercising that portion of the warrants that would result in the holder and its affiliates owning, after
    such exercise a number of shares of common stock in excess of the applicable beneficial ownership limitation. The address of Mr.
    Lytton and the Foundation is 467 Central Park West, New York, NY 10025.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(7)</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Based solely on the Schedule 13G filed with the SEC by CVI Investments,
    Inc. (&#8220;CVI&#8221;) on July 3, 2025. CVI has shared voting and dispositive power with regard to the entirety of the shares of
    common stock. Heights Capital Management, Inc. (&#8220;HCM&#8221;), the investment manager to CVI, is also reported to have shared
    voting and dispositive power with regard to the entirety of the shares of common stock. The address of CVI is: P.O. Box 309GT, Ugland
    House, South Church Street, George Town, Grand Cayman KY1-1104, Cayman Islands. The address of HCM is: 101 California Street, Suite
    3250, San Francisco, California 94111.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: left">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(8)</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Based solely on the Schedule 13G filed with the SEC by L1 Capital
    Global Opportunities Master Fund, Ltd. (&#8220;L1&#8221;) on July 7, 2025. L1 has sole voting and dispositive power with regard to
    the entirety of the shares of common stock. David Feldman and Joel Arber are the Directors of L1. The address of L1 is 161A Shedden
    Road, 1 Artillery Court, PO Box 10085, Grand Cayman, Cayman Islands KY1-1001.</span></td></tr>
  <tr style="vertical-align: top">
    <td>&#160;</td>
    <td style="text-align: justify">&#160;</td></tr>
  <tr style="vertical-align: top">
    <td><span style="font-size: 10pt">(9)</span></td>
    <td style="text-align: left"><span style="font-size: 10pt">Based solely on the Schedule 13G filed with the SEC by 1 Main Capital
    Management, LLC (&#8220;1 Main&#8221;) on September 4, 2025. 1 Main has sole voting and dispositive power with regard to the entirety
    of the shares of common stock, which includes 150,000 shares of common stock underlying warrants. 1 Main acts as the investment adviser
    to (i) 1 Main Capital Partners, L.P. (&#8220;Fund 1&#8221;), which holds 622,380 shares of common stock and 150,000 shares of common
    stock underlying warrants, and (ii) 2055 Partners L.P. (&#8220;Fund 2&#8221;), which holds 136,030 shares of common stock. Yaron
    Naymark is the Principal of 1 Main and has sole voting and dispositive power with regard to the entirety of the shares of 1 Main
    (held by Fund 1 and Fund 2). The address of 1 Main, Mr. Naymark, Fund 1, and Fund 2 is 8 Wright Street, Suite 107, Westport, Connecticut,
    06880.</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: -0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0.5in; text-align: left; text-indent: -0.5in"></p>


<!-- Field: Page; Sequence: 43; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_009"></span>OTHER
MATTERS</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_010"></span>Householding
of proxy materials</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">
&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
SEC has adopted rules that permit companies and intermediaries (<i>e.g.</i>, brokers) to satisfy the delivery requirements for notices
or proxy statements and annual reports with respect to two or more stockholders sharing the same address by delivering a single notice
or proxy statement and annual report addressed to those stockholders. This process is commonly referred to as &#8220;householding.&#8221;
This process benefits both stockholders and Sonim because it can significantly reduce our printing and mailing costs and eliminates unnecessary
mailings delivered to your home. It also helps the environment by conserving natural resources.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under
this procedure, we are delivering a single copy of the notice of Internet availability and, if applicable, the proxy materials to multiple
stockholders who share the same address unless we received contrary instructions from the impacted stockholders prior to the mailing
date. Stockholders who participate in householding will continue to be able to access and receive separate proxy cards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon
written or oral request, we will deliver promptly a separate copy of a separate copy of the annual report to security holders,
proxy statement, or notice of internet availability of proxy materials, as applicable, to any stockholder at a shared address to
which we delivered a single copy of any of these documents. To receive a separate copy of a separate copy of the annual report to
security holders, proxy statement, or notice of internet availability of proxy materials, as applicable, stockholders may contact
our Secretary by written request to Sonim Technologies, Inc., 4445 Eastgate Mall, Suite 200, San Diego, CA 92121, or at (650) 378-8100.
The same phone number and addresses may be used to notify us that you wish to receive a separate set of proxy materials in the future,
or to request delivery of a single copy of our proxy materials if you are receiving multiple copies.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_011"></span>Stockholder
proposals for the 2026 annual meeting of stockholders</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Rule
14a-8 of the Exchange Act</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
a stockholder would like us to consider including a proposal in our proxy statement for our 2026 annual meeting pursuant to Rule 14a-8
of the Exchange Act, then the proposal must be received by our Secretary at our principal executive offices on or before February 18,
2026. In addition, stockholder proposals must comply with the requirements of Rule 14a-8 regarding the inclusion of stockholder proposals
in company-sponsored proxy materials. Proposals should be addressed to:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Attention:
Secretary</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4445
Eastgate Mall, Suite 200</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">San
Diego, CA 92121</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Advance
notice procedure</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our
amended and restated bylaws also establish an advance notice procedure for stockholders who wish to present a proposal or nominate a
director at an annual meeting, but do not seek to include the proposal or director nominee in our proxy statement. In order to be properly
brought before our 2026 annual meeting of stockholders under the advance notice provisions of our amended and restated bylaws, the stockholder
must provide timely written notice that must be received by the Secretary at the principal executive offices of the Company, and any
such proposal or nomination must constitute a proper matter for stockholder action. The written notice must contain the information specified
in our amended and restated bylaws. To be timely, a stockholder&#8217;s written notice must be received by the Secretary at the principal
executive offices of the Company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    earlier than the close of business, on March 20, 2026; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    later than the close of business on April 19, 2026.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span>&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"></p>


<!-- Field: Page; Sequence: 44; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
the event that we hold our 2026 annual meeting more than 30 days before or more than 30 days after the first anniversary of the 2025
annual meeting, then written notice required by our amended and restated bylaws must be received by the Secretary at the principal
executive offices of the Company:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    earlier than the close of business on the 120th day prior to the day of the 2026 annual meeting of stockholders; and</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">no
    later than the later of</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.75in; text-indent: -0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    close of business on the 90th day before the 2026 annual meeting of stockholders; or</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">the
    close of business on the 10th day following the day on which the public announcement of the date of the 2026 annual meeting of stockholders
    was first made by us.</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify; text-indent: -0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;Public
announcement&#8221; means disclosure in a press release reported by the Dow Jones News Service, Associated Press, or comparable national
news service or in a document publicly filed by the Company with the SEC pursuant to Section 13, 14 or 15(d) of the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition to satisfying the foregoing requirements of our bylaws, to comply with Rule 14a-19 under the Exchange Act (the universal proxy
rules), stockholders who intend to solicit proxies in support of director nominees other than our nominees for our 2025 annual meeting
of stockholders must also comply with the additional requirements of Rule 14a-19 under the Exchange Act, including providing a statement
that such stockholder intends to solicit the holders of shares representing at least 67% of the voting power of the Company&#8217;s shares
entitled to vote on the election of directors in support of director nominees other than the Company&#8217;s nominees, as required by
Rule 14a-19(b) under the Exchange Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left; text-indent: 0.5in">&#160;</p>



<!-- Field: Page; Sequence: 45; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_013"></span>ANNEX
A</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT TO THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMENDED
AND RESTATED CERTIFICATE OF INCORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF
SONIM TECHNOLOGIES, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under the General Corporation Law of the State
of Delaware, hereby certifies as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 4.5pt; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
This Certificate of Amendment (the &#8220;Certificate of Amendment&#8221;) amends the provisions of the Corporation&#8217;s Amended and
Restated Certificate of Incorporation, as amended to date, filed with the Secretary of State of the State of Delaware on May 14, 2019
(the &#8220;Amended and Restated Certificate of Incorporation&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Article IV, Paragraph A of the Amended and Restated Certificate of Incorporation is hereby amended and restated in its entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">&#8220;A.&#160;&#160;&#160;&#160;This
</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Company <span style="background-color: white">is
authorized to issue two classes of stock to be designated, respectively, &#8220;<b><i>Common Stock</i></b>&#8221; and &#8220;<b><i>Preferred
Stock</i></b>.&#8221; The total number of shares which the </span>Company <span style="background-color: white">is authorized to
issue is 105,000,000 shares. 100,000,000 shares shall be Common Stock, having a par value per share of $0.001, and 5,000,000 shares shall
be Preferred Stock, having a par value per share of $0.001.</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-indent: 0in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
as of [&#9679;] Eastern Time on [date] (the &#8220;Effective Time&#8221;), every [&#9679;] shares of Common Stock issued and outstanding
prior to the Effective Time shall, automatically and without further action by the Corporation or the holders thereof, be combined and
converted into one (1) share of Common Stock (the &#8220;Reverse Split&#8221;); provided, however, no fractional shares of Common Stock
shall be issued in connection with the Reverse Split, and instead, <span style="background-color: white">the </span>Corporation shall
pay to the stockholder of such fractional share a sum in cash equal to such fraction multiplied by the closing sales price of Common
Stock as reported on the Nasdaq Capital Market on the date this Certificate of Amendment to the Amended and Restated Certificate of Incorporation
is filed with the Secretary of State of the State of Delaware.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
This amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
All other provisions of the Amended and Restated Certificate of Incorporation shall remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by [&#9679;], its [&#9679;], this [date].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"></p>

<!-- Field: Page; Sequence: 46; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">A-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_014"></span>ANNEX
B</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF AMENDMENT TO THE</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AMENDED
AND RESTATED</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>CERTIFICATE
OF INCORPORATION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>OF
SONIM TECHNOLOGIES, INC.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sonim
Technologies, Inc. (the &#8220;Corporation&#8221;), a corporation organized and existing under the General Corporation Law of the State
of Delaware, hereby certifies as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.
This Certificate of Amendment (the &#8220;Certificate of Amendment&#8221;) amends the provisions of the Corporation&#8217;s Amended and
Restated Certificate of Incorporation, as amended to date, filed with the Secretary of State of the State of Delaware on May 14, 2019
(the &#8220;Amended and Restated Certificate of Incorporation&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
Article IV, Paragraph A of the Amended and Restated Certificate of Incorporation is hereby amended and restated in its entirety as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8220;A.
This Company is authorized to issue two classes of stock to be designated, respectively, &#8220;<b><i>Common Stock</i></b>&#8221; and
&#8220;<b><i>Preferred Stock</i></b>.&#8221; The total number of shares which the Company is authorized to issue is 1,005,000,000 shares.
1,000,000,000 shares shall be Common Stock, having a par value per share of $0.001 and 5,000,000 shares shall be Preferred Stock, having
a par value per share of $0.001.&#8221;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.
This amendment was duly adopted in accordance with the provisions of Section 242 of the General Corporation Law of the State of Delaware.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
All other provisions of the Amended and Restated Certificate of Incorporation shall remain in full force and effect.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by [&#9679;], its [&#9679;], this [date].</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 47; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">B-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="aab_015"></span>ANNEX
C</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Sonim
Technologies, Inc.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>Amended
and Restated 2019 Equity Incentive Plan</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Adopted
by the Board of Directors: March 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: May 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">IPO
Date/Effective Date: May 9, 2019</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: May 31, 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: September 29, 2020</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Restated
to illustrate the effect of the reverse stock split: September 15, 2021</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: September 15, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: October 26, 2022</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: August 14, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: September 28, 2023</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: May 17, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: June 20, 2024</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amended
by the Board of Directors: September 18, 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Approved
by the Stockholders: [XX], 2025</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>1.
General.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Successor to and Continuation of Prior Plan.</b> The Plan is the successor to and continuation of the Sonim Technologies, Inc. 2012 Equity
Incentive Plan (the &#8220;<b><i>Prior Plan</i></b>&#8221;). From and after 12:01 a.m. Pacific Time on the Effective Date, no additional
stock awards will be granted under the Prior Plan. All Awards granted on or after 12:01 a.m. Pacific Time on the Effective Date will
be granted under this Plan. All stock awards granted under the Prior Plan will remain subject to the terms of the Prior Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>Any shares that would otherwise remain available for future grants under the Prior Plan as of 12:01 a.m. Pacific Time on the Effective
Date (the &#8220;<b><i>Prior Plan&#8217;s Available Reserve</i></b>&#8221;) will cease to be available under the Prior Plan at such time.
Instead, that number of shares of Common Stock equal to the Prior Plan&#8217;s Available Reserve will be added to the Share Reserve (as
further described in Section 3(a) below) and will be immediately available for grants and issuance pursuant to Stock Awards hereunder,
up to the maximum number set forth in Section 3(a) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>In addition, from and after 12:01 a.m. Pacific Time on the Effective Date, with respect to the aggregate number of shares of Common
Stock subject, at such time, to outstanding stock awards granted under the Prior Plan that (1) expire or terminate for any reason prior
to exercise; (2) are forfeited or repurchased because of the failure to meet a contingency or condition required to vest such shares
or otherwise return to the Company; or (3) are reacquired, withheld (or not issued) to satisfy a tax withholding obligation in connection
with an award (such shares the &#8220;<b><i>Returning Shares</i></b>&#8221;) will immediately be added to the Share Reserve as shares
of Common Stock (as further described in Section 3(a) below) as and when such a share becomes a Returning Share, up to the maximum number
set forth in Section 3(a) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Eligible Award Recipients.</b> Employees, Directors and Consultants are eligible to receive Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Available Awards.</b> The Plan provides for the grant of the following Awards: (i) Incentive Stock Options, (ii) Nonstatutory Stock Options,
(iii) Stock Appreciation Rights, (iv) Restricted Stock Awards, (v) Restricted Stock Unit Awards, (vi) Performance Stock Awards, (vii)
Performance Cash Awards, and (viii) Other Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Purpose.</b> The Plan, through the grant of Awards, is intended to help the Company secure and retain the services of eligible award
recipients, provide incentives for such persons to exert maximum efforts for the success of the Company and any Affiliate, and provide
a means by which the eligible recipients may benefit from increases in value of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>2.
Administration.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Administration by Board.</b> The Board will administer the Plan. The Board may delegate administration of the Plan to a Committee or
Committees, as provided in Section 2(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 48; Options: NewSection; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Powers of Board.</b> The Board will have the power, subject to, and within the limitations of, the express provisions of the Plan:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>To determine: (A) who will be granted Awards; (B) when and how each Award will be granted; (C) what type of Award will be granted;
(D) the provisions of each Award (which need not be identical), including when a person will be permitted to exercise or otherwise receive
cash or Common Stock under the Award; (E) the number of shares of Common Stock subject to, or the cash value of, an Award; and (F) the
Fair Market Value applicable to a Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>To construe and interpret the Plan and Awards granted under it, and to establish, amend and revoke rules and regulations for administration
of the Plan and Awards. The Board, in the exercise of these powers, may correct any defect, omission or inconsistency in the Plan or
in any Award Agreement or in the written terms of a Performance Cash Award, in a manner and to the extent it will deem necessary or expedient
to make the Plan or Award fully effective.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>To settle all controversies regarding the Plan and Awards granted under it.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>To accelerate, in whole or in part, the time at which an Award may be exercised or vest (or the time at which cash or shares of Common
Stock may be issued in settlement thereof).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>To suspend or terminate the Plan at any time. Except as otherwise provided in the Plan or an Award Agreement, suspension or termination
of the Plan will not impair a Participant&#8217;s rights under the Participant&#8217;s then-outstanding Award without the Participant&#8217;s
written consent, except as provided in subsection (viii) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vi)
</b>To amend the Plan in any respect the Board deems necessary or advisable, including, without limitation, by adopting amendments relating
to Incentive Stock Options and certain nonqualified deferred compensation under Section 409A of the Code and/or to make the Plan or Awards
granted under the Plan compliant with the requirements for Incentive Stock Options or exempt from, or compliant with, the requirements
for nonqualified deferred compensation under Section 409A of the Code, subject to the limitations, if any, of applicable law. If required
by applicable law or listing requirements, and except as provided in Section 9(a) relating to Capitalization Adjustments, the Company
will seek stockholder approval of any amendment of the Plan that (A) materially increases the number of shares of Common Stock available
for issuance under the Plan, (B) materially expands the class of individuals eligible to receive Awards under the Plan, (C) materially
increases the benefits accruing to Participants under the Plan, (D) materially reduces the price at which shares of Common Stock may
be issued or purchased under the Plan, (E) materially extends the term of the Plan, or (F) materially expands the types of Awards available
for issuance under the Plan. Except as provided in the Plan (including subsection (viii) below) or an Award Agreement, no amendment of
the Plan will impair a Participant&#8217;s rights under an outstanding Award unless (1) the Company requests the consent of the affected
Participant, and (2) such Participant consents in writing.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vii)
</b>To submit any amendment to the Plan for stockholder approval, including, but not limited to, amendments to the Plan intended to satisfy
the requirements of (A) Section 422 of the Code regarding &#8220;incentive stock options&#8221; or (B) Rule 16b-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(viii)
</b>To approve forms of Award Agreements for use under the Plan and to amend the terms of any one or more Awards, including, but not
limited to, amendments to provide terms more favorable to the Participant than previously provided in the Award Agreement, subject to
any specified limits in the Plan that are not subject to Board discretion; <i>provided, however,</i> that a Participant&#8217;s rights
under any Award will not be impaired by any such amendment unless (A) the Company requests the consent of the affected Participant, and
(B) such Participant consents in writing. Notwithstanding the foregoing, (1) a Participant&#8217;s rights will not be deemed to have
been impaired by any such amendment if the Board, in its sole discretion, determines that the amendment, taken as a whole, does not materially
impair the Participant&#8217;s rights, and (2) subject to the limitations of applicable law, if any, the Board may amend the terms of
any one or more Awards without the affected Participant&#8217;s consent (A) to maintain the qualified status of the Award as an Incentive
Stock Option under Section 422 of the Code; (B) to change the terms of an Incentive Stock Option, if such change results in impairment
of the Award solely because it impairs the qualified status of the Award as an Incentive Stock Option under Section 422 of the Code;
(C) to clarify the manner of exemption from, or to bring the Award into compliance with, Section 409A of the Code; or (D) to comply with
other applicable laws or listing requirements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ix)
</b>Generally, to exercise such powers and to perform such acts as the Board deems necessary or expedient to promote the best interests
of the Company and that are not in conflict with the provisions of the Plan or Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"></p>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(x)
</b>To adopt such rules, procedures and sub-plans related to the operation and administration of the Plan as are necessary or appropriate
under local laws and regulations to permit participation in the Plan by Employees, Directors or Consultants who are foreign nationals
or employed outside the United States (provided that Board approval will not be necessary for immaterial modifications to the Plan or
any Award Agreement made to ensure or facilitate compliance with the laws or regulations of the relevant foreign jurisdiction).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(xi)
</b>To effect, with the consent of any adversely affected Participant, (A) the reduction of the exercise, purchase or strike price of
any outstanding Stock Award; (B) the cancellation of any outstanding Stock Award and the grant in substitution therefor of a new (1)
Option or SAR, (2) Restricted Stock Award, (3) Restricted Stock Unit Award, (4) Other Stock Award, (5) cash and/or (6) other valuable
consideration determined by the Board, in its sole discretion, with any such substituted award (x) covering the same or a different number
of shares of Common Stock as the cancelled Stock Award and (y) granted under the Plan or another equity or compensatory plan of the Company;
or (C) any other action that is treated as a repricing under generally accepted accounting principles (collectively (A) through (C),
an &#8220;<b><i>Exchange Program</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Delegation to Committee</b>.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
General. </b>The Board may delegate some or all of the administration of the Plan to a Committee or Committees. If administration of
the Plan is delegated to a Committee, the Committee will have, in connection with the administration of the Plan, the powers theretofore
possessed by the Board that have been delegated to the Committee, including the power to delegate to a subcommittee of the Committee
any of the administrative powers the Committee is authorized to exercise (and references in this Plan to the Board will thereafter be
to the Committee or subcommittee, as applicable). Any delegation of administrative powers will be reflected in resolutions, not inconsistent
with the provisions of the Plan, adopted from time to time by the Board or Committee (as applicable). The Board may retain the authority
to concurrently administer the Plan with the Committee and may, at any time, revest in the Board some or all of the powers previously
delegated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Rule 16b-3 Compliance. </b>The Committee may consist solely of two or more Non-Employee Directors, in accordance with Rule 16b-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Delegation to an Officer.</b> The Board may delegate to one (1) or more Officers the authority to do one or both of the following (i)
designate Employees who are not Officers to be recipients of Options and SARs (and, to the extent permitted by applicable law, other
Stock Awards) and, to the extent permitted by applicable law, the terms of such Awards, and (ii) determine the number of shares of Common
Stock to be subject to such Stock Awards granted to such Employees; <i>provided, however</i>, that the Board resolutions regarding such
delegation will specify the total number of shares of Common Stock that may be subject to the Stock Awards granted by such Officer and
that such Officer may not grant a Stock Award to himself or herself. Any such Stock Awards will be granted on the form of Stock Award
Agreement most recently approved for use by the Committee or the Board, unless otherwise provided in the resolutions approving the delegation
authority. The Board may not delegate authority to an Officer who is acting solely in the capacity of an Officer (and not also as a Director)
to determine the Fair Market Value pursuant to Section 13(x)(iii) below.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
<td style="font: 10pt Times New Roman, Times, Serif; width: 72pt"/><td style="font: 10pt Times New Roman, Times, Serif; width: 27.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Effect
                                            of Board&#8217;s Decision.</b> All determinations, interpretations and constructions made
                                            by the Board in good faith will not be subject to review by any person and will be final,
                                            binding and conclusive on all persons.</span></td></tr></table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>3.
Shares Subject to the Plan.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Share Reserve.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>Subject to Section 9(a) relating to Capitalization Adjustments, and the following sentence regarding the annual increase, the aggregate
number of shares of Common Stock that may be issued pursuant to Stock Awards will not exceed 2,874,054, which number is the sum of:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(A)
18,851 shares that were approved in connection with the initial adoption of the Plan on the Effective Date; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(B)
the number of shares that remained available for issuance under the Prior Plan&#8217;s Available Reserve as of the initial adoption of
the Plan on the Effective Date; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(C)
the Returning Shares, if any, which become available for grant under this Plan from time to time; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(D)
30,000 shares that were approved at the Company&#8217;s 2020 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(E)
the entirety of the evergreen increases under the Plan; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(F)
500,000 shares approved at the Company&#8217;s 2022 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(G)
200,000 shares approved at the Company&#8217;s 2023 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(H)
300,000 shares approved at the Company&#8217;s 2024 Annual Meeting of Stockholders; plus</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(I)
1,000,000 shares approved at the Company&#8217;s 2025 Annual Meeting of Stockholders</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(such
aggregate number of shares described in (A) through (H) above, the &#8220;<b><i>Share Reserve</i></b>&#8221;).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In
addition, the Share Reserve will automatically increase on January 1st of each calendar year, beginning on January 1 in the calendar
year following the calendar year in which the IPO Date occurs and ending on (and including) January 1, 2029 (each, an &#8220;<b><i>Evergreen
Date</i></b>&#8221;) in an amount equal to five percent (5%) of the total number of shares of Capital Stock outstanding on the last day
of the preceding calendar year. Notwithstanding the foregoing, the Board may act prior to the Evergreen Date of a given year to provide
that there will be no increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser
number of shares of Common Stock than would otherwise occur pursuant to the preceding sentence.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>For clarity, the Share Reserve in this Section 3(a) is a limitation on the number of shares of Common Stock that may be issued pursuant
to the Plan. As a single share may be subject to grant more than once (<i>e.g.</i>, if a share subject to a Stock Award is forfeited,
it may be made subject to grant again as provided in Section 3(b) below), the Share Reserve is not a limit on the number of Stock Awards
that can be granted.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>Shares may be issued in connection with a merger or acquisition as permitted by NASDAQ Listing Rule 5635(c) or, if applicable, NYSE
Listed Company Manual Section 303A.08, AMEX Company Guide Section 711 or other applicable rule, and such issuance will not reduce the
number of shares available for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Reversion of Shares to the Share Reserve.</b> If a Stock Award or any portion thereof (i) expires or otherwise terminates without all
of the shares covered by such Stock Award having been issued or (ii) is settled in cash (<i>i.e.</i>, the Participant receives cash rather
than stock), such expiration, termination or settlement will not reduce (or otherwise offset) the number of shares of Common Stock that
may be available for issuance under the Plan. If any shares of Common Stock issued pursuant to a Stock Award are forfeited back to or
repurchased by the Company because of the failure to meet a contingency or condition required to vest such shares in the Participant
or shares of Common Stock that are surrendered to the Company pursuant to an Exchange Program, then the shares that are forfeited, repurchased
or so surrendered will again become available for issuance under the Plan. Any shares reacquired by the Company in satisfaction of tax
withholding obligations on a Stock Award or as consideration for the exercise or purchase price of a Stock Award will again become available
for issuance under the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b></b></span></p>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Incentive Stock Option Limit.</b> Subject to the provisions of Section 9(a) relating to Capitalization Adjustments, the aggregate maximum
number of shares of Common Stock that may be issued pursuant to the exercise of Incentive Stock Options will be a number of shares of
Common Stock equal to three (3) multiplied by the Share Reserve.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Limitation on Compensation of Non-Employee Directors.</b> During any one calendar year, no Non-Employee Director may receive Stock Awards
under the Plan that, when combined with cash compensation received for service as a Non-Employee Director, exceeds $600,000 in a calendar
year, increased to $1,000,000 in the calendar year of his or her initial services as a Non-Employee Director (calculating the value of
any such Stock Awards based on the grant date fair value of such Stock Awards for financial reporting purposes). Stock Awards granted
to an individual while he or she was serving in the capacity as an Employee or Consultant but not a Non-Employee Director will not count
for purposes of the limitations set forth in this Section 3(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Source of Shares.</b> The stock issuable under the Plan will be shares of authorized but unissued or reacquired Common Stock, including
shares repurchased by the Company on the open market or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>4.
Eligibility.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Eligibility for Specific Stock Awards.</b> Incentive Stock Options may be granted only to employees of the Company or a &#8220;parent
corporation&#8221; or &#8220;subsidiary corporation&#8221; thereof (as such terms are defined in Sections 424(e) and 424(f) of the Code).
Stock Awards other than Incentive Stock Options may be granted to Employees, Directors and Consultants; <i>provided, however</i>, that
Stock Awards may not be granted to Employees, Directors and Consultants who are providing Continuous Service only to any &#8220;parent&#8221;
of the Company, as such term is defined in Rule 405 of the Securities Act, unless (i) the stock underlying such Stock Awards is treated
as &#8220;service recipient stock&#8221; under Section 409A of the Code (for example, because the Stock Awards are granted pursuant to
a corporate transaction such as a spin off transaction), (ii) the Company, in consultation with its legal counsel, has determined that
such Stock Awards are otherwise exempt from Section 409A of the Code, or (iii) the Company, in consultation with its legal counsel, has
determined that such Stock Awards comply with the requirements of Section 409A of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Ten Percent Stockholders. </b>A Ten Percent Stockholder will not be granted an Incentive Stock Option unless the exercise price of such
Option is at least 110% of the Fair Market Value on the date of grant and the Option is not exercisable after the expiration of five
years from the date of grant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>5.
Provisions Relating to Options and Stock Appreciation Rights.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each
Option or SAR will be in such form and will contain such terms and conditions as the Board deems appropriate. All Options will be separately
designated Incentive Stock Options or Nonstatutory Stock Options at the time of grant, and, if certificates are issued, a separate certificate
or certificates will be issued for shares of Common Stock purchased on exercise of each type of Option. If an Option is not specifically
designated as an Incentive Stock Option, or if an Option is designated as an Incentive Stock Option but some portion or all of the Option
fails to qualify as an Incentive Stock Option under the applicable rules, then the Option (or portion thereof) will be a Nonstatutory
Stock Option. The provisions of separate Options or SARs need not be identical; <i>provided, however</i>, that each Award Agreement will
conform to (through incorporation of provisions hereof by reference in the applicable Award Agreement or otherwise) the substance of
each of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Term.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, no Option or SAR will be exercisable after the
expiration of ten years from the date of its grant or such shorter period specified in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Exercise Price.</b> Subject to the provisions of Section 4(b) regarding Ten Percent Stockholders, the exercise or strike price of each
Option or SAR will be not less than 100% of the Fair Market Value of the Common Stock subject to the Option or SAR on the date the Award
is granted. Notwithstanding the foregoing, an Option or SAR may be granted with an exercise or strike price lower than 100% of the Fair
Market Value of the Common Stock subject to the Award if such Award is granted pursuant to an assumption of or substitution for another
option or stock appreciation right pursuant to a Corporate Transaction and in a manner consistent with the provisions of Section 409A
of the Code and, if applicable, Section 424(a) of the Code. Each SAR will be denominated in shares of Common Stock equivalents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Purchase Price for Options.</b> The purchase price of Common Stock acquired pursuant to the exercise of an Option may be paid, to the
extent permitted by applicable law and as determined by the Board in its sole discretion, by any combination of the methods of payment
set forth below. The Board will have the authority to grant Options that do not permit all of the following methods of payment (or otherwise
restrict the ability to use certain methods) and to grant Options that require the consent of the Company to use a particular method
of payment. The permitted methods of payment are as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>by cash, check, bank draft or money order payable to the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>pursuant to a program developed under Regulation T as promulgated by the Federal Reserve Board that, prior to the issuance of the
stock subject to the Option, results in either the receipt of cash (or check) by the Company or the receipt of irrevocable instructions
to pay the aggregate exercise price to the Company from the sales proceeds;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>by delivery to the Company (either by actual delivery or attestation) of shares of Common Stock;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>if an Option is a Nonstatutory Stock Option, by a &#8220;net exercise&#8221; arrangement pursuant to which the Company will reduce
the number of shares of Common Stock issuable upon exercise by the largest whole number of shares with a Fair Market Value that does
not exceed the aggregate exercise price; <i>provided, however</i>, that the Company will accept a cash or other payment from the Participant
to the extent of any remaining balance of the aggregate exercise price not satisfied by such reduction in the number of whole shares
to be issued. Shares of Common Stock will no longer be subject to an Option and will not be exercisable thereafter to the extent that
(A) shares issuable upon exercise are used to pay the exercise price pursuant to the &#8220;net exercise,&#8221; (B) shares are delivered
to the Participant as a result of such exercise, and (C) shares are withheld to satisfy tax withholding obligations; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>in any other form of legal consideration that may be acceptable to the Board and specified in the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Exercise and Payment of a SAR.</b> To exercise any outstanding SAR, the Participant must provide written notice of exercise to the Company
in compliance with the provisions of the Stock Appreciation Right Agreement evidencing such SAR. The appreciation distribution payable
on the exercise of a SAR will be not greater than an amount equal to the excess of (A) the aggregate Fair Market Value (on the date of
the exercise of the SAR) of a number of shares of Common Stock equal to the number of Common Stock equivalents in which the Participant
is vested under such SAR, and with respect to which the Participant is exercising the SAR on such date, over (B) the aggregate strike
price of the number of Common Stock equivalents with respect to which the Participant is exercising the SAR on such date. The appreciation
distribution may be paid in Common Stock, in cash, in any combination of the two or in any other form of consideration, as determined
by the Board and contained in the Award Agreement evidencing such SAR.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Transferability of Options and SARs.</b> The Board may, in its sole discretion, impose such limitations on the transferability of Options
and SARs as the Board will determine. In the absence of such a determination by the Board to the contrary, the following restrictions
on the transferability of Options and SARs will apply:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Restrictions on Transfer. </b>An Option or SAR will not be transferable except by will or by the laws of descent and distribution (or
pursuant to subsections (ii) and (iii) below), and will be exercisable during the lifetime of the Participant only by the Participant.
The Board may permit transfer of the Option or SAR in a manner that is not prohibited by applicable laws or regulations. Except as explicitly
provided in the Plan, neither an Option nor a SAR may be transferred for consideration.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Domestic Relations Orders. </b>Subject to the approval of the Board or a duly authorized Officer, an Option or SAR may be transferred
pursuant to the terms of a domestic relations order, official marital settlement agreement or other divorce or separation instrument
as permitted by Treasury Regulations Section 1.421-1(b)(2) or comparable non-U.S. law. If an Option is an Incentive Stock Option, such
Option may be deemed to be a Nonstatutory Stock Option as a result of such transfer.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"></p>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Beneficiary Designation. </b>Subject to the approval of the Board or a duly authorized Officer, a Participant may, by delivering written
notice to the Company or to any third party designated by the Company, in a form approved by the Company (or the designated broker),
designate a third party who, upon the death of the Participant, will thereafter be entitled to exercise the Option or SAR and receive
the Common Stock or other consideration resulting from such exercise. In the absence of such a designation, upon the death of the Participant,
the executor or administrator of the Participant&#8217;s estate or the Participant&#8217;s legal heirs will be entitled to exercise the
Option or SAR and receive the Common Stock or other consideration resulting from such exercise. However, the Company may prohibit designation
of a beneficiary at any time, including due to any conclusion by the Company that such designation would be inconsistent with the provisions
of applicable laws.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
Vesting Generally.</b> The total number of shares of Common Stock subject to an Option or SAR may vest and become exercisable in periodic
installments that may or may not be equal. The Option or SAR may be subject to such other terms and conditions on the time or times when
it may or may not be exercised (which may be based on the satisfaction of Performance Goals or other criteria) as the Board may deem
appropriate. The vesting provisions of individual Options or SARs may vary. The provisions of this Section 5(f) are subject to any Option
or SAR provisions governing the minimum number of shares of Common Stock as to which an Option or SAR may be exercised.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)
Termination of Continuous Service.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the
Participant and the Company, if a Participant&#8217;s Continuous Service terminates (other than for Cause and other than upon the Participant&#8217;s
death or Disability), the Participant may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise
such Award as of the date of termination of Continuous Service) within the period of time ending on the earlier of (i) the date which
occurs three (3) months following the termination of the Participant&#8217;s Continuous Service (or such longer or shorter period specified
in the applicable Award Agreement), and (ii) the expiration of the term of the Option or SAR as set forth in the Award Agreement. If,
after termination of Continuous Service, the Participant does not exercise his or her Option or SAR (as applicable) within the applicable
time frame, the Option or SAR will terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(h)
Extension of Termination Date.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant
and the Company, if the exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than
for Cause and other than upon the Participant&#8217;s death or Disability) would be prohibited at any time solely because the issuance
of shares of Common Stock would violate the registration requirements under the Securities Act, then the Option or SAR will terminate
on the earlier of (i) the expiration of a total period of time (that need not be consecutive) equal to the applicable post termination
exercise period after the termination of the Participant&#8217;s Continuous Service during which the exercise of the Option or SAR would
not be in violation of such registration requirements, and (ii) the expiration of the term of the Option or SAR as set forth in the applicable
Award Agreement. In addition, unless otherwise provided in a Participant&#8217;s Award Agreement, if the sale of any Common Stock received
upon exercise of an Option or SAR following the termination of the Participant&#8217;s Continuous Service (other than for Cause) would
violate the Company&#8217;s insider trading policy, then the Option or SAR will terminate on the earlier of (i) the expiration of the
period of months (that need not be consecutive) equal to the applicable post-termination exercise period after the termination of the
Participant&#8217;s Continuous Service during which the sale of the Common Stock received upon exercise of the Option or SAR would not
be in violation of the Company&#8217;s insider trading policy, or (ii) the expiration of the term of the Option or SAR as set forth in
the applicable Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Disability of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant
and the Company, if a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s Disability, the Participant
may exercise his or her Option or SAR (to the extent that the Participant was entitled to exercise such Option or SAR as of the date
of termination of Continuous Service), but only within such period of time ending on the earlier of (i) the date which occurs 12 months
following such termination of Continuous Service (or such longer or shorter period specified in the Award Agreement), and (ii) the expiration
of the term of the Option or SAR as set forth in the Award Agreement. If, after termination of Continuous Service, the Participant does
not exercise his or her Option or SAR within the applicable time frame, the Option or SAR (as applicable) will terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"></p>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)
Death of Participant.</b> Except as otherwise provided in the applicable Award Agreement or other agreement between the Participant and
the Company, if (i) a Participant&#8217;s Continuous Service terminates as a result of the Participant&#8217;s death, or (ii) the Participant
dies within the period (if any) specified in the Award Agreement for exercisability after the termination of the Participant&#8217;s
Continuous Service for a reason other than death, then the Option or SAR may be exercised (to the extent the Participant was entitled
to exercise such Option or SAR as of the date of death) by the Participant&#8217;s estate, by a person who acquired the right to exercise
the Option or SAR by bequest or inheritance or by a person designated to exercise the Option or SAR upon the Participant&#8217;s death,
but only within the period ending on the earlier of (i) the date 18 months following the date of death (or such longer or shorter period
specified in the Award Agreement), and (ii) the expiration of the term of such Option or SAR as set forth in the Award Agreement. If,
after the Participant&#8217;s death, the Option or SAR is not exercised within the applicable time frame, the Option or SAR (as applicable)
will terminate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(k)
Termination for Cause.</b> Except as explicitly provided otherwise in the applicable Award Agreement or other written agreement between
the Participant and the Company, if a Participant&#8217;s Continuous Service is terminated for Cause, the Option or SAR will terminate
immediately upon such Participant&#8217;s termination of Continuous Service, and the Participant will be prohibited from exercising his
or her Option or SAR from and after the date of such termination of Continuous Service. If a Participant&#8217;s Continuous Service is
suspended pending an investigation of the existence of Cause, all of the Participant&#8217;s rights under the Option or SAR will also
be suspended during the investigation period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(l)
Non-Exempt Employees</b>. If an Option or SAR is granted to an Employee who is a non-exempt employee for purposes of the U.S. Fair Labor
Standards Act of 1938, as amended, the Option or SAR will not be first exercisable for any shares of Common Stock until at least six
months following the date of grant of the Option or SAR (although the Award may vest prior to such date). Consistent with the provisions
of the U.S. Worker Economic Opportunity Act, (i) if such non-exempt Employee dies or suffers a Disability, (ii) upon a Corporate Transaction
in which such Option or SAR is not assumed, continued, or substituted, (iii) upon a Change in Control, or (iv) upon the Participant&#8217;s
retirement (as such term may be defined in the Participant&#8217;s Award Agreement in another agreement between the Participant and the
Company, or, if no such definition, in accordance with the Company&#8217;s then current employment policies and guidelines), the vested
portion of any Options and SARs may be exercised earlier than six months following the date of grant. The foregoing provision is intended
to operate so that any income derived by a non-exempt employee in connection with the exercise or vesting of an Option or SAR will be
exempt from his or her regular rate of pay. To the extent permitted and/or required for compliance with the U.S. Worker Economic Opportunity
Act to ensure that any income derived by a non-exempt employee in connection with the exercise, vesting or issuance of any shares under
any other Stock Award will be exempt from the employee&#8217;s regular rate of pay, the provisions of this Section 5(l) will apply to
all Stock Awards and are hereby incorporated by reference into such Stock Award Agreements.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>6.
Provisions of Stock Awards other than Options and SARs.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Restricted Stock Awards.</b> Each Restricted Stock Award Agreement will be in such form and will contain such terms and conditions as
the Board will deem appropriate. To the extent consistent with the Company&#8217;s bylaws, at the Board&#8217;s election, shares of Common
Stock may be (x) held in book entry form subject to the Company&#8217;s instructions until any restrictions relating to the Restricted
Stock Award lapse; or (y) evidenced by a certificate, which certificate will be held in such form and manner as determined by the Board.
The terms and conditions of Restricted Stock Award Agreements may change from time to time, and the terms and conditions of separate
Restricted Stock Award Agreements need not be identical. Each Restricted Stock Award Agreement will conform to (through incorporation
of the provisions hereof by reference in the agreement or otherwise) the substance of each of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Consideration. </b>A Restricted Stock Award may be awarded in consideration for (A) cash, check, bank draft or money order payable to
the Company, (B) past services to the Company or an Affiliate, or (C) any other form of legal consideration (including future services)
that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Vesting. </b>Shares of Common Stock awarded under the Restricted Stock Award Agreement may be subject to forfeiture to the Company in
accordance with a vesting schedule to be determined by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Termination of Participant&#8217;s Continuous Service. </b>If a Participant&#8217;s Continuous Service terminates, the Company may receive
through a forfeiture condition or a repurchase right any or all of the shares of Common Stock held by the Participant that have not vested
as of the date of termination of Continuous Service under the terms of the Restricted Stock Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
Transferability. </b>Rights to acquire shares of Common Stock under the Restricted Stock Award Agreement will be transferable by the
Participant only upon such terms and conditions as are set forth in the Restricted Stock Award Agreement, as the Board will determine
in its sole discretion, so long as Common Stock awarded under the Restricted Stock Award Agreement remains subject to the terms of the
Restricted Stock Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
Dividends. </b>A Restricted Stock Award Agreement may provide that any dividends paid on Restricted Stock will be subject to the same
vesting and forfeiture restrictions as apply to the shares of Common Stock subject to the Restricted Stock Award to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Restricted Stock Unit Awards.</b> Each Restricted Stock Unit Award Agreement will be in such form and will contain such terms and conditions
as the Board will deem appropriate. The terms and conditions of Restricted Stock Unit Award Agreements may change from time to time,
and the terms and conditions of separate Restricted Stock Unit Award Agreements need not be identical. Each Restricted Stock Unit Award
Agreement will conform to (through incorporation of the provisions hereof by reference in the Agreement or otherwise) the substance of
each of the following provisions:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Consideration. </b>At the time of grant of a Restricted Stock Unit Award, the Board will determine the consideration, if any, to be paid
by the Participant upon delivery of each share of Common Stock subject to the Restricted Stock Unit Award. The consideration to be paid
(if any) by the Participant for each share of Common Stock subject to a Restricted Stock Unit Award may be paid in any form of legal
consideration that may be acceptable to the Board, in its sole discretion, and permissible under applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Vesting. </b>At the time of the grant of a Restricted Stock Unit Award, the Board may impose such restrictions on or conditions to the
vesting of the Restricted Stock Unit Award as it, in its sole discretion, deems appropriate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Payment. </b>A Restricted Stock Unit Award may be settled by the delivery of shares of Common Stock, their cash equivalent, any combination
thereof or in any other form of consideration, as determined by the Board and contained in the Restricted Stock Unit Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
Additional Restrictions. </b>At the time of the grant of a Restricted Stock Unit Award, the Board, as it deems appropriate, may impose
such restrictions or conditions that delay the delivery of the shares of Common Stock (or their cash equivalent) subject to a Restricted
Stock Unit Award to a time after the vesting of such Restricted Stock Unit Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
Dividend Equivalents. </b>Dividend equivalents may be credited in respect of shares of Common Stock covered by a Restricted Stock Unit
Award, as determined by the Board and contained in the Restricted Stock Unit Award Agreement. At the sole discretion of the Board, such
dividend equivalents may be converted into additional shares of Common Stock covered by the Restricted Stock Unit Award in such manner
as determined by the Board. Any additional shares covered by the Restricted Stock Unit Award credited by reason of such dividend equivalents
will be subject to all of the same terms and conditions of the underlying Restricted Stock Unit Award Agreement to which they relate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vi)
Termination of Participant&#8217;s Continuous Service. </b>Except as otherwise provided in the applicable Restricted Stock Unit Award
Agreement, such portion of the Restricted Stock Unit Award that has not vested will be forfeited upon the Participant&#8217;s termination
of Continuous Service.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Performance Awards.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Performance Stock Awards. </b>A Performance Stock Award is a Stock Award that is payable (including that may be granted, may vest or
may be exercised) contingent upon the attainment during a Performance Period of certain Performance Goals. A Performance Stock Award
may but need not require the Participant&#8217;s completion of a specified period of Continuous Service. The length of any Performance
Period, the Performance Goals to be achieved during the Performance Period, and the measure of whether and to what degree such Performance
Goals have been attained will be conclusively determined by the Board or Committee, in its sole discretion. In addition, to the extent
permitted by applicable law and the applicable Award Agreement, the Board may determine that cash may be used in payment of Performance
Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
Performance Cash Awards. </b>A Performance Cash Award is a cash award that is payable contingent upon the attainment during a Performance
Period of certain Performance Goals. A Performance Cash Award may also require the completion of a specified period of Continuous Service.
At the time of grant of a Performance Cash Award, the length of any Performance Period, the Performance Goals to be achieved during the
Performance Period, and the measure of whether and to what degree such Performance Goals have been attained will be conclusively determined
by the Board or Committee, in its sole discretion. The Board may specify the form of payment of Performance Cash Awards, which may be
cash or other property, or may provide for a Participant to have the option for his or her Performance Cash Award, or such portion thereof
as the Board may specify, to be paid in whole or in part in cash or other property.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
Board Discretion. </b>The Board retains the discretion to adjust or eliminate the compensation or economic benefit due upon attainment
of Performance Goals and to define the manner of calculating the Performance Criteria it selects to use for a Performance Period.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Other Stock Awards.</b> Other forms of Stock Awards valued in whole or in part by reference to, or otherwise based on, Common Stock,
including the appreciation in value thereof (e.g., options or stock rights with an exercise price or strike price less than 100% of the
Fair Market Value of the Common Stock at the time of grant) may be granted either alone or in addition to Stock Awards provided for under
Section 5 and the preceding provisions of this Section 6. Subject to the provisions of the Plan, the Board will have sole and complete
authority to determine the persons to whom and the time or times at which such Other Stock Awards will be granted, the number of shares
of Common Stock (or the cash equivalent thereof) to be granted pursuant to such Other Stock Awards and all other terms and conditions
of such Other Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>7.
Covenants of the Company.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Availability of Shares.</b> The Company will keep available at all times the number of shares of Common Stock reasonably required to
satisfy then-outstanding Stock Awards.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Compliance with Law.</b> The Company will seek to obtain from each regulatory commission or agency, as necessary, such authority as may
be required to grant Stock Awards and to issue and sell shares of Common Stock upon exercise or vesting of the Stock Awards; <i>provided,
however</i>, that this undertaking will not require the Company to register under the Securities Act the Plan or other securities or
applicable laws, any Stock Award or any Common Stock issued or issuable pursuant to any such Stock Award. If, after reasonable efforts
and at a reasonable cost, the Company is unable to obtain from any such regulatory commission or agency the authority that counsel for
the Company deems necessary or advisable for the lawful issuance and sale of Common Stock under the Plan, the Company will be relieved
from any liability for failure to issue and sell Common Stock upon exercise or vesting of such Stock Awards unless and until such authority
is obtained. A Participant will not be eligible for the grant of an Award or the subsequent issuance of cash or Common Stock pursuant
to the Award if such grant or issuance would be in violation of any applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
No Obligation to Notify or Minimize Taxes. </b>The Company will have no duty or obligation to any Participant to advise such holder as
to the time or manner or tax treatment of exercising such Stock Award. Furthermore, the Company will have no duty or obligation to warn
or otherwise advise such holder of a pending termination or expiration of an Award or a possible period in which the Award may not be
exercised. The Company has no duty or obligation to minimize the tax consequences of an Award to the holder of such Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>8.
Miscellaneous.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Use of Proceeds from Sales of Common Stock.</b> Proceeds from the sale of shares of Common Stock pursuant to Stock Awards will constitute
general funds of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Corporate Action Constituting Grant of Awards.</b> Corporate action constituting a grant by the Company of an Award to any Participant
will be deemed completed as of the date of such corporate action, unless otherwise determined by the Board, regardless of when the instrument,
certificate, or letter evidencing the Award is communicated to, or actually received or accepted by, the Participant. In the event that
the corporate records (e.g., Board consents, resolutions or minutes) documenting the corporate action constituting the grant contain
terms (e.g., exercise price, vesting schedule or number of shares) that are inconsistent with those in the Award Agreement or related
grant documents as a result of a clerical error in the papering of the Award Agreement or related grant documents, the corporate records
will control and the Participant will have no legally binding right to the incorrect term in the Award Agreement or related grant documents.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Stockholder Rights.</b> No Participant will be deemed to be the holder of, or to have any of the rights of a holder with respect to,
any shares of Common Stock subject to an Award unless and until (i) such Participant has satisfied all requirements for exercise of,
or the issuance of shares of Common Stock under, the Award pursuant to its terms, and (ii) the issuance of the Common Stock subject to
such Award has been entered into the books and records of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
No Employment or Other Service Rights.</b> Nothing in the Plan, any Award Agreement or any other instrument executed thereunder or in
connection with any Award granted pursuant thereto will confer upon any Participant any right to continue to serve the Company or an
Affiliate in the capacity in effect at the time the Award was granted or will affect the right of the Company or an Affiliate to terminate
(i) the employment of an Employee with or without notice and with or without cause, (ii) the service of a Consultant pursuant to the
terms of such Consultant&#8217;s agreement with the Company or an Affiliate, or (iii) the service of a Director pursuant to the bylaws
of the Company or an Affiliate, and any applicable provisions of the corporate law of the state or foreign jurisdiction in which the
Company or the Affiliate is domiciled or incorporated, as the case may be. Furthermore, to the extent the Company is not the employer
of a Participant, the grant of an Award will be not establish an employment or other service relationship between the Company and the
Participant.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
Change in Time Commitment.</b> In the event a Participant&#8217;s regular level of time commitment in the performance of his or her services
for the Company and any Affiliates is reduced (for example, and without limitation, if the Participant is an Employee of the Company
and the Employee has a change in status from a full-time Employee to a part-time Employee or takes an extended leave of absence) after
the date of grant of any Award to the Participant, the Board has the right in its sole discretion to (x) make a corresponding reduction
in the number of shares or cash amount subject to any portion of such Award that is scheduled to vest or become payable after the date
of such change in time commitment, and (y) in lieu of or in combination with such a reduction, extend the vesting or payment schedule
applicable to such Award. In the event of any such reduction, the Participant will have no right with respect to any portion of the Award
that is so reduced or extended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
Incentive Stock Option Limitations.</b> To the extent that the aggregate Fair Market Value (determined at the time of grant) of Common
Stock with respect to which Incentive Stock Options are exercisable for the first time by any Optionholder during any calendar year (under
all plans of the Company and any Affiliates) exceeds U.S. $100,000 (or such other limit established in the Code) or otherwise does not
comply with the rules governing Incentive Stock Options, the Options or portions thereof that exceed such limit (according to the order
in which they were granted) or otherwise do not comply with such rules will be treated as Nonstatutory Stock Options, notwithstanding
any contrary provision of the applicable Option Agreement(s).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)
Investment Assurances.</b> The Company may require a Participant, as a condition of exercising or acquiring Common Stock under any Award,
(i) to give written assurances satisfactory to the Company as to the Participant&#8217;s knowledge and experience in financial and business
matters and/or to employ a purchaser representative reasonably satisfactory to the Company who is knowledgeable and experienced in financial
and business matters and that such Participant is capable of evaluating, alone or together with the purchaser representative, the merits
and risks of exercising the Award; and (ii) to give written assurances satisfactory to the Company stating that the Participant is acquiring
Common Stock subject to the Award for the Participant&#8217;s own account and not with any present intention of selling or otherwise
distributing the Common Stock. The foregoing requirements, and any assurances given pursuant to such requirements, will be inoperative
if (A) the issuance of the shares upon the exercise or acquisition of Common Stock under the Award has been registered under a then currently
effective registration statement under the Securities Act, or (B) as to any particular requirement, a determination is made by counsel
for the Company that such requirement need not be met in the circumstances under the then applicable securities laws. The Company may,
upon advice of counsel to the Company, place legends on stock certificates issued under the Plan as such counsel deems necessary or appropriate
in order to comply with applicable securities laws, including, but not limited to, legends restricting the transfer of the Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(h)
Withholding Obligations.</b> Unless prohibited by the terms of an Award Agreement, the Company may, in its sole discretion, satisfy any
U.S. and non-U.S. federal, state or local tax withholding obligation relating to an Award by any of the following means or by a combination
of such means: (i) causing the Participant to tender a cash payment; (ii) withholding shares of Common Stock from the shares of Common
Stock issued or otherwise issuable to the Participant in connection with the Stock Award; <i>provided, however, </i>that (A) no shares
of Common Stock are withheld with a value exceeding the maximum amount of tax that may be required to be withheld by law (or such other
amount as may be permitted while still avoiding classification of the Stock Award as a liability for financial accounting purposes),
and (B) with respect to a Stock Award held by any Participant who is subject to the filing requirements of Section 16 of the Exchange
Act, any such share withholding must be specifically approved by the Compensation Committee as the applicable method that must be used
to satisfy the tax withholding obligation or such share withholding procedure must otherwise satisfy the requirements for an exempt transaction
under Section 16(b) of the Exchange Act; (iii) withholding cash from a Stock Award settled in cash; (iv) withholding payment from any
amounts otherwise payable to the Participant; (v) by means of a &#8220;cashless exercise&#8221; pursuant to a program developed under
Regulation T as promulgated by the Federal Reserve Board, or (vi) by such other method as may be set forth in the Award Agreement.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
Electronic Delivery.</b> Any reference herein to a &#8220;written&#8221; agreement or document will include any agreement or document
delivered electronically, filed publicly at www.sec.gov (or any successor website thereto) or posted on the Company&#8217;s intranet
(or other shared electronic medium controlled by the Company to which the Participant has access).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)
Deferrals.</b> To the extent permitted by applicable law, the Board, in its sole discretion, may determine that the delivery of Common
Stock or the payment of cash, upon the exercise, vesting or settlement of all or a portion of any Award may be deferred and may establish
programs and procedures for deferral elections to be made by Participants. Deferrals by Participants will be made in accordance with
Section 409A of the Code. Consistent with Section 409A of the Code, the Board may provide for distributions while a Participant is still
an employee or otherwise providing services to the Company. The Board is authorized to make deferrals of Awards and determine when, and
in what annual percentages, Participants may receive payments, including lump sum payments, following the Participant&#8217;s termination
of Continuous Service, and implement such other terms and conditions consistent with the provisions of the Plan and in accordance with
applicable law.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(k)
Compliance with Section 409A of the Code.</b> Unless otherwise expressly provided for in an Award Agreement, the Plan and Award Agreements
will be interpreted to the greatest extent possible in a manner that makes the Plan and the Awards granted hereunder exempt from Section
409A of the Code, and, to the extent not so exempt, in compliance with Section 409A of the Code. If the Board determines that any Award
granted hereunder is not exempt from and is therefore subject to Section 409A of the Code, the Award Agreement evidencing such Award
will incorporate the terms and conditions necessary to avoid the consequences specified in Section 409A(a)(1) of the Code, and to the
extent an Award Agreement is silent on terms necessary for compliance, such terms are hereby incorporated by reference into the Award
Agreement. Notwithstanding anything to the contrary in this Plan (and unless the Award Agreement specifically provides otherwise), if
the shares of Common Stock are publicly traded, and if a Participant holding an Award that constitutes &#8220;deferred compensation&#8221;
under Section 409A of the Code is a &#8220;specified employee&#8221; for purposes of Section 409A of the Code, no distribution or payment
of any amount that is due because of a &#8220;separation from service&#8221; (as defined in Section 409A of the Code without regard to
alternative definitions thereunder) will be issued or paid before the date that is six months following the date of such Participant&#8217;s
&#8220;separation from service&#8221; or, if earlier, the date of the Participant&#8217;s death, unless such distribution or payment
can be made in a manner that complies with Section 409A of the Code, and any amounts so deferred will be paid in a lump sum on the day
after such six month period elapses, with the balance paid thereafter on the original schedule.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(l)
Exchange Program.</b> Without prior stockholder approval, the Board may engage in an Exchange Program.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(m)
Clawback/Recovery</b>. All Awards granted under the Plan will be subject to recoupment in accordance with any clawback policy that the
Company is required to adopt pursuant to the listing standards of any national securities exchange or association on which the Company&#8217;s
securities are listed or as is otherwise required by the U.S. Dodd-Frank Wall Street Reform and Consumer Protection Act or other applicable
law. In addition, the Board may impose such other clawback, recovery or recoupment provisions in an Award Agreement as the Board determines
necessary or appropriate, including but not limited to a reacquisition right in respect of previously acquired shares of Common Stock
or other cash or property upon the occurrence of an event constituting Cause. No recovery of compensation under such a clawback policy
will be an event giving rise to a right to resign for &#8220;good reason&#8221; or &#8220;constructive termination&#8221; (or similar
term) under any agreement with the Company or an Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>9.
Adjustments upon Changes in Common Stock; Other Corporate Events.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
Capitalization Adjustments.</b> In the event of a Capitalization Adjustment, the Board will appropriately and proportionately adjust:
(i) the class(es) and maximum number of securities subject to the Plan pursuant to Section 3(a), (ii) the class(es) and maximum number
of securities that may be issued pursuant to the exercise of Incentive Stock Options pursuant to Section 3(c), and (iii) the class(es)
and number of securities and price per share of stock subject to outstanding Stock Awards. The Board will make such adjustments, and
its determination will be final, binding and conclusive.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
Dissolution or Liquidation.</b> Except as otherwise provided in the Stock Award Agreement, in the event of a dissolution or liquidation
of the Company, all outstanding Stock Awards (other than Stock Awards consisting of vested and outstanding shares of Common Stock not
subject to a forfeiture condition or the Company&#8217;s right of repurchase) will terminate immediately prior to the completion of such
dissolution or liquidation, and the shares of Common Stock subject to the Company&#8217;s repurchase rights or subject to a forfeiture
condition may be repurchased or reacquired by the Company notwithstanding the fact that the holder of such Stock Award is providing Continuous
Service; <i>provided, however</i>, that the Board may, in its sole discretion, cause some or all Stock Awards to become fully vested,
exercisable and/or no longer subject to repurchase or forfeiture (to the extent such Stock Awards have not previously expired or terminated)
before the dissolution or liquidation is completed but contingent on its completion.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
Corporate Transaction.</b> The following provisions will apply to Stock Awards in the event of a Corporate Transaction unless otherwise
provided in the Stock Award Agreement or any other written agreement between the Company or any Affiliate and the Participant or unless
otherwise expressly provided by the Board at the time of grant of a Stock Award. In the event of a Corporate Transaction, then, notwithstanding
any other provision of the Plan, the Board may take one or more of the following actions with respect to Stock Awards, contingent upon
the closing or completion of the Corporate Transaction:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>arrange for the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company)
to assume or continue the Stock Award or to substitute a similar stock award for the Stock Award (including, but not limited to, an award
to acquire the same consideration paid to the stockholders of the Company pursuant to the Corporate Transaction);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>arrange for the assignment of any reacquisition or repurchase rights held by the Company in respect of Common Stock issued pursuant
to the Stock Award to the surviving corporation or acquiring corporation (or the surviving or acquiring corporation&#8217;s parent company);</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>accelerate the vesting, in whole or in part, of the Stock Award (and, if applicable, the time at which the Stock Award may be exercised)
to a date prior to the effective time of such Corporate Transaction as the Board determines (or, if the Board does not determine such
a date, to the date that is five days prior to the effective date of the Corporate Transaction), which exercise is contingent upon the
effectiveness of such Corporate Transaction with such Stock Award terminating if not exercised (if applicable) at or prior to the effective
time of the Corporate Transaction; <i>provided, however</i>, that the Board may require Participants to complete and deliver to the Company
a notice of exercise before the effective date of a Corporate Transaction</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 60; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>arrange for the lapse, in whole or in part, of any reacquisition or repurchase rights held by the Company with respect to the Stock
Award;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>cancel or arrange for the cancellation of the Stock Award, to the extent not vested or not exercised prior to the effective time
of the Corporate Transaction, in exchange for such cash consideration, if any, as the Board, in its sole discretion, may consider appropriate;
and</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vi)
</b>make a payment, in such form as may be determined by the Board equal to the excess, if any, of (A) the per share amount (or value
of property per share) payable to holders of Common Stock in connection with the Corporate Transaction, over (B) the per share exercise
price under the applicable Stock Award, multiplied by the number of shares subject to the Stock Award. For clarity, this payment may
be zero (U.S. $0) if the amount per share (or value of property per share) payable to the holders of the Common Stock is equal to or
less than the exercise price of the Stock Award. In addition, any escrow, holdback, earnout or similar provisions in the definitive agreement
for the Corporate Transaction may apply to such payment to the holder of the Stock Award to the same extent and in the same manner as
such provisions apply to the holders of Common Stock.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board need not take the same action or actions with respect to all Stock Awards or portions thereof or with respect to all Participants.
The Board may take different actions with respect to the vested and unvested portions of a Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
Change in Control.</b> A Stock Award may be subject to additional acceleration of vesting and exercisability upon or after a Change in
Control as may be provided in the Stock Award Agreement for such Stock Award or as may be provided in any other written agreement between
the Company or any Affiliate and the Participant, but in the absence of such provision, no such acceleration will occur.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>10.
Termination or Suspension of the Plan.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Board may suspend or terminate the Plan at any time. No Incentive Stock Options may be granted after the tenth anniversary of the earlier
of (i) the Adoption Date, or (ii) the date the Plan is approved by the stockholders of the Company. No Awards may be granted under the
Plan while the Plan is suspended or after it is terminated.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>11.
Existence of the Plan; Timing of First Grant or Exercise.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Plan will come into existence on the Adoption Date; <i>provided, however</i>, no Stock Award may be granted prior to the IPO Date (that
is, the Effective Date). In addition, no Stock Award will be exercised (or, in the case of a Restricted Stock Award, Restricted Stock
Unit Award, Performance Stock Award, or Other Stock Award, will be granted) and no Performance Cash Award will be settled unless and
until the Plan has been approved by the stockholders of the Company, which approval will be within 12 months after the Adoption Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 1.5in; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>12.
Choice of Law.</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
law of the State of Delaware will govern all questions concerning the construction, validity and interpretation of this Plan, without
regard to that state&#8217;s conflict of laws rules.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1.5in"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b>13.
Definitions. </b></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As used in the Plan, the following
definitions will apply to the capitalized terms indicated below:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(a)
</b>&#8220;<b><i>Adoption Date</i></b>&#8221; means the date the Plan is adopted by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(b)
</b>&#8220;<b><i>Affiliate</i></b>&#8221; means, at the time of determination, any &#8220;parent&#8221; or &#8220;subsidiary&#8221; of
the Company as such terms are defined in Rule 405 of the Securities Act. The Board will have the authority to determine the time or times
at which &#8220;parent&#8221; or &#8220;subsidiary&#8221; status is determined within the foregoing definition.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(c)
</b>&#8220;<b><i>Award</i></b>&#8221; means a Stock Award or a Performance Cash Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(d)
</b>&#8220;<b><i>Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the terms
and conditions of an Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(e)
</b>&#8220;<b><i>Board</i></b>&#8221; means the Board of Directors of the Company.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 61; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(f)
</b>&#8220;<b><i>Capital Stock</i></b>&#8221; means each and every class of common stock of the Company, regardless of the number of
votes per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(g)
</b>&#8220;<b><i>Capitalization Adjustment</i></b>&#8221; means any change that is made in, or other events that occur with respect to,
the Common Stock subject to the Plan or subject to any Stock Award after the Adoption Date without the receipt of consideration by the
Company through merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other
than cash, large nonrecurring cash dividend, stock split, reverse stock split, liquidating dividend, combination of shares, exchange
of shares, change in corporate structure or any similar equity restructuring transaction, as that term is used in Statement of Financial
Accounting Standards Board Accounting Standards Codification Topic 718 (or any successor thereto). Notwithstanding the foregoing, the
conversion of any convertible securities of the Company will not be treated as a Capitalization Adjustment.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(h)
</b>&#8220;<b><i>Cause</i></b>&#8221; will have the meaning ascribed to such term in any written agreement between the Participant and
the Company defining such term and, in the absence of such agreement, such term means, with respect to a Participant, the occurrence
of any of the following events: (i) such Participant&#8217;s commission of any felony or any crime involving fraud, dishonesty or moral
turpitude under the laws of the United States, any state thereof, or any applicable foreign jurisdiction; (ii) such Participant&#8217;s
attempted commission of, or participation in, a fraud or act of dishonesty against the Company or any Affiliate; (iii) such Participant&#8217;s
intentional, material violation of any contract or agreement between the Participant and the Company or any Affiliate or of any statutory
duty owed to the Company or any Affiliate; (iv) such Participant&#8217;s unauthorized use or disclosure of the Company&#8217;s or any
Affiliate&#8217;s confidential information or trade secrets; or (v) such Participant&#8217;s gross misconduct. The determination that
a termination of the Participant&#8217;s Continuous Service is either for Cause or without Cause shall be made by the Company in its
sole discretion. Any determination by the Company that the Continuous Service of a Participant was terminated by reason of dismissal
without Cause for the purposes of outstanding Stock Awards held by such Participant shall have no effect upon any determination of the
rights or obligations of the Company or such Participant for any other purpose.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>&#8220;<b><i>Change in Control</i></b>&#8221; means the occurrence, in a single transaction or in a series of related transactions,
of any one or more of the following events:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>any Exchange Act Person becomes the Owner, directly or indirectly, of securities of the Company representing more than 50% of the
combined voting power of the Company&#8217;s then outstanding securities other than by virtue of a merger, consolidation or similar transaction.
Notwithstanding the foregoing, a Change in Control will not be deemed to occur (A) on account of the acquisition of securities of the
Company directly from the Company, (B) on account of the acquisition of securities of the Company by an investor, any affiliate thereof
or any other Exchange Act Person that acquires the Company&#8217;s securities in a transaction or series of related transactions the
primary purpose of which is to obtain financing for the Company through the issuance of equity securities, (C) on account of the acquisition
of securities of the Company by any individual who is, on the IPO Date, either an executive officer or a Director (either, an &#8220;<b><i>IPO
Investor</i></b>&#8221;) and/or any entity in which an IPO Investor has a direct or indirect interest (whether in the form of voting
rights or participation in profits or capital contributions) of more than 50% (collectively, the &#8220;<b><i>IPO Entities</i></b>&#8221;)
or on account of the IPO Entities continuing to hold shares that come to represent more than 50% of the combined voting power of the
Company&#8217;s then outstanding securities as a result of the conversion of any class of the Company&#8217;s securities into another
class of the Company&#8217;s securities having a different number of votes per share pursuant to the conversion provisions set forth
in the Company&#8217;s Amended and Restated Certificate of Incorporation; or (D) solely because the level of Ownership held by any Exchange
Act Person (the &#8220;<b><i>Subject Person</i></b>&#8221;) exceeds the designated percentage threshold of the outstanding voting securities
as a result of a repurchase or other acquisition of voting securities by the Company reducing the number of shares outstanding, provided
that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of voting securities
by the Company, and after such share acquisition, the Subject Person becomes the Owner of any additional voting securities that, assuming
the repurchase or other acquisition had not occurred, increases the percentage of the then outstanding voting securities Owned by the
Subject Person over the designated percentage threshold, then a Change in Control will be deemed to occur;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 62; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>there is consummated a merger, consolidation or similar transaction involving (directly or indirectly) the Company and, immediately
after the consummation of such merger, consolidation or similar transaction, the stockholders of the Company immediately prior thereto
do not Own, directly or indirectly, either (A) outstanding voting securities representing more than 50% of the combined outstanding voting
power of the surviving Entity in such merger, consolidation or similar transaction or (B) more than 50% of the combined outstanding voting
power of the parent of the surviving Entity in such merger, consolidation or similar transaction, in each case in substantially the same
proportions as their Ownership of the outstanding voting securities of the Company immediately prior to such transaction; <i>provided,
however</i>, that a merger, consolidation or similar transaction will not constitute a Change in Control under this prong of the definition
if the outstanding voting securities representing more than 50% of the combined voting power of the surviving Entity or its parent are
owned by the IPO Entities;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>there is consummated a sale, lease, exclusive license or other disposition of all or substantially all of the consolidated assets
of the Company and its Subsidiaries, other than a sale, lease, license or other disposition of all or substantially all of the consolidated
assets of the Company and its Subsidiaries to an Entity, more than 50% of the combined voting power of the voting securities of which
are Owned by stockholders of the Company in substantially the same proportions as their Ownership of the outstanding voting securities
of the Company immediately prior to such sale, lease, license or other disposition; <i>provided, however</i>, that a sale, lease, exclusive
license or other disposition of all or substantially all of the consolidated assets of the Company and its Subsidiaries will not constitute
a Change in Control under this prong of the definition if the outstanding voting securities representing more than 50% of the combined
voting power of the acquiring Entity or its parent are owned by the IPO Entities; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>individuals who, on the date the Plan is adopted by the Board, are members of the Board (the &#8220;<b><i>Incumbent Board</i></b>&#8221;)
cease for any reason to constitute at least a majority of the members of the Board; <i>provided, however</i>, that if the appointment
or election (or nomination for election) of any new Board member was approved or recommended by a majority vote of the members of the
Incumbent Board then still in office, such new member will, for purposes of this Plan, be considered as a member of the Incumbent Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Notwithstanding
the foregoing or any other provision of the Plan, the term Change in Control will not include a sale of assets, merger or other transaction
effected exclusively for the purpose of changing the domicile of the Company and the definition of Change in Control (or any analogous
term) in an individual written agreement between the Company or any Affiliate and the Participant will supersede the foregoing definition
with respect to Awards subject to such agreement; <i>provided, however</i>, that if no definition of Change in Control or any analogous
term is set forth in such an individual written agreement, the foregoing definition will apply. To the extent required for compliance
with Section 409A of the Code, in no event will a Change in Control be deemed to have occurred if such transaction is not also a &#8220;change
in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial portion of the assets
of&#8221; the Company as determined under Treasury Regulations Section 1.409A-3(i)(5) (without regard to any alternative definition thereunder).
The Board may, in its sole discretion and without a Participant&#8217;s consent, amend the definition of &#8220;Change in Control&#8221;
to conform to the definition of &#8220;Change in Control&#8221; under Section 409A of the Code, and the regulations thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(j)
</b>&#8220;<b><i>Code</i></b>&#8221; means the Internal Revenue Code of 1986, as amended, including any applicable regulations and guidance
thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(k)
</b>&#8220;<b><i>Committee</i></b>&#8221; means a committee of one or more Directors to whom authority has been delegated by the Board
in accordance with Section 2(c).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(l)
</b>&#8220;<b><i>Common Stock</i></b>&#8221; means, as of the IPO Date, the common stock of the Company, having one vote per share.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(m)
</b>&#8220;<b><i>Company</i></b>&#8221; means Sonim Technologies, Inc., a Delaware corporation.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 63; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(n)
</b>&#8220;<b><i>Consultant</i></b>&#8221; means any person, including an advisor, who is (i) engaged by the Company or an Affiliate
to render consulting or advisory services and is compensated for such services, or (ii) serving as a member of the board of directors
of an Affiliate and is compensated for such services. However, service solely as a Director, or payment of a fee for such service, will
not cause a Director to be considered a &#8220;Consultant&#8221; for purposes of the Plan. Notwithstanding the foregoing, a person is
treated as a Consultant under this Plan only if a Form S-8 Registration Statement under the Securities Act is available to register either
the offer or the sale of the Company&#8217;s securities to such person.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(o)
</b>&#8220;<b><i>Continuous Service</i></b>&#8221; means that the Participant&#8217;s service with the Company or an Affiliate, whether
as an Employee, Director or Consultant, is not interrupted or terminated. A change in the capacity in which the Participant renders service
to the Company or an Affiliate as an Employee, Consultant or Director or a change in the entity for which the Participant renders such
service, provided that there is no interruption or termination of the Participant&#8217;s service with the Company or an Affiliate, will
not terminate a Participant&#8217;s Continuous Service; <i>provided, however</i>, that if the Entity for which a Participant is rendering
services ceases to qualify as an Affiliate, as determined by the Board, in its sole discretion, such Participant&#8217;s Continuous Service
will be considered to have terminated on the date such Entity ceases to qualify as an Affiliate. For example, a change in status from
an Employee of the Company to a Consultant of an Affiliate or to a Director will not constitute an interruption of Continuous Service.
To the extent permitted by law, the Board or the chief executive officer of the Company, in that party&#8217;s sole discretion, may determine
whether Continuous Service will be considered interrupted in the case of (i) any leave of absence approved by the Board or chief executive
officer, including sick leave, military leave or any other personal leave, or (ii) transfers between the Company, an Affiliate, or their
successors. Notwithstanding the foregoing, a leave of absence will be treated as Continuous Service for purposes of vesting in an Award
only to such extent as may be provided in the Company&#8217;s leave of absence policy, in the written terms of any leave of absence agreement
or policy applicable to the Participant, or as otherwise required by law. In addition, to the extent required for exemption from or compliance
with Section 409A of the Code, the determination of whether there has been a termination of Continuous Service will be made, and such
term will be construed, in a manner that is consistent with the definition of &#8220;separation from service&#8221; as defined under
Treasury Regulation Section 1.409A-1(h) (without regard to any alternative definition thereunder).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(p)
</b>&#8220;<b><i>Corporate Transaction</i></b>&#8221; means the consummation, in a single transaction or in a series of related transactions,
of any one or more of the following events:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>a sale or other disposition of all or substantially all, as determined by the Board, in its sole discretion, of the consolidated
assets of the Company and its Subsidiaries;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>a sale or other disposition of more than 50% of the outstanding securities of the Company;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>a merger, consolidation or similar transaction following which the Company is not the surviving corporation; or</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iv)
</b>a merger, consolidation or similar transaction following which the Company is the surviving corporation but the shares of Common
Stock outstanding immediately preceding the merger, consolidation or similar transaction are converted or exchanged by virtue of the
merger, consolidation or similar transaction into other property, whether in the form of securities, cash or otherwise.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 64; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If
required for compliance with Section 409A of the Code, in no event will a Corporate Transaction be deemed to have occurred if such transaction
is not also a &#8220;change in the ownership or effective control of&#8221; the Company or &#8220;a change in the ownership of a substantial
portion of the assets of&#8221; the Company as determined under Treasury Regulation Section 1.409A-3(i)(5) (without regard to any alternative
definition thereunder).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(q)
</b>&#8220;<b><i>Director</i></b>&#8221; means a member of the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(r)
</b>&#8220;<b><i>Disability</i></b>&#8221; means, with respect to a Participant, the inability of such Participant to engage in any substantial
gainful activity by reason of any medically determinable physical or mental impairment that can be expected to result in death or that
has lasted or can be expected to last for a continuous period of not less than 12 months, as provided in Sections 22(e)(3) and 409A(a)(2)(c)(i)
of the Code, and will be determined by the Board on the basis of such medical evidence as the Board deems warranted under the circumstances.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(s)
</b>&#8220;<b><i>Effective Date</i></b>&#8221; means the IPO Date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(t)
</b>&#8220;<b><i>Employee</i></b>&#8221; means any person employed by the Company or an Affiliate. However, service solely as a Director,
or payment of a fee for such services, will not cause a Director to be considered an &#8220;Employee&#8221; for purposes of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(u)
</b>&#8220;<b><i>Entity</i></b>&#8221; means a corporation, partnership, limited liability company or other entity.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(v)
</b>&#8220;<b><i>Exchange Act</i></b>&#8221; means the U.S. Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(w)
</b>&#8220;<b><i>Exchange Act Person</i></b>&#8221; means any natural person, Entity or &#8220;group&#8221; (within the meaning of Section
13(d) or 14(d) of the Exchange Act), except that &#8220;Exchange Act Person&#8221; will not include (i) the Company or any Subsidiary
of the Company, (ii) any employee benefit plan of the Company or any Subsidiary of the Company or any trustee or other fiduciary holding
securities under an employee benefit plan of the Company or any Subsidiary of the Company, (iii) an underwriter temporarily holding securities
pursuant to a registered public offering of such securities, (iv) an Entity Owned, directly or indirectly, by the stockholders of the
Company in substantially the same proportions as their Ownership of stock of the Company; or (v) any natural person, Entity or &#8220;group&#8221;
(within the meaning of Section 13(d) or 14(d) of the Exchange Act) that, as of the Effective Date, is the Owner, directly or indirectly,
of securities of the Company representing more than 50% of the combined voting power of the Company&#8217;s then outstanding securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(x)
</b>&#8220;<b><i>Fair Market Value</i></b>&#8221; means, as of any date, the value of the Common Stock determined as follows:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(i)
</b>If the Common Stock is listed on any established stock exchange or traded on any established market, the Fair Market Value of a share
of Common Stock will be, unless otherwise determined by the Board, the closing sales price for such stock as quoted on such exchange
or market (or the exchange or market with the greatest volume of trading in the Common Stock) on the date of determination, as reported
in a source the Board deems reliable.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>Unless otherwise provided by the Board, if there is no closing sales price for the Common Stock on the date of determination, then
the Fair Market Value will be the closing selling price on the last preceding date for which such quotation exists.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(iii)
</b>In the absence of such markets for the Common Stock, the Fair Market Value will be determined by the Board in good faith and in a
manner that complies with Sections 409A and 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(y)
</b>&#8220;<b><i>Incentive Stock Option</i></b>&#8221; means an option granted pursuant to Section 5 of the Plan that is intended to
be, and qualifies as, an &#8220;incentive stock option&#8221; within the meaning of Section 422 of the Code.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(z)
</b>&#8220;<b><i>IPO Date</i></b>&#8221; means the date of the underwriting agreement between the Company and the underwriter(s) managing
the initial public offering of the Common Stock, pursuant to which the Common Stock is priced for the initial public offering.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 65; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(aa)
</b>&#8220;<b><i>Non-Employee Director</i></b>&#8221; means a Director who either (i) is not a current employee or officer of the Company
or an Affiliate, does not receive compensation, either directly or indirectly, from the Company or an Affiliate for services rendered
as a consultant or in any capacity other than as a Director (except for an amount as to which disclosure would not be required under
Item 404(a) of Regulation S-K promulgated pursuant to the Securities Act (&#8220;<b><i>Regulation S-K</i></b>&#8221;)), does not possess
an interest in any other transaction for which disclosure would be required under Item 404(a) of Regulation S-K, and is not engaged in
a business relationship for which disclosure would be required pursuant to Item 404(b) of Regulation S-K; or (ii) is otherwise considered
a &#8220;non-employee director&#8221; for purposes of Rule 16b-3.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(bb)
</b>&#8220;<b><i>Nonstatutory Stock Option</i></b>&#8221; means any Option granted pursuant to Section 5 of the Plan that does not qualify
as an Incentive Stock Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(cc)
</b>&#8220;<b><i>Officer</i></b>&#8221; means a person who is an officer of the Company within the meaning of Section 16 of the Exchange
Act.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(dd)
</b>&#8220;<b><i>Option</i></b>&#8221; means an Incentive Stock Option or a Nonstatutory Stock Option to purchase shares of Common Stock
granted pursuant to the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ee)
</b>&#8220;<b><i>Option Agreement</i></b>&#8221; means a written agreement between the Company and an Optionholder evidencing the terms
and conditions of an Option grant. Each Option Agreement will be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ff)
</b>&#8220;<b><i>Optionholder</i></b>&#8221; means a person to whom an Option is granted pursuant to the Plan or, if applicable, such
other person who holds an outstanding Option.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(gg)
</b>&#8220;<b><i>Other Stock Award</i></b>&#8221; means an award based in whole or in part by reference to the Common Stock which is
granted pursuant to the terms and conditions of Section 6(d).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(hh)
</b>&#8220;<b><i>Other Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of an Other Stock
Award evidencing the terms and conditions of an Other Stock Award grant. Each Other Stock Award Agreement will be subject to the terms
and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ii)
</b>&#8220;<b><i>Own,</i></b>&#8221; &#8220;<b><i>Owned,</i></b>&#8221; &#8220;<b><i>Owner,</i></b>&#8221; &#8220;<b><i>Ownership</i></b>&#8221;
means a person or Entity will be deemed to &#8220;Own,&#8221; to have &#8220;Owned,&#8221; to be the &#8220;Owner&#8221; of, or to have
acquired &#8220;Ownership&#8221; of securities if such person or Entity, directly or indirectly, through any contract, arrangement, understanding,
relationship or otherwise, has or shares voting power, which includes the power to vote or to direct the voting, with respect to such
securities.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(jj)
</b>&#8220;<b><i>Parent</i></b>&#8221; means any corporation (other than the Company) in an unbroken chain of corporations ending with
the Company, if each of the corporations other than the Company owns stock possessing 50% or more of the total combined voting power
of all classes of stock in one of the other corporations in such chain. A corporation that attains the status of a Parent on a date after
the adoption of the Plan shall be considered a Parent commencing as of such date.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(kk)
<i>&#8220;Participant</i></b>&#8221; means a person to whom an Award is granted pursuant to the Plan or, if applicable, such other person
who holds an outstanding Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ll)
</b>&#8220;<b><i>Performance Cash Award</i></b>&#8221; means an award of cash granted pursuant to the terms and conditions of Section
6(c)(ii).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(mm)
</b>&#8220;<b><i>Performance Criteria</i></b>&#8221; means the one or more criteria that the Board or Committee (as applicable) will
select for purposes of establishing the Performance Goals for a Performance Period. The Performance Criteria that will be used to establish
such Performance Goals may be based on any one of, or combination of, the following as determined by the Board or Committee (as applicable):
(1) earnings (including earnings per share and net earnings); (2) earnings before interest, taxes and depreciation; (3) earnings before
interest, taxes, depreciation and amortization; (4) total stockholder return; (5) return on equity or average stockholder&#8217;s equity;
(6) return on assets, investment, or capital employed; (7) stock price; (8) margin (including gross margin); (9) income (before or after
taxes); (10) operating income; (11) operating income after taxes; (12) pre-tax profit; (13) operating cash flow; (14) sales or revenue
targets; (15) increases in revenue or product revenue; (16) expenses and cost reduction goals; (17) improvement in or attainment of working
capital levels; (18) economic value added (or an equivalent metric); (19) market share; (20) cash flow; (21) cash flow per share; (22)
share price performance; (23) debt reduction; (24) implementation or completion of projects or processes; (25) subscriber satisfaction;
(26) stockholders&#8217; equity; (27) capital expenditures; (28) debt levels; (29) operating profit or net operating profit; (30) workforce
diversity; (31) growth of net income or operating income; (32) billings; (33) the number of subscribers, including but not limited to
unique subscribers; (34) employee retention; and (35) other measures of performance selected by the Board.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 66; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(nn)
</b>&#8220;<b><i>Performance Goals</i></b>&#8221; means, for a Performance Period, the one or more goals established by the Board or
Committee (as applicable) for the Performance Period based upon the Performance Criteria. Performance Goals may be based on a Company-wide
basis, with respect to one or more business units, divisions, Affiliates, or business segments, and in either absolute terms or relative
to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise
by the Board or Committee (as applicable) (i) in the Award Agreement at the time the Award is granted or (ii) in such other document
setting forth the Performance Goals at the time the Performance Goals are established, the Board or Committee (as applicable) will appropriately
make adjustments in the method of calculating the attainment of Performance Goals for a Performance Period as follows: (1) to exclude
restructuring and/or other nonrecurring charges; (2) to exclude exchange rate effects; (3) to exclude the effects of changes to generally
accepted accounting principles; (4) to exclude the effects of items that are &#8220;unusual&#8221; in nature or occur &#8220;infrequently&#8221;
as determined under generally accepted accounting principles; (6) to exclude the dilutive effects of acquisitions or joint ventures;
(7) to assume that any business divested by the Company achieved performance objectives at targeted levels during the balance of a Performance
Period following such divestiture; (8) to exclude the effect of any change in the outstanding shares of common stock of the Company by
reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, spin-off, combination
or exchange of shares or other similar corporate change, or any distributions to common stockholders other than regular cash dividends;
(9) to exclude the effects of stock based compensation and the award of bonuses under the Company&#8217;s bonus plans; (10) to exclude
costs incurred in connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting
principles; and (11) to exclude the goodwill and intangible asset impairment charges that are required to be recorded under generally
accepted accounting principles. In addition, the Board or Committee (as applicable) retains the discretion to reduce or eliminate the
compensation or economic benefit due upon attainment of Performance Goals and to define the manner of calculating the Performance Criteria
it selects to use for such Performance Period. Partial achievement of the specified criteria may result in the payment or vesting corresponding
to the degree of achievement as specified in the Stock Award Agreement or the written terms of a Performance Cash Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(oo)
</b>&#8220;<b><i>Performance Period</i></b>&#8221; means the period of time selected by the Board or Committee (as applicable) over which
the attainment of one or more Performance Goals will be measured for the purpose of determining a Participant&#8217;s right to and the
payment of a Stock Award or a Performance Cash Award. Performance Periods may be of varying and overlapping duration, at the sole discretion
of the Board or Committee (as applicable).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(pp)
</b>&#8220;<b><i>Performance Stock Award</i></b>&#8221; means a Stock Award granted under the terms and conditions of Section 6(c)(i).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(qq)
</b>&#8220;<b><i>Plan</i></b>&#8221; means this Sonim Technologies, Inc. 2019 Equity Incentive Plan, as it may be amended from time to
time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(rr)
</b>&#8220;<b><i>Restricted Stock Award</i></b>&#8221; means an award of shares of Common Stock which is granted pursuant to the terms
and conditions of Section 6(a).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ss)
</b>&#8220;<b><i>Restricted Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Restricted
Stock Award evidencing the terms and conditions of a Restricted Stock Award grant. Each Restricted Stock Award Agreement will be subject
to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(tt)
</b>&#8220;<b><i>Restricted Stock Unit Award</i></b>&#8221; means a right to receive shares of Common Stock which is granted pursuant
to the terms and conditions of Section 6(b).</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(uu)
</b>&#8220;<b><i>Restricted Stock Unit Award Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a
Restricted Stock Unit Award evidencing the terms and conditions of a Restricted Stock Unit Award grant. Each Restricted Stock Unit Award
Agreement will be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(vv)
</b>&#8220;<b><i>Rule 16b-3</i></b>&#8221; means Rule 16b-3 promulgated under the Exchange Act or any successor to Rule 16b-3, as in
effect from time to time.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ww)
</b>&#8220;<b><i>Securities Act</i></b>&#8221; means the Securities Act of 1933, as amended.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<!-- Field: Page; Sequence: 67; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(xx)
</b>&#8220;<b><i>Stock Appreciation Right</i></b>&#8221; or &#8220;<b><i>SAR</i></b>&#8221; means a right to receive the appreciation
on Common Stock that is granted pursuant to the terms and conditions of Section 5.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(yy)
</b>&#8220;<b><i>Stock Appreciation Right Agreement</i></b>&#8221; means a written agreement between the Company and a holder of a Stock
Appreciation Right evidencing the terms and conditions of a Stock Appreciation Right grant. Each Stock Appreciation Right Agreement will
be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(zz)
</b>&#8220;<b><i>Stock Award</i></b>&#8221; means any right to receive Common Stock granted under the Plan, including an Incentive Stock
Option, a Nonstatutory Stock Option, a Restricted Stock Award, a Restricted Stock Unit Award, a Stock Appreciation Right, a Performance
Stock Award or any Other Stock Award.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(aaa)
</b>&#8220;<b><i>Stock Award Agreement</i></b>&#8221; means a written agreement between the Company and a Participant evidencing the
terms and conditions of a Stock Award grant. Each Stock Award Agreement will be subject to the terms and conditions of the Plan.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(bbb)
</b>&#8220;<b><i>Subsidiary</i></b>&#8221; means, with respect to the Company, (i) any corporation of which more than 50% of the outstanding
capital stock having ordinary voting power to elect a majority of the board of directors of such corporation (irrespective of whether,
at the time, stock of any other class or classes of such corporation will have or might have voting power by reason of the happening
of any contingency) is at the time, directly or indirectly, Owned by the Company, and (ii) any partnership, limited liability company
or other entity in which the Company has a direct or indirect interest (whether in the form of voting or participation in profits or
capital contribution) of more than 50%.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: left; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>(ccc)
</b>&#8220;<b><i>Ten Percent Stockholder</i></b>&#8221; means a person who Owns (or is deemed to Own pursuant to Section 424(d) of the
Code) stock possessing more than 10% of the total combined voting power of all classes of stock of the Company or any Affiliate.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 68; Value: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 33%">&#160;</td><td style="text-align: center; width: 34%">C-<!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td><td style="width: 33%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="vertical-align: top">
  <td style="text-align: left; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="proxy_001.jpg" alt="" style="width: 80px; height: 36px"/></span><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                                                                                                                                                                            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">P.O.
                                            BOX 8016, CARY, NC 27512-9903</span></p>
                                                                                                                                                                            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p>
                                            <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left; width: 40%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: rgb(207,16,44)"><b>Your
                                            vote</b></span></p>
                           <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: rgb(207,16,44)"><b>matters!</b></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center; width: 10%"><span style="font-family: Times New Roman, Times, Serif; font-size: 18pt; color: rgb(207,16,44)"><b>&#9746;</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"/>
  <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)">Have
                                            your ballot ready and please use one</span></p>
                                            <p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)">of
                                            the methods below for <b><span style="text-decoration: underline">easy voting</span>:</b></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 50%"><p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 2%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p></td>
  <td rowspan="2" style="border-bottom: rgb(207,16,44) 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-top: 3px; vertical-align: top; text-align: center; width: 15%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;Your
                                            control number&#160;</span></p></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 33%"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>
                                                          <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="border-top: rgb(207,16,44) 1pt solid; border-bottom: rgb(207,16,44) 1pt solid; border-left: rgb(207,16,44) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>

  <td style="border-top: rgb(207,16,44) 1pt solid; border-right: rgb(207,16,44) 1pt solid; border-bottom: rgb(207,16,44) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;<br/>
  <br/>
  <br/>
  </b></span></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left; width: 50%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Have
  the 12 digit control number located in the box above available when you access the website and follow the instructions.</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)"><b>Scan
                                            QR for</b></span></p>
                                                      <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)"><b>digital
                                            voting </b></span></p></td></tr>
</table>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: bold 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 55%"><span style="font-family: Times New Roman, Times, Serif; font-size: 12pt; color: rgb(207,16,44)"><b>Sonim
  Technologies, Inc.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 6%"/>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.1in; width: 37%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)"><b>Internet:</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; color: White; background-color: rgb(207,16,44); vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 14pt"><b>Special
  Meeting of <span style="letter-spacing: -0.1pt">Stockholders</span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="proxy_002.jpg" alt="" style="width: 40px; height: 34px"/></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>www.proxypush.com/SONM</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;&#160;&#160;&#160;<span style="font-style: normal; font-weight: normal">Cast
        your vote online</span></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;&#160;&#160;&#160;<span style="font-style: normal"><b>Have
        your Proxy Card ready</b></span></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;&#160;&#160;&#160;<span style="font-style: normal; font-weight: normal">Follow
        the simple instructions to record your vote</span></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; background-color: Black; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif">For
                                            stockholders of record as of September 15, 2025</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0.1in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)"><b>Phone:</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; color: rgb(207,16,44)">Thursday,
                                            October 16,</span><span style="color: rgb(207,16,44); font-family: Times New Roman, Times, Serif">
                                            2025, 9:00 AM, Pacific Time</span></p>
                                                         <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; color: rgb(207,16,44)">Special
                                            Meeting to be held live via the Internet - please visit</span></p>
                                                         <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; color: rgb(207,16,44)">www.proxydocs.com/SONM
                                            for more details.</span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="proxy_003.jpg" alt="" style="width: 30px; height: 45px"/></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1-866-451-4349</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;&#160;&#160;&#160;<span style="font-style: normal; font-weight: normal">Use
        any touch-tone telephone</span></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;&#160;&#160;&#160;<span style="font-style: normal"><b>Have
        your Proxy Card ready</b></span></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;&#160;&#160;&#160;&#160;<span style="font-style: normal; font-weight: normal">Follow
        the simple recorded instructions</span></span></p></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="border-top: rgb(207,16,44) 1pt solid; font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 28.55pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>YOUR
                                            VOTE IS <span style="letter-spacing: -0.1pt">IMPORTANT!</span></b></span></p>
                                                         <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif"><b>PLEASE
                                            VOTE BY: 08:59 PM Pacific Time on October 15, 2025.</b></span><span style="letter-spacing: -0.1pt"></span></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: middle; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="proxy_004.jpg" alt=""/></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)"><b>Mail:</b></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;<span style="font-style: normal; font-weight: normal">&#160;&#160;&#160;&#160;Mark,
        sign and date your Proxy Card</span></span></p>
        <p style="font: 10pt Times New Roman, Times, Serif; margin-left: 0.1in; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font: normal 10pt Times New Roman, Times, Serif">&#9679;&#160;&#160;&#160;&#160;Fold
        and return your Proxy Card in the postage-paid envelope provided</span></p></td></tr>
</table>


<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; color: rgb(207,16,44)"><b>This
proxy is solicited by the Board of Directors</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">The
undersigned stockholder(s) hereby appoint(s) Peter Liu, Clayton Crolius, and Katherine Schooler (the &#8220;Named Proxies&#8221;), and each
or either of them, as proxies, each with the power to appoint his substitute, and hereby authorize(s) them, and each of them, to represent
and to vote, as designated on the reverse of this proxy card, all of the shares of common stock of Sonim Technologies, Inc. that the
undersigned stockholder(s) is/are entitled to vote at the Special Meeting of Stockholders to be held at 9:00 a.m., Pacific Time on Thursday,
October 16, 2025 via a live webcast at www.proxydocs.com/SONM, and any continuation, postponement, or adjournment thereof.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">The
Named Proxies are authorized to vote in their discretion on any matter that the Board of Directors did not know would be presented at
the Special Meeting of Stockholders by a reasonable time before the proxy solicitation was made, and on such other business as may properly
be brought before the Special Meeting of Stockholders or any continuation, postponement, or adjournment thereof. <b>This proxy, when
properly executed, will be voted in the manner directed herein. If no such direction is made, this proxy will be voted in accordance
with the Board of Directors&#8217; recommendations.</b></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Important
Notice Regarding the Availability of Proxy Materials for the Special <span style="letter-spacing: -0.1pt">Meeting:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif"><b>The
Notice of Special Meeting and Proxy Statement are available at <span style="letter-spacing: -0.1pt">www.proxydocs.com/SONM</span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif">Please
be sure to sign and date this proxy card and mark on the reverse <span style="letter-spacing: -0.2pt">side</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right"><span style="font-family: Times New Roman, Times, Serif">Copyright
&#169; 2024 BetaNXT, Inc. or its affiliates. All Rights <span style="letter-spacing: -0.1pt">Reserved</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img src="proxy_001.jpg" alt=""/></span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: right; width: 60%"><p style="font: 10pt Arial, Helvetica, Sans-Serif; margin: 0; color: #CF102C"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Sonim
                                            Technologies, Inc. Special Meeting of <span style="letter-spacing: -0.1pt">Stockholders</span></b></span></p></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Please
make your marks like this: &#9746;</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">The
Board of Directors recommends you vote FOR each of the following <span style="letter-spacing: -0.1pt">Proposals <span style="letter-spacing: -0.1pt">1, 2, 3 AND 4</span>:</span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" border="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; background-color: Gray"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; background-color: Gray; padding-right: 5px; vertical-align: bottom; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROPOSAL</b></span></td>
  <td colspan="3" style="font: 10pt Times New Roman, Times, Serif; background-color: Gray; vertical-align: bottom; padding-left: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>YOUR
  VOTE</b></span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>BOARD
    OF DIRECTORS RECOMMENDS</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>AGAINST</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>ABSTAIN</b></span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><img src="proxy_005.jpg" alt="" style="width: 30px; height: 34px"/></b></span></td></tr>

<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 4%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1.</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
  of our certificate of incorporation to effect a reverse stock split of our outstanding common stock at a ratio ranging between 1-for-2
  and 1-for-30, as determined by our Board of Directors in its discretion.</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 8%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; width: 10%; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
                                            of our certificate of incorporation to increase the number of authorized shares of common
                                            stock from 100,000,000 to 1,000,000,000.</span></p></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3.</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><p style="font: 8pt Arial, Helvetica, Sans-Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amendment
                                            of our equity incentive plan to increase the number of available shares authorized for issuance
                                            by 1,000,000.</span></p></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">One
  or more adjournments of the Special Meeting, if necessary or appropriate, from time to time, to a later date or dates, even if a quorum
  is present, to solicit additional proxies if there are not sufficient votes at the time of the Special Meeting to approve any of the
  above-referenced proposals 1 through 3.</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#9744;</b></span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>FOR</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
<tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
  <td style="font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: left"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE:
                                            To transact any other business properly brought before the Special Meeting or any continuation,
                                            postponement or adjournment thereof.</b></span></p></td>
  <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-left: Gray 1pt solid; font: 10pt Times New Roman, Times, Serif; padding-right: 5px; text-align: center; padding-left: 5px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&#160;</b></span></td></tr>
</table>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif">You
must register to attend the meeting online and/or participate at <span style="letter-spacing: -0.1pt">www.proxydocs.com/SONM</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin-left: 0.5in; margin-top: 0pt; margin-bottom: 0pt; text-align: left"><span style="font: normal 10pt Times New Roman, Times, Serif">Authorized
Signatures - Must be completed for your instructions to be <span style="letter-spacing: -0.1pt">executed.</span></span></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0.9in 0pt 0.5in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-style: normal; font-weight: normal">Please
sign exactly as your name(s) appear(s) on your account. If held in joint tenancy, all persons should sign. Trustees, administrators,
etc., should include title and authority. Corporations should provide full name of corporation and title of authorized officer signing
the Proxy/Vote Form.</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 40%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left; width: 9%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    (and Title if applicable)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Signature
    (if held jointly)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Date</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: left; width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>



<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<!-- Field: Set; Name: xdx; ID: xdx_088_labels -->
<!-- eJyFjzFPhEAQhXsT/8OEShPv9qIdHRoLkwtS0BmLAeaQuLtDlgHu/r27azzB5GI5b9778l6SNU0nHVvUsMeK9JDcJR8ifarUPM/bY+X0ll2r7ne7B+VYk9LBllxfJVQ3aTH1JVaaSjrKo+b608cLPME0QEHuwM6grQneogmCC6Lt/QwgLllQP7HpMyMh/vwKUYKgkR0w9IPM8GhlEctqGVHrU4Fds07/fCC8LlHGYdMi9mlO8mJrNrTnIYz3N3wLcBOkW8hEXFeNEicIe6qj3yY5W18m932m9s8S/9qEPnnoNJHDlv5ftuRF1GLmZewauNp/xn8BIhCn3w== -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>logo_01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo_01.jpg
M_]C_X  02D9)1@ ! 0$       #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  ] ,@# 2(  A$! Q$!_\0
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M;OGFOY.?[0#Q+YG_ ,89P*TV]&N(7U:2YEF23Z:I*]KV5[+^QU^S5\*DE?Q
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MG3E# XB%3][?TS?#C(?$W@Z7"_A=E%?@#@K),JX!RKB[,<)Q!A^.,OX(KX#
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M:YI6F:Q9>;'/]DU73[34;;S8O]7+]GNXI8?,C)8I)LWIN8*1FN:_X5?\//\
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M.M^"].T.VL?!_B[Q#:7?AT_$7X+79B@@\*ZC-9'1]6\)^'KB,V6DZKH.K/\
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@<80;E;F?:UEHM;MNHHHKSSUPHHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>formdef14a_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" !" ,,# 2(  A$! Q$!_\0
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MXR0N>3CUK"M&4HZ.Q]#D>+P^$Q:EB*$:M]$I.T5)M6;Z676Y\/P_ /\ :/\
MB4HNM:U?4+2*7YMFI:L8P/\ MDI.W_OD5*W[%GQITE?M%CXCMGN!R%M]5E1L
M_4@?SJI8V/[2_P =%:^CN]6L-/E):-O.&GPXSC"XVDC\ZM2?LZ?M(Z(INX-?
MOKB2,;MD&O,Y/MM9ADUY/+%ZJ$GYG[A+&8J@_8SQN%I/^11NEY-MHIW'B[]I
M3X L)]5.J7^F1$;VOP-0MC[&4$D?]]"OL[X _$G5_BQ\-;#Q)K&C)HL]RS!(
MXY"RRJIQYBY&0"<\<].M>%_LO^//C3J7Q"NO"?CJSDFTRUMFFNY=5MMDR @!
M K@ /DGWXSS7UK:VL%C;QV]M#';P1C:D42A54>@ X%=V&B_B4G;LS\WXLQ5.
MZPM;#TE6TE[2D]'%WTMW>CUOIL2T445WGYL%%%% !1110 4444 %%<=\4OBO
MX=^#_AE]:\1WGD09V0P1C=-</C.Q%[G]!W-?'?BC_@H]KLU[(OA[PMI]M9]%
M;4'>:0^_RE0/IS7/4Q%.EI)GU&4\-9IG474PE*\5U;27X[_(^]:*^"O#7_!1
M_7(;I1K_ (4T^ZMN 3I\KPR#W^8N#^E?5GPB_:"\&?&JU)T#4-FH(-TNF78$
M=P@[G;GYA[J2/I2IXBG5=HO4O-.%\VRB'M<31]SNK-?.VWSL>DT45X[\;?VI
M/!WP2W6=]*^JZ\5#+I5F1O4'H9&/" ^_/M6TIQ@KR=D>#@\%B<PK+#X6#G-]
M%_6B\V>Q45^?^L?\%'?%<UU)_9?AC2+2VS\@N6EF<#W(91^E;?@W_@H]<F\6
M/Q5X4@-LQ ,VDRLK(.YV.3N^FX5RK&46[7/M9\!Y]"G[3V*?DI1O^9]RT5R_
MP[^)GASXJ>'TUCPUJ,>H6A.UP/EDB;'W74\J?\C-=178FI*Z/@JU&IAZCI58
MN,ENGHT%%>8_&K]H3PI\#=.236KAKG4IU+6VEVN#-*/[QSPJY_B/X9KY+\0?
M\%&O%EU=O_8_AS2K"US\HN3)/)CW(91^E<]3$4Z3M)ZGU&5\*YMG%/VV&I>Y
MW;LGZ7W^1^@5%?#?@/\ X*-W#7T</B_PU!]E8@&ZTEV5T'J8W)W?@PK[(\%^
M-M%^(7AVUUS0+^/4=-N1E)8^H/=6!Y5AW!YJJ=:G5^!G+FW#^99+9XRE:+V:
MU7WKKY,\'_:VD^,$-YH$/PXFNVTZ\#0SPZ;&!,DPR06D/1&7W !7WKPB'PO^
MU'X/N+>]2?6IEDD7>HNDN%&2!ATR>/PK[6^,GQ&_X5/\.-7\5?8?[2_L]8S]
MF\SR]^Z14^]@XQNST[5X;\%_VW#\7/B+I?A;_A%!IWVTN/M(O?,V;49ON[!G
M[N.O>N6M"G[2TIM-GVF1XW,HY4ZF&P%*I2I<W/*2C=V]YWU3=D^S/I?P_#J%
MOH>GQZO<1W6JK @NIHDV(\NT;RH[#.<5H45\Q?'3]N+0?AGJESH?AVR7Q)K-
MNQ2>4R;+:%QU7(Y<@]<8 ]:[)U(THWDS\_R_+,9G.(=+!T^:6[MHE^B1].T5
M^?%C_P %&_&4=ZKW?AS1)K7<-T40EC;'?#%SS]0:^J?@S^TYX1^,7AR_U&&;
M^QKO3(3/J%C>.,P1CK(&Z,GOV[@<5E3Q-*H[1>I[.9\)YOE-+VV(I7CWBT[>
MMM?T/7J*^*OB9_P42CL-3FL_!.@PWUO$Y7^T-4+!91ZI&I! ]R?P%8'A/_@H
MYK<>H1KXD\,6%S8D@.^G.\4JC/7#,P/TX^M2\913M<[J? V>U*/ME1MY.24O
MNO\ @]3[THKF/AU\2-!^*GAFWUWP]>"[LI>&4C;)$_='7LPKIZZTU)71\-6H
MU*%25*K%QDM&GNF%%%%,R/S(_;F\;7OB;XZ:CI4LK?8-$CCM;>+/R@LBR.V/
M4EL?117NG[+'[)?@/7/AEI'BKQ'9_P#"1:AJB-,(Y9&6"W4,5"A5(W-QR3W.
M,<5SG[:_[,NOZMXLN?'OAFRDU2WNXE_M"UMU+312(H7S HY92JC..A'O7S;X
M#^./Q!^#ZR6.AZW=Z;;+)NDL9E#QAN_R.#M_#%>#)JE7E*M&Z/Z6P]&KG7#>
M'PV1XA4YQ4>:S:=TO>3:U5WKY^C/N_XA_L-?#CQ=ITHT:RD\+ZE@F.XLW9H]
MW;=&Q((_W<&F_LL_LJQ_!%K[6-;EM]1\2S,T,,L&3'!!G^'/.YNI]!@>M?/?
MAG_@HEXWTY@-9T;2M73IF,-;O^8)'Z5]4? G]J;PK\<I'L+02:3KT:>8VFW1
M!+J.K1L.& ].H]*[*<L-4FI1T9\#FV%XLRW+JF'Q<G.@]VGS67K\2CWOH:7[
M2OQA'P6^%U]K,!1M7N&%II\;\CSF!^8CN% +?@!WK\R/!?@_Q+\;_B!'IMB9
M-2UK4I6EFN+AR<<Y>21NP'<U]3_\%)-6F-]X*TS+"W6*XN2.Q8LB_F #^=7?
M^";OAVU^Q^,M<9%:]#P6:/W6,AG8?B0O_?-85KU\0J3V1])D,H<-\+5,WIQ3
MJS_^2Y8KT6YV'@[_ ()[^!-+TR(>(+_4M:U$K^\>&400@_[*@$_F?RKA/C9^
MP#;Z7H=UJ_@"^NKB:V0R/I-\P=I%')\IP!SC^$CGUK[CHKNEA:3CR\I^<4.,
ML[HXA8AXARUU3^%^5ME\K'Y&_ ?XQ:K\#OB':ZI"\@L&<0:E9$G;+#GYLK_>
M7J/<>YK]6K[Q3867A.X\1><)-,BLVOO-3D&()OR/PK\M/VJO#=KX6^//BNSL
MD6.W>Z^T+&@ ">8H<@#ZL:^R?!NM7&J?L&7-Q*[&6/PU>6X9NNU%DC'Z 5Q8
M6<J;G3?0_1.-,#A\RI8#-8*SJN,7YJ2NOFM4? WCCQ?K/Q;\?7VLWQ>ZU/5+
MC]W$N3M!.$C4>@& !7V/\-/^">&C?V#!<>-M7OGU69 SVFF,D<<!(^Z696+$
M>HP/K7RG^SM$DWQV\#)(H=&UBVRI'!_>"OUXJ,'1C5YISU.OCK.\7DOU? 9=
M+V<7&^F]EHDNR5C\Z?VEOV+_ /A4WAV3Q/X9U&XU318&"W5O=JIF@!( ?<H
M9<\'@8R*I?L'_%*\\)_%:/PO+,QTG7U:,PG[JW"J61QZ9 93ZY'I7W'^T!;Q
MW7P4\:1RH'0Z7,2I]ER/U%?F1^SQ,\'QT\%-&VUO[5A&1Z%L']**T%0KQ<-+
MFF1X^OQ)PYC*68/GE!-)]?ANF_-/J?H=^V1_R;CXO_ZYP?\ H^.OAO\ 8O\
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MW94N[6]VM+$"<!PR@ KG (QQGK7U5^Q[&L?[./@W: -T4Y/N?M$M:G[4 !^
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M_N0_._\ 9+_Y.(\%?]?;?^BVK]7+BZ@LXP\\T<"$[0TC!1D]!DU^4G[)8/\
MPT1X*_Z^V_\ 1;5]C_'>WOV\=7CWKQ0KM0Z9-J#[+3[.(#YB*20OFF;^$G)&
MP=*XL'+DI-VZGZ%QU@5F&<T:3GR_NK_^3/\ KT/IFBOE>SM?B_\ 9U_X0AI(
M_"N3]@6_41R[,G/RMRJ[MVT=EVT5W>V_NL_-GD"O_O5->LK/YKH^ZZ'U.0&!
M!&17AGQX^'OA6XM7O9?#.CR7C*2UP]A$9#]6VYHHJ<3\!V\(_P"_?(J?L_\
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7%<=<,,T45$-CNS+^-'T'4445L>&?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>formdef14a_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  H + # 2(  A$! Q$!_\0
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M>U 'CWPO^/7[1-[H(T#7?@U8ZGXVLUC-UJ!\06]C8R(ZAA(%P[D@,-P12,Y
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>formdef14a_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #? G$# 2(  A$! Q$!_\0
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M9N^7?C;NXSGB@#YZ_P"&2?V9O^B&_#?_ ,)JP_\ C='_  R3^S-_T0WX;_\
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M(HH ^=_^&2?V9O\ HAOPW_\ ":L/_C='_#)/[,W_ $0WX;_^$U8?_&Z^B**
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M\)?^FN&OI*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.A>-=1T!;I?">K>.]#LY3;:-XZU70;SQ=I4*0I8:U;BW@\L _GQ^/G_!4?\
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M5AJ6F>#?BXUC!KD6F1^+-%LM7U*%)X;*.TO6NY)]2M+RX"2K]Q4 ?RR?"O\
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ML^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\
M#9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?
M\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<
MT?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\
MG<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_
M /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQ
MO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PR
MGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^-?\
MPRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\ T,?C
M7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O_0Q^
M-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[/O\
MT,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9?[/O
M_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\ #9?[
M/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+G_#9
M?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\N?\
M#9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4=%?+
MG_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]1T5\
MN?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<T ?4
M=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=S0!]
M1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_ /G<
MT ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&__P"=
MS0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PRGQO_
M /G<T ?4=%?+G_#9?[/O_0Q^-?\ PRGQO_\ G<T?\-E_L^_]#'XU_P##*?&_
M_P"=S0!]1T5\N?\ #9?[/O\ T,?C7_PRGQO_ /G<T?\ #9?[/O\ T,?C7_PR
MGQO_ /G<T ?4=%>!?#;]IWX*_%W6;30?AYXGUCQ!?7UIJ%[:3-X ^(VCZ//;
MZ6_EWY3Q#KWA/2_#YEMY=T)MSJ8N'GCE@BB>6&5$]E\0W.L66@:Y>>'=.@UC
MQ!::/J=SH>D7-TMC;:IK$%E/+IFG7%ZX*6<%]>I!;2W3 K;QRM,00AH V**_
MF(^$/[;7[5OPB_9 _;)_:!^)O[67A#Q_^T%H.B?#_P 4_%3]F3XT_ +6OA;X
MC_X)[?%_XC>-/!_PU\67-SHEGXLN?$/C;]D/X4:/J.H>,=+\1&TO=+\<V'@+
M7O%VD_$DP>(?$":?W/AW_@HY\?/ 7@S]LOX%Z%^U-\ OVX/C1\*M8_8Q\-_
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M'+]>:***\@]\**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MXUM\-+BP^+?P/^!OP\_9W\'_  2NO@3XH7Q_\"(O@A\#/#D_B;POX8TOX?\
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M?\5WE\1Z#X0N=&\%#Q'X-AGCU(Z1K#@ _2C]C[]IWQG^T!9_%[P9\9/A);?
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M./,U&[7ZXT5_ET?\-B?M5_\ 1P?Q5_\ "JO:/^&Q/VJ_^C@_BK_X55[7Y_\
M\1+R?_H S/[L'_\ -!^-_P#$=^%_^A1Q!_X#E?\ \VG^HO17^71_PV)^U7_T
M<'\5?_"JO:/^&Q/VJ_\ HX/XJ_\ A57M'_$2\G_Z ,S^[!__ #0'_$=^%_\
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M_1/+W_PX/Q-_^;*C_ABC]FC_ *)Y>_\ AP?B;_\ -E0!]4T5\K?\,4?LT?\
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M/]IGQI\:/C:G[,'[=GQZ_:W\=?M)_%W5? 7[(TOC?]I^^^&OQ\\:3?&#6/\
MA 8M>N+7PKIWAGP#I'CYY-.\4ZW\-[^"ZC^'<<MUX*U(ZFFF,ES_ *+M?RM?
M%C_@HW^UG\ ]._;"_8'\(_LR?M/R?M]^.OVG?C'>_L=_$3X1?LS^%5_9SUCX
M=?&+XHR>+OA1\4-<^(EE8?\ "'?V%X<\-:K./C=XB\8Z9?\ BN;6[7Q/<ZCJ
M1U%C>:2 ?U-:>"+"R!M5L2+2V!L5*%;,B% ;52GR%;<_N04^0A/EXQ5NJ]I]
MI^R6WVTPF\^SP_:S;AA;FY\M?/, <EQ"9=YB#DMLV[CG-6* "BBB@ HKY*_;
M%_;8^ G[#'PVTWXE_'?Q!JMI:^(?$=CX4\'>#_"'AW6?&_Q%\=:[<G[3J%EX
M+\"^&;/4O$?B,^'-!AU'Q5XEETZPFAT7PWI&H:E>R1)'$LNCK7[;/[)OA[3_
M -G;4]6^/OPXM[;]K;7?#'AS]FN*+7$O=1^,VK>,([670H_!&D6$=SJNIV<J
M7UD=2U9K*'2= -W:IK]]ICW$2N ?4E%<'\4?BC\//@I\//&/Q9^+/C'0?A_\
M-OA_H5]XF\9>,_$U]%INA^']#TZ/S+J^O[J4\ 92&W@B66ZO+J6"SLX+B[N(
M89/G#P=_P4)_8T\>?L[^-_VK?#OQY\+_ /"AOAI>W^E?$3QIKVG>*?!]YX&U
MS3YM.@?PWXL\$^+]!T+Q_P"'_%-]+K.AIH?A;5/"UKXA\1G7_#Y\/Z9J:Z[I
M!O #[+KE_&FG^+-5\-:E8>!O$NF>$/%$XMAI?B'6/#C>+=.T]H[RWENC<>'U
MUGP^U^+BR2XM(P-7M/L\LZ769O(\B7S7]GG]I3X'_M6_#BV^+/[/_P 0-.^(
MG@6?6-7\.W&HVNGZYH6J:+XDT"X%KK?AGQ3X4\5:7H7B[P?XFTJ5HFO_  [X
MJT+1]:MH+FSNI;%;6\M)IM_XTVGA2^^&GB6U\;^%/%OC?PO*FF_VGX8\"V'B
M34_%.IJNL:>]J-+L?"-S9^(9S:WBV]Y=#3[B,QV5O<RW&ZU2=& /E7]CSPY\
M8[35?BOJ&O\ Q/\ "VL>%+/]H'XW6/B+PY9?#&31M2UWQ.FNM#<^(;#Q$?&V
MH+HNG7&H$7L>@MH^JM! OV(ZQ+_Q\+]^U^4O[$&C_!^#Q]XVN]!^$/QDT+Q5
M;?%OXS6OA[Q5K_AWXGVGA/P]X96^>.V\,^([_6-6N/#EIXHMM/SI]S9:Y:S:
M^FH$0SSM>XD/ZM4 %?G_ /\ !5;_ )1P_MI?]F^_$#_TTR5^@%?G_P#\%5O^
M4</[:7_9OOQ _P#33)7GYM_R*LS_ .Q=C_\ U#Q1XW$?_)/9_P#]B/.?_55F
M)_FKT445_+Y_  4444 ?T^_\&O\ _P ER_:X_P"R4?"K_P!2_P 8U_977\:G
M_!K_ /\ )<OVN/\ LE'PJ_\ 4O\ &-?V5U^_\!_\DQ@?^OV._P#4N9_9/@]_
MR0.5_P#87G'_ *LJ@4445]B?IX4444 %%%4M2U+3M&L+S5=7U"RTK2]/MY;N
M_P!2U*Z@L;"QM85+S7-Y>74D5O;6\2 O+--(D<:@LS #--)MI)-MM)))MMMV
M222;;;:223;;22;:0FU%-R:22;;;2223;;;:222;;;223;:2;5VBOQ _:V_X
M+U_L7?LZG4O#7PTU6\_:6^)%JTEI'H_PTN8(_ MCJ2R/"+?6?B5>1R:+(5D5
M28?"MMXIN'!,92&0.4_,<:W_ ,%O?^"L_P NBVTG['G[-/B#<OVI3KOPQTG5
M-#N?D<G4Y(Y/B]\1HY8DVN--AT'PI>3>8"+6-BL7V. X(S:OAXX_-JF%X;RI
MV?U[.ZCPLJD;*5L+@'_MV*FXZPC"A34KK7E?,?GF:>)>0X;%2RK(J6-XQSQ7
M2RSAJBL="E*[BGCLT7_"7@::GI.=3%57&TM.9<I^[7[6G_!5K]BK]CM-0TOX
MA_%2Q\5_$.RBD*?"OX9?9_&GC<W"!PMOJT%A<KI'A;]XJK(_BG5M'9$82113
MG:C?AOK/_!3+_@JM_P %*=5O_!?_  3\^!&I_!7X77,\FGW7Q2Q:7.JVUK(-
MK2ZK\7?$UK:^"/#5RJ*9S8^"--U;Q);DF.TU"Y8(TOZ%_LE?\$ OV/?@(^G>
M*?C*-1_:>^(\$L5_/=>/+:/3?AS::F"DSS6'P\L[BYM]5*W/F'[1XRU3Q*UR
MNV1[:"1I0W[CZ-HFC>'-*L="\/:1IF@Z)I=NEIIFCZ-86NEZ5IUK'G9;6.GV
M,4%I:6Z9.R&WACC7)PHR:[?[3X-X?TR;+*G$^8PVS7/H.CEE.HOMX3)J<N:L
MDU>$L;4:=DW#5H\W^Q?$/BSWN(<YI<%Y14U>1\+55B,ZK4G_ ,N\?Q%6CRX>
M4HOEJ0RVDG%N2C5T3/\ -\_X*0_LC?&+]C'XQ^"?"'QW^+4/QD^*WQ.^&5I\
M6/%GB>*]\1ZR-/O=3\5>)_#?]AMXB\53R:QXCEMQX=-U+JL]KIT+-=?9[:QC
MA@5W_.]F9SEB6/J:_HG_ .#F+_D]SX,?]FO:%_ZM/XFU_.M7\M>)G&G%/$W$
M&8X3.<ZQN*R_!8M4\%E4*GU;*<'3A1P[A'#Y9A?88.+ASR4:M6CB*Z3LJT4D
MC^7^,,GP.1\5Y]EF7TZD<-@\PE1I2KUJN*Q,H^PP=24JV*KRG7K5*E2M5J5*
MDY7E*<GM9(HHHK\U/G0K_22_X)'_ /*-/]C#_LA_AG_T.\K_ #;:_P!)+_@D
M?_RC3_8P_P"R'^&?_0[ROT?PS_Y&V8_]BV/_ *F4S]Q\!_\ DI,Z_P"Q%'_U
M:8<_1:H;BWM[NWGM;J"&YM;F&6WN;:XB2:WN+>9&CF@GAD5HY898V:.6*162
M1&9'4J2#-17[3MJM&M4UHTUU1_4[2:::335FGJFGHTT[IIIM-----IIIM'X
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M%X9\+Z]XUOM&G\7+8Z'#;Z9)8:U9W5I;P0W"Q+]64 ?DI_P51\4?LV_#:Q^
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M_P!ALO\ TQA#^'/$?_DN^*?^QK/_ -1<O"BBBOG3XH*_T$?^"7/@W]I'4?\
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MM&I4]K42IMI4T^=I'])G_" _M:?]''_"_P#\1SO/_GST?\(#^UI_T<?\+_\
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M^!+;Q09?&OBXZ4UMXDOM!L+'Q)%90B5%TNQUG6I/"Z.NF79MI4VM^A=?#O[
M_C#6==^!GA_0]0^'GC+PM9:')XHGL?$^OOX8;1/$\FI_$'QC<75MH:Z/XCU7
M5UGT63_1-3.L:5I41N.=/EOH/WU?<5 !17D/A'X__!'QXOQ4?P?\5O >OQ?
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M)9?\(+]L^&']H _\+'>?_A+/L7_"T_\ A'/L9'_$G^U?VE_;?GCRC8_8,7%
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M\+3680<\3BL9BL-AZ$%.#E6K4X\\+\T?P0_MC6O^@[KW_@\U;_Y,H_MC6O\
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M6D_$CPYH-AH\&FZ3XZTR_FDNK#Q59V\6N6DS;H+Y-J@;UC^S-^SII?QNU/\
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M'XJW_P 3[:U\2>)-4_:K\'^ /B3\4M8\427OPVU]M;3_ (50-;\.7_VSX6^
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M*;&D)J&GW4&F20MY\5LMKB.OTCH **** "BBB@ HHHH **** "BBB@ HHHH
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M743JVH74DT20V=K-(TJ!=P /S#BU+_@J3\,/"/A'XD7.A?\ !+;]O[X+>$]
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MCMI@2Q$L" 12 LQWH>3UK^43XH?M0?L"?\%*/VMOB?\ "ZU\,?\ !0#X)O\
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M5/%>HZQ\/[ZUT1Y[GXIZEX)T%M6\42:UXL\%:7XH\)ZS"EC]7?\ !-+]H/\
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MX)_^7==!_P *B^$__1,/AY_X17AO_P"5E'_"HOA/_P!$P^'G_A%>&_\ Y64
M<_\ \-$_L_?]%T^#G_ASO!/_ ,NZ/^&B?V?O^BZ?!S_PYW@G_P"7==!_PJ+X
M3_\ 1,/AY_X17AO_ .5E'_"HOA/_ -$P^'G_ (17AO\ ^5E '/\ _#1/[/W_
M $73X.?^'.\$_P#R[H_X:)_9^_Z+I\'/_#G>"?\ Y=UT'_"HOA/_ -$P^'G_
M (17AO\ ^5E'_"HOA/\ ]$P^'G_A%>&__E90!S__  T3^S]_T73X.?\ ASO!
M/_R[H_X:)_9^_P"BZ?!S_P .=X)_^7==!_PJ+X3_ /1,/AY_X17AO_Y64?\
M"HOA/_T3#X>?^$5X;_\ E90!S_\ PT3^S]_T73X.?^'.\$__ "[H_P"&B?V?
MO^BZ?!S_ ,.=X)_^7==!_P *B^$__1,/AY_X17AO_P"5E'_"HOA/_P!$P^'G
M_A%>&_\ Y64 <_\ \-$_L_?]%T^#G_ASO!/_ ,NZ/^&B?V?O^BZ?!S_PYW@G
M_P"7==!_PJ+X3_\ 1,/AY_X17AO_ .5E'_"HOA/_ -$P^'G_ (17AO\ ^5E
M'/\ _#1/[/W_ $73X.?^'.\$_P#R[H_X:)_9^_Z+I\'/_#G>"?\ Y=UT'_"H
MOA/_ -$P^'G_ (17AO\ ^5E'_"HOA/\ ]$P^'G_A%>&__E90!S__  T3^S]_
MT73X.?\ ASO!/_R[H_X:)_9^_P"BZ?!S_P .=X)_^7==!_PJ+X3_ /1,/AY_
MX17AO_Y64?\ "HOA/_T3#X>?^$5X;_\ E90!S_\ PT3^S]_T73X.?^'.\$__
M "[H_P"&B?V?O^BZ?!S_ ,.=X)_^7==!_P *B^$__1,/AY_X17AO_P"5E'_"
MHOA/_P!$P^'G_A%>&_\ Y64 <_\ \-$_L_?]%T^#G_ASO!/_ ,NZ/^&B?V?O
M^BZ?!S_PYW@G_P"7==!_PJ+X3_\ 1,/AY_X17AO_ .5E'_"HOA/_ -$P^'G_
M (17AO\ ^5E '/\ _#1/[/W_ $73X.?^'.\$_P#R[H_X:)_9^_Z+I\'/_#G>
M"?\ Y=UT'_"HOA/_ -$P^'G_ (17AO\ ^5E'_"HOA/\ ]$P^'G_A%>&__E90
M!S__  T3^S]_T73X.?\ ASO!/_R[H_X:)_9^_P"BZ?!S_P .=X)_^7==!_PJ
M+X3_ /1,/AY_X17AO_Y64?\ "HOA/_T3#X>?^$5X;_\ E90!S_\ PT3^S]_T
M73X.?^'.\$__ "[H_P"&B?V?O^BZ?!S_ ,.=X)_^7==!_P *B^$__1,/AY_X
M17AO_P"5E'_"HOA/_P!$P^'G_A%>&_\ Y64 <_\ \-$_L_?]%T^#G_ASO!/_
M ,NZ/^&B?V?O^BZ?!S_PYW@G_P"7==!_PJ+X3_\ 1,/AY_X17AO_ .5E'_"H
MOA/_ -$P^'G_ (17AO\ ^5E '/\ _#1/[/W_ $73X.?^'.\$_P#R[K\"/^"D
M?_!-OX,?MY_M()\?='_;W^!'PSC?X=>%? UUX9OKGPAXED:?PQ?^(;I-435;
M;XBZ-O6\AUQ(6@ELR\'V-0L\D;JL?]"__"HOA/\ ]$P^'G_A%>&__E91_P *
MB^$__1,/AY_X17AO_P"5E>KDV=9ED&,^OY5B%AL5[&KA_:.E2K+V5;D]I'DK
M0G#WO9PM*W,K:-7=_#XAX;R?BK+_ .RL\PLL9@?K%#%>RCB*^&:KX?VGLIJK
MAJE.I[OM:B<>;EDI>\G96_/G_@G7X"^!'["7[,?A_P#9\OOVLO@M\2;S2/%7
MC7Q1<>*+;Q=X,\,V\[^+M=N-86RATJ3Q?K$B)8QRI 9WO6:X</)Y42E4'W-_
MPT3^S]_T73X.?^'.\$__ "[KH/\ A47PG_Z)A\//_"*\-_\ RLH_X5%\)_\
MHF'P\_\ "*\-_P#RLKDQN,Q&88S$X_%U/:XK&5ZF(Q%10A!3K56I3DH0481N
MTO=C%16R1WY;EV$RG+\%E> I.C@LOPU+"82BZE2JZ="C%QIP=2K*52;BF[SG
M*4I-W;.?_P"&B?V?O^BZ?!S_ ,.=X)_^7='_  T3^S]_T73X.?\ ASO!/_R[
MKH/^%1?"?_HF'P\_\(KPW_\ *RC_ (5%\)_^B8?#S_PBO#?_ ,K*Y3M.?_X:
M)_9^_P"BZ?!S_P .=X)_^7='_#1/[/W_ $73X.?^'.\$_P#R[KH/^%1?"?\
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M7B'X7>%=:\)7=UIIMO!FCW_A[3[J\F6TU#Q5J)OO'5[8VD_BEX$ /TVHHHH
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M\4^)_"EII$UUJ%QINH_\))::C+>P1Z:^E"T>VU2XEBS/VM?V<K^\_;X_8B\
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MS?\ !*?XF_L^?"/X3^'/B3I5IKW[7MIK7[4D7[/W@OPY;ZWHNG>(O'ZVEO\
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M=1011W%X;:,Q6QNIT02W'V>(F*#S6?RHR4CVKQ5FBB@ HHHH **** "BBB@
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M_P".OC#6OV@/&/A&Z_8!T/X!?$S2_A#\0(X_B^]CXB_9K\+_ !$L=#L[#3_
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ME1B\#4RZO.AS86EAJG+*K/G]I[1-*:2_@CQ?\7/I6\.>(_%&2>'OAW6SK@W
M8G!0R/-(>'>89W'%T*N59;B,3-9I1SC"TL5R8^OC:/-&A35-TO8M-TW)_LQ_
MP^B_8R]?B[_X;J3_ .7%>[_LZ?\ !1?]G7]J+XBM\+_A>?'W_"4+X=U7Q.1X
MD\(MHFG?V9H]QIUM>8O6U"YS<>;JEKY4/E?O%\P[UV -_/A_PZ-_;L_Z)QX.
M_P##H>$O_DBOOK_@FW^P5^T]^S7^TA/\3?BWX-T+1_":?#/Q?X>6YT?QGH'B
M&]DU;4[_ ,.7=E;1Z?IT[7!$T6F78\T@1(ZHKNID7/;QCX=_1_RWA3B',.'.
M,J6-S[!Y5B<1E&#7&>$QSQ./INA["BL'#+:4\2YJ=7]S&I!RY=)+E=_+\-_&
M3Z7>=\?<(91QEX:U\KX3S+/L%A.(<QEX:YCE4<%E558KZUB7F-7.J]/!*FZ=
M#_:)T:L8<]G!\ZM^FL?[;WPW;]M35?V*I_#GB^S\1Z7\+G\>M\5+N+1H?A;=
M>++.WT[Q%K/P;M]1;5O[;'Q'T3X;:YX?^*>H6TVC1:*O@S6(+F+5I+V"ZM(O
MI^V^(GP_O+#P;JMIXY\'76E_$6:WMOA]J5MXFT6>P\=W%UI5YKMK!X-O(KYK
M?Q/-<Z'IVH:S;Q:))?/-I5C>:C&K6EM/,G\]5C^QO^V_I.A>&O\ @H)-X[_:
M)U/XW3_MC/\ M9:__P $Y1%^SR_@K3_"_CWQ4_P(\1>#;'QD/!4/Q!?QIX>_
M8YU2W6>TO/C3=>%)O$N@/IPTNXMTL[5>[^$/[*?Q7^&_Q,^*_@[XQ^#M1\&?
ML<_\$^_A[^UIJ/[)/C23QCX5\,Z7XPT?]JB/4O$^EW_A?Q2VI7>H>!+K]E/X
M/2>._@<GB7Q=I>A0Z#;>,$U+39M7TFVNKJ/^2#_0L_97PK^U)^S+X[\?W/PH
M\$?M%_ GQE\4K*[UBPO/AKX5^+OP_P#$/C^TOO#T<TNOV5SX.TCQ#>>(H+O0
MXK>XDUBWETY)M,C@F>]2!8G*^&^#?V_/A+XO_:J_:J_9!.A>,- ^)_[+7A3P
MEXVN[K6[;3(?#OQ8\-^(O /AWQWK=W\,=0@U*>34+OX?)XN\+:+XWTS6+?2;
M[2[WQ-X?OH8;K2-4AOE_ 7_@B='\&_"OQ]_9MOOBYX'T'X.?'CQ'^QQ;_!/]
MFGPQIW_!-/XR_LEVGQ#\/^%M'T#XD?$#Q5XB_:%^)^EW7AO]H/XTZ7X8LIH+
M[Q9\+KWP[X0UWPM?>+?%=E:W\?C=;:V^_OC%^QM^T#XE^*G_  4,^/\ \,O!
M;Z5\</!OQ^^%7QU_8XU35[_1]/T?XU6&B_L6?#/X0_&#X.ZAJ23WESIW@GXP
MV%AXM^%6K-K<.GV^C^,+7PMXY6"8>$]-NV /;]6_X*KZGKEK^R9;?L^_L4_M
M"?M)^,?VL_V7+S]KC0_ _@CQ?^S_ ."M4^'OPLT^_P#AQI%X_C75_BW\6/ G
MAB75H=8^*7A?3/L?AW6M9:6>::2#S+>)YE],^)O_  4+\1> KOX0_"_P[^QM
M^T-\5OVN/BA\,)?C%KO[)W@/6O@DWBSX-?#RRU1= O\ Q%\6OBUXA^*6A_ /
M0+9_$AD\-^'8M.^)6L7?C'6K34K;PS;:C#I>H7-M^)OC[]C7QAIVG?\ !)_4
M?VAOV OVR?VB_ 7P4_X)G:U\$_'_ ,._V7_BA8^ ?B;\)_CIJ6K_ +/6HZ7I
M/C?7_"_[2O[/$NL:=8Z%X-\:Z5J4.E>--?\ #]QK45G>)I-P8K2]L_T3EE^/
MO[._[0'@[]M[X6_L4?M%_%'X*_'#]C_X4_L_?$G]G+3-9^%=S^U[^SWXH^!?
MB_QOJWPNU'4-%\=_&2#P7X[\/>(] ^(FN:)XZ.F_&?6O$6CZQH^D^)KF[\01
M:A>BW /TM_96_:M^''[6OPNU'XE>"=-\7^"[WPEXR\6_#+XI_#7XGZ&OA/XD
M?!_XH^ KM;/QC\/_ (A:%]KOK33M:T?SK/4H;S3]3U/0]:\/ZIH_B+1-4O\
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MC0SS2%%Q\-_\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
ME!0!]]T5\"?\/-OV.?\ HH^K_P#A ^.?_E!1_P /-OV.?^BCZO\ ^$#XY_\
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8 !^,O_#I#XE_]!&V_P# R>BOZ/:* /_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>formdef14a_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 formdef14a_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #? G$# 2(  A$! Q$!_\0
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MPUC2QK'A^^U#3SJ&EWL;VM_:"X\^TG4QSQHW%=O0!\[_ /#)/[,W_1#?AO\
M^$U8?_&Z/^&2?V9O^B&_#?\ \)JP_P#C=?0DDL46SS98X_,<1Q^8ZIOD;.U$
MW$;G;!PJY8X.!4E 'SO_ ,,D_LS?]$-^&_\ X35A_P#&Z/\ ADG]F;_HAOPW
M_P#":L/_ (W7T13))(X4:261(HUP6DD=4102 "S,0HR2 ,D<D#J: /GK_ADG
M]F;_ *(;\-__  FK#_XW1_PR3^S-_P!$-^&__A-6'_QNOH.2>&%!++-%%&2H
M$DDB(A+?= =B%);^'GGM39KJVMMOVBX@@WYV>=-'%NVXSMWLN[&1G&<9&>M
M'S]_PR3^S-_T0WX;_P#A-6'_ ,;H_P"&2?V9O^B&_#?_ ,)JP_\ C=?0ZLK*
MK*P96 964@JRD9#*1D$$$$$'!'(I: /G?_ADG]F;_HAOPW_\)JP_^-T?\,D_
MLS?]$-^&_P#X35A_\;KZ(J#[5;>6\OVB#RHF*22^;'Y<;J0&1WW;48$@%6((
M) (R10!\_?\ #)/[,W_1#?AO_P"$U8?_ !NC_ADG]F;_ *(;\-__  FK#_XW
M7T0"",@Y!Y!'0CUI@DC+M$)$,B*K/&&4NJMG:S(#N56P=I( .#C.#0!\]?\
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M(HH ^=_^&2?V9O\ HAOPW_\ ":L/_C='_#)/[,W_ $0WX;_^$U8?_&Z^B**
M/FZ?]D3]G8[I=*^&FE^$]0$92#6? ]_K7@G6[-_FV3VFJ>%]2TJ[AGC9BR2"
M1N>&#)E3S4>N>._V=O$?A_1_'7BG5/B-\$?%NLV7AK1O'GB5XI_'/PR\3:Q=
MBU\/Z1XXU:""WC\4^#]=O9K?1].\6WD2Z[H^KS6L/B.YU&RO5U*S^MJ\Y^+_
M (3TSQU\*_B)X0UB%9]/\0>#?$.G2JV08I)=,N&M;J)@08[BRNU@O+652&AN
M8(I5(9 : /1J*_EI_P"'G/QZ_P"@E_XZG_Q^B@#^@3]CO_DUGX!?]DM\)?\
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M?M=OYMO)=6HDMOM,2OO7R_\ 9V_X+,_MU^&?%'[$7C#]I:?X-_&GX=_MG_\
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M V@Z;X8\)>&=*21-.T/0=(MDM-.TVT$TDTQAMK>-$#S2RS2$&26621F<]C0
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MR?)-$C<5:_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_ &??^AC\:_\
MAE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^&R_V??\ H8_&
MO_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_ &??^AC\
M:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^&R_V??\
MH8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_ &??
M^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^&R_V
M??\ H8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_X;+_
M &??^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*^7/^
M&R_V??\ H8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCHKY<_
MX;+_ &??^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH ^HZ*
M^7/^&R_V??\ H8_&O_AE/C?_ /.YH_X;+_9]_P"AC\:_^&4^-_\ \[F@#ZCH
MKY<_X;+_ &??^AC\:_\ AE/C?_\ .YH_X;+_ &??^AC\:_\ AE/C?_\ .YH
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M^-?_  RGQO\ _G<T ?4=%?+G_#9?[/O_ $,?C7_PRGQO_P#G<T?\-E_L^_\
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MG2;GX?P7/BZ-I[TVUM=_V3"[-8S7*7>VQ:Y8 'RG^QYK?QJN=5^*]GXA\ >
MM+\(7/[0'QNNO$FN:9\1]6U?6](\5/KK2W6BZ3H$_@/3;76-&AU+%K%K=QK>
MD7,]L3>-HL,G^C'[]K\J/V(-0^#<OCWQQ!H'Q"^-NJ>+)OB[\9I_#NA>(M8^
M-MQX/UCPPU\[VVM^)K3Q%I\7@^X\5S:=FZNKGQ//'XM;4@LEU$-2VH/U7H *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBOFSXT_MB_LL?L[03S?&OX
M_?"WX=SVQ82:3KGBW3#XC=T7>8K?PO8S7GB.[FV\K#:Z7-*X!VHV#6U##8C%
M5(T<+AZ^)K2TC2P]&K7JR]*=&G5F_7EMW:.?%8S"8&C+$8W%87!X>"O.OB\1
M0PM&.E_>JXBM0IK3ISMOI%GTG17\]GQM_P"#C_\ 8N\ O<Z=\(O"/Q2^.^LQ
MR216L]CI5O\ #WPG=LC;5:'6_%Q779HY?O1M:>$+K*Y#^6WRU\?'_@IU_P %
MI/VQRUI^R-^Q\?A9X6OG:&U\93^!]1U<I!,"$EF\??%F3PUX#C8P-YL<EAH$
MK@IYEK+<%55_KL-P!Q+5I+$8S#8;),(]7BL]QN%RRFEO=4Z]66(D[:\L:*F]
ME&Y\!C?%;@VA6>$R[&8SB3'JZ6!X8RW'9U5<MK.MAJ$<'!7TYY8EP6[G;4_K
M.N+FWM();J[GAM;:!&EGN+B5(((8T&6DEFE98XT4<L[LJ@<DBO@_XX?\%/\
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MV>V'AOQ+JO\ :7A_POJ^B77B&&2XG.@:SH=AJFGQ0QO<PK]H0#^+/]ISP?\
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M_!KXS:3\3]8_9^\86/A_PA%%'\,8M*\(Z7X=B^+>C/<O=W/B"[OK?PFL.G+
MWR]K'[&'[:?QFTGXY_M<>,_ 7PC^%?[6WB+]H_\ 9"^/WP5_9KE^*5SXW\!:
M/X=_8KAO-/T3X=_$3XV:'X0TN&?Q)\8[/Q?\5WE\1Z#X0N=&\%#Q'X-AGCU(
MZ1K#@ _2C]C[]IWQG^T!9_%[P9\9/A);? G]H7]GKXAVWPY^,/PTTCQU%\3O
M"4,^N^$M \?^"/&?@#X@IX=\'W/BKP/XW\&>)],U'3+S5?"/A?6]/U2VUO0]
M5T2VN=*,US]/^-1XW;PSJ8^',GA6+QD1;?V._C6'5Y_#*M]LM_MG]IQ:%-;Z
MJP-A]J%M]EF0B\-NTN81(I^(_P!ACX/?'?P]XA_:=_:0_:9\)^#_ (9_&+]J
M_P")_A3Q5<?![P-XQ'Q%T?X3_#[X7_#3PQ\*_A_X6U/X@QZ)X=L_&7B^_M=
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M;M*[7Z&45_EO67[9'[5TME:22?M"_%9Y)+6W=V/BJ\RSO$C,QQ@9+$DX '/
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M=6TJ[?QQ\0[Q+74-/\!ZY=6=PUI>^++BSN?(N(HY?(N[>>VE*!)X98F>-O\
M.L7[J_[H_E7YOQCQ3F/#^*P5#!4\).&)PU6M4>)I5*DE.&(5**@X5J24>75I
MIN^M[:'Y)XG^(.=\&YCE.$RJAEM6ECL!B,56>.P]>M.-2EC5AXJFZ6*PZC!T
MW=IQDW+522T/]!S_ (?W?\$OO^B\>(/_  S7QB_^8>C_ (?W?\$OO^B\>(/_
M  S7QB_^8>O\^6BOC_\ B)&??\^,L_\ ">O_ /-9^9?\1RXP_P"@/(/_  AQ
MG_SQ/]!K_A_=_P $OO\ HO'B#_PS7QB_^8>O9_V?/^"MW["7[4?Q:\,_ _X*
M_%G6?%'Q)\7P:[<Z#H=U\,_B5X?@NX?#>AZAXCUAY-7\0>%=-TFU^RZ1IE[<
M@75["9VB$$ DGDCC;_-^K]2O^"+G@GPQ\1?^"D?P#\'^,M-?5_#NJZ7\7'OK
M!-1U72GF>P^$OC&_LV6_T6^T[4H3#=V\,V(+R-9=GE3K+"[QMWY7Q_G6-S/+
M\'5H9<J6*QN&P]1PH5HS4*U6,)N#>)DE)1;Y6XR2>Z>QZ_#_ (R<59IGN399
MB<+DD</F&:8#!5Y4L'BHU8T<3B84:CIRECYQC449-PE*$TI6;C):'^B]17RM
M_P ,4?LT?]$\O?\ PX/Q-_\ FRH_X8H_9H_Z)Y>_^'!^)O\ \V5?L)_3AVO[
M0G[-/P/_ &J/A]??#'X\?#W0OB!X4NQ)):Q:I 8]5T'4'CV1ZSX9URV:'5O#
MNLV^$:+4=*N[:<A!%.9K=I(7_E]^*W_!.S]OS_@DQX[UG]H3_@G9X^\4_%[X
M*/.^I^,_A9<V3^(/$,.BVJF66U\>_#RT\C3_ (C:796?FQ0>,O!UOIGCG2((
MWN3:6J(]X_\ 2;_PQ1^S1_T3R]_\.#\3?_FRIR_L5?LU(P9/A]?*RG(9?B%\
M300?4$>,LBOI<BXIS+(XU,+%4<PRG$Z8W)<QA]8R[$QDUS-4Y<SPU9K6.(PS
MIU(S492C-Q4H_'<3\#Y/Q-.CC9O$93GV#L\NXCRBI]4S?!SBGR)UH<D<9AE>
MTL)C%6I2@YPA*DIRC+X,_P""?O\ P6D_9Y_;*;2OASX^^S? +]HB0I82?#_Q
M7J21^&O&&J1@QSCX=^*;]+*._NY9T?'A'6HM/\56K,+:"VU@127A_9JOPU_;
M2_X(1?LJ_M$Z!=:Y\$[%/V=/C3:O/J.G^+M!?5=7\+^*-3+?:(T\>Z!?:C/<
MW,LETJNGB70[S3_$%C(\ET[ZKA;5OQ)\$?&7XZ_\$QOB?:?!3_@I?^S]XK^+
M_P *=5U$Q>&_BWI7COX@7?B!-.4HC7O@'QG:^*M,\._$#1K:W*W-UX*\1)HO
MC+2B#&MW;X-G/[M3AW*.)J<\7P;6=#'J,JN)X4S"O!8R%DY5)9-BZDH4\QH1
MU<:$Y1Q$(65[I)_+T>+N(.#*M/+_ !#PZQ65RG&C@N.\IPU1Y?4YI*%*'$.7
MTHU*N4XF5XJ>)IPG@YSYI6:>G]P%%?G'^SY\//\ @GS^U/\ #[3_ (G_  '_
M +.^(/A*]"1W$^E?$GXG)JFAW[*6DT;Q-H=UXPAU?PYK5N5=9M-U>SM+DA?.
MA66V>*9_<_\ ABC]FC_HGE[_ .'!^)O_ ,V5?!5J%;#5JF'Q%&K0KT9RIU:-
M:G.E5ISB[2A.G4C&<9)[J45T:NFI/]2PV)P^,H4<5A*]'%8;$4XU:&(P]6G7
MH5J4U>-2E5I3G3G"2V<9/6Z:C)2C'ZIHKY6_X8H_9H_Z)Y>_^'!^)O\ \V5'
M_#%'[-'_ $3R]_\ #@_$W_YLJR-SZIHKY6_X8H_9H_Z)Y>_^'!^)O_S94?\
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MRQ>)P$<FA4Q>#P\JU"6%Q,<1BJV$QM%XNERUY4UA*M-4U-*MSN245^-OP/\
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MO_ZF(_E_Q[_Y'?#O_8GQO_JTB.HHHK\S/P<*_73_ ((3?\I2/V<_^P3\9_\
MU37C>OR+K]=/^"$W_*4C]G/_ +!/QG_]4UXWKU^'_P#D>Y-_V-,#_P"I$#Z3
M@W_DKN%_^R@RC_U.I'^AI1117],G]Z!1110 5YO\6?@_\+_CMX%UKX:?&'P+
MX<^(G@3Q!"8=4\-^)]/BO[&8A66*ZMV;;<Z=J-KO9['5=.GM-2L)2)K*[@F
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M%#6A:)&-JP0! ;<GRB$ 4%/E &*_SUOVM_%7[0_Q\_:NUSQM\$?^"/O[:O\
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M_P#B.=Y_\^>C_A ?VM/^CC_A?_XCG>?_ #YZ^HJ*^_/V0^7?^$!_:T_Z./\
MA?\ ^(YWG_SYZ/\ A ?VM/\ HX_X7_\ B.=Y_P#/GKZBHH ^7?\ A ?VM/\
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MO5O$$&F^+M(U$Z!X6MKF;PM\.-0CTSP5XV\36=O?-X<@TR"PN+C7QI3W<O\
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M0?#.EQK*HAM/C%XDL?!_BK7KNW5T@L]2\6VNNZE]G@A_M"^U&Y22YG /8O\
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MO;NW)>OM3_AH;Q]_T:3^T5_WU\%?_GPT ?45> ?M8?\ )K/[2O\ V0#XR?\
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MA@U5ELX0HI;,]H_X?.?MH_W/@Q_X;_6?_FUH_P"'SG[:/]SX,?\ AO\ 6?\
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MKZ[B#KXD\"!7$5S<2QAU#, P7< Q .":^?\ _AV+^W'_ -$,U/\ \*3P7_\
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MZ1I8M.*\+?\ !.']COPG^SU\1?V7[?X57.O_  H^+NNMXK^* \<^/_B1X_\
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MI/%\UWX\CU[6&\72ZQ+?SR/]WT4 ?*_A7]B;]E[P/JWA+5/"?PET70[;P/\
MLZ:C^R=X:\+V>H:]_P (%8_ '5]7TS7-4\!7'P_FU67P9JL>H:AI%H][K^K:
M'?>)[N!KVTN=9EM=1OXKGR+X8_\ !++]A/X2_#GXR_";PQ\#(-4\ _'OPOIG
M@'XE:+\0/'7Q*^*$]_\ #7P_%>P^$?A=X?USXB^,/$_B#P/\-/ HU&^G\!>!
MO!6JZ!X<\%WUR^I>&[#3=16*Z3]!:* /S@O_ /@F]\(?!O[-?C/]F#X VMWX
M%\(?&SXB>%]=_:#\8>./&OQ'^*WQ5^)/@U-6\/+X_L=6^)_Q#\3>*_'GB+Q/
MXB\!>&[3X9:!J'BKQ%J6G^%/"MQ]FTRUB@TZSLV^S?C-X5\6>+_A'X^\(?#S
MXJWOP'\7:UX5U+2O#?Q>T?P]X9\3ZA\-;R6WV1>*=.\/>,+>Z\*ZE<Z1"'EM
MK;7;6?3$=5EN(9$BV'U*N;\9>#O"GQ$\(^*/ /COP]I'B[P3XV\/:QX3\7^%
M?$%C!J>A>)/#/B'3[C2=<T+6=-NDDMK_ $O5M,N[FQO[.XC>&YM9Y89%9'((
M!_*IXZ^ '_!+CP?^SY\=OVM/VB_^"A7_  5+^(ND_!7XZ>)_V<_%?QTU[]K;
M]H/0_$?BGX]^%=0L/"6MZ!^S_P""/A"?"W@SQ9%>^*&N-%T:+P1X0U/P[;WF
MCZY:2SQ6/AO5[FU_73_@D5J_@3Q;^SQJGCWX,_MW_'?]N#X%>*_$)3X9/^TQ
M::/+\;/@;_PC<FH>'O%OPQ\=>)7\*^#_ (@^(-3L_$%C*I3XF:.=>TR.Q5;'
M4-4TV\CU"Y_G \5:G_P21_8K_;.NO''C+6_^"G^F_LS_ +(7[1WQ ^*/PN_8
MS_X94^(C_L,_!K]I2PU/4?#^M_$WX9:NOABRTZ]\&V6O1ZMXJ^'NF6M\NAV.
ML:H^NZ)J=SHVH'3+G^AC_@C;JW["_P 7O@Q\<?VNOV(I?'/BNP_:I_:4^+/C
M_P"+OQ9^*_A&#PM\3/'7CT^*-3U?^P]0,>DZ0]WX*^'5OXIF\,> ;=89;?3M
M.%\CSSZM<ZO<W !^P58?B?\ Y%KQ#_V ]6_](+BMRL/Q/_R+7B'_ + >K?\
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MZZ#_ (5%\)_^B8?#S_PBO#?_ ,K*/^%1?"?_ *)A\//_  BO#?\ \K* .?\
M^&B?V?O^BZ?!S_PYW@G_ .7='_#1/[/W_1=/@Y_X<[P3_P#+NN@_X5%\)_\
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M)_9^_P"BZ?!S_P .=X)_^7='_#1/[/W_ $73X.?^'.\$_P#R[KH/^%1?"?\
MZ)A\//\ PBO#?_RLH_X5%\)_^B8?#S_PBO#?_P K* .?_P"&B?V?O^BZ?!S_
M ,.=X)_^7='_  T3^S]_T73X.?\ ASO!/_R[KH/^%1?"?_HF'P\_\(KPW_\
M*RC_ (5%\)_^B8?#S_PBO#?_ ,K* .?_ .&B?V?O^BZ?!S_PYW@G_P"7='_#
M1/[/W_1=/@Y_X<[P3_\ +NN@_P"%1?"?_HF'P\_\(KPW_P#*RC_A47PG_P"B
M8?#S_P (KPW_ /*R@#G_ /AHG]G[_HNGP<_\.=X)_P#EW1_PT3^S]_T73X.?
M^'.\$_\ R[KH/^%1?"?_ *)A\//_  BO#?\ \K*/^%1?"?\ Z)A\//\ PBO#
M?_RLH Y__AHG]G[_ *+I\'/_  YW@G_Y=T?\-$_L_?\ 1=/@Y_X<[P3_ /+N
MN@_X5%\)_P#HF'P\_P#"*\-__*RC_A47PG_Z)A\//_"*\-__ "LH Y__ (:)
M_9^_Z+I\'/\ PYW@G_Y=T?\ #1/[/W_1=/@Y_P"'.\$__+NN@_X5%\)_^B8?
M#S_PBO#?_P K*/\ A47PG_Z)A\//_"*\-_\ RLH Y_\ X:)_9^_Z+I\'/_#G
M>"?_ )=T?\-$_L_?]%T^#G_ASO!/_P NZZ#_ (5%\)_^B8?#S_PBO#?_ ,K*
M/^%1?"?_ *)A\//_  BO#?\ \K* .?\ ^&B?V?O^BZ?!S_PYW@G_ .7='_#1
M/[/W_1=/@Y_X<[P3_P#+NN@_X5%\)_\ HF'P\_\ "*\-_P#RLH_X5%\)_P#H
MF'P\_P#"*\-__*R@#G_^&B?V?O\ HNGP<_\ #G>"?_EW1_PT3^S]_P!%T^#G
M_ASO!/\ \NZZ#_A47PG_ .B8?#S_ ,(KPW_\K*/^%1?"?_HF'P\_\(KPW_\
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M#S_PBO#?_P K* .?_P"&B?V?O^BZ?!S_ ,.=X)_^7='_  T3^S]_T73X.?\
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M3I<EQ-KEEX=GMKVW\07_ (:TM=0\1Z?H4]E?0:Q>Z5!ILUE>1W+6TO\ .?\
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MSXM\3:?\,/"EZT0^SW>O:_XLL_"VG-NN;[5X;1'F7Z*M/BGX$.FZS=ZUXO\
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M>UW]@^V&;[']J9KC[/Y?GL9=QKU;6/\ @DAX7_9#_9HO?AU^RI#\4?BWK_Q
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M26SMWCUJ^!/^'FW['/\ T4?5_P#P@?'/_P H*/\ AYM^QS_T4?5__"!\<_\
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MP)\0_BWXM\-_$#XT6-CX4\*>#[Z'7_A]\&--U.#76C\21"3^S_&WQ*UZS/\
M9.LZ[I$<AE\->'-$-UH/A^^8:P^J:OJL5I+8 'XR_P##I#XE_P#01MO_  ,G
(HK^CVB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>proxy_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  D % # 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#^_BBL*?6X
M[.![J_6WLK:&/?<W,]XD=M;$9+>;<2Q111PA=O[^5HE+L$"[L9I:;XOT;6H3
M<:)?Z9K4295Y-)U6RU*)),@+"TMD\\:ROSL1V5GVL%#$8J'."<(RDHRG)1A"
M34:C;=E^[;4_-OELHIR=HIR2N_9NLH594H^S4ZD:-:4*<ZL5.G2J2A3E&G7E
M%I^QG*-5;2C%Z'545R^I^*],T6%;G6;O3M)ML#S+C5-3MM/AC:3/DJ7NQ""\
MP5C'%Q.Y5D2%Y%=$FL_$MAJ5K'>:9<6.HVLQ M[BQOXKN"<E2R^5-;I)&X=?
MGC(;YD.XA<,!5US1AS1YIS=.*4D[SBKN-T[723=K[:^CL^7GE&<*?/[-5JM.
MI2H2J7IKEAB*E.-";YJM.+Y:S2G)1NY:%Z^E\N:$ $DHQ'RDCAEY)'3KS[>_
M7XW_ &DOVYOV;OV7]?TCP7\3?%^N/\2?$FE-K_A_X8^!?A[XY^(OCS7=(6]F
MT\ZK;:)X,T'55T[3'O;:YLTU?7KK3--N+F![>*]:8HI^J]:\3Z'H\,=[KVLZ
M-H%J08UGU;5M/TZ*28_,8H;B]GM@[A0QV #(5B2"HQ\D_M>?!:X^.GPGU*\\
M#^(?B;:^)M"23Q/HO_"B/BS;?!CQ=\3['2=+U1K7X7#XQZ?8ZE?>%O#7BK6Y
MXY+^\LKC:;RSM8K@FQEELY56J^RI5%2M[:,:DY14H7M"_.USM0YE&#:A=RT4
ME&2E%/W>&<)D^)SK QXFIX]</XJLL/4QF"J3PE.$Y/V<74QDL/5A[&,G)U*E
M'G<8*4TX1HU:D?'?"7_!5O\ 9/U+Q'H_AGQT_P :O@9J/B+4;+1?#\_QM^!W
MQ#\#>'=8U76+F.UTVU@\46^@ZQX<TF74;R2.SL%\2ZSI)N[R6&SA\RZN((9O
MTXTYUDCE926!E^\5=2QVJ"?G5<],;@,<8/(-?B=^P9^R[\1]+\9:YX\^*.A?
MM#?"C3O#6S3K+X5>,?VY+S]LCX5_$N[UZQ$Z^*;O2-<\&^'HO#/B7P1J5M J
MSP12)>:G?F^6\F-BCS?L7I7B[0+J6[L=,UG1M6O[/9+J-K::S8W%]8(R*J?;
MX(Y9KJW)(0!KT*S[G(E?80,\-5K3H0EB*E.]>%*I!2<(MPFE.$V[QY5+FLE.
M,)+3F3<HL^@\2,JX/R7B.>7<'2Q]?"8#!X59A5KX[^U:-"I7C&5'DQ]#"PPL
MZ+A*$Y8B&*JX5NI[M6DX581[>BN4L_%^CZAJ-YI-EJ.BW>IV!VWFG6FN:=<Z
MC:N9'0)<V$,C7=N<(&)GBC!#8B,N,GHH[@OUC"]< N2V1C((V#:03C!YXSZ@
M;*S3E&49).S<91E9[V=F[:?T]SX.490DX3A4IR5.%7EJ4YP;IU$G"<5.,7)2
M3NFDTTFTVHMK^<7_ (+DZSX\L9?V8XO'%G\6$_8H;Q3J]]^TU<?":26SU>2T
M@U7P\-+TW5M1BU"PV6S:.-?>Q_MG4=.T&?4)[&47A\06NB6;9'_!.+PU_P $
MLKS]I3PWXJ_8D^._Q3\"^(?^$;U^U?\ 9EU_Q5X\T7P]X^OY-->6YUN30_&-
MV^H^([WP]8V.K:K=Z''J^MZ,1'%KUC&EM9///^BW[:GB[_@HE\-O$?PU\:?L
M??"_X;?&+X<Z-::DWQ9^%NOZU9:'X\\337LHM[+^P]7U7Q%X=L(-+TBU\R^6
M+2KF;5[G5!!'-I&MZ<\FEI^:O@;]F?\ :6_;'_;?_9X_:*\??L4^%/V'_AU^
MSUK,_C3Q=J$&I^'(OB!\8_%,-Q::IIVDZCI6D75E>W=G%J6EVUM)JU[H5K(/
M#VL^)K:?7-8GU+38-,^;Q$,1A\VA/#X;$8JI7K8;V3Q>%J3G1@I1A6J4LT]L
MX4J=.DIR=.='][)RI<T544S^R>"\YP.9>!5'(,WXFPO"&595P9Q_6J9EP[XD
M<'UZF=YAG%6IG6#R/C3PNSW)8\4YOG^9X^CAN&\CS3*<RCB,'@,;A_95<%3P
ME>H<%\-?@GJW_!9#]J/]JCQG^T'\0O&VC?LS_L[_ !%U'X1?#?X-^#=7_L:V
MU&YTO5-5M)[W5'DM+ZP>XCLM"M->UK4S:WFM7^L>*K?1[35=(TC3HH6V=#^'
M'B;_ ())?MW_ ++'@;X3?$7Q=XF_93_;#\3VWPUU#X8^,=4BUV?PIXLDUOP]
MH\UWIV;*RL;231=9\9^'[ZTU_3QI^HSZ=<ZUI.NKK$-K;7"^F>,/V?/V[O\
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M?#N]\:?%+PWK/P2N_$'A>TU_P?I$VG6OA3PE?:;KES)JOB/Q/H&@3KI=_<+
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M)/+J47!OFC3J\98RG4A&3YYJ-2G*4)Q4[2@^5WBDHZRQIYQ& %E1=R@ +Z$
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8&$XA4)/5Q4%AX047NE""48VM:.BT/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>proxy_002.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_002.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  B "@# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#ZL^%OQB_8
M0_:"MO OQ_\ VW_$UU\=?BS\6/B-\1?&'QC\+_%3PC^V-X^\,? KX0:WKWBC
M4O WP@_9KT_PAX?N? &CIX6E/AG3[S4-.GDT_5]-M[ZYO'EU=WD;K_@]=_\
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MK?Q(_P#+VK_,O^GI^KX;(<A=[Y%D;_<8AZY)DSU5.FT]<G>J>J>Z>S1^IO\
MP1BU75/B]_P4=_9V\-_%G4K_ .*'AW2M;USQ;I>@?$2\N/&NBZ;XJ\.:!>ZI
MX>\36&E^)9-3L;/Q!H.IV]OJ.BZS;P1ZEI=]!#=V-S!<1)(I117Z7X>I5<OS
M*55*K+^T:*YJB525EEF":7-4525DVVES63;:2N[_ .,W[32<\J\8^!<+E4YY
J5A7X:0JO"Y7.>685U9\9\3J=5X;+9Y=AG5FH04ZKP[J34(*=2:A!0__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>proxy_003.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_003.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  M !X# 2(  A$! Q$!_\0
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CADF3X?CW,,'/.,;BL]RRABG5IU\MP=&>;S=25*&#G/\ _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>proxy_004.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_004.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  D "0# 2(  A$! Q$!_\0
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JN;RX=06DE? R><    #  KMZ**UA\*/%S&4IXRLY.[YG^844459YQ__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>proxy_005.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 proxy_005.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  M "@# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>12
<FILENAME>sonm-20241231.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWaWImbP9z5Z82ekhvWBybem6DyIiP6wdnysCudS2MUoI -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2022-03-31" xmlns:SONM="http://sonimtech.com/20241231" elementFormDefault="qualified" targetNamespace="http://sonimtech.com/20241231">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://sonimtech.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20241231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20241231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="sonm-20241231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Definition Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/ecd/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
    <element id="SONM_HaoPeterLiuMember" name="HaoPeterLiuMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" name="GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" name="FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" name="ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" name="FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" name="ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
    <element id="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" name="FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" nillable="true" xbrli:periodType="duration" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>13
<FILENAME>sonm-20241231_def.xml
<DESCRIPTION>XBRL DEFINITION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="sonm-20241231.xsd#Cover" roleURI="http://sonimtech.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosureWithAdditionalMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosureWithAdditionalMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpTable" roleURI="http://xbrl.sec.gov/ecd/role/PvpTable" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsToCompensation" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsToCompensation" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListsByExecutiveCategory" roleURI="http://xbrl.sec.gov/ecd/role/TabularListsByExecutiveCategory" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TabularListMeasures" roleURI="http://xbrl.sec.gov/ecd/role/TabularListMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpMeasures" roleURI="http://xbrl.sec.gov/ecd/role/PvpMeasures" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpExecutiveCategoriesOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#IndividualsOnly" roleURI="http://xbrl.sec.gov/ecd/role/IndividualsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTypeOnly" roleURI="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#TradingArrangmentsOnly" roleURI="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ForgoneRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/ForgoneRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#OutstandingRecoveries" roleURI="http://xbrl.sec.gov/ecd/role/OutstandingRecoveries" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardsCloseToMnpiDisc" roleURI="http://xbrl.sec.gov/ecd/role/AwardsCloseToMnpiDisc" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangemenstByInd" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangementsByInd" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#Defaults" roleURI="http://xbrl.sec.gov/ecd/role/Defaults" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
    <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
    <link:definitionLink xlink:type="extended" xlink:role="http://sonimtech.com/role/Cover" xlink:title="00000001 - Document - Cover" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpExecutiveCategoriesOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" order="10" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:label="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:type="arc" order="20" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:label="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:type="arc" order="30" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:label="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:type="arc" order="40" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:label="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:type="arc" order="50" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/IndividualsOnly">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_HaoPeterLiuMember" xlink:label="loc_SONMHaoPeterLiuMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_SONMHaoPeterLiuMember" xlink:type="arc" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" order="10" />
    </link:definitionLink>
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/AwardTypeOnly" />
    <link:definitionLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/TradingArrangementsOnly" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>14
<FILENAME>sonm-20241231_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="ecd_IndividualAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_IndividualAxis" xlink:to="ecd_IndividualAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_IndividualAxis_lbl" xml:lang="en-US">Individual [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_HaoPeterLiuMember" xlink:label="SONM_HaoPeterLiuMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_HaoPeterLiuMember" xlink:to="SONM_HaoPeterLiuMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_HaoPeterLiuMember_lbl" xml:lang="en-US">Hao Peter Liu [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="ecd_AdjToCompAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAxis" xlink:to="ecd_AdjToCompAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAxis_lbl" xml:lang="en-US">Adjustment to Compensation [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:to="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xml:lang="en-US">Grant Date Fair Value Of Option Awards And Stock Awards Granted In Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:to="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_lbl" xml:lang="en-US">Fair Value At Fiscal Year End Of Outstanding And Unvested Option Awards And Stock Awards Granted In Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:label="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:to="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_lbl" xml:lang="en-US">Change In Fair Value Of Outstanding And Unvested Option Awards And Stock Awards Granted In Prior Fiscal Years [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:label="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:to="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_lbl" xml:lang="en-US">Fair Value At Vesting Of Option Awards And Stock Awards Granted In Fiscal Year That Vested During Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:label="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:to="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_lbl" xml:lang="en-US">Change In Fair Value As Of Vesting Date Of Option Awards And Stock Awards Granted In Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:label="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:to="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_lbl" xml:lang="en-US">Fair Values Of Prior Fiscal Year End Of Option Awards And Stock Awards Granted In Prior Fiscal Years That Failed To Meet Applicable Vesting Conditions During Fiscal Year [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="ecd_NonPeoNeoMember" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoMember" xlink:to="ecd_NonPeoNeoMember_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoMember_lbl" xml:lang="en-US">Non-PEO NEO [Member]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="ecd_PvpTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTable" xlink:to="ecd_PvpTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTable_lbl" xml:lang="en-US">Pay vs Performance Disclosure [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="ecd_PvpTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PvpTableTextBlock" xlink:to="ecd_PvpTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PvpTableTextBlock_lbl" xml:lang="en-US">Pay vs Performance [Table Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="ecd_CoSelectedMeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureName" xlink:to="ecd_CoSelectedMeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureName_lbl" xml:lang="en-US">Company Selected Measure Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NamedExecutiveOfficersFnTextBlock" xlink:to="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NamedExecutiveOfficersFnTextBlock_lbl" xml:lang="en-US">Named Executive Officers, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="ecd_PeerGroupIssuersFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupIssuersFnTextBlock" xlink:to="ecd_PeerGroupIssuersFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupIssuersFnTextBlock_lbl" xml:lang="en-US">Peer Group Issuers, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="ecd_ChangedPeerGroupFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ChangedPeerGroupFnTextBlock" xlink:to="ecd_ChangedPeerGroupFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ChangedPeerGroupFnTextBlock_lbl" xml:lang="en-US">Changed Peer Group, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="ecd_PeoTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoTotalCompAmt" xlink:to="ecd_PeoTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoTotalCompAmt_lbl" xml:lang="en-US">PEO Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="ecd_PeoActuallyPaidCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoActuallyPaidCompAmt" xlink:to="ecd_PeoActuallyPaidCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoActuallyPaidCompAmt_lbl" xml:lang="en-US">PEO Actually Paid Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="ecd_AdjToPeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToPeoCompFnTextBlock" xlink:to="ecd_AdjToPeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToPeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment To PEO Compensation, Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgTotalCompAmt" xlink:to="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgTotalCompAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Total Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:to="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonPeoNeoAvgCompActuallyPaidAmt_lbl" xml:lang="en-US">Non-PEO NEO Average Compensation Actually Paid Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:to="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToNonPeoNeoCompFnTextBlock_lbl" xml:lang="en-US">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:to="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EquityValuationAssumptionDifferenceFnTextBlock_lbl" xml:lang="en-US">Equity Valuation Assumption Difference, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:to="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:to="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsNetIncomeTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Net Income [Text Block]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Company Selected Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:to="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnVsPeerGroupTextBlock_lbl" xml:lang="en-US">Total Shareholder Return Vs Peer Group</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:to="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CompActuallyPaidVsOtherMeasureTextBlock_lbl" xml:lang="en-US">Compensation Actually Paid vs. Other Measure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="ecd_TabularListTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TabularListTableTextBlock" xlink:to="ecd_TabularListTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TabularListTableTextBlock_lbl" xml:lang="en-US">Tabular List, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="ecd_TotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TotalShareholderRtnAmt" xlink:to="ecd_TotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TotalShareholderRtnAmt_lbl" xml:lang="en-US">Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeerGroupTotalShareholderRtnAmt" xlink:to="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeerGroupTotalShareholderRtnAmt_lbl" xml:lang="en-US">Peer Group Total Shareholder Return Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_NetIncomeLoss_lbl" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="ecd_CoSelectedMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_CoSelectedMeasureAmt" xlink:to="ecd_CoSelectedMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_CoSelectedMeasureAmt_lbl" xml:lang="en-US">Company Selected Measure Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="ecd_OtherPerfMeasureAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OtherPerfMeasureAmt" xlink:to="ecd_OtherPerfMeasureAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OtherPerfMeasureAmt_lbl" xml:lang="en-US">Other Performance Measure, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="ecd_AdjToCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AdjToCompAmt" xlink:to="ecd_AdjToCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AdjToCompAmt_lbl" xml:lang="en-US">Adjustment to Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="ecd_PeoName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PeoName" xlink:to="ecd_PeoName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PeoName_lbl" xml:lang="en-US">PEO Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="ecd_MeasureName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MeasureName" xlink:to="ecd_MeasureName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MeasureName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonGaapMeasureDescriptionTextBlock" xlink:to="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonGaapMeasureDescriptionTextBlock_lbl" xml:lang="en-US">Non-GAAP Measure Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="ecd_Additional402vDisclosureTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Additional402vDisclosureTextBlock" xlink:to="ecd_Additional402vDisclosureTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Additional402vDisclosureTextBlock_lbl" xml:lang="en-US">Additional 402(v) Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="ecd_PnsnBnftsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_PnsnBnftsAdjFnTextBlock" xlink:to="ecd_PnsnBnftsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_PnsnBnftsAdjFnTextBlock_lbl" xml:lang="en-US">Pension Benefits Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_EqtyAwrdsAdjFnTextBlock" xlink:to="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_EqtyAwrdsAdjFnTextBlock_lbl" xml:lang="en-US">Equity Awards Adjustments, Footnote</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="ecd_ErrCompRecoveryTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompRecoveryTable" xlink:to="ecd_ErrCompRecoveryTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompRecoveryTable_lbl" xml:lang="en-US">Erroneously Awarded Compensation Recovery [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="ecd_RestatementDateAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDateAxis" xlink:to="ecd_RestatementDateAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDateAxis_lbl" xml:lang="en-US">Restatement Determination Date [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="ecd_RestatementDeterminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDeterminationDate" xlink:to="ecd_RestatementDeterminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDeterminationDate_lbl" xml:lang="en-US">Restatement Determination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="ecd_AggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompAmt" xlink:to="ecd_AggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompAmt_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="ecd_ErrCompAnalysisTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ErrCompAnalysisTextBlock" xlink:to="ecd_ErrCompAnalysisTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ErrCompAnalysisTextBlock_lbl" xml:lang="en-US">Erroneous Compensation Analysis</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:to="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_StkPrcOrTsrEstimationMethodTextBlock_lbl" xml:lang="en-US">Stock Price or TSR Estimation Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="ecd_OutstandingAggtErrCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingAggtErrCompAmt" xlink:to="ecd_OutstandingAggtErrCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingAggtErrCompAmt_lbl" xml:lang="en-US">Outstanding Aggregate Erroneous Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:to="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AggtErrCompNotYetDeterminedTextBlock_lbl" xml:lang="en-US">Aggregate Erroneous Compensation Not Yet Determined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="ecd_ForgoneRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_ForgoneRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:to="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt_lbl" xml:lang="en-US">Forgone Recovery due to Expense of Enforcement, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:to="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt_lbl" xml:lang="en-US">Forgone Recovery due to Violation of Home Country Law, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt_lbl" xml:lang="en-US">Forgone Recovery due to Disqualification of Tax Benefits, Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:to="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock_lbl" xml:lang="en-US">Forgone Recovery, Explanation of Impracticability</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="ecd_OutstandingRecoveryIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_OutstandingRecoveryIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="ecd_OutstandingRecoveryCompAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryCompAmt" xlink:to="ecd_OutstandingRecoveryCompAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryCompAmt_lbl" xml:lang="en-US">Compensation Amount</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:to="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_RestatementDoesNotRequireRecoveryTextBlock_lbl" xml:lang="en-US">Restatement does not require Recovery</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="ecd_AwardsCloseToMnpiDiscTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTable" xlink:to="ecd_AwardsCloseToMnpiDiscTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTable_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_AwardTypeAxis_lbl" xml:lang="en-US">Award Type [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="ecd_AwardTmgMnpiDiscTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiDiscTextBlock" xlink:to="ecd_AwardTmgMnpiDiscTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiDiscTextBlock_lbl" xml:lang="en-US">Award Timing MNPI Disclosure</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="ecd_AwardTmgMethodTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMethodTextBlock" xlink:to="ecd_AwardTmgMethodTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMethodTextBlock_lbl" xml:lang="en-US">Award Timing Method</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="ecd_AwardTmgPredtrmndFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgPredtrmndFlag" xlink:to="ecd_AwardTmgPredtrmndFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgPredtrmndFlag_lbl" xml:lang="en-US">Award Timing Predetermined</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgMnpiCnsdrdFlag" xlink:to="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgMnpiCnsdrdFlag_lbl" xml:lang="en-US">Award Timing MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:to="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardTmgHowMnpiCnsdrdTextBlock_lbl" xml:lang="en-US">Award Timing, How MNPI Considered</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="ecd_MnpiDiscTimedForCompValFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MnpiDiscTimedForCompValFlag" xlink:to="ecd_MnpiDiscTimedForCompValFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MnpiDiscTimedForCompValFlag_lbl" xml:lang="en-US">MNPI Disclosure Timed for Compensation Value</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:to="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscTableTextBlock_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Table</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="ecd_AwardsCloseToMnpiDiscIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="ecd_AwardUndrlygSecuritiesAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardUndrlygSecuritiesAmt" xlink:to="ecd_AwardUndrlygSecuritiesAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardUndrlygSecuritiesAmt_lbl" xml:lang="en-US">Underlying Securities</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="ecd_AwardExrcPrice" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardExrcPrice" xlink:to="ecd_AwardExrcPrice_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardExrcPrice_lbl" xml:lang="en-US">Exercise Price</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="ecd_AwardGrantDateFairValue" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardGrantDateFairValue" xlink:to="ecd_AwardGrantDateFairValue_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardGrantDateFairValue_lbl" xml:lang="en-US">Fair Value as of Grant Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="ecd_UndrlygSecurityMktPriceChngPct" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_UndrlygSecurityMktPriceChngPct" xlink:to="ecd_UndrlygSecurityMktPriceChngPct_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_UndrlygSecurityMktPriceChngPct_lbl" xml:lang="en-US">Underlying Security Market Price Change</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="ecd_TradingArrByIndTable" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrByIndTable" xlink:to="ecd_TradingArrByIndTable_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrByIndTable_lbl" xml:lang="en-US">Trading Arrangements, by Individual [Table]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="ecd_TradingArrAxis" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TradingArrAxis" xlink:to="ecd_TradingArrAxis_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TradingArrAxis_lbl" xml:lang="en-US">Trading Arrangement [Axis]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_MtrlTermsOfTrdArrTextBlock" xlink:to="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_MtrlTermsOfTrdArrTextBlock_lbl" xml:lang="en-US">Material Terms of Trading Arrangement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="ecd_TrdArrIndName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:label="ecd_TrdArrIndName_lbl" xml:lang="en-US">Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="ecd_TrdArrIndTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndTitle" xlink:to="ecd_TrdArrIndTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndTitle_lbl" xml:lang="en-US">Title</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="ecd_Rule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrAdoptedFlag" xlink:to="ecd_Rule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="ecd_NonRule10b51ArrAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrAdoptedFlag" xlink:to="ecd_NonRule10b51ArrAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrAdoptedFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="ecd_TrdArrAdoptionDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrAdoptionDate" xlink:to="ecd_TrdArrAdoptionDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrAdoptionDate_lbl" xml:lang="en-US">Adoption Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="ecd_Rule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_Rule10b51ArrTrmntdFlag" xlink:to="ecd_Rule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_Rule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="ecd_NonRule10b51ArrTrmntdFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_NonRule10b51ArrTrmntdFlag" xlink:to="ecd_NonRule10b51ArrTrmntdFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_NonRule10b51ArrTrmntdFlag_lbl" xml:lang="en-US">Non-Rule 10b5-1 Arrangement Terminated</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="ecd_TrdArrTerminationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrTerminationDate" xlink:to="ecd_TrdArrTerminationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrTerminationDate_lbl" xml:lang="en-US">Termination Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="ecd_TrdArrExpirationDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrExpirationDate" xlink:to="ecd_TrdArrExpirationDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrExpirationDate_lbl" xml:lang="en-US">Expiration Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="ecd_TrdArrDuration" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrDuration" xlink:to="ecd_TrdArrDuration_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrDuration_lbl" xml:lang="en-US">Arrangement Duration</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrSecuritiesAggAvailAmt" xlink:to="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrSecuritiesAggAvailAmt_lbl" xml:lang="en-US">Aggregate Available</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="ecd_InsiderTradingPoliciesProcLineItems" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTradingPoliciesProcLineItems" xlink:to="ecd_InsiderTradingPoliciesProcLineItems_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTradingPoliciesProcLineItems_lbl" xml:lang="en-US">Insider Trading Policies and Procedures [Line Items]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:to="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcAdoptedFlag_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Adopted</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:to="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock_lbl" xml:lang="en-US">Insider Trading Policies and Procedures Not Adopted</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_ForgoneRecoveryIndName" xlink:to="ecd_ForgoneRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_ForgoneRecoveryIndName_2_lbl" xml:lang="en-US">Forgone Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_OutstandingRecoveryIndName" xlink:to="ecd_OutstandingRecoveryIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_OutstandingRecoveryIndName_2_lbl" xml:lang="en-US">Outstanding Recovery, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_AwardsCloseToMnpiDiscIndName" xlink:to="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_AwardsCloseToMnpiDiscIndName_2_lbl" xml:lang="en-US">Awards Close in Time to MNPI Disclosures, Individual Name</link:label>
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="ecd_TrdArrIndName" xlink:to="ecd_TrdArrIndName_2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="ecd_TrdArrIndName_2_lbl" xml:lang="en-US">Trading Arrangement, Individual Name</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>15
<FILENAME>sonm-20241231_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 6.1b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="sonm-20241231.xsd#Cover" roleURI="http://sonimtech.com/role/Cover" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:roleRef xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" />
    <link:presentationLink xlink:type="extended" xlink:role="http://sonimtech.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:title="995410 - Disclosure - Pay vs Performance Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PayVsPerformanceDisclosureLineItems" xlink:label="loc_ecdPayVsPerformanceDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTable" xlink:label="loc_ecdPvpTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_HaoPeterLiuMember" xlink:label="loc_SONMHaoPeterLiuMember" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_SONMHaoPeterLiuMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoMember" xlink:label="loc_ecdNonPeoNeoMember" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllIndividualsMember" xlink:to="loc_ecdNonPeoNeoMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAxis" xlink:label="loc_ecdAdjToCompAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPvpTable" xlink:to="loc_ecdAdjToCompAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember" xlink:label="loc_ecdAllAdjToCompMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAdjToCompAxis" xlink:to="loc_ecdAllAdjToCompMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMGrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:label="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:label="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:label="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:label="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="sonm-20241231.xsd#SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:label="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAllAdjToCompMember" xlink:to="loc_SONMFairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PvpTableTextBlock" xlink:label="loc_ecdPvpTableTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPvpTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureName" xlink:label="loc_ecdCoSelectedMeasureName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdCoSelectedMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NamedExecutiveOfficersFnTextBlock" xlink:label="loc_ecdNamedExecutiveOfficersFnTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNamedExecutiveOfficersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupIssuersFnTextBlock" xlink:label="loc_ecdPeerGroupIssuersFnTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupIssuersFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ChangedPeerGroupFnTextBlock" xlink:label="loc_ecdChangedPeerGroupFnTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdChangedPeerGroupFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoTotalCompAmt" xlink:label="loc_ecdPeoTotalCompAmt" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoActuallyPaidCompAmt" xlink:label="loc_ecdPeoActuallyPaidCompAmt" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoActuallyPaidCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToPeoCompFnTextBlock" xlink:label="loc_ecdAdjToPeoCompFnTextBlock" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToPeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgTotalCompAmt" xlink:label="loc_ecdNonPeoNeoAvgTotalCompAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgTotalCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonPeoNeoAvgCompActuallyPaidAmt" xlink:label="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdNonPeoNeoAvgCompActuallyPaidAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToNonPeoNeoCompFnTextBlock" xlink:label="loc_ecdAdjToNonPeoNeoCompFnTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToNonPeoNeoCompFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EquityValuationAssumptionDifferenceFnTextBlock" xlink:label="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdEquityValuationAssumptionDifferenceFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:label="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsTotalShareholderRtnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsNetIncomeTextBlock" xlink:label="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsNetIncomeTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" />
      <link:presentationArc order="2140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsCoSelectedMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnVsPeerGroupTextBlock" xlink:label="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" />
      <link:presentationArc order="2150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnVsPeerGroupTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CompActuallyPaidVsOtherMeasureTextBlock" xlink:label="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" />
      <link:presentationArc order="2160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCompActuallyPaidVsOtherMeasureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TabularListTableTextBlock" xlink:label="loc_ecdTabularListTableTextBlock" />
      <link:presentationArc order="2170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTabularListTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TotalShareholderRtnAmt" xlink:label="loc_ecdTotalShareholderRtnAmt" />
      <link:presentationArc order="2180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeerGroupTotalShareholderRtnAmt" xlink:label="loc_ecdPeerGroupTotalShareholderRtnAmt" />
      <link:presentationArc order="2190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeerGroupTotalShareholderRtnAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_NetIncomeLoss" xlink:label="loc_us-gaapNetIncomeLoss" />
      <link:presentationArc order="2200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_us-gaapNetIncomeLoss" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_CoSelectedMeasureAmt" xlink:label="loc_ecdCoSelectedMeasureAmt" />
      <link:presentationArc order="2210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdCoSelectedMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OtherPerfMeasureAmt" xlink:label="loc_ecdOtherPerfMeasureAmt" />
      <link:presentationArc order="2220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdOtherPerfMeasureAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AdjToCompAmt" xlink:label="loc_ecdAdjToCompAmt" />
      <link:presentationArc order="2230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdAdjToCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PeoName" xlink:label="loc_ecdPeoName" />
      <link:presentationArc order="2240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdCoSelectedMeasureName" xlink:to="loc_ecdPeoName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MeasureName" xlink:label="loc_ecdMeasureName" />
      <link:presentationArc order="2250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdMeasureName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonGaapMeasureDescriptionTextBlock" xlink:label="loc_ecdNonGaapMeasureDescriptionTextBlock" />
      <link:presentationArc order="2260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdMeasureName" xlink:to="loc_ecdNonGaapMeasureDescriptionTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Additional402vDisclosureTextBlock" xlink:label="loc_ecdAdditional402vDisclosureTextBlock" />
      <link:presentationArc order="2270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdAdditional402vDisclosureTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_PnsnBnftsAdjFnTextBlock" xlink:label="loc_ecdPnsnBnftsAdjFnTextBlock" />
      <link:presentationArc order="2280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdPnsnBnftsAdjFnTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_EqtyAwrdsAdjFnTextBlock" xlink:label="loc_ecdEqtyAwrdsAdjFnTextBlock" />
      <link:presentationArc order="2290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdPayVsPerformanceDisclosureLineItems" xlink:to="loc_ecdEqtyAwrdsAdjFnTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:title="995440 - Disclosure - Recovery of Erroneously Awarded Compensation">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RecoveryOfErrCompDisclosureLineItems" xlink:label="loc_ecdRecoveryOfErrCompDisclosureLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompRecoveryTable" xlink:label="loc_ecdErrCompRecoveryTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdErrCompRecoveryTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDateAxis" xlink:label="loc_ecdRestatementDateAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdRestatementDateAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdErrCompRecoveryTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDeterminationDate" xlink:label="loc_ecdRestatementDeterminationDate" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRecoveryOfErrCompDisclosureLineItems" xlink:to="loc_ecdRestatementDeterminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompAmt" xlink:label="loc_ecdAggtErrCompAmt" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ErrCompAnalysisTextBlock" xlink:label="loc_ecdErrCompAnalysisTextBlock" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdErrCompAnalysisTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_StkPrcOrTsrEstimationMethodTextBlock" xlink:label="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdStkPrcOrTsrEstimationMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingAggtErrCompAmt" xlink:label="loc_ecdOutstandingAggtErrCompAmt" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdOutstandingAggtErrCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AggtErrCompNotYetDeterminedTextBlock" xlink:label="loc_ecdAggtErrCompNotYetDeterminedTextBlock" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdAggtErrCompNotYetDeterminedTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryIndName" xlink:label="loc_ecdForgoneRecoveryIndName" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:label="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAggtErrCompAmt" xlink:to="loc_ecdForgoneRecoveryDueToExpenseOfEnforcementAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:label="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToViolationOfHomeCountryLawAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:label="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdRestatementDeterminationDate" xlink:to="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:label="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdForgoneRecoveryExplanationOfImpracticabilityTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryIndName" xlink:label="loc_ecdOutstandingRecoveryIndName" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_OutstandingRecoveryCompAmt" xlink:label="loc_ecdOutstandingRecoveryCompAmt" />
      <link:presentationArc order="2120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdOutstandingRecoveryCompAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_RestatementDoesNotRequireRecoveryTextBlock" xlink:label="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" />
      <link:presentationArc order="2130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt" xlink:to="loc_ecdRestatementDoesNotRequireRecoveryTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:title="995443 - Disclosure - Award Timing Disclosure">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgDiscLineItems" xlink:label="loc_ecdAwardTmgDiscLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTable" xlink:label="loc_ecdAwardsCloseToMnpiDiscTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_ecdIndividualAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_AwardTypeAxis" xlink:label="loc_us-gaapAwardTypeAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardsCloseToMnpiDiscTable" xlink:to="loc_us-gaapAwardTypeAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapAwardTypeAxis" xlink:to="loc_us-gaapShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiDiscTextBlock" xlink:label="loc_ecdAwardTmgMnpiDiscTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiDiscTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMethodTextBlock" xlink:label="loc_ecdAwardTmgMethodTextBlock" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMethodTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgPredtrmndFlag" xlink:label="loc_ecdAwardTmgPredtrmndFlag" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgPredtrmndFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgMnpiCnsdrdFlag" xlink:label="loc_ecdAwardTmgMnpiCnsdrdFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgMnpiCnsdrdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardTmgHowMnpiCnsdrdTextBlock" xlink:label="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardTmgHowMnpiCnsdrdTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MnpiDiscTimedForCompValFlag" xlink:label="loc_ecdMnpiDiscTimedForCompValFlag" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdMnpiDiscTimedForCompValFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscTableTextBlock" xlink:label="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscTableTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardsCloseToMnpiDiscIndName" xlink:label="loc_ecdAwardsCloseToMnpiDiscIndName" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardsCloseToMnpiDiscIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardUndrlygSecuritiesAmt" xlink:label="loc_ecdAwardUndrlygSecuritiesAmt" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardUndrlygSecuritiesAmt" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardExrcPrice" xlink:label="loc_ecdAwardExrcPrice" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardExrcPrice" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AwardGrantDateFairValue" xlink:label="loc_ecdAwardGrantDateFairValue" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdAwardGrantDateFairValue" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_UndrlygSecurityMktPriceChngPct" xlink:label="loc_ecdUndrlygSecurityMktPriceChngPct" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdAwardTmgDiscLineItems" xlink:to="loc_ecdUndrlygSecurityMktPriceChngPct" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:title="995445 - Disclosure - Insider Trading Arrangements">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingArrLineItems" xlink:label="loc_ecdInsiderTradingArrLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrByIndTable" xlink:label="loc_ecdTradingArrByIndTable" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTradingArrByIndTable" order="100" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TradingArrAxis" xlink:label="loc_ecdTradingArrAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdTradingArrAxis" order="10" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllTradingArrangementsMember" xlink:label="loc_ecdAllTradingArrangementsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrAxis" xlink:to="loc_ecdAllTradingArrangementsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_IndividualAxis" xlink:label="loc_ecdIndividualAxis" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdTradingArrByIndTable" xlink:to="loc_ecdIndividualAxis" order="20" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllIndividualsMember" xlink:label="loc_ecdAllIndividualsMember" />
      <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdIndividualAxis" xlink:to="loc_ecdAllIndividualsMember" order="0" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_MtrlTermsOfTrdArrTextBlock" xlink:label="loc_ecdMtrlTermsOfTrdArrTextBlock" />
      <link:presentationArc order="2000" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdMtrlTermsOfTrdArrTextBlock" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndName" xlink:label="loc_ecdTrdArrIndName" />
      <link:presentationArc order="2010" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndName" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrIndTitle" xlink:label="loc_ecdTrdArrIndTitle" />
      <link:presentationArc order="2020" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrIndTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrAdoptedFlag" xlink:label="loc_ecdRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2030" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrAdoptedFlag" xlink:label="loc_ecdNonRule10b51ArrAdoptedFlag" />
      <link:presentationArc order="2040" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrAdoptionDate" xlink:label="loc_ecdTrdArrAdoptionDate" />
      <link:presentationArc order="2050" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrAdoptionDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_Rule10b51ArrTrmntdFlag" xlink:label="loc_ecdRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2060" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_NonRule10b51ArrTrmntdFlag" xlink:label="loc_ecdNonRule10b51ArrTrmntdFlag" />
      <link:presentationArc order="2070" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdNonRule10b51ArrTrmntdFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrTerminationDate" xlink:label="loc_ecdTrdArrTerminationDate" />
      <link:presentationArc order="2080" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrTerminationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrExpirationDate" xlink:label="loc_ecdTrdArrExpirationDate" />
      <link:presentationArc order="2090" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrExpirationDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrDuration" xlink:label="loc_ecdTrdArrDuration" />
      <link:presentationArc order="2100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrDuration" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_TrdArrSecuritiesAggAvailAmt" xlink:label="loc_ecdTrdArrSecuritiesAggAvailAmt" />
      <link:presentationArc order="2110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingArrLineItems" xlink:to="loc_ecdTrdArrSecuritiesAggAvailAmt" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:title="995447 - Disclosure - Insider Trading Policies and Procedures">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTradingPoliciesProcLineItems" xlink:label="loc_ecdInsiderTradingPoliciesProcLineItems" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcAdoptedFlag" xlink:label="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcAdoptedFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:label="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecdInsiderTradingPoliciesProcLineItems" xlink:to="loc_ecdInsiderTrdPoliciesProcNotAdoptedTextBlock" xlink:type="arc" />
    </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Sonim
Technologies, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001178697<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.2</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="2" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="3">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance [Table Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_z47h2QC5BAEg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure">
  <tr style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Fiscal
    Year<sup>(1)</sup></b></span></td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48F_eecd--PeoTotalCompAmt_zPWYpX7BY1y4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Summary
    Compensation Table Total for PEO</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_48D_eecd--PeoActuallyPaidCompAmt_z6QTbuWckXr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Compensation
    Actually Paid to PEO <span><sup id="xdx_F5E_zlxExA700jh9">(2)(3)</sup></span></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zmX6tJNMchSa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Average
    Summary Compensation Table Total for non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_482_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zK8qojNlOHC5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average
    Compensation Actually Paid to non-PEO NEOs<span><sup id="xdx_F5D_zcAGgP7m0JGh">(2)(3)</sup></span></b></span></td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zFsTtwURtV06" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Value
    of Initial Fixed $100 Investment Based on Total Shareholder Return</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="2" id="xdx_483_eus-gaap--NetIncomeLoss_pn4n6_zujGOLenNDSb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Net
    Income $(M)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr id="xdx_419_20240101__20241231_z17raC7cefBg" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 40%; text-align: justify">2024 <span id="xdx_F4F_zKye9O5bypN8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">672,918</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">(134,334</td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">624,083</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">513,490</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">34.23</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 6%; text-align: right">(33.65</td><td style="width: 1%; text-align: justify">)</td></tr>
  <tr id="xdx_411_20230101__20231231_zgepqSx6J0dd" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">2023 <span id="xdx_F48_z39ZYnRz6Yy9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">677,266</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">2,136,138</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">626,135</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">688,442</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">79.72</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(0.09</td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_419_20220101__20221231_z3t53rsJkoB6" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">2022 <span id="xdx_F40_zr6nbVDxiDD5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span>&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">1,986,962</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">1,975,045</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">420,553</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">409,019</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">46.08</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(14.09</td><td style="text-align: justify">)</td></tr>
  </table><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_894_eecd--NamedExecutiveOfficersFnTextBlock_dU_zJDYIFlhrccc" style="margin-top: 0; margin-bottom: 0">&#160;</p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    PEO in all reporting years is <span id="xdx_904_eecd--PeoName_c20220101__20221231_zWQXT0fWJXb1">Hao (Peter) Liu</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.
    The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles Becher. The non-PEO NEOs in the 2022 reporting
    year are Clay Crolius, Charles Becher and Robert Tirva.</span></td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 672,918<span></span>
</td>
<td class="nump">$ 677,266<span></span>
</td>
<td class="nump">$ 1,986,962<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2],[3]</sup></td>
<td class="num">$ (134,334)<span></span>
</td>
<td class="nump">2,136,138<span></span>
</td>
<td class="nump">1,975,045<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_89F_eecd--AdjToPeoCompFnTextBlock_dU_zhtKAfqlD0A8" style="margin: 0">&#160;</p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>


<p style="margin-top: 0; margin-bottom: 0"></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49B_20220101__20221231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zRmyg8yiJwW1" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49F_20230101__20231231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zM8TeJ3zPbl8" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_499_20240101__20241231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zeIEOg4C9Gbc" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">PEO: Liu, Hao (Peter)</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_403_eecd--PeoTotalCompAmt_z8wTlCOLAoNl" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$1,986,962</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$677,266</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$672,918</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_ziC9i9iwwajb" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal
    Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(1,501,393</td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: justify">&#160;</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">0</td><td style="width: 1%; text-align: justify">&#160;</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zEx3ioprQtFl" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards
    Granted in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">1,445,577</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zRGNaL9ew0Ih" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(2,346</td><td style="text-align: justify">)</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">681,465</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(610,049</td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zNrcz4FKd753" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">47,046</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zYpBRL2k8dIi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(801</td><td style="text-align: justify">)</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">777,407</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(197,203</td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zziuWZWGhd5i" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock
    Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_407_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_z1r5DOJCEK6g" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_401_eecd--PeoActuallyPaidCompAmt_z6sgagb5w35" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">1,975,045</td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">2,136,138</td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">(134,334</td><td style="font-weight: bold; text-align: justify">)</td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 624,083<span></span>
</td>
<td class="nump">626,135<span></span>
</td>
<td class="nump">420,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1],[2],[3]</sup></td>
<td class="nump">$ 513,490<span></span>
</td>
<td class="nump">688,442<span></span>
</td>
<td class="nump">409,019<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_89A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zLHcZwDFeuE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <tr style="display: none; vertical-align: bottom">
    <td style="display: none; font-weight: bold">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_49D_20220101__20221231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOgDLtqyoti" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_491_20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zluQS9WxHLq2" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td><td style="display: none">&#160;</td>
    <td colspan="2" id="xdx_498_20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zmt9hzDfbUWi" style="display: none; text-align: right">&#160;</td><td style="display: none">&#160;</td></tr>
<tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold; padding-bottom: 1pt">&#160;</td>
    <td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center">Non-PEO NEOs</td><td style="padding-bottom: 1pt; font-weight: bold">&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Prior Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2021</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Current Fiscal Year-End</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">12/31/2024</td><td>&#160;</td></tr>
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold">Fiscal Year</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2022</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2023</td><td>&#160;</td><td>&#160;</td>
    <td colspan="2" style="text-align: right">2024</td><td>&#160;</td></tr>
  <tr id="xdx_40D_eecd--NonPeoNeoAvgTotalCompAmt_zwsyvuSEQ4W3" style="vertical-align: bottom">
    <td style="border-bottom: Black 1pt solid; font-weight: bold">SCT Total</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$420,553</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$626,135</td><td style="padding-bottom: 1pt">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td colspan="2" style="border-bottom: Black 1pt solid; text-align: right">$624,083</td><td style="padding-bottom: 1pt">&#160;</td></tr>
<tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zFzemYrirRga" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 52%; text-align: justify">(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal
    Year</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(87,981</td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(78,760</td><td style="width: 1%; text-align: justify">)</td><td style="width: 2%">&#160;</td>
    <td style="width: 1%; text-align: justify">$</td><td style="width: 12%; text-align: right">(44,676</td><td style="width: 1%; text-align: justify">)</td></tr>
  <tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zwNHF0PogJC6" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards
    Granted in Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">48,383</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">91,269</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">19,886</td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zWh8lRkfNPV3" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Prior Fiscal Years</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">37,406</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(35,262</td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zO92Vm5FeK7j" style="vertical-align: bottom; background-color: White">
    <td style="text-align: justify">Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">38,115</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">0</td><td style="text-align: justify">&#160;</td></tr>
  <tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zD8Di9Vq7wCc" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="text-align: justify">Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(10,049</td><td style="text-align: justify">)</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">12,392</td><td style="text-align: justify">&#160;</td><td>&#160;</td>
    <td style="text-align: justify">$</td><td style="text-align: right">(50,540</td><td style="text-align: justify">)</td></tr>
  <tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zxjsv5Jo25E3" style="vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock
    Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zjNkJj75UDyf" style="display: none; vertical-align: bottom; background-color: White">
    <td style="text-align: left; padding-bottom: 1pt">Adjustment to Compensation Amount</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td><td style="padding-bottom: 1pt">&#160;</td>
    <td style="border-bottom: Black 1pt solid; text-align: justify">$</td><td style="border-bottom: Black 1pt solid; text-align: right">0</td><td style="padding-bottom: 1pt; text-align: justify">&#160;</td></tr>
<tr id="xdx_40C_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zSQ8dUpTohCi" style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: justify">Compensation Actually Paid</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">409,019</td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">688,442</td><td style="font-weight: bold; text-align: justify">&#160;</td><td style="font-weight: bold">&#160;</td>
    <td style="font-weight: bold; text-align: justify">$</td><td style="font-weight: bold; text-align: right">513,490</td><td style="font-weight: bold; text-align: justify">&#160;</td></tr>
</table>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_892_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKBM8YzztKd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and TSR</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s cumulative indexed Total Shareholder
Return (&#8220;TSR&#8221;) (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="formdef14a_004.jpg" style="width: 28px; height: 30px"/></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income [Text Block]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text"><p id="xdx_891_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zrGuaEIDN0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Relationship
between CAP and net income (loss)</i></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#8217;s net income (loss) for the fiscal
years ended December 31, 2022, 2023 and 2024:</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><img alt="" src="formdef14a_005.jpg"/></span></p>

<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="nump">$ 34.23<span></span>
</td>
<td class="nump">79.72<span></span>
</td>
<td class="nump">46.08<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss) Attributable to Parent</a></td>
<td class="th" style="border-bottom: 0px;"><sup>[1]</sup></td>
<td class="num">(33,650,000)<span></span>
</td>
<td class="num">(90,000.00)<span></span>
</td>
<td class="num">$ (14,090,000.00)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Hao (Peter) Liu<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">672,918<span></span>
</td>
<td class="nump">677,266<span></span>
</td>
<td class="nump">$ 1,986,962<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(134,334)<span></span>
</td>
<td class="nump">2,136,138<span></span>
</td>
<td class="nump">1,975,045<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member] | Grant Date Fair Value Of Option Awards And Stock Awards Granted In Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="num">(1,501,393)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member] | Fair Value At Fiscal Year End Of Outstanding And Unvested Option Awards And Stock Awards Granted In Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,445,577<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member] | Change In Fair Value Of Outstanding And Unvested Option Awards And Stock Awards Granted In Prior Fiscal Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(610,049)<span></span>
</td>
<td class="nump">681,465<span></span>
</td>
<td class="num">(2,346)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member] | Fair Value At Vesting Of Option Awards And Stock Awards Granted In Fiscal Year That Vested During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">47,046<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member] | Change In Fair Value As Of Vesting Date Of Option Awards And Stock Awards Granted In Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(197,203)<span></span>
</td>
<td class="nump">777,407<span></span>
</td>
<td class="num">(801)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember', window );">Hao Peter Liu [Member] | Fair Values Of Prior Fiscal Year End Of Option Awards And Stock Awards Granted In Prior Fiscal Years That Failed To Meet Applicable Vesting Conditions During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">624,083<span></span>
</td>
<td class="nump">626,135<span></span>
</td>
<td class="nump">420,553<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">513,490<span></span>
</td>
<td class="nump">688,442<span></span>
</td>
<td class="nump">409,019<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Grant Date Fair Value Of Option Awards And Stock Awards Granted In Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(44,676)<span></span>
</td>
<td class="num">(78,760)<span></span>
</td>
<td class="num">(87,981)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value At Fiscal Year End Of Outstanding And Unvested Option Awards And Stock Awards Granted In Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">19,886<span></span>
</td>
<td class="nump">91,269<span></span>
</td>
<td class="nump">48,383<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Change In Fair Value Of Outstanding And Unvested Option Awards And Stock Awards Granted In Prior Fiscal Years [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(35,262)<span></span>
</td>
<td class="nump">37,406<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Value At Vesting Of Option Awards And Stock Awards Granted In Fiscal Year That Vested During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">38,115<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Change In Fair Value As Of Vesting Date Of Option Awards And Stock Awards Granted In Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="num">(50,540)<span></span>
</td>
<td class="nump">12,392<span></span>
</td>
<td class="num">(10,049)<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_IndividualAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO [Member] | Fair Values Of Prior Fiscal Year End Of Option Awards And Stock Awards Granted In Prior Fiscal Years That Failed To Meet Applicable Vesting Conditions During Fiscal Year [Member]</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure [Table]</strong></a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation Amount</a></td>
<td class="th" style="border-bottom: 0px;"><sup></sup></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr><td colspan="4"></td></tr>
<tr><td colspan="4"><table class="outerFootnotes" width="100%">
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[1]</td>
<td style="vertical-align: top;" valign="top">The
    PEO in all reporting years is Hao (Peter) Liu. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[2]</td>
<td style="vertical-align: top;" valign="top">Amounts
    reflect Summary Compensation Table (&#8220;SCT&#8221;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</td>
</tr>
<tr class="outerFootnote">
<td style="vertical-align: top; width: 12pt;" valign="top">[3]</td>
<td style="vertical-align: top;" valign="top">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</td>
</tr>
</table></td></tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=SONM_HaoPeterLiuMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=SONM_HaoPeterLiuMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_IndividualAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_IndividualAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.2</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>45</ContextCount>
  <ElementCount>18</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>true</FootnotesReported>
  <SegmentCount>8</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>4</UnitCount>
  <MyReports>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://sonimtech.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="formdef14a.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="formdef14a.htm">formdef14a.htm</File>
    <File>sonm-20241231.xsd</File>
    <File>sonm-20241231_def.xml</File>
    <File>sonm-20241231_lab.xml</File>
    <File>sonm-20241231_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>formdef14a_001.jpg</File>
    <File>formdef14a_002.jpg</File>
    <File>formdef14a_004.jpg</File>
    <File>formdef14a_005.jpg</File>
    <File>logo_01.jpg</File>
    <File>proxy_001.jpg</File>
    <File>proxy_002.jpg</File>
    <File>proxy_003.jpg</File>
    <File>proxy_004.jpg</File>
    <File>proxy_005.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="3">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="76">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>24
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "formdef14a.htm": {
   "nsprefix": "SONM",
   "nsuri": "http://sonimtech.com/20241231",
   "dts": {
    "inline": {
     "local": [
      "formdef14a.htm"
     ]
    },
    "schema": {
     "local": [
      "sonm-20241231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "sonm-20241231_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "sonm-20241231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "sonm-20241231_pre.xml"
     ]
    }
   },
   "keyStandard": 18,
   "keyCustom": 0,
   "axisStandard": 2,
   "axisCustom": 0,
   "memberStandard": 1,
   "memberCustom": 7,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 45,
   "entityCount": 1,
   "segmentCount": 8,
   "elementCount": 103,
   "unitCount": 4,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 76,
    "http://xbrl.sec.gov/dei/2024": 4,
    "http://fasb.org/us-gaap/2024": 3
   },
   "report": {
    "R1": {
     "role": "http://sonimtech.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-01-01to2024-12-31",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "formdef14a.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r94"
     ]
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r70",
      "r80",
      "r90",
      "r115"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "auth_ref": [
      "r126"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "SONM_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value As Of Vesting Date Of Option Awards And Stock Awards Granted In Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change In Fair Value Of Outstanding And Unvested Option Awards And Stock Awards Granted In Prior Fiscal Years [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r105"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r104"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r103"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://sonimtech.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r98"
     ]
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r102"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r67",
      "r77",
      "r87",
      "r112"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]"
       }
      }
     },
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "SONM_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value At Fiscal Year End Of Outstanding And Unvested Option Awards And Stock Awards Granted In Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value At Vesting Of Option Awards And Stock Awards Granted In Fiscal Year That Vested During Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Values Of Prior Fiscal Year End Of Option Awards And Stock Awards Granted In Prior Fiscal Years That Failed To Meet Applicable Vesting Conditions During Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Forgone Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r116"
     ]
    },
    "SONM_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Grant Date Fair Value Of Option Awards And Stock Awards Granted In Fiscal Year [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "SONM_HaoPeterLiuMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://sonimtech.com/20241231",
     "localname": "HaoPeterLiuMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Hao Peter Liu [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]"
       }
      }
     },
     "auth_ref": [
      "r71",
      "r81",
      "r91",
      "r108",
      "r116",
      "r120",
      "r128"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r132"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r132"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r63",
      "r132"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r133"
     ]
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]"
       }
      }
     },
     "auth_ref": [
      "r108"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r100"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r69",
      "r79",
      "r89",
      "r114"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Outstanding Recovery, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r72",
      "r82",
      "r92",
      "r117"
     ]
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r101"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r96"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r97"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]"
       }
      }
     },
     "auth_ref": [
      "r95"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "auth_ref": [
      "r64",
      "r74",
      "r84",
      "r109"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]"
       }
      }
     },
     "auth_ref": [
      "r65",
      "r75",
      "r85",
      "r110"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r66",
      "r76",
      "r86",
      "r111"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r73",
      "r83",
      "r93",
      "r118"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r68",
      "r78",
      "r88",
      "r113"
     ]
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r107"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r99"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r106"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Name",
        "label": "Trading Arrangement, Individual Name"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r133": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>25
<FILENAME>0001493152-25-014244-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001493152-25-014244-xbrl.zip
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MTR5>)X')?7+<I(W_;+VP U@HS"OD?H$B7AP02;Q_79AE4?-NF_/6TL^+@YR
M%@L$'&57XOGA^"8<'T,WQ>43LSQ0-%(W]VOS'!"22/1%!#*4B.EWO!?W8Q)X
M "*;I)C]083  0,<;FC.M7D3>R_4SW@GP<]R./(%<F4U36%DGBH.TTC-! \1
M(NZK]?,F3UZ_NC?T6X(V7G^9?2T]_*$O1633(D2M''%T\H_B&95?SB9[73>;
MFFL$FQIZ%1! DHN2CTXB#O*5Z''RW\IO ?KF[]"*\[D]\PW]M3F[_DYMY6W;
MN\5 T5_KO+E;=]C<K65O;C?;W.Y:;V[W#IO;??#-_>ZF<0+BV"].^$TD(OHL
MTR]BV!/1X^QZOI7B$MEQ_KWZQ0-(;D:^=&7"<-H>7*@!J;,O0%;?ASM$7DDO
M=?S#&QF_.$#1<[^RNO>O:P<SP'A="\?3Q(H*/VNPXF&Q8B49\7:&%=L-5CP&
M5JRD[#/[#:)_^#ER H+[DR.C?SE^*D[[IR-4.0^OG<B+#P/O/ G='_R)GA;>
M2?!)QJ[C_RZ<J$&R.:8[]/ZX"(_"X<B8;4$GT%R:=[LT&T)H"&$QA+#F<D)#
M" TA+(80GHAHE.W^89)O[7'@P6&D"7HTT2\+9_%K<"5B.(&&2!Z22![@=!J1
MZGXB54- #0$UHM@]1+&&@!H":D2X>XAP1P,GN!2PKX8@?=>S^09P1_D!Q0W]
MW)-^EG\XC0!W/P&N(9^&?!KQ[<[B6T,^#?DTPMLB[&__@I. 4YG3#'HQ<.A-
MX7U,(WB]T7V6H?LLYVP:T6UAMK>&>!KB:02W.]K=&N)IB*<1V^YE<SN,3_OJ
MJ!"XF8ZK+%%_"J/?!M(='([P3)R>+]2(1R&@) X7_R8B<>XD,@:4;\ANZ>K2
MZIQJ(RHNV,JW.D?;$&Q#L(UXVA!L0[#/DV"?B$B<'2F<:.F$.%Y@_H-%+0:&
M]85W$7X1(IERP VE+DL%7:'C;(3@!=E+5^A,&Q)M2'01)/I$Q-Y5/-.&1!L2
M702)KHF@"V?Y_6L8?!/A5Q$^+0K [TI+:V2JZ3)5@PW-]9U?WPTV-#?%U)NB
M23!>&'+=1^Y:]^SB];T<&P)H".!9RP,- 30$T(A 36+O*A/'4\[J77_1J2&<
MAG :D>L.(E=#. WA-*+:'42U)HEW5>GF"6?PKK^@UI!-0S:-F#:WF-:034,V
MC9!V'WM:D["[2E3S=+-UUU]$:XBF(9I&0+N[':TAFH9H&O'L3C:TU4EM;,BM
MR59M1,*&4!M"?4:$NOYBZ J?:D.H#:$VHF^3M/KT*'05S[(1=N]O_URAXVQ(
MLR'-1KQM2+,AS:=)FH\OT*:!9+K\]?QC&:6'PHG32!S(.-SN=M[LPR-Z*/U3
M87P<JW[P\X$3B7C2^&KQ],P=)P#0OM5/0MA>W5!\\VLZ%)&3A%7,GGWM9?!J
MQC1F_"B"<"B#6^:\=3_*D]8,JW\VEW_[-IZ!XA=./Z81_#G3(;V7-_N1\!VB
MNX$<V7W@_&>B'\,=X+A)&]G=S@L["=5W89@$82+P^ZVM%Z]G'6)WTA!VX>-V
M\>/.[!.\N3^,;Y<-X]Z]8>RV[S]$Y_Y#=)>\4]VM^\.XO6P8[T\5W8E4,?L0
M]\?[[K+QOGM_O-^:B/<+@G'K_E2Q-9$JU!"O:8PX3"-7Q/ -?3$0CH<RS/O7
M< <<6);U?F3'R=@'";0/@L"^W6F/$OL")+;8_BJN[;-PZ 0M_J)EGX/\T']G
M#YWH4@8;23C:M^'Q[(M>F(!@KKY#H6+#\>5EL&^[( NA</P^'CF!.=]&WQE*
M?[Q_VXST;"S_*QC %P=__TMGM_WN_6L<\.#]Z]'!0Z^$I_P_&QOV)RE\;]\^
M2WVQ\<VY%/;&QL%[V%T-S4QS7$LO&2#,[;^]*+S="R,X,'[[@^^X/^QM6%8<
M^M)[9ZL?]4C\>R?_W=PV<]?P[-7_&BMX75A"@QJ/N9*WN)+WO8-?OYY<''^T
MSB\.+X[/W[_N'3R1=9T?'_UZ=G)Q<GQN'7[]:!__^^B7PZ\_']M'IU^^G)R?
MGYQ^?0*+[:K%_N8 #P\NDS!H61\WCS;M;GMG>^\)++"M%JA)[E$7-"]'IK%L
M)TW"N=CO<V>OJW+<B^1&/!CJNC?>S?>]]H?OPA-R8^-CZ*9HVKD8C\1W[^;S
M=Q=-+>U.N_/]._[5Z6YUOO_W\.KS/_^[^_/;?W[R0223"4*TO__OC__>W_]X
M_.EOW79G^[ $\$8LW UYLS&0GB=@53!M5Z*FC-:^%P?G1[\<?_SU\[$%;V9;
MK/ZS]INNL>A;%-Z,K?/$203NL?TMC>+4@3^2$%YS4?2U.]LOG5=VV+>3@7A"
M2X?EI9%,I(BMXQN7?/KVH9O@0CM[6]M/:*4KP2J:FV%MC[L&\#_2.)']\2(A
M_X1N JLW1C9CGXE+&2?H5K#__I>]-]N[B](E'F8M"U5_'GC['7OD1,G8#N$<
M(C@,&+_N1+;7:WEK>")' ^'^L'#OG=$H"D>1A%O:[H4W^XM<QK(W.4%O'S Z
MWX=O7=# ?GK1?D&?1X[GZ<]SK\"X$C(3C!OZOC.* 1S]%SE,WB?1_.-?B2B1
MKN/K\P6>KKPO[Q/OSN"V-[L[,ECLEA=I,?'N#.4BP?H6"5^BXRL:$S@D9]J9
MG&F""_\3K<8QY0A\KUTT!EFEM3UYG#L*@S['93A^BP#JAY']:RR4[F(?A<.A
MC#$(PCX-_+']THGMD8B&,DF$9\/5AR(@J#O.QNY+\>IE]]6K!D_7'D]W5PY/
M/XJ^#$#QO!(-:UR-M3UYUEA"N4./@ZX<W_X": >"I1\W>-?@W<+!.@\I: ^D
M?()&(YN=!B"OVW@J;]YUM]N;>.=VNK4H^)H4B(/&'O/X"[K-4G],P9:YH>"K
M,Q3UUGKW.MSY\$_1_KH- \J;_2 ,*#Q/NK8*A3P3_7)$<A+F,98O.&)91UEU
M7]B!@Q&\ ,=^'1B(BH$<6A?"'02A'UY*7.-)X&Y21$8^_U.S\;_$U5L@ !OV
M&Q![ST?"Q?!E#_; /DEB^VC@1##UJZ>PYB<1?/#DN(=>4(:1WT04A\'+^)7]
M2?IP190EX98M^Y.MD*^>T):LJ<7^FS/&<\*S5"?X20C[)=DM;<?WT58) \+A
M)6C"],>O&LME8[E<@G:^=$S_&K(]"= [$G^F,A+>DH35!K.?"&8O1AE;OMM/
ML$E@Y$C/'D7B2H9I[(]A<Y(!?M96?$#/:8:"!O$;Q%]9*X3&<3<<CE(T]8<@
M3!(FR, 6-P/9DTG&U]$/< ("J-W=>=E[A?X!NQ >A#Z"6#D)Y*N7G5>V$WAV
M>Z/3629A/"'_^.,%[1NQ0;5!^T90O[D_#QD[]&B'73@17,D[>/O/5 0NOD7+
M(DJN;O#$Q(?;CF^7^'W.DDT67&;1Q2FKO+7$@ZM*5LYV:YCII W/V58!R\K6
M9$WD*I^GLD^1<'YL]$0_C ">$>VMN3>[]:@-\X^*E*"^UM./"A.:Z/B4H]C6
M\@J_SVUM[K0O^DE5'."#R=:P0YQ0#B_M.')QIFCHB3[<6-_;[<[F'Z/+%Z"<
M)S^]>/'ZOK+I3( LDA=&\G)0H  C57L)_S2P%V%G&_H\4-39V]7*EP'@XCC0
M]O;V#H%Y[,3))0;>?7%\'YY/)?S=;;=-KK3ZRSEW H+RHQ278<L^.K3WNIUN
MQUC$>HJMZVL\!<B_AL ]R13>;7=WV">#+GDAT&.ZCBL"5<BJQ+,L=AF-F/'P
ME@*^R!>Y[5@8A\!"Y1D?WR\<P;VDDASH)3/5BT$:Q9XSYF##4S<)L=)29[>E
MU[&PF8A!O.]%KWE;]O;;;=O9'&ZV0%5#/ZY+ SSA$)ZIHM2*+7>AA/(Y=!T,
MU5H@?2R5)KXYN)=RI.G[2D9)"I+3V'82&PNKC?!Z\$(WWG3#X6LL//;4[&93
M32G=QI3R[$PICV?!74LIIC&6K*@26<6PU5=\UQ'FW,Q29SY9IY4T5I0F=KF.
M-3.L,RV2+26G%R='Q_;I)U*$K/-OQT<GAY_M+\?'%R=??\;OSR].C_[QR^GG
MC\=GJD33P\.Y<G8)!25>A/O%4@I;,IAR<V?K(PKB5\NW^3Q*$TJR1_!<+Y(M
M^Q?A7PE\%=;O!/%&4:;87HJI878S@P)C%\&X/T>JY4>9V< T&;"&OQ V6#OI
M1)-!F6<MZX1G,0/,.<H#P+Q03/P7Z\+:P#L1%Y>% X9N;H>!+P.@BV2).#=)
MW6]0[L%0[DRXP.1MY($/CFY'?LBYU[TT!ER+8T"Z)6+;N1@E7.N^LY.ST\4)
M9"L@%ZQA$9.+T K3R*9F 8/0!WDC7F@2P+H$QA&4,L#R!!AYN8/RU]PB/@IR
MBU<TJTJF_?+O?WG;[;;?T0,M^M!Y1PDXZ@=L'>$$X^RG,-*_7 OUW2L0Z7S?
MQD.W91+7^CB1.YBH8;TTYB@]FPT;!O9D$:J%=N8)PLZF?1':<"%AW7U:3#@:
MA7 E!S(98ZT(:Y1=D%@C@FHA]:(0BS7;EU&8CA#<V "7Q$H]H(.IB[&,$ZRC
MAS_ QRL12/PH;K#K UJ L; >IL84AHG$I1-Y/K'(ON4KDW^+8"SO&&UJ3]@#
M@?L:P+3*Q+X18DV+H7H,#5E.LEG877XW"!-\G_0( &8T&,=X?9&%'F#WS%DM
M->OF\DB6K715\FAH>+:UG?2M<9C:3H08&%%ZG, P9@/!D#I[(A! !XA)X76
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MG3Y7PP *0#@9 X%O<_OH"2KS 9"!T@>ECX%_5<:@=T2Y*G#L88B:)BF@R0!
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M67%^WE>UI_71C<]U4VG_E)&LM)M*@%;;:&PLFO: [:>47,C5ZQ%[!1>8DKK
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MI=<5R(]#C@OB5M7*%TB!@7BSA 3%5$]^0W0-G W[?K(GM#[L^S#)F-4P8U+
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MZ7H2O2ZIGZ"A'F8;$]O@D3--$F <""<#2)4@-E05EL])8")U$><P1S;&JAG
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M_K39]8TQE8"S32L*#3EA(U\15XZ?,I&A$!9:U%V%9%G5]%0/1\%/&!7K>%?
MHIQ+$:8&7ZI*&Y1^QE-B)GYTI<H_1O)RD%#:#.Y<+IOG[UK:-J&\#<D Q+V,
MT2BX:J]BE-![\%(X]?"F;I_LM]2E:U4OW5KU8[8CNPN:D&QA*5E/!G6*<JM
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M^\O%13]N=F4AM)(*!'$,+'D[T22./RK36A)BB "L(8@Y;&PN8# V#MV7ZM:
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M1L5N.XXJ9;2QLI:1V@BLZ<H?ECV7:K:MR'Y  00N8SP.L86$.B*7.X4 \A)
M:D@&%J,2J2QJ=B24\J;+J?UJ7YD0']I:3:P"'?82^?H%F-/3"K! B<$;CIZU
MLW0+2CA@8IJ18D2<>"X(=Y5>% $Z<^A8KB_Z$/!\I3!'N^9X/Q>4+B7NCQXK
MN0J9FKL#?(Y+7NCB-N#(E54^(S:4M[XD/A:9EN+= B<EEV(8>$Y(6?E>":.0
M417T;C?)O=S"G=3S5FJGQ;E;I86&?U2WR2EQ],;QU;X!>[RT=B)36V'#>5G:
M*QQNFA]0$GI5KC=!N!-P<>U:.Q@0I ).*JW),M4$"&MBOW5P#C,21)[Z#-<%
MC1C:8Q!&9)&,'03?4%0@2Q[<6[Y.GE;)FU\.P5*0@O]2@<"LU)?DJD-#"W?4
M=DO5"4H086+"S,..?E:5J.';]U:9UF?MJ\33^ 4,E&+F_@F'+R?_4E7^RQ(6
MI>(K#@+OE+AF(VS2 NH(,@G#-RVJMVOHTM+AB.O8>G9 QT5A"G51Q1%L^9<Q
M>N/NF6K'_LD/^XADKA0_6,085#15\2ZH9!2&1Z<O[ '&@7!S= LS!>K$%W@Z
M4[6.R@EN6JE0):#!>U=V/"'[HN>>BCX1RXA#C)0=BP5ZO#+76MFA\TOM=ZJD
MT(\M(*$V"7/H?O;QVY[A]$T1T]#7+,SV4\BN.WK72_,P:$>(5JK1B8UT4AR(
M7@JB$<'1-PS$MA69(\AA@6X49\)!,(P!=H&3!HA^J B"<>&HO%Y:SNAX@*Z\
MMZD*39.0\!['11IST:U0ZOO/U\]<$:2"Q7\GN=F;)ZR??VI_4(M6K& <YCB&
M5#-0M8L<:,1 (%'9;8!PPF386@VQ?)C7?[$,6U\N?(B4S=Q^-R*/9HPF.OU4
M,K<'&<+YHE*PK^I_%9"M8GX5D I0=,U+?%45[K*D%E7&H5 ;YP/ 0_$!S=(1
MT(Y@F+>C\V\.4G>S%^87 9U!,0=&M_^2H7F^:'26(O;C<$H0/8[>F\PM.?5;
MK[A/Q"^^9_?=Q\\/WC4A*N=;UGQ 6$%245E?[V)%EX_>]\=^<&4)HD#*BG:0
M>%?G]U\XX,-'.#<4_+H+!6\R%'S:A8)W-Q3<-)V%>,JWBI!'?WBES(P'"T=_
M_^[ZM_\<G9Q]IYC:I\\?/WV\OOC-Z;LVJT/V=][O]=^X[S]<?KZZN+YR/[YS
M+_[X\L^/G]__GZM?W>M_7GR^NL9?7G[\_?>/']SK+Q\O_]>*1/T*!7?Y -!!
M%X[O:4O^P4;UBJ;<\IWM21JH404B7+&Z-O$S6T41>#;L&C *AI'/[1VE\;<G
M(.6BQ"@;L@9)+F-X9'+/!W)T*J#H!FV*X/RL2H>(K67J1.KGN3]$BQ0+4ZGI
MO(MT[KL3,'K__MW??'_PGZ/>"5@IH'U_=7_Y^4?_K4WA+7MS7BO_<>9OHPV(
M=2'8?%CAP=Y1#5)H<*>XJ3O#,^>EEAV^>;TIP5?:V9'; UBH=\3_AP/VU _X
M?Z7>\_2).?-Z3/]YYS']Y]W%^\__LE#_><?J/U]?H*4+KTIYV[C1L>@'#>YU
M(\AB*Q&H/?(4X!<3);J4YE.B:X.PJT9GN@&(SN/!9%^NL\ H_#PBU';Q$A1#
MZ:I$EEA&D#:TZ4+21@N?LL*)DPPG<Z?A4UG3-,QS72"OZ1/^BR]6\!5[,\(W
MS-HL#J<<?.5F:KAU3-6$1^8DC%(:(!P^^]I\05,/8JEH4 X#'HZ*"!+T?HRP
M1 14(6PI0^G9#&17X;^K\"L\,;W;LOJR%$?=$9'=MISP[27?HNL5]O#E_SD\
M0V_A \>&.%>D'H1ZK2N9PA*0Q51Z-<L#DGR]4\_M'_5/.6V0^P!0QD.I@[=[
MAWJ!N;PHF[!G([ ;DH"60&P.FGM6 PK5D<+TH>B]\EZ=][S7O=>.QG2DA QI
M#,F73,/Y>^ZKH[[WZOA, 2Q+85B&\1P0@,P\\%:B@,RIGF,6Q)D$.B(_SEB3
MZGF]XV/OK']:&LC1 S7X#W%4N[/ '64X8J7'!;7 @-]AV9K?MLUNTS93QRGX
M?^='WC'LPZO^D3.OR.C6#R.2PY*G(UF72H\++,@R58=A!5XDVGN O6G(5VOE
M=*;N+"$?+'5V@,T3D$_/*6$/J]$J.4BF/X_TST(L2/J$PK4NQ]QTBY_5N&*W
MAF6&;S^EJA+HA;(9JXY(V1V&?3AM/$+(IIW1G#:PF9G>ZQJG@;_6F8WB,$Z,
MJ1%^*Y?AGQ4[.BU_E[K#F29JN$VHS+C_*F*\)Y^H?A21B7&@"C6P)F-4(:>B
M$1H46<GJH;!D@AD:"Y@KE>UX!A=KOI/?(-VR7P[VKL"22PP&X<:IX-'#QI@H
MSN6TL0H*O13T\:=T/5PV2>[<^L>:<M7V,#]*3/PF+'_&X%7 ZQ4%=O_)3M/X
M/&T?9]4'6IY4_^%)E5R@K:[2[] A.<<?RIZ[[\1M.<\+6G)\JL>;?H??1M/U
M[]_UJZY<Y2<<5#WZ39^;[[[ CF@Z=??G0?HC?]]2#TH1D ?F_*3K^ /MSBN[
M<819#RS0W#OSZ^H%7&2MC 2S #4TA>W_=GEY=?7N79U0A S/D J;1?K<Y5\T
M\>(R$G!]595O]W]HI,W*4[VV"2[PZEGE78HQ/K0T2[-?8!'?,+UM7;_MVUO1
M#GP3#4M<>AZK^Q:JK6@/B[*>N=-8\/F%SN-TD;-8=!:[OY+UL,-'$-/'![M&
M;ATI&:?#SM/2:I:R)7SINJW^I]W5T^#FH8F0JV?K"$^<5SM/=2M8Q];PKQ:B
MLX)S34Z_K2,M[=#<>>):R4JVFZ.5_;B*I6T=31FG],X3U>O5K$63E4(:7%/@
MS4Z"7&-\S_K G(3'_E&7\+C)A,>S+N%Q=Q,>G_9RFT:_/L?\ H5O.,__O<:I
M;#PP\/%6VBO,L&@E0S^\'U$9;.8Y=P%7EA39W P;#PO#,,N$X?TF0.<9=]J-
M;Y XL(\LHW'2'\(8Z2Z\Q;)J57%'QD@@V(2!@ C0>([ $:IJL+0ZM&^7BPM(
M17R;1&@!^;K#X5@C#%.I-+Z!^7F"F:A0&#G8/=;P/%+1: +&CJDV_ZA[TPZ"
M* QN@U++WM9&O;)YE"NP9(Y=";*"RM"I-T9"J'F88G-#E=>I.XZ"KZIRF2/S
MV"TH5:$Z-/9BA>5IPM@:BC(.@E%F]X3#<E&JM83W0/$;DM,+M^,F',)$0G@]
MIS+[EC(BW/HP+G28R-[R9Q]VLQ/62H?L6(>,0+9%+.'5%C0%SF,+8I(QB'>I
M^EY3/.TKWB&^4-)B>:RS"IKR[3P=,59!9LK8I*0TS#F0Y+1J B61#"$-&WJQ
MD*>>[U'^:3?154@HM#V\B5;>2,OYR?F/B[Q(FS-F+.!S!?2@8K8_[5(\<X%)
ME52.LN'YK2T+*C;*MY1SR2Q/SF=?U]NW80<FO=?;7\^,5SE)K6?0]"S%P,KP
MHM;,0VD3?\OINMS[N'YG$0F7H*7S$*^!@;QNZ+JQG42\*W3;S;.CI.V;YUY_
M!YB>T<5Q>J8+069L'6&"':UM\3'N[CP[2MJN>>X=[P#7NJ' (,VM5H:@7$0!
M!Z;?("/K"&Y[SW)WY]E1TG;-<^]D!U@7.Z9Q:O5*(G8-"2!3[MX'N3M =$^%
M.!>,ZHW85A8AI?_I+5;U\C1NM NL9 IN0RGA5_YD*NYRV)T>4M^D'&,!/H,%
MUAS(5IV!QC75[DBKSH%]SUDQG99>I99K>&+#"3IF_9LT8.!]BH<%(R>,$1?O
MOE38!Z__JX Y]UYQ@=JA^V>@7/\&H4X7<"U01D'5*Z4 0&5-#D8O!-N3"L("
MXW=W;;^[_OS JDGGUH'B=50QB,KN<1%%GMDN8G+]VT5)5!V287!,NCI&P8T_
MO#<N?/>?R1U&CJ@N:8B'FKLWA8\"/I"],9UW6I:@2HCU>9&SV3I)9XFMQ;/Q
MW!CG!$]&%-FI'Q5GE6AT1,N#NQC$ 4W9'X^Q!*%@3  ,G>#$RP$8M+Y@$51Q
MKCU4)<.,N^6E07R38VTU?LHTL-.MC+ ]%,:]""H29Z$VTJI,5$&!@DH6$47X
MT/TC)MA<&P7! M2,_#NJ4:<U:8!DPC?W$%1N7*04#%,(> 9H$[?%*<<H-'"D
M?*J*S$L].- 19ZW^F<0-*)#\28?3N,(I6X!:=S.>3"63&IWFJ<HVGR2D-R?6
MH]!/=(&O8B6^PBK-L$=>;N"R63$8$FPK7/4[8L#HF0Z!S082DJ:D+87Q/!>>
MG[O5W5G!1=WNI/;"*"$=A925&<K &=E<YF,(:D/=.>CJ6JLV'21KD;#G<YO#
MM[^&44%;PI?YA9&YSATO"T>F/J=*3$  S8D@1%Z^.RKO)>I3@9_&%';11<><
M]Q&7U!'1AI1O )\ 441Y"42HA\X[EE 8./54?!7UE8R;0I@6U Q@W)+$8KIA
M8F\:G4P"O\O4<%/\H)L,@?H];#X8$=8/EJY&]XYO@'Y0Q?495D9ZJ5(/C$:0
M @2U1V1X+OT6I0&N&Z(.! UP!,W8\;I3@8.3]BJ=;<H0 J1LW[.L1I1YGWN1
M!BFOG7!;7-.I) TBGP%K$JO NE%%LC1+AS#UZ4,SK$B@_!'XVG-B#Q= 50>Y
M_U> P-9/SB.>"L'@RWSMQJ%[XHF33T.JA^FPF.+%I$ZSS"-B2K&H[BBG6C$N
M$5] ;!;"Z%HJUR7%2O!@Q$U$Y&V\SY3GQ=DV=H?YPG2P!5UXZ+.RS 'B1BN@
M*3]'["O^79Z4VG_S/#'KRH"AT HH;VN&&CT9MGJR@]"".5?(8H+-E"E<^+E)
M9;9%5\-9>@A(@7D9 :Q@ABN?1[E.']O;PKAL?10QYBH/N>FV6H.?H]&.""^_
MW)N\,NR<9[_*UB@;?J O)6-C$\P=U7L 'DS6P+R40-YFV&T 3@WX*:7T5<'_
MD'S"#+TV CYF6E93=]D)'&*0"NLVS0U,-0+UQZU,4W>G59UQ]=-\ 7QW&J0W
M0?J< %WFI)?J)$E$;T0:YF43B(C3FAK7(%UT,B%UJ%/>G#)E!1Q'P&P./H<:
M93[GO5Z@,J'7529LLC+A55>9\.PJ$Y[.M?29ZGJU(YN,'[++!R#R!9*G+N)W
MW,OTD%B18F?VOM*6> Z(&906ILR^(?V9U"3E*U4>3JDA:  ;XIJ#"%4A%&+<
M6F@8* =GHV;B6.BU8\\5)W@.*W<U1EQ@X\ LX"KTC)>?O/3DND\080D$81HP
M,K&E.*(FXG!%0IQ0PS1L?M2F1CX4&%ALW;8;'A1!MM51[QW[MTG:ODB#\WJ?
M%*ZT)X$_4* HRA*M%"@MDBG -@*:KT)]7L[[L05VJM&I1-G%Y3\ ?\7)HP;G
M+XF# VI1AY45Z! 0;-B&]BV>O:4FJ,'^0)_Z"]H.=/T9#76ENK16M:=Y0(AF
M-78%[3-1AX@[@LC%1C]^B*; 9W(,/3>.5T8_2SG 3!W$(^#W* GT!H@+MPX.
MK+Q<96QSMX1M7@O:/,B4B)ER]TR'#55NELY>']6%K6: <5-&9?W1G)\32:ZC
M+==6$./%0Y%89Z/]M-R6?EK.)OMI*8'5T$_+64L_K6VA\C7VTMH*8F_LCV76
MFSG<^4JWO'HX3>'36JF@O$7S_0']SA^P27_ >></V%U_0--T7FYKIO-Z:Z9C
MMZD9TY=_7JDN3!?_OGC_V\4OOUVY?WSX]>HSXYO2WS]^>/^[^^7J\I\?/O[V
M\1_OKZX]'./0[1_U7KM7_]\?[[_\#_[BZL.7]_^^<C_]=O%A)0WOMF!G7:>2
MF;N1YGW-;9>^@3I*7:IV=R5/<QIBX<6NU07A7#6;,&X*#89=[55%.FT"JHG[
M)1A.XB1*;D*<"QAUZ@IQZL1[75;Q*<(YFQ96KMT?ZNK])^D#A7JV_!+'<? U
MTR+*PGQK1AB@7DAVLP<KN E& 6G*%"OCR*M>$W<%EP8W*N?),AP=:N>@/7DM
M6OV7<L<;\J\\KJ65.P^&S&$C&P>DO<8]DJX6E0X6Z%CL57#Y?Y)&6=[YJQ/O
MZ/3$"B[W*[\CLT,:6'"'*[(Y!@&ZUZ;^2"=HZ&GP'NB(F_Y]Z>2Y45J64\:M
M#XN:LG_-2AA!]Z$-Q5XUY#U&/*$67".GN<79J6IQ=JE:G$E+M-7T%EXX2+:N
MBHJ=7,-UDR>RUBRJ2E9XVD1U*I?1QJ+9"_?=*5Q!T'ZSD?]_W2C,.%>+'0&F
M+G4OA"=]3/#FZZ1XDV10)C.=&$W#\5VRQI!IOD>QC=D:V$,@+M"!/2+'0N_U
M^5DKB\.'%",[=-\A.S%Y'U9S>2<-;GQB7\P.BC3EYO78/RYEM!7B9$E: E7U
M$'N%^98@?+"73GW_Y]"Z(-/__N?HJ/_=VZNOP9!3Y'#<7]6XE]:X>'<.,;]'
M)N\@+ GZQL&0H#AX0,YS3!\+;L/@;M$IQ"%,H0=3:&D#9.\)WU\]!6H$1)@E
MUC/*A7@C'GKJO3.OS= *&^!US.!Q:W@_=MKZ8S;D#\[C#U(%4&FX9V3BR&Z8
M5Q';2-&4XD%T,PXCS.GZ'-R$5.T04C\R>%T%8MYAD\WK@W,F>7PJ2!ORLYM%
MM]LBNGW'SIRTEGKH2N"HM$EC&-L5]WO+9E7V!G@8QGFX^9^*0J(C7 GV7,O&
M7::HYW K+BC3>='^9)9.N; B28703:3H8"^YDV/O=?_5H7O1I%&66\]ABI4-
MOEP3I*;B#2GU:XA55M&]>W9Z[IT?O6ZK94!A%"=M10<MP,^H4:8A:?C\'.;A
M83%#%)E64=3*C9:O&UE6[F(\<F[]%*L%1?/E<&@G,K;!6J:<%#\#XL+@(SG!
M#0LTP8[.*= *U;68LVF J=VBF6$@=\2&'VIE4TQQ1?8Q\U,45XZ"ES3:U22,
MDBR93>XY+5P%9C9V8U;86WSY]* 2-*<DPMP&Z;VU<[HQ.#QZ0RA?&H74XVK4
M")^30BRE[6?N'CK!6;5!UX9HU;J?';RA# S"SR0P"_BC234N'9,"!T1U!IX(
M2J>-BE!"F@V_:2!^\#V$@DP#4KZ'?/.B,/X+EI[?8>$YOV*J277&CT/H0),D
MTW4IS&++ECT^A,H*9>W[/&DP)' Y93I+$^#DTT.WR83@V6-)BK4_6 T"OYR$
M,V<(>UQ@\<XTR0F2+;,?I T8$K9IR='$K0MA@EC<BTG\O'KKBN3W,XPY1/>V
MF,*]TUT+V9V2Q"/3OC.9<CP79CU$N1-3WM0!YE3))VDN6+C*G99KF"6\%9FK
M\'-#,G*&\M-=DO[%?JU!$4:CAB4-[AT_!W5WJ.>)W:9#PFP%<D]]\JB!7,1.
M\W[$[>\6HEJ><>5NW 6JBDCJ[ /DYY1&73KO1N/-'_[EH\9J^P!D\DP[<J)<
M.D23M;JEJ[Q\]>$1J /)'66%C)RL& Y7A!"[PP+^FZ3&GRHG@9(-O\Y4<4@>
M^%-VSVI,4^X!>0M[40"7D&.H@/4^D0C9NC-YTC7 #=8PU,HFL%3F-+"NH"><
MPRO?1?%?L2/NK^#> M[>,[#/P,<H!8SNOGI@WS/<Q'-JG(88JM1 ^?=84$@B
M+6,0[TS#JU\:"&P+_QO^,E6/A,P5TG!0: .&A)MFQA:K@*F.P^8DUMQVCM$'
M<'N&Y$D$)H]::AK")J%2H$ R5$8E,Z"&SJ92)Z6,P"DS9V>6))'BI7YTY]]G
M',O [0XY$5A#1% *TYT[H>PHC3B>B3ND5!_763K?S B_E"X)D-R \J-+L@P)
MZ0;KA6)R#E%^](RD,%(N-S%FP0U$DU-B6,45I$J5M8[U<G3NU9'+GX&CJYE9
M.V]2/$3+HZKRLEIHU8E/BXRBB=3 X+_ U88,/,0EI8WZC#YO8*2.?>:,I0.J
MM91TPOJQ??*]&P.#RW0.K(*90=*8A#"OE+ =N+J]R) )H9^&,*$PQ1:Q^='H
MH.G"F.."'"1VCKBFID-*VT5%G%)J,V*+PJO*$N!1Q*K8)? VJG0PX%;F5CB5
M6Z&EQ4_/CD?-3YT[[E+G-IDZ][I+G=O=U+G6FSVG+=RCG9)E%(1=YDFPE'<&
M2 PKJ)BMDQN@079E0]!N25L,W[IEA8?B[!FAE"6Z'L/')'8?--4TY7XA54]&
M9C>! 7M"1=5*(7IVX&>>BFW,9BFJL/0G+D/QZM$ EMX-?\ P@;LGSK3/UW]H
M'YIZ0RP*DD7EL:BUC?DK89_)'QF1@):MDUMLC#:&K7-A^<._(E8==-R2DKU]
M*81),>.;L_NM#JJ6TA ;)XK;Z$0I*S'8'?-&$AHJCA,VW-K=)A4#!:2[8_74
MV66Z?PY&.MS=#XG#\ 2Q(6\5C--X>PW7A>_O1115WD&B:'UI7AC-(3580:P$
M7X-TB-!" DF$,TG#O]3/P -\BF939)+[22DH'XQTIPK1B%V5C8A&L8GRZ]0]
M1[C%G)6C<UZ6T5'PDZ\!*/@WQ%+)L(P*RYR4"Z@YX\E(G:G_-9P6T\90>%OH
M6*RY>42L7"1W2+NC(E5EL-@U:8@,<N2GU+A.P4PVSMDC4!!$-;T)R.&B:Q!)
M7(S1!3;S0TIS++3/R1[*T<N729")2A]&MBR>+BH25JF['F=]4+GF5ZJ>_OY,
MLD"1PQ.>%E^G/5C)L!#<6ZJ 4[?,BFP,?#!G57$;9P_07:/;R2_@3$S()PTP
MV$4N/?$;[B/<F==8Z%G>2YB?X!@V[Z>#DC1,L4!O-DM".CV$*8TDNS>Q=^%[
MG?W:W>\G7P/BEQ$].>@PL.XBT,XX"#$>]^,P\N^PW[.(I*9+BL=;]CU80Z$?
MIYBI0"6G@I-N9FZ=?,&9(?+3O8:3Q(%T#3R!3X+\8!!DWZ2<J>122CNAR0F<
M5.S7D2HUM"UF>V99HF1/HD@<52CK>:J8QH2R$;^!XLEP(!M,%Z?R:S(:';R#
MK?G+_1.37*Y!5P0I^3D@_S?*[DM"-H8M^\0.&?SV!?IEE._78/(ZL"N'[GN#
MPNQIB,WIC *V'+>4S?-HHS&N32B&UJZ7_42^K7T;V&M;R_=)V86E,>2P(X(Y
MUEP"-M@&\![*+B@6K]9"W%3W"@05F\"/"2IAR%FT#(=(85O.P*WED/H#3(O#
M4U$+=85*JLFU%L+AUWLWTPF"M8S77W7HPC79MA\E&N+),2FOUS^TUTL*FRXK
MT]BS=AK-IS0%820;@UM,A<!B2QT0URZ)S'V\58=BX>PV,WDF#!%4=@3F0VA!
M(/P;@H09@BQ+J3A")0X0*0LOX4)O!!9L,KLULH@RN:EP!0-319X@E0]AR5@S
MG8!1IX;'SJ#,:>E#?N.G=GFCGP^Q1.& ^P-73\@=!6,".;05XWE/U=WX@OGH
M*^XEWU)9]]8'G(N&H>VFR&3_P;\+2H4A!FSR-90OH3[$O" #!T3DEG3VVA:L
M 8.<!/OD*US-9=P'Q&AF)N=*M]7(S9A$*BRPB:;?CUO>4390F#GJ=8EXT]M4
ME4/TVY+VN\?ZF%24,79(TW?0F@RS3#0 Y*OC($IBAH)"Y3*%+9-NX!B>'Z=^
M,<+\A6P"@AHVW9-^N^CQ ,L(E-X11^+:OEC$5JD@)IRA&1AFPRC)BM3RAL1C
MAG4O5Q,)).TH0#4S#7(TPRI?<EF+F80#0D&EXD#QV*!L0"4'!M%I>HN=;G<[
M5Y%(!4,2,+:)'+,>S4'=(>B_XP+XZZZ'_)?!1;$:M%!03-2<S%$PS\U5=6ZY
MJJZYZ5MS#>T*,5-6W?6ZOU37ZS=N:VBPVA"[&O]C\C2=QNQH7K5AEDQ7DW3/
MOE#V\_!QO%]__ZY?C5VJ5P?E$#;<C-61&0<IZ;)1H8N^0#2]M7RG7M*C/OJH
MC6QH)-=\;G#PL(\W:0*2#P\_27]R_W9Y>77U[EV]>9P0S#G&;.L,M9052%[$
M97RNK:5"\QJPR83Z/S134?FIWORG[(,A064NR-F#ZY6BI07FVGMPK <: BY^
MCJ"WY(%U,>=_]L\ %QV,#GSX LJ0:FAFO-P9->WU U/X?M[^U<[GP3,Y/#DY
M/WYH:JN]*<ONL4[6),UV-7N\#(T_M(>]P_YK<KT_^/D-4NJW,1=4BU2Q!CDV
MGF1CQ8>W5=2YX+XN6"_Z)-O*]:F[1ZOM>\H.[&:E].>LF+W=ZV&/TF+V]DDV
MO'_JG?=/=I&,+9[P-*SUE??JO.>][C5J#4]$KI] P^;D8'0B<-F%"/\RO682
MQ@VH09:@JUQR3RCW=\K)V!JEX+&6_M'AJ]/CLX5/9R4]<S=N^3UDWI6Z2#]P
M5,R*ZKLU_ZW/@;3DRM15)40,LN"M"*L.[5Y=?_JTQJ[%+3FA:_)HF)S3A_NE
MG'1)WAM,\NX?=4G>SR#)>[/7^9$.RA%FUT84H&]R2U*V%3=5ON<&B":9J<5=
MR2E7&1;[D/F&+J4^.9:..;$ _G7B2:J)*@%RTB!/$U\E&OLCW*Z@5(6#4^D=
MP.@'O2-$]<)ND\K>FD6A !A@ 7P);:G2KOQDXX[3!>[-XN)SL1OV+8Y3ZV)5
MKJG<VSOR). @$7#V%?I5:U)CD>\W.37?,?7]#U ?8^OB'/#LJPMLF/PB7VV3
M!<]MOXZ[_5IJO_IKV:]O,<'2F\%>_^C$ZQ^?>_W3T_U6Q_K)Z[I8;A*[RSO
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M8)4#W@89%9MDPTDP*B)*IP>.Y@OV'?G/Q1S-DYN _/V$]P.6J7[9'PZ#*.
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M7QL7D_52DNVY_U7B=*-@AN">7'- \9\'WO)*KPC(+[JR_Y_4+6# A]W!5C=
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MMO$;L:1V V>U0X==(\Z5GZ;D9A3$;^8-Z &>,4>3W#MQ5RKII/ 0:PVWJ9
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MQ[PN>8+M^J'2!1;B#/)9BZ?,=40Y:W!$>=62MKFN.#2LG.5#[^6$0.D&1^)
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MW;@""U!YG')!AJH9^;[GPEY%*VP"L.5G_)+H&?CU%ZH()C1%I UR\'&IB%2
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MM?NY@@N_ =5^&^>XW#6?H_W7+I[6_#OE\FD- 4XRZNR '5M.DQW06FJT!C,
M1LO"44#U3JC%PVH75NXEK\TW.OE6Z.A=7*"+"SSUK'<E+@#Z.\VMK,.+ZBY(
MSZ2GO^G\^)T?O_/C[XP?O_EB7W[\Y?,%J 7A=%"D&2F(FW+H;XF,WN'E_#.Y
M0[W*<T#IVY3.:&6EV%[B29B">1BSG]AYA)^XC G;:8F=EKB=(J33$BE[A*)"
M+$]Z_0<UQ4Y+[+3$3DO<A8DNK"5VYE]WL;N+C1=[1VZVU5VKU.%+RD^*^);Z
MPI=!MBT,7<3HIE*ANZ2(1@RQ3#4G=V'&>-K!2/+$&:":099%_:\&>+?&R-QA
M]+7U1(X^!3'B/CNJ/JDK!=P2POI8I$Y;1Q)W%([<.,DKX/H>6O?FDFKT4##@
M=?D9W7"/?C?CH\>75%A(5;TA5EPJX&@(=);-P#A/I BQR%3-6_^H?_*<L0EV
MA_;A)G](8H1F(C1Y9X0 >GA>EQ:*77>WMX34'GNW0<3&S=<90?[UZ;OZ],MX
MD!%.OWR3G1=RD^>CC)QU*".;1!GI=R@C'<K(2^'U.RIP0:&X$K1?91N0 .D,
MA&TAK#_Q8"+$CV-#'8UP8+C8\P?C=-SDB,W[ TS('BDC/\1RC%N0=\3[T*\7
M!XA]P8Y\2V'(DR3BL6E9C,5L(#/ 9/#C(:+-4#,B;E@E_2/K:@W!G.( ^C6W
M]IJ-LG'HOH]UMV_*/7MPM8Z"\3,=*IK6/PFB68963!UIA-[4$"(-J\"_@[""
MKP,3S33(R"BX31AS)$SA5+(<<]Z3E&%8<*J#(@,#*^,!S X(ZLBA^V_CGBE[
M9/9X';#F6/U*]1"#Z<*&%/@.U]1(SX^4<W7WG=!&\\Y#QE:14 TV><BD?SL=
M3<%SP]_!PGQN &>:K</^(-X*4,4T\+,B#0[=C\T';0&((\0ASAD,$L0KBD/J
MIQ #B4_ O!02)80BA%=$)4"!@9OX]7/62G=X-3904:LI,RS "HES( 5!CE?^
M [SC6:/O$<?K'_5>NU?\Q_<:V_X3FB_LD@P4\<" @I_C2&J"4)\@*E*:*[H\
M!0O9 M*!Z\G@_O1YJV4 O4.3$0P?;M$VU"Y4W1: L)$KBW=D\<U=#*V&N]B1
MA)?\S8W*3M&BS!&3"378ZA=S5_=/.N;.,R?8HL3<J[!K5[+-J_F$308=D2.*
MA\Z* 1 RWK0 [7>2C^I&H'^_3 -VFQ^Y8/WF"W;H_AE8UY8YM!G0:1^PY<8>
MNA?P=F)!GZIIJJ;.0<I0NWB'TB$Z+F<I2B4--!XGL,]9QC(0@2S&?I@J(#'4
M8P).,^)1FO!Z!3Y=-;0D/H&S*$^NI8TDISWUCNPVDC@+-1J-Y-DX7JJ#9/!U
M%DJ#16[6H%H<D;:E.H' HFJL4W./=FG=R<6M7(V _%H=T1A_7U&WDCU !R!P
M5-#=D,=<:K#":AX\-@Q@C?4^6-93V.S=)/Z-"L+ &^$L6',FU[^?3P[=SR#<
MX-J11*4[4P"GT4JHB*C/UW]8K6SU"E$P2K-@^(DPL4_DMK#ZZCQ"?0661HWV
MICZZ.U7$$:09O;_O52&4Y:8$HYI:"SN=%#<3A\2U$N(4E7PN1+?KH8M_!GY$
M>:0@%8)HC&R\BT=N&8W]&2"H+'8(G(;%E/.&0?-%7R;V!RDHDQ=[:,5Y^3=X
MJMQ<V/R6WD:U8EQ$T4$.7S:]I1 \?Q@5I,HV6!=*P=;@HR7(4?_6#R.[^V3C
M!YJ;A$?^72=5M^+F<$7KR5%O[Z]]![7(KF??-J\&6 .J..Q T[D$&G@7;WXE
MH8#M>-UW+8"YAG@%_SB\/K2ZS+&) %KR;):D.6HDY.S+4%%'#F*-BCW:' +'
M'=V"?N#?H*\!>Z<?NE=J=#,P*A44)#6?+C?HPX4 JSN $2GR2MV0^"?IR&ZJ
M(;#/<)$G*>P=OB/&O<,*$>@X4X+]C4L;8J=:T:+?HR\4'6V?I4_(93(B\Z+W
M^OR,&IFJ5JJE]KWPD%+(#KD#J?X L4-0*X>4 T9F">@_.JK,C0])K03"".$@
M<+;^<)@4:/()*C-\"]FV:%]POEF ,,[T;_PE=XB-:.[(G3,:(27F+=MC?5%!
M&SG<S(0[\UWI4R',Z"D*%<9X9EQGI6'R]\G%6MY*=M,PMV#J"K,2]C2HCR8V
MSOM^S9]W\"U_W[0S' 7&46V-J+<J#2)"0\A3+(2N? 3)#^34%&YAZ2ON:>TK
M8'FB%Q[>.#!)&Y5+XE4H1O;37BB[DP@#&FF8G6MW>&8(_&W:(UI4@0YL/XT1
M(IKMX@1DJ#_%4Z<3<##W .:EA"@9%_J(X*DPHBT:I?X=YPZ%F0!LC[1Q;$^R
MXE*02T^&=CZ<(*&4. 7MG%,=X[FPRET7R[]*%R)GV.45;1]U8;,AR]-$5SC#
M9E,8B\(V?NCT]D4@W_C,IDN"#UD#)A!Q5A#>0FIKQ5RNYD?VD..0CI[$!XI)
MF$Y5SMTDX8#2B)I;J=^KX:G%(8Y_J+"I/1KM<A(&8_=*NT$^LL;OJ> 4"FB,
MJ=5:8[G 0]Q1 H\@$Y/\QQ*IDMJ $%3*28""50^@XP3EO"D_) ZO\+.;AHA=
ML_RFO7,:]HZ&R/79N)9<QUA R<5_]MW;ZV(ZK8=H\8S1G6^Y\5U_D-RNV;GQ
M1'UA5XJ&MU@Z3[68LIK PTE?]?**AW+&:.5W07@SR7&0:/3=6TR4JF9 R8KU
M.#U[D^P"!)@\[MG?O^M7\Y5:IU#/+(*37 _WT\.O4AB] XUD*6 KX6Y)6I%8
M[BZM^A.PHZ56#:SETL\FN[SFO>_W*]-?]IYT5VJAC;Y&W_\N4PH'&7[.BMG;
MO1Z6:A6SJN=HI];34?Z&-IH#=[M,*AWI=Z3_J(W^DN1^M0?@2Z.4>BOQ9D4?
MS 8X_9LT*>(1F@Y)^I.;W@SV^D<G7O_XW.N?GNXWUUJ7E/T6Q\8EN\E<Y6;)
MU#KFE9PO@1)L/YKB;!9YL&7,;DH[.:5O(?0_)V$>U*E;K.43-)97=Z]_#X<3
M/XC<WPL,T+)8.]9BS:HFKTVD_T,S:R\_U?MA*8!M]5;U-3F-WA%UDV][ZU'?
M>I)UG#UJ'70\Z'\Z?OUFKZ]/:6N610&<?NM;.W,\_<<=S_HEW0HO_K^"\3@-
M[MT__?AF[K5?'V\]/FW:Y2=E]\T'WS(FW4/>N^IE7*= :KQC3[IKKQ]WD"L4
MDJN\&&AW7"/P8I:G\R7B^G;TM+L:S^-J]'J;OQN;D1\^/G_I9YD?)]TMZ6[)
M4]Z2U;='L3HCJBCLP8;#L!UP[>H0Y7J[@2?W91)RK!4X>3'%_)$Q)@)R33@F
MZ4FM&%5%48$65V9AL@07E%3*/Q9,,<'L"JDX'NFR,YI(GK@7UY?NEV06#MU7
MO7-\DKXDU=ZE/(DPEJJPF'RVE,-GE6'G\ O,NY-<PN:E(-RMM1*:Q)W/W<Y&
MJL9, 5]S#9LI;IM3EF:EH)L/J^QVE9DW2BBG157J8Z[I,$G3 /%\1FH_:+1A
MCHF</&5*LY4*FC08)C<Q'*F5IE<ZF<$]_:XYEZ?>^6D+K^K+!J>L3_4%G1.K
M*=M_2.]4>A[?6;AOS.4X67P:! H&@C.%I_#=>YU];.-C>%)^WG1;B2T)\H+[
MRCM_?>IBZ1XRG'\5,7Y2F.O$OU53\=NYWO>L.G8L8.NIZV6S@./=8 $7K#K
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MMU/%E%2.;_?]N)4A(YKV;):$- /LT2'X* KXN8'K&41G;HD;"TR(P-TX]6!
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M8ZWOQAO_]_KAX-=FO[^ UC=/"TS\9D&]._KR;>_X?_\5?/QV\-?C\8K5NS4
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M[GL?_KX\O/4_O7^&J]HIN:HG5"7+%T7B^TQ(H-M!%/IV\Z?KTT_TK]9/#9$
MA+G-F%AGUC=D;INJ-.B%$;;Q#KFP%J];?7F6?GGVOWP[?;_W^4WKCX__3;NK
MN3QKP,G)"+K]_='O@]&?KQ]_7<V")M^>_0F";G(28^65$!<NSB*8VVX?=P&S
M[/ 171'ECL=#(#"D_^OS4SM*41X-0+\6%>TXDTSQ$0LU[M2$GX!;^^,<5VW9
M-1E[AV9-!A:2]L]EU=2'P<#O>5%\$9@U&CK3\^BX([-@I[WWI?_[EV^_GOWU
M]F)X&_5ZO1^>J*E/?6W1%[XC^#V#5ZT>OVL-"O@RYCF;EISE@\?-CJZ;P)OP
MI5?F1/_\GS\_-0>??_VSVU)^CPGW>)IQ?O1#UN>)'_[AWSG]/6\CJS,0:=O+
MVK9=VK3EVPISV@DTBX5MA0E<-[^-!@\\.?OR[?K-^> A[/SYV]C/,;8B"_N.
M&,Q,ZM%2N,N6P'MNBF*_1OVBTS3YU$G_[T\A,"M<;+56(<OX*IXF7>(V^>UD
M\-_A6?/DJ+YRSW'EM@20<RNM@55!;3Y'%?F3=/ 9(&-679F=,V9G+=0NLX%G
MJ:G*O#='Z=3QZ[+,C2_$1]\"\[_S^T#R)P]^_.5+#PX^'+UZ!<HBJ8J@*+XG
M%+4OWSZ.'F^.'OU?[S^WJLSYDDC4O$M9QGHORI)IYU[O^Z-/WJ][WZZZP\K*
MI@U9;VG)V-SK]=Z>?[CIG!Z_Z?96N5[6*N:'-YA2JC<ES7TI]8BM AK54PL+
M09C\B,:88T97EEQ:^-1]AED2O"%C.1".PZMS[#LS(7YMTFEUE+K5_M=>ZU]
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MV>'FRI<Z2HYOOYT-NK]_7NFIUDAS!M+<I0%=.I.+H0:8VUCXM!I@K@:8^\X
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M& : 3]2(L2]NK;^C16\EBHS[:>01"#7ZWLJN8"\<*_N8KR/^]!;Y#?8S=^^
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M R^*')2,\ L:V+IP_4@V(R$Y;[OC\1"6*_Q+KFFAK]-<63(=OJ0PR"=L'1^
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MJE&"6J@ VTBR-S]XZU*:.:/"*<Q9JEL QLGH^'SKL(X<^;R_Z^W*BH(L5*!
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M^SZ&R$N>4UY7E$HH!!G@!?7.OC<@+4*'GV*[T^X HR)7/OYST-"SZWN-W0S
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M:+THT[B-O&K32RW*I1U=#AQ&5KXHLR'*9F\\Z>LG!2=!VX4T7%$Y[V:F=Z4
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M[ 2B[JYG>P.LC(NI4 *9@/FW7A@GV=I3VAV9^VR2A_KB%!)AC5*K,>0;#-,
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M+:,'O>S/):2';5MG>[?5;\.UVWOX%\8S&N-I(V^3/V%#71XLU1$7>H*9K!B
M0+-P1JC,\[1$3=4AC!@2W$M<8->/_$&0N1.$@U=:UA3O5_.#+!$RZ1MYUD$
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MW9VM[2/WE)*-N@8+[H9$=<(X8#W"1,U<%(X>>>S GTT][H-+1&+KMW()D80
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M8'JPZO;O+UQ6J-BE;)KR$:A*'2I9::1D>W-=&K,4"%G9&QR#0P-Y2C%XX<.
M"]J#B1\$P"X.'P51+TXFW (+TB7^8" \(D1E4":$ %'I) PR>8\XS]+,BS#'
M7(!->7@AW$O\;S2$[[M^=NO[D;N],8B3C1V'0*7TK]TM!F^)'3#&]O3=*3[
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M,# Q+FIP9YV69UC339>'_W3I(H0F$ 6D*RA56BQ4$1!0$&D6J@@H2!%"HO(
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MK1<O?^Z9WGZUJIE]2@IV<#FBW5A8M/15H6033MG U!+E?>0<VD*@0@ &X,L
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MO/Z"_,9I'MV$$2)P/A9@&0G890"I3M\1!-MYLKHYO5-7D0'(I&2?B;IN<O=
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M9@#6Q>OSTTR=4O,'0DT,8+)J)8BDN$W-*6.JLAZ@QTI':U.@\%ZV?/H7'09
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MI7K#40,340OR<JJ*%E:]O2[S(E^7ONUA:Y%M>Z1W(5JR!#XO)N1T#8<J@>:
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MXG.15>*D'=X]&'O"4I@0W#/G$4/:UQ?G02S:V''NJTJLN.4.<YU^A\]9I9Z
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MW++N?J>^M@$WH#)8'^M*[BVU]JO<*8N^L>+^:):.UW(R3;/M_.C)ZO?^)*Q
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M4+GH&@RR8EXZ^:2J&VMV>Y2"@U_&&"=Y"3ETZ@9D]U/(/=YO1X?(9@\ENC"
M;G=O2R &B[<4M&A_JR^FEU[_0._!_,=2&\ [M2H!O[GE2-.IG8?@+7Y6LUT\
MW]_6Q\3L="0?*;<.-8HZ7+JK,LSQ(:'T0R [H/CG!Z=VX? ZOPLKK'MXQZ-;
M'V%.CNRZUW?(_GC<0V_FX=QHDGM/T*[_1%,XYG;W_ZX6\G^;M\>L>*[P'_S%
M82([MGIZ"YKO7Q8 9Y+$.D7J,LMVQDS%:JKI<U;O@7OA,LQ08*G#W6WXPIQ6
M+)G^ST-49$+STV;@Q=!WW6TOMXY0G 8TY"PNG.SIVUIL%V@'7SM^KBP7'0+5
M^!^,+1+2:BN2[K[?[;,F\X]+JMS^^21<S%&/0\,_K@<-8+<WT&XPA[JJ#EH=
M:ID'J4@LCYRB6+'+GGBS9L*&+RM:$S=X/-_Y=.7$-4(A6\),I0D9Q<90>KI"
M#0Y*"A.KP]>;J_<Q)T:-P!)RP,&NMBL#!R!!]B-2J>F'/WJB+XCZ1C=^6A5_
M(.QD0'N:N_H.!FON1<2/X,?<"C@]J"&/>^!=3;L\PI_]F[-K>%E40I6 ,/*G
M9<"O;3'$Q=4[<\U?W]%^-+A8_7 64B%G<(3W"/IL'&4'_  B[)9?IA$=P+ZR
M3!$S"U^MV^CDU2S'2:2/8 -)8",^2D181;8.AC MN@9-;%TH=]I)Q2]S8A6K
M*3]!F,N(!PE$QNM'6)4?YF;Z;X;3A0S8FG0%8T?B=P;"?;*-U#Y\-0G9]HD.
MMHZ)C6] .A[P+DD,H06W!6X^0G&& \!)S&7!2NJF03A;S,SH4%'1EKKD3_&Z
MF)_J+':!Q^I3 H/)::\3 /GIN^Q]\NL<HEQ=6E8+WR@)H6R"ZV1X)!3>)O9$
M<PG&5 W*F>Y&FW+*/C 8KMA3!P4DVP\T@%;9V$0A20\.;F6;/3?-N\R$@UL6
M.FZ]'R(ZV7Q[VE_C>;A9P/N*AC?--NM>E.:D"^-H.CCGJ%&U7L5V,E-*!-MF
M@A^2/;C]2J":EHV/PBR.JG]<+B:E.-ERT-GE4/>D-.8VF;ZG"DIX(#1W%/77
M2?#+B53=+DHPC1E8^>@ENM0PX.,_'M76<(0]9!Y(X#NV:21'&^="V?6.NG'<
M @N1ICNA%'%!RE==31%]QE-$2EVH?'Q=,G).9/3QAGCD(J__3)0U[;C8QM(+
MOBIBJDU98$"7OZCV8&W1PW']]R'<!??=&D:&U[D&3:NK7<W>O_ZYUGW=_HN9
M^:L>!ZTTRMC^NE;ZY6U8SHZ,GPM]' Y,5[W3A,Y#1.E*J+5<=@HY*;^+4W']
MIGI\-3UWCHCF[Q!K9B%KH +IU>^_@!&0][4PC.=FT&U!OW' AEBV%GP]= !K
M54J^V&:QIK8>\DJIB7';G]]MOC;&Z>BCDMR?_12J3DK*%-0R6]  F1D@?X8_
MA5*CMJ/UXF97.MP28992\/# /<HO/5A78=?=B0!W<7"G7N1"PJWE5RG\D=:*
MTB+3H\7>I')NTL?3#7X$"4-Z29XU0_&6A2CZ0[?",B6P^*#*M5L*/G6=*J[1
MC&SV&M!QQN"NHA>W'CYSCUP@*E+)[5@FQ:P,OOB2;Y)%>VK7N03&=?O>@=>*
MNX6Y 4WYA<M+'@Q'!N5V?+P1(9^.BK3LL1OO'_5PS6OMTGCT]F3AH$UCM,V'
M7_]ZM>Z'\V=WK6O8%-9_">./SE0"?P5!*/FE.9+\AV>5K__CE4U#-<2FR]50
M35Y ;:-])N(!SG0^[*$$/'\9Z/;[0II.5 (;JD$=Q2O2%<[7 =VD];LM7*%9
M"2F9$X%*&<7!'R!3M&&GD);&-R.G\Y["ULU!\WG(3W&]];4U"5W(>M%%&[?0
M_D^6UR9WK:OM.?UX0][(J>?Q1W^^,8 H@;G./!JX!\^/:&68XAS*IYMD"90+
M\DHD7N:.A/11-&26'A(:GRH3,=LZ33VAE*-*X,H2FPOB@>;ZQ#2*^CWRM[]Z
M&GTK$4=.\B0^_4Q[O+#RX&14V?9CJJ(]0[,F&..%)306XZ6+L[19?AFQE&VG
M]GRF"JA.\G+JME%%&TT?IT]]HS B#'4>A>.A;'%.L2WL#>T[!F>&'U<"2Q.E
M)NE8^X=O<8[D[%:G<"60];%_AN)U[OZDFW?8^7N7:+Y!Y+7-?YKY/5W;/6AF
MM-'_3<9/9GZ;/AO5X9]KX/8:?) 8Q5;PD\JG\P4Q6V]U5G.EU;$K@V\Q;"A?
M@+/']H:/GECN<7KXV9C]B4O:&^]>TK;^BSEL(AV$M63+* X]U/5((K2D(HHH
M1NL/PKY-HR@P/3V>88:X0OT-9ZD]]P/)F)?L5=6]C6[B':*.)>9N+:'K"PX_
M*30WX5XX<.=!Z*L5;BO:2RJIP_@J4GJ-$A@:]NUCXY"==;7R2I9@&?F<E)AE
M<P83C\[AU^58L@KVTIM,7:\D.CTNC]A,"#3W\"=NC"L"1OAEG*0R%]XA(=K'
M^QBZ!9V%1^&T*5B(WL+(QFU[1T4C#C#M#H%\JS5T!V3_-2@V721''::_J6=S
MZG\#E_B8D=<&QC)M2Y/?OM7);L@X?GT,I4EKVDL+\[*@OE4XRBLHSM!8LQ(
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MD/7V[/"LG(N4 B^?R1L>>:$&UWR])D6[#P0'AS^RV52?:,4Q7+TGM%Z,2R
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M7<D$QK"_M^_"SO^ATM(H["NZ0FRG*^V4(U[2%7+-X]3_"EV!;!V*VRM+P_(
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MIJ9I+7[9U+6]1"M0CDCBQIX"?]8*O,8CU@;?$)P>KLR,?<XB]K(W[MFA-*O
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M0F8M"9/29'\TZ';LV ,Y0AUC)-G]%LIKF_XM_KM#\PVD)'K11S?FY0H/=_*
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M28Z^A0#RK[@#$E=I26 Y^NY%QFN$[-ES6@N6:RS M@!W4: 3,!35JL-)H;N
M"ZVH6EL4B&.2Y0@=S&88ZY;=)#,"J8G88"I*H@-26]&J03K?'YYM -.*2B=(
M:,[5817\L5C?3J1SI</U$EQP=."R;J(]M/10(XSDX[ANLE4"D,)'MU!7RSXL
MC@HK%"71!;M#+5!L6^-H*FFMQ$Y:&39OZBAH:Z8M)YZ&4'=KF4E^&MVV@&4"
MW4ZC1@TN/N/+*A'XU1J29ZX.GPD]KCF&ZCMU!6/3&QV&;VZLI#Z%1^9XK:67
MZ^(YK1Z:!@;]9K_\]>=K7M5X8':^[/NE+1M>[53"'"Z_J%HT[!SQ[<O6/8;?
M1R7JN0=K81L(_Z>A-AU)@]^<@57%5L0(." ,O,AJS;>$4.PX'*^?T@+<S$?
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M2948%8D5A&^2(W2)Q^ M$*ME#\'"#+.>4""* OYJBBDF<-Z1[/K2*(63(YK
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MNGY@^UKFWO%\ERG%&(U%J#/E$8O.+-_MH0>:KQ?P=SC(^^LM4K+,/WEH(;G
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M781O,"ZC]W$Q[.V(+-)'1EM(%[& @Y,F-#PT)!<NU0A)*-P">OO5CC3Z2E]
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M&0E#Q_K$WM5YLHK'U\E*[C5NV.2'7>V,.J&B515ROL )N20!LOO,(WT84!*
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M4>: DXKU1? I=3''D.;>6W>Z#/+W:@$+,JN"J"3I "^UI&' PTLRN7"8JG<
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M>$7ULWA19[O;I^MSFQ#60RTJF\&Y->TOA==9]26MS&4G(-)+1*N[49E*MQ?
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M8>9G1^./9*Y=-/;ZG<Z;+4Z7<FZ\JGZ]^JR-OPDSD;TA*@W&T;9*OS_X^&[
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MOPF\CR1=!8JQ4T1C7/BAJF"CXG?5KPBY?ZSWN;>V^.V;VT>\&7L8__45."]
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MD-:NZIA'(1%N3<M3'X9O*X'D?C;/=<I4<YBDV:P-[@3".2EV:W4/&:NU]C
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MY,-W=C?]G5*:P;D=\>GOJ*[FA*!5G:7?K]KJS2V=.A+EUGZ_H7C\HW=>/OF
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M +&:J.EN<1_X]X=II"-N$=G^[YL8CH62'R"OJCS'V6O\,.3NJJ%^.;H9J\O
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M]9$SV#UGK\NE[U"@%S'^(=?D)6F/EPQ',K: K!= "F$5Y))U4?TQ-%*_IH.
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M7T*LT<9 #F$UQ &W]OIB[[5YHK#5G29]R7+-.VO11+Z@W+RX%H6Y)@3'T1G
MC&GM/.K%RS'.F#H3-3_POP!02P,$%     @ L8 S6U?J,+T5YP  *@H! !(
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MP?.'96/XJ</9OB%(VMLPWF^D#7M=1EAB?L8#^5^=XG(;!HO&S8:T[POO@]F
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MUET>=3U8[$,?70S8O?*=[UG59S,;,;;DY'!T.*KB>[E%Q9G:EJR;J>?OMGB
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M<&.%0HR82@I'ZA*,!*-,<PR"31Q@L3OAB0VT>0T>)IFX63#4\)SZ$K("/B0
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M'?&L/-,I+J2#LLHH;K8=&26-[VRTN3.Z/;:VH\('1B@6&4:0]"IBL.E"XA9
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M7^4HIVPY!YU$(V $< \5<X77=$H'27V!-V@]9^MCF\>ICW1#W!N'?X@CMS.
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MFR%O\>,:S#A.."D0Y@+RW+X&<3%JT[<;V62KLB8,1ZS4&S!XE33^DS?\_*Y
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MO?P&:N#:X7KE;]/*4(/EX3<BJ2GS"Q7E4EC_4T8Z!=QN=INX$\/#INI-R>
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M)3]3[Z^4ZC X"X0!%#T]V%&X/\R[(]&486O\F,C@$=B,-5O\-<&F5WR?.2U
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M<CC/XWGU@#EK^!)W:VE9F.4S?.A2.F7VM\5X^F)6OY-=[7C^%U9[N<GWRLB
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M_/&$GOXB</>[YQ\3G0- HHY>5!(CI0T7/>.96WHPS<"M.%&KRC4UBF[UG?6
MCU0@'>X :2JG+_CJYI^)NO>.8MG"O; P%:![#$Z!C6HF>\I*[[?(D,/QB)'[
MC4;<74_Z@Q[\59G+_/?40(4OF\[)T.N0F;L4T9+9#(AZ<4)[*6)]10NP9$J4
M&4LND/7[ [ 6:*T2;P0F>Z,H$I4@O%@9M=+U/RW0]5^*0T$[6$=12^8/9*A[
M\Y/,3P]1^@#PD.EO&^HMCN# (DV,M57 ][<!UC30I?M3O:!8_+?$C%C-P[3B
M/W7SUC46AW,4"2+-X-"Q+X'<6D&I.CV61U ,=_WLRZZ 9X[4^ZC5]CPMCLV8
M^J;R!J%4I1$MOO_O8A??,HJ&UCFV2O1Y/R/UWH$OFWS<#?ZY +:/C;N=-, K
MWFQCKW>TJ=G5-U&\M\7LU9;,.S4EM?AI6@]*1D6ODS9TPD#:'EM@W43T"UIJ
M5-:>=V]5 U*2-'3O!2U>B!G709MJ8S_QMO>6VT3@+D;=?%DH=U92])^G$9&O
M)!==5,2R1BN(B/#U4-[\L*6[<"_Y@YZ^!D<[O?>CCS_)]$5FRW*)6C![ \#5
M?$7UA.G!X:&7;1ES\]63;IPI3-"0R3DA7G!S"+2?9X$?1M%21+&CN(@US[C!
M$L$ARZ>-N@=JT@WQO8N**GY]YG/AAP<J#?L6G?4]J^KZ:UX=:YFV3)KN//&,
MF1+NU.ET[WY1P?"W[9MR+<_>UG24^_:O^:T;KA<\&R*MX>)5B)PV3M7\W)I"
M&-O<A!HD>?#BP\;)Z[H(Q7 <>SCF/:,R+&>]-\GG16.V+L:Y^F5C]CZ?*]_U
MK+U.)WD=*U[GF]S5>?O WI<_+_[89FB%#N_(R3K<F9=KRV0.^=:[NC:[YST>
M*]_F/!"S-SZWK-#*M7^":9=;5C;Q_L%>U<^O!O2A8D'?GX?^>2B9?=DRXM%L
M20JX J+XAA3&66AE#MO85,F?>(F-\RYZGNO8I 57:28.L>>.<-LQ7%2_UL]F
MJV_V80Z467O]'W^V6]$P[@#6V(;]V:C3"'MMD9-(6V]K9U>7)N-&6\&N]K\#
MMSQ1KP=41/K!:Y,52WLE LPMO=5.\XIAZY?%;KT?&MD;)C>U($4DI$H18_D_
M-C>$<92]=#UDL-UB5K*V G%R#$[3.R#WMR(I7>@'-+NRQF0GULW?Z$B0R&0@
M;U7EE< 5;[@$O<E1[1YSZBWRZA=Y45;^&R!S;^%G>SW!'FSQ]!K@89BB%+%)
M<>>$/&YZ%WG+A6]!2:594056.[O D_Q9\/XKG<YE.E*$<6J/S:GR,Y@1$+I\
M]]G'ERYNCH_Z'^0&\_9F^/W]%7[[>Y[B&\ZVQ=P;R*O,X(J.Q&1W)UYZ:>(;
M?KJ86H=+R64&I+UN?Q"PW=#H).\!=DK6A%$CL#O#=E\QW-A<L+&'B>,2E$ZQ
MRR?]-X."TN G(;E--.NMVEW[W)_EQNWKO+)K?_::_%CC39NRKG$8/RO@95+$
M2@69FA2IT'FU(DP5IF, _B3<%^9=P7$$.WE!-Y>VYE>&_K!A5CR&(Q6^'.&\
M;C(]N5F?1U@^S0@N/T8+8?5%GC[7E[GD#!J*=**$RG!"R[!G!=]4@>0+&B9O
MK:,(@]E5DPWJ+T,#R6=P+YQ-?:N''E)Q?2L2LP<E3KJ65SZLRF[Y]'-#M\4_
M(0$_IA_8W_[V&U@/UF@+[@_Z^:<?'9\S,'386^A2>NQ^1%C4W?B2BB/6,3&8
M4!?E-,Z'"]TIG^T>O'_J]^#,+M^]!5R5#&.YU'?//"[.VJ??K1CWZK(]]&S#
MK.U\]VJ;!6CWS3O1TR^Z.A9P$OD8\T$IXEG.G*(%\Z=/%XIB:QV8.QJZ,==,
MIHHG$I=MWW'\SJ:-6?M.!3FZ9VU!\8.%@=Y2Q,/OKV1.U.4C160:_\KA.XC4
M: *\F"71)%8+;,5Y<\PX'B%=BM!^\K#'=OG#:2W/Q%+O, V)7O\.4<3C+4N)
M';?>69:ONL[-]YXA):S]L+KC'8^%D2*X?W9/%BMUR>BO/':EC$HXXOLQ1QC*
MMK;_6)O:M 0_\/K[=)0'L:!N<Y;1HI@Y?F!\;XR!JY/BM7<;BZ8/1KEFA1R#
M")]*^DM%NQ=>@R.M&%72(>[L3[:+=M>+/H/7X#F44?LW7[.43NC>#LO0M;^L
MVK$K_4NL$U84IV2HJ"0QMME<#$L/NS@1^H.1Q*JS8"RMF^' M@.LWWNH<^GA
MDH2&7Q*D!4%RG/$2^->J.HCV:0CX4D219KFL)8YC+$FH\9*^1-_T)G[!]T*W
MQ!?X>4LB.SWY_-(AH*>"3VV47=83  X)VFNEB -?XF2HE%LOTW^X&5/1>LJ)
M_DC@O+.+<27V)#-5HDK+0+UE]C.>\M8U;0$WXM;[?G;:$+/V]2Z_U[L18[F_
M96SZ7SEXUB\YD<J\P$_\F'5VGAI+4T-OE+QOLAU<T*92R/^+O3</:BIK]X7C
MB(H0E4E $I5)&R&M@"B$Q!D1,2HM" AI&Q%"A+0"$B4D C*#::4%A1<B,DDS
M1" !A9  @:251F26T)"I'9AD;X>P)0,WGJ_N5[?N>>_]OG_.?Z>*596B]MJ5
M]:QG_8;LO=9C"61?#]XP0MTR.=WS9,:,E\K6C4]+]@4%=*)BG[0_ZFR826KH
MO>-[#TT'Y4HYWJ /?Y>8/[G[Y:<ZU)^[G^=AMPDN/MUWTJ59 64?]93\:^>9
M=R\^>(@\?9X,S_@$SRR,XH?1<,!$B+  D_E7%K# 3-:GOW)WROYNMBBXO&\X
M9;$"ONI$\>4_9+NW_,LSD]&07'O4*U_/?_(J>W^$7+VS__^WLJ05A2EW).C*
MXKUFM,IKYGH *?T]D%H26Q%\,%16&!CIH'C/7]C3.://7%71''FC].^>7_ZY
M8.5:5-[[>W9BU,5[VU]2]=1TM+U<%VND^GD(Q<7,4*T'OLR+=&3=J=62<;J^
MRIG- BLJ=K$>C'<WQXEP:7/L&=TJFSP[>>@C\?GPDMFSSO6!-QQ"<D><Q3D8
M:Q"3\P<YKHM67RFLC3XX,AL5TQMR;#A2HR,FM%04W3 X&!=""XL&;QYWJ(VZ
M&)=)MO&X<W[L[E#5=JZW^EXD!RGM,]>:H_.O>2%PHZF66212=:.$@-DWH'(&
MK@W@4EI6/W%*V$/3%>,K[TA'=NU2[0^)BQ&UT5/MV0GH\Q/>B+S%['N>>C J
M:^3 Z!?C(;:[16S;UNE%&T9H-='U]%#-J_*RJ8!<?$51U?3U[23V><)B\E1
M@7_PQ%$C]B"A>6;E/7.W1$0;=0-4*LGOQHO$$AV581(JU;67FP^29*BYWAJR
MN9:I\2807?I8Y0-9*'\DT]L1^OF*J!8H7S*<V\W35^T&2=+1%$J(]"WHE_;H
MWH('+=/L8QW00ZJ*V'1\F;*D(N)F5'/%U.*KG"?GIT68VA!"U51 W<,X$JUB
M^F:D:N/$^6FSA*\U]T23;R9%/4:]Y1.LAO&_.W9%'[843 N^TMPQFR!3X+ <
M.6LNFT]$KL:&SHOP70'T6298&0RDI6OY[5]45W43)0ZXR,&""#W'#M?R]_R]
MT$(%]/Y" DU"3T8[RVMU97T=BD%*6!5DLZ@7>/A94_T@LV[[:Q9M-;1"6D@3
M#4JUA+!I7+%7_0ACJR* C,Y6,8PZ6= GQ*^/0!IP;55N(#,=XT;]B[&)LPV8
M/ZS^%R=>WK>>+.J1^67MXETF<!)D;7:GALV%+F<HQQA24@IUZ[2+6?GCFBO+
MU![]^!3>>FPX/0=AK!4)YBH"-%@*R;N*]T'E $XR/T>7,M.01E_'(<Y!6=\F
M F.9Z@88)QWEHS("! UGSZL\F8&07X?(N*V*.%C6*[/PP#T;_JCZ1JH(@\SE
M?<GF"NN1>=[E^3&F/$YH@9+&S>&5>Z@O;RX(4:818@MT@EQL"/EU,0QXD:0D
M<:.8SB/0UD.# HT5B. !2@%^L\:,@@.+"^MF$$;<_IBU[*(5'J!Q8@7A)B.M
M[-DC^/3XN=$8[_4$8>"(4^V6B,7:XI2R(K_3K$%!5>WTKIG*#XM76PN03=/-
M<UNRPBK';S3'G;RS->5EDS/Q6S-HR[?0D?C=XDF>8AO$G;0-T @\F=; Z&2.
M+2AJU8PO/$/M.NC&&[#QMWAF.DEH ACU_AA RZ9NFRG^ 62GW-8X0 <E\^DC
M 3;5,EUY.9[<%USH;;R(2]_>@.P/2XWU=Q;K0?$7"C9&[FTLF7*M:9+<L_]G
MZ(K]Q\D-YU=OMWD@T(51@P\X+5.%4,?QF[_R,O!-HUWSD&WSG%8+Z&RD.$.1
M$D86UB3_($\[K5JOM5()^"G$_#X]*$UP/7@KX-&1Q10I>HYHV@&/+O4/@J 5
M1]A@1;.L%6?P0=0_R/;V7>-,_/-*I69P3FJL  (SK!\<7'\Z(RS:ZE/ZW=.>
M3K=76#&;8^X<V/5/TW[F^Q#%'6T2Z$?0C-^_9B'3>*P[R1+D"JA:D:Q^IMFA
M>>WBRFO_OK.X4*9S1V-*_;MX#Q0O1YJI7%Y3CNY]KL>F9ZEVH(VBI4P="GXX
M,HKC+6W;-'\XTOC5*Y)>A\7\%USDRNM-0$#GYL.1ZT\?L9CTV-B99;;Z;H_;
MTW/F16-%=_PSK I@!4]56H[:/II.F]6IIDVMZH[ZWS<N/()+HS)W/(+/MBK<
MM/SO#VEI[%)S)WZ1F,J]QRRD:9V5,^,67N%%L5Z"53PC3OT ^X2BWT0)&!M5
M"%"1H70CR[6F7H^[=]K5_##P7HC1NF1ACLI<VDL)"CS>S-T*U%:4E/\]LQ<>
MGN];2]+[ M_2*+R&%F_EVX(),GH&#SB#3.ZG!*ASL)%X".6A,LA5D/!FJHM0
M-0W$B$:[BJV&L1$\'6B%#-=M']*]*5BU=W0\$ >=6Q$(O%V"C6.,(2V;_#00
MI=D,>?CULXP#-U9TW:5%#ZN,:1U'M*.ACUFV:] L*$?*'#=0K ;BM#!HJUFW
M2AE.60OF=V'I^)4<HAQKM$S>ER->Q]T9-.WJDJ&5U>NAO'>CBE1U-H5$,$E"
MNX"V/Q4>AW A4I)1>+'^"+O-X978-TFU0OF4-Y!_ <CYF!9:.^WK54.^]OX$
M"T04_5I=$^!04N%>9C:1,^9[INJ C9<R,"GEZ(!5^7$9+Q4[GJ:('<)*_K4$
M8U'O2V@BIF;=]]+J+P'Q[+ <GQ3@EXG93$F $N3P#91S]:"?4)=D0FX2"L1K
MO[Y 6TL+_^1LNU$"N?9UN(K3:IBLA[@,9%= V]RKYV4!X7>[X]4OH&I^/M4&
M<$E765^4)81UCFJV L7UTAZL*42HO:(Z+.UI\_-X-FBOPCUR.VQ]OZZQS/O7
M@KK?!9->YU&U$AN3C.O(?TB:=6FR)=@R35?Q#G6^9A7%2YO5E5KC$^G<EQW@
MTHY:1G8\ PAG PE2N@64+_PT <D%+?A4[H^JBV9OR]M8M V:G<2!:8SNZT=!
M\6=&.4<)DGA=\A6FPZZ/;#L /C$/6593?BK4K&U5[IY4A3/D"?/TKW@X67B^
M99A&L/!=@IV#)ICD:#_HOMS=HSW8&DI3/QG ?U@<S>#H1$MK*63?=_'-0$Y>
M.5&:PFG-.N&5@3U9_;E'L]9;GF,KP\WJ*C'0_ $H0WE:=?ZU"E=&;O89H&ZC
MCC6UV.?/(65$'2A1]JQV'K-M'+KY;OXXWGJ[TB05,2##.78:MZS/7QGDU$Y-
M?:TCQ#9YS&*!:,48$)4F[<MP*<8 M S.-IKS0B+&CK(=2I9C4QB&J@T%M8*"
MXEV#%*P<MYPXB1@)Z:<0'T_Q^9,[^J/J/L;4>N'NV^3U*0\)3[6R/C.U^7^"
M^<91-IJ"T8?,N['+:KY\?X"U%KC$6,]95D(V$8@W:LS&>)U9K;78TR.8C9!<
MH_6>62H7EZXE6 K5:HC5JN?7C8%!=U&9'$=94,!:9V_BJ38>A_NL1:W[^!;F
M#)2CW$#M81A_9:2+^KI(*:YQF6G=M$0J0EU(B2X1$ZD[TCK-&!WSZ\AT/S L
M5>5X43)N$37(1VSAOE8=K)V,T&:BRKF<@' 8?)?FK;1YOF[*[#Q+QK'70JA4
M?4=EJW2G'%7GSVF,+FA%VSJ,PTRMC)>Y0HL$T%VM@DZGNH/9T>&-4U1G$"M
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MQ2KLM?5)>G]BZ.--YFWQ4Y=N[SC-6J+R@.:E%C>QZRE8:$H9-*8968)MX"3
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M$1^A^*EKG!@IC,V4<Y(VOY.)5 3%5)VOBE7Z:%Y3W:(38N,D3!V"R4(39LV
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M7-@)1+=<[FSAHJA'(E(CH;PGU$^1/7K[NUYB!_/,D)_ZDO,3A@YG&XP1KXB
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M*FRD1ILG!/JE8@H\'RC:-[7X/8YX/P0W/6$T'</% N$:+ZA4&TR78FK04Y8
M-@ ZH>Y<'%?$,'[ 8#IL[X>C%90\D3E/;@H3P*(KN'U*BL-$I"7H-I*GO)OJ
MWZ=WHD8EMQ/-J92(7G[^>E//O]Z/(JA156P:U"SB6\.KZIL9P&.>Z(;>"9(
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MT*'P5TK"X+FV0Y ],'>DH;\:G9.(PRB@U:;&1P>2+=,VORA.$VVB=]%=$7)
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M+4G**<A?JLU'!?6_0][\PGH4C6@)&)L:^I]\:&F$<8H[QB64/P#G<N^LG((
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M<X)VM2VVU#G[4@*>]H7OSS#"G*NU&JD.V,K^LC"\9K5P+,-BB;B%$%+')A;
MB;0D7+9HOR<;L6F69,S.OTO+)_.]=[,(K28O]JXV'JDW'C3ADG/?06_L5@IT
ME3D0W^!C,C?Q;E"]0;,0)[R=__*;/;A22HS @@;S7Z1XMNS,2@ZCB-I@<YVK
MP3%<IE "@@5VR!97NH5F!ZDX]()9\T6,1P0:S-VA7-=5'Q]=GO3X_CW_!KT,
M$"N2U[[W0@Q(>_+*>F P8C>"$/$ Q'91FY6*>=ZT8'M0E</4!/,X/[J%2'JP
M? <85+M A#YS9!=!\67>K:\%$1=#Z]Z?L4T>@! 3:OH3<([O7ZJB%.\NVE1(
M5%O%P&7[ST@-N#M7Z^T:$=2N%?S.Q5TF./)@O51%,X+W;$61.GB^*W77R.IV
M;1IIYUC\Q+, %_+)NK,!QU<[<E\.QG(,VJ(26DDS2=3-1%8GL\'W"XV__0RY
ML8K:E-7-5"3HM_%$%%Z/A?HK=DKEA;6@"],T=;(LTRE7#/!3,*,]8B#"O?ZS
M!;3E:RSNQ/ZX9B.;I%)XO5Y?&'<"?E>FH(O-MO>O\?6RLK2W5CN[YWJ %VVN
M7.O$J#[&L^XHO#SYRJV2VX:RQL*(X6DZW"(?Z<94;K/( Z=[4VU9)!L.@:98
MR&VEWWI,0+&'+#;M+LFVW&SNGW>[-UB?1T)L/??2)3"KOO3C\5(+AQY.+._:
M>;M!U9SKV&HJBT1M+:R46,276'2(H $6$[DS?$Z*P%-(M1!)^7T:"YBC9HT?
M)G.R\IL==<#"Q:]X\_3B!6/=N' =I_J="055Z0[/J3@QT!TF!J*5,V%;B:P*
M)-</EXG<" _GN.,D!C2T9L"568Q<V_:P*(1F&[<_GW!B1HZW?$D,R,YGQQ@V
M5GA^M9IF-@5A(QNSEUH"'09M3I\YCRV *1$CQ$ !LQDM@&:M8;B,+FJF[BZP
M]B'H+9+O8,-TP3(W;D%Z0(8HAU6O0' >MH [<5(^7,5OUG(IBH8O'9A+S,.7
MNQN[#=^ZF,9W3>U#MB3F(M0DO0Z1MG-7NF#94T/U?(S@(*A6*WHU5FI_\'>F
M5G1\?5:J<NOHL@!@Q.8\=+KSSM5 JXI;HE;YP1:C(@;N^L],.WU/TB9.W#B
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MT;M8L^YA$L[6R^=VVBTQ()[\!U!+ P04    " "Q@#-;8P7N1>H%  !^!@
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M[_F<YW,>= "5 J,@_T!_ $$0.*AM@#X#.U>GUZI5R.LR(/0!(!&!,W#$0C8
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M@PA@N,ZJS9M)[*Y]/]$/,-'!WP%02P,$%     @ L8 S6\%^MW*-!   ]A8
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MGG8\2,<5V]MN6]-+'V0X_!]02P,$%     @ L8 S6Y.)O)3G!   B"<  !4
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M ,=Q'1D295&^XF!TNTDC<H8HLZX9-&"=Q3H;W2JZZ8!!R,G&KA?!<CP0!J^
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M]*,A.$Y(KKM0RR4K@J5FM+0#<-8Y4A*K>D*MJT$H04FIU\=9+HG\A#RHTDX
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M1%2LH9&6/G;TM@/8T_E7)K5Z>)<M9[$J@=@,7&EF&/%2.F9T$ H:1-&>5)[
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MG,T'.M5NQ@RX^6X0O\PBDMJ6!MU*.IL*="9>AP5P VTI5=M0IAJ<#08[:6_
MBF?#*3J[7#LM5ADL-G,N[&PNT%E_32[ N]@M'R/:M'=I"CM;"G2]H"87OOM4
M^#A-0GJ%&7?)7AG$G:T!NHA@U1<^IFDGL#I99^9!EQ#,FD(E1^KP;RWD; C0
M!01'W7=JD6'('G.5IJPS"L-)89:$L^4W:_L47WQ=#1BO"%,=.2CD*F+NFR;
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M  X              ( !     &9O<FUD968Q-&$N:'1M4$L! A0#%     @
ML8 S6XW@;ZXS%0  $!8  !(              ( !Y94! &9O<FUD968Q-&%?
M,# Q+FIP9U!+ 0(4 Q0    ( +& ,UL8UJQXJ0L  $X,   2
M  "  4BK 0!F;W)M9&5F,31A7S P,BYJ<&=02P$"% ,4    " "Q@#-;3DU"
M#M3F   L"0$ $@              @ $AMP$ 9F]R;61E9C$T85\P,#0N:G!G
M4$L! A0#%     @ L8 S6U?J,+T5YP  *@H! !(              ( !)9X"
M &9O<FUD968Q-&%?,# U+FIP9U!+ 0(4 Q0    ( +& ,UMHG6D@;34  )XV
M   +              "  6J% P!L;V=O7S Q+FIP9U!+ 0(4 Q0    ( +&
M,UN:>T"P&Q   /@0   -              "  0"[ P!P<F]X>5\P,#$N:G!G
M4$L! A0#%     @ L8 S6\EW[8>V"P  I0P   T              ( !1LL#
M '!R;WAY7S P,BYJ<&=02P$"% ,4    " "Q@#-;UR3^6?D*  #J"P  #0
M            @ $GUP, <')O>'E?,# S+FIP9U!+ 0(4 Q0    ( +& ,UMC
M!>Y%Z@4  'X&   -              "  4OB P!P<F]X>5\P,#0N:G!G4$L!
M A0#%     @ L8 S6Z&^"T*G!   H04   T              ( !8.@# '!R
M;WAY7S P-2YJ<&=02P$"% ,4    " "Q@#-;P7ZW<HT$  #V%@  $0
M        @ $R[0, <V]N;2TR,#(T,3(S,2YX<V102P$"% ,4    " "Q@#-;
MDXF\E.<$  "()P  %0              @ 'N\0, <V]N;2TR,#(T,3(S,5]D
M968N>&UL4$L! A0#%     @ L8 S6RE(%D@1$@  0>P  !4
M ( !"/<# '-O;FTM,C R-#$R,S%?;&%B+GAM;%!+ 0(4 Q0    ( +& ,UOY
MK$K APT  #&Q   5              "  4P)! !S;VYM+3(P,C0Q,C,Q7W!R
;92YX;6Q02P4&      \ #P"D P  !A<$

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>formdef14a_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:SONM="http://sonimtech.com/20241231"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="sonm-20241231.xsd" xlink:type="simple"/>
    <context id="From2024-01-01to2024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">SONM:HaoPeterLiuMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001178697</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">SONM:FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="Ratio">
        <measure>pure</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2024-01-01to2024-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2024-01-01to2024-12-31" id="Fact000004">0001178697</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2024-01-01to2024-12-31" id="xdx2ixbrl0011">DEF 14A</dei:DocumentType>
    <dei:EntityRegistrantName contextRef="From2024-01-01to2024-12-31" id="Fact000012">Sonim Technologies, Inc.</dei:EntityRegistrantName>
    <ecd:PvpTableTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000014">&lt;table cellpadding="0" cellspacing="0" id="xdx_886_eecd--PvpTableTextBlock_z47h2QC5BAEg" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Fiscal
    Year&lt;sup&gt;(1)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48F_eecd--PeoTotalCompAmt_zPWYpX7BY1y4" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Summary
    Compensation Table Total for PEO&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_48D_eecd--PeoActuallyPaidCompAmt_z6QTbuWckXr9" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Compensation
    Actually Paid to PEO &lt;span&gt;&lt;sup id="xdx_F5E_zlxExA700jh9"&gt;(2)(3)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_489_eecd--NonPeoNeoAvgTotalCompAmt_zmX6tJNMchSa" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Average
    Summary Compensation Table Total for non-PEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_482_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zK8qojNlOHC5" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;Average
    Compensation Actually Paid to non-PEO NEOs&lt;span&gt;&lt;sup id="xdx_F5D_zcAGgP7m0JGh"&gt;(2)(3)&lt;/sup&gt;&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_488_eecd--TotalShareholderRtnAmt_pp2d_zFsTtwURtV06" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Value
    of Initial Fixed $100 Investment Based on Total Shareholder Return&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_483_eus-gaap--NetIncomeLoss_pn4n6_zujGOLenNDSb" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Net
    Income $(M)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20240101__20241231_z17raC7cefBg" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 40%; text-align: justify"&gt;2024 &lt;span id="xdx_F4F_zKye9O5bypN8" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;672,918&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(134,334&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;624,083&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;513,490&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;34.23&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 6%; text-align: right"&gt;(33.65&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_411_20230101__20231231_zgepqSx6J0dd" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;2023 &lt;span id="xdx_F48_z39ZYnRz6Yy9" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;677,266&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;2,136,138&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;626,135&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;688,442&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;79.72&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(0.09&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_419_20220101__20221231_z3t53rsJkoB6" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;2022 &lt;span id="xdx_F40_zr6nbVDxiDD5" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,986,962&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,975,045&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;420,553&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;409,019&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;46.08&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(14.09&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000015"
      unitRef="USD">672918</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000016"
      unitRef="USD">-134334</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000017"
      unitRef="USD">624083</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="0"
      id="Fact000018"
      unitRef="USD">513490</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-01to2024-12-31"
      decimals="2"
      id="Fact000019"
      unitRef="USD">34.23</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-01to2024-12-31"
      decimals="-4"
      id="Fact000020"
      unitRef="USD">-33650000</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000021"
      unitRef="USD">677266</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000022"
      unitRef="USD">2136138</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000023"
      unitRef="USD">626135</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000024"
      unitRef="USD">688442</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="2"
      id="Fact000025"
      unitRef="USD">79.72</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="-4"
      id="Fact000026"
      unitRef="USD">-90000.00</us-gaap:NetIncomeLoss>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000027"
      unitRef="USD">1986962</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000028"
      unitRef="USD">1975045</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000029"
      unitRef="USD">420553</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31"
      decimals="0"
      id="Fact000030"
      unitRef="USD">409019</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2022-01-012022-12-31"
      decimals="2"
      id="Fact000031"
      unitRef="USD">46.08</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2022-01-012022-12-31"
      decimals="-4"
      id="Fact000032"
      unitRef="USD">-14090000.00</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000037">&lt;p id="xdx_894_eecd--NamedExecutiveOfficersFnTextBlock_dU_zJDYIFlhrccc" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 48px; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(1)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    PEO in all reporting years is &lt;span id="xdx_904_eecd--PeoName_c20220101__20221231_zWQXT0fWJXb1"&gt;Hao (Peter) Liu&lt;/span&gt;&lt;/span&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;.
    The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles Becher. The non-PEO NEOs in the 2022 reporting
    year are Clay Crolius, Charles Becher and Robert Tirva.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="From2022-01-012022-12-31" id="Fact000038">Hao (Peter) Liu</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000040">&lt;p id="xdx_89F_eecd--AdjToPeoCompFnTextBlock_dU_zhtKAfqlD0A8" style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
  &lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 48px"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;(3)&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
  &lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;


&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49B_20220101__20221231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zRmyg8yiJwW1" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49F_20230101__20231231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zM8TeJ3zPbl8" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_499_20240101__20241231__ecd--IndividualAxis__custom--HaoPeterLiuMember_zeIEOg4C9Gbc" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;PEO: Liu, Hao (Peter)&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Prior Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_403_eecd--PeoTotalCompAmt_z8wTlCOLAoNl" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: justify"&gt;SCT Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$1,986,962&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$677,266&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$672,918&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_ziC9i9iwwajb" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal
    Year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(1,501,393&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zEx3ioprQtFl" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards
    Granted in Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;1,445,577&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zRGNaL9ew0Ih" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Prior Fiscal Years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(2,346&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;681,465&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(610,049&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zNrcz4FKd753" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;47,046&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zYpBRL2k8dIi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(801&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;777,407&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(197,203&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zziuWZWGhd5i" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock
    Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_407_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_z1r5DOJCEK6g" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Adjustment to Compensation Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_401_eecd--PeoActuallyPaidCompAmt_z6sgagb5w35" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Compensation Actually Paid&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;1,975,045&lt;/td&gt;&lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;2,136,138&lt;/td&gt;&lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;(134,334&lt;/td&gt;&lt;td style="font-weight: bold; text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000042"
      unitRef="USD">1986962</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000043"
      unitRef="USD">677266</ecd:PeoTotalCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000044"
      unitRef="USD">672918</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000046"
      unitRef="USD">-1501393</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000047"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000048"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000050"
      unitRef="USD">1445577</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000051"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000052"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000054"
      unitRef="USD">-2346</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000055"
      unitRef="USD">681465</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000056"
      unitRef="USD">-610049</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000058"
      unitRef="USD">47046</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000059"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000060"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000062"
      unitRef="USD">-801</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000063"
      unitRef="USD">777407</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000064"
      unitRef="USD">-197203</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000066"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000067"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000068"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000070"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000071"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000072"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2022-01-012022-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000074"
      unitRef="USD">1975045</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000075"
      unitRef="USD">2136138</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_HaoPeterLiuMember"
      decimals="0"
      id="Fact000076"
      unitRef="USD">-134334</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000078">&lt;p id="xdx_89A_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zLHcZwDFeuE3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
  &lt;tr style="display: none; vertical-align: bottom"&gt;
    &lt;td style="display: none; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_49D_20220101__20221231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zCOgDLtqyoti" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_491_20230101__20231231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zluQS9WxHLq2" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" id="xdx_498_20240101__20241231__ecd--IndividualAxis__ecd--NonPeoNeoMember_zmt9hzDfbUWi" style="display: none; text-align: right"&gt;&#160;&lt;/td&gt;&lt;td style="display: none"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="10" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;Non-PEO NEOs&lt;/td&gt;&lt;td style="padding-bottom: 1pt; font-weight: bold"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Prior Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2021&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Current Fiscal Year-End&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;12/31/2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="font-weight: bold"&gt;Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2022&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="text-align: right"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eecd--NonPeoNeoAvgTotalCompAmt_zwsyvuSEQ4W3" style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold"&gt;SCT Total&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$420,553&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$626,135&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: right"&gt;$624,083&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_402_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zFzemYrirRga" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 52%; text-align: justify"&gt;(Minus): Grant Date Fair Value of Option Awards and Stock Awards Granted in Fiscal
    Year&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(87,981&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(78,760&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;)&lt;/td&gt;&lt;td style="width: 2%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="width: 12%; text-align: right"&gt;(44,676&lt;/td&gt;&lt;td style="width: 1%; text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_406_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember_zwNHF0PogJC6" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Fair Value at Fiscal Year-End of Outstanding and Unvested Option Awards and Stock Awards
    Granted in Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;48,383&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;91,269&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;19,886&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40D_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember_zWh8lRkfNPV3" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Change in Fair Value of Outstanding and Unvested Option Awards and Stock Awards Granted
    in Prior Fiscal Years&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;37,406&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(35,262&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_404_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember_zO92Vm5FeK7j" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Fair Value at Vesting of Option Awards and Stock Awards Granted in Fiscal Year That Vested
    During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;38,115&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40F_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember_zD8Di9Vq7wCc" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: justify"&gt;Plus: Change in Fair Value as of Vesting Date of Option Awards and Stock Awards Granted in Prior
    Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(10,049&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;12,392&lt;/td&gt;&lt;td style="text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: justify"&gt;$&lt;/td&gt;&lt;td style="text-align: right"&gt;(50,540&lt;/td&gt;&lt;td style="text-align: justify"&gt;)&lt;/td&gt;&lt;/tr&gt;
  &lt;tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zxjsv5Jo25E3" style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;(Minus): Fair Value as of Prior Fiscal Year-End of Option Awards and Stock
    Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40B_eecd--AdjToCompAmt_hecd--AdjToCompAxis__custom--FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember_zjNkJj75UDyf" style="display: none; vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left; padding-bottom: 1pt"&gt;Adjustment to Compensation Amount&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&#160;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="border-bottom: Black 1pt solid; text-align: right"&gt;0&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr id="xdx_40C_eecd--NonPeoNeoAvgCompActuallyPaidAmt_zSQ8dUpTohCi" style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;Compensation Actually Paid&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;409,019&lt;/td&gt;&lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;688,442&lt;/td&gt;&lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: justify"&gt;$&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;513,490&lt;/td&gt;&lt;td style="font-weight: bold; text-align: justify"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000080"
      unitRef="USD">420553</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000081"
      unitRef="USD">626135</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000082"
      unitRef="USD">624083</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000084"
      unitRef="USD">-87981</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000085"
      unitRef="USD">-78760</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_GrantDateFairValueOfOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000086"
      unitRef="USD">-44676</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">48383</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000089"
      unitRef="USD">91269</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtFiscalYearEndOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInFiscalYearMember"
      decimals="0"
      id="Fact000090"
      unitRef="USD">19886</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">37406</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueOfOutstandingAndUnvestedOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">-35262</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">38115</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000097"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValueAtVestingOfOptionAwardsAndStockAwardsGrantedInFiscalYearThatVestedDuringFiscalYearMember"
      decimals="0"
      id="Fact000098"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">-10049</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000101"
      unitRef="USD">12392</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_ChangeInFairValueAsOfVestingDateOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsForWhichApplicableVestingConditionsWereSatisfiedDuringFiscalYearMember"
      decimals="0"
      id="Fact000102"
      unitRef="USD">-50540</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000104"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000105"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000106"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_custom_FairValuesOfPriorFiscalYearEndOfOptionAwardsAndStockAwardsGrantedInPriorFiscalYearsThatFailedToMeetApplicableVestingConditionsDuringFiscalYearMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2022-01-012022-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">409019</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">688442</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">513490</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000116">&lt;p id="xdx_892_eecd--CompActuallyPaidVsTotalShareholderRtnTextBlock_dU_zKBM8YzztKd4" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Relationship
between CAP and TSR&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#x2019;s cumulative indexed Total Shareholder
Return (&#x201c;TSR&#x201d;) (assuming an initial fixed investment of $100) for the fiscal years ended December 31, 2022, 2023 and 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdef14a_004.jpg" style="width: 28px; height: 30px"/&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="From2024-01-01to2024-12-31" id="Fact000118">&lt;p id="xdx_891_eecd--CompActuallyPaidVsNetIncomeTextBlock_dU_zrGuaEIDN0i" style="font: 10pt Times New Roman, Times, Serif; margin: 0; display: none; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;Relationship
between CAP and net income (loss)&lt;/i&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
graph below reflects the relationship between the PEO and Average Non-PEO NEO CAP and the Company&#x2019;s net income (loss) for the fiscal
years ended December 31, 2022, 2023 and 2024:&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;img alt="" src="formdef14a_005.jpg"/&gt;&lt;/span&gt;&lt;/p&gt;

</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000015"
          xlink:label="Fact000015"
          xlink:type="locator"/>
        <link:footnote id="Footnote000033" xlink:label="Footnote000033" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    PEO in all reporting years is Hao (Peter) Liu. The non-PEO NEOs in the 2024 and 2023 reporting years are Clay Crolius and Charles
    Becher. The non-PEO NEOs in the 2022 reporting year are Clay Crolius, Charles Becher and Robert Tirva.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000015"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000016"
          xlink:label="Fact000016"
          xlink:type="locator"/>
        <link:footnote id="Footnote000034" xlink:label="Footnote000034" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
    reflect Summary Compensation Table (&#x201c;SCT&#x201d;) Total Pay for our PEO and non-PEO NEOs for each corresponding year.</link:footnote>
        <link:footnote id="Footnote000035" xlink:label="Footnote000035" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
    Compensation Actually Paid to our PEO and non-PEO NEOs reflects the following adjustments required by applicable SEC rules from total
    compensation reported in the SCT:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000016"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000017"
          xlink:label="Fact000017"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000017"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000018"
          xlink:label="Fact000018"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000018"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000019"
          xlink:label="Fact000019"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000019"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000020"
          xlink:label="Fact000020"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000020"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000021"
          xlink:label="Fact000021"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000021"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000022"
          xlink:label="Fact000022"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000022"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000023"
          xlink:label="Fact000023"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000023"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000024"
          xlink:label="Fact000024"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000024"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000025"
          xlink:label="Fact000025"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000025"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000026"
          xlink:label="Fact000026"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000026"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000028"
          xlink:label="Fact000028"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000028"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000030"
          xlink:label="Fact000030"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000035"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000030"
          xlink:to="Footnote000034"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000032"
          xlink:label="Fact000032"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000032"
          xlink:to="Footnote000033"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
